1	Thrombosis	NNP	ORGANIZATION	Thrombosis	nn	2	SENT_1	[p1l8t136r293b179],
2	Research	NNP	ORGANIZATION	Research	_	0	SENT_1	[p1l318t136r537b179],
3	(	CD	NUMBER	(	num	4	SENT_1	[p1l565t137r718b190],
4	2007	CD	DATE	2007	dep	2	SENT_1	[p1l565t137r718b190],
5	)	NN	O	)	dep	2	SENT_1	[p1l565t137r718b190],
6	120	CD	NUMBER	120	num	5	SENT_1	[p1l747t137r855b189],
7	,	,	O	,	_	0	SENT_1	[p1l747t137r855b189],
8	893-899	CD	NUMBER	893-899	appos	5	SENT_1	[p1l883t137r1092b179],

1	REGULAR	JJ	O	regular	amod	2	SENT_2	[p1l14t824r358b888],
2	ARTICLE	NN	O	article	_	0	SENT_2	[p1l386t824r693b888],

1	Role	NN	O	role	_	0	SENT_3	[p1l17t995r294b1104],
2	of	IN	O	of	_	0	SENT_3	[p1l339t997r472b1104],
3	the	DT	O	the	det	5	SENT_3	[p1l508t995r723b1104],
4	T744C	NN	O	t744c	nn	5	SENT_3	[p1l765t998r1185b1104],
5	polymorphism	NN	O	polymorphism	prep_of	1	SENT_3	[p1l1233t995r2152b1132],

1	TH	NN	O	th	nn	2	SENT_4	[p1l894t1547r1149b1681],
2	RMBOSIS	NNS	O	rmbosis	_	0	SENT_4	[p1l1177t1547r2122b1681],

1	RESEARCH	NN	O	research	_	0	SENT_5	[p1l1052t1828r1974b1962],

1	i	FW	O	i	dep	115	SENT_6	[p1l432t2260r451b2334],
2	ntl.elsevierhealth.com	FW	O	ntl.elsevierhealth.com	dep	115	SENT_6	[p1l463t2257r1487b2334],
3	/	:	O	/	dep	115	SENT_6	[p1l1501t2260r1537b2334],
4	journalsl	NN	O	journalsl	dep	115	SENT_6	[p1l1546t2257r1956b2354],
5	thre	CD	NUMBER	thre	dep	115	SENT_6	[p1l1969t2257r2153b2334],
6	of	IN	O	of	dep	115	SENT_6	[p1l7t2589r245b2781],
7	the	DT	O	the	dep	115	SENT_6	[p1l308t2586r693b2781],
8	P2Y12	NN	O	p2y12	dep	115	SENT_6	[p1l785t2591r1511b2779],
9	gene	NN	O	gene	dep	115	SENT_6	[p1l1592t2634r2150b2832],
10	on	IN	O	on	dep	115	SENT_6	[p1l99t2870r187b2915],
11	platelet	NN	O	platelet	dep	115	SENT_6	[p1l223t2852r517b2931],
12	response	NN	O	response	dep	115	SENT_6	[p1l553t2870r889b2931],
13	to	TO	O	to	dep	115	SENT_6	[p1l921t2858r997b2915],
14	a	DT	O	a	dep	115	SENT_6	[p1l1029t2870r1069b2915],
15	600-mg	JJ	O	600-mg	dep	115	SENT_6	[p1l1104t2853r1385b2931],
16	loading	NN	O	loading	dep	115	SENT_6	[p1l1421t2852r1690b2931],
17	dose	NN	O	dose	dep	115	SENT_6	[p1l1722t2852r1893b2915],
18	of	IN	O	of	dep	115	SENT_6	[p1l1926t2853r2003b2915],
19	clopidogrel	NN	O	clopidogrel	dep	115	SENT_6	[p1l99t2950r522b3030],
20	in	IN	O	in	dep	115	SENT_6	[p1l554t2952r620b3013],
21	597	CD	NUMBER	597	dep	115	SENT_6	[p1l659t2952r796b3014],
22	patients	NNS	O	patient	dep	115	SENT_6	[p1l830t2952r1136b3030],
23	with	IN	O	with	dep	115	SENT_6	[p1l1166t2950r1332b3014],
24	non-ST-segment	JJ	O	non-st-segment	dep	115	SENT_6	[p1l1369t2952r1976b3030],
25	elevation	NN	O	elevation	dep	115	SENT_6	[p1l99t3050r450b3113],
26	acute	JJ	O	acute	dep	115	SENT_6	[p1l485t3056r695b3113],
27	coronary	JJ	O	coronary	dep	115	SENT_6	[p1l728t3068r1068b3129],
28	syndrome	NN	O	syndrome	dep	115	SENT_6	[p1l1099t3050r1470b3129],
29	Thomas	NNP	PERSON	Thomas	dep	115	SENT_6	[p1l96t3215r302b3259],
30	Cuisseta	NNP	PERSON	Cuisseta	dep	115	SENT_6	[p1l325t3212r566b3269],
31	,	,	O	,	_	0	SENT_6	[p1l325t3212r566b3269],
32	Corinne	NNP	PERSON	Corinne	dep	115	SENT_6	[p1l593t3216r800b3260],
33	Frereb	NNP	PERSON	Frereb	dep	115	SENT_6	[p1l825t3204r1025b3269],
34	,	,	O	,	_	0	SENT_6	[p1l825t3204r1025b3269],
35	Jacques	NNP	PERSON	Jacques	dep	115	SENT_6	[p1l1050t3217r1265b3271],
36	Quilicia	NNP	PERSON	Quilicia	dep	115	SENT_6	[p1l1288t3212r1510b3269],
37	,	,	O	,	_	0	SENT_6	[p1l1288t3212r1510b3269],
38	Pierre-Emmanuel	NNP	PERSON	Pierre-Emmanuel	dep	115	SENT_6	[p1l100t3282r563b3326],
39	Morangeb	NNP	PERSON	Morangeb	dep	115	SENT_6	[p1l585t3270r864b3337],
40	,	,	O	,	_	0	SENT_6	[p1l585t3270r864b3337],
41	Noémie	NNP	PERSON	Noémie	dep	115	SENT_6	[p1l893t3282r1092b3326],
42	Sautb	NNP	PERSON	Sautb	dep	115	SENT_6	[p1l1115t3270r1284b3336],
43	,	,	O	,	_	0	SENT_6	[p1l1115t3270r1284b3336],
44	Marc	NNP	PERSON	Marc	dep	115	SENT_6	[p1l1309t3283r1435b3326],
45	Lambert	NNP	PERSON	Lambert	dep	115	SENT_6	[p1l1460t3279r1735b3336],
46	“	NNP	O	“	dep	115	SENT_6	[p1l1460t3279r1735b3336],
47	,	,	O	,	_	0	SENT_6	[p1l1460t3279r1735b3336],
48	Laurence	NNP	PERSON	Laurence	dep	115	SENT_6	[p1l100t3350r346b3392],
49	Camoinc	NNP	PERSON	Camoinc	dep	115	SENT_6	[p1l369t3345r617b3402],
50	,	,	O	,	_	0	SENT_6	[p1l369t3345r617b3402],
51	Irene	NNP	PERSON	Irene	dep	115	SENT_6	[p1l646t3349r781b3392],
52	Juhan	NNP	PERSON	Juhan	dep	115	SENT_6	[p1l803t3348r963b3392],
53	Vague	NNP	O	Vague	dep	115	SENT_6	[p1l985t3337r1197b3404],
54	”	NN	O	”	dep	115	SENT_6	[p1l985t3337r1197b3404],
55	,	,	O	,	_	0	SENT_6	[p1l985t3337r1197b3404],
56	Jean-Louis	NNP	PERSON	Jean-Louis	dep	115	SENT_6	[p1l1222t3349r1511b3392],
57	Bonnet	NNP	PERSON	Bonnet	dep	115	SENT_6	[p1l1536t3345r1775b3402],
58	“	NNP	O	“	dep	115	SENT_6	[p1l1536t3345r1775b3402],
59	,	,	O	,	_	0	SENT_6	[p1l1536t3345r1775b3402],
60	Marie-Christine	NNP	PERSON	Marie-Christine	dep	115	SENT_6	[p1l97t3415r507b3459],
61	Alessi	NNP	PERSON	Alessi	dep	115	SENT_6	[p1l529t3415r678b3459],
62	"	``	O	"	dep	115	SENT_6	[p1l693t3403r757b3439],
63	’	CD	NUMBER	’	dep	115	SENT_6	[p1l693t3403r757b3439],
64	*	CD	NUMBER	*	dep	115	SENT_6	[p1l693t3403r757b3439],
65	a	DT	O	a	dep	115	SENT_6	[p1l97t3534r110b3548],
66	Department	NNP	ORGANIZATION	Department	dep	115	SENT_6	[p1l124t3537r323b3572],
67	of	IN	ORGANIZATION	of	dep	115	SENT_6	[p1l336t3536r372b3571],
68	Cardiology	NNP	ORGANIZATION	Cardiology	dep	115	SENT_6	[p1l385t3536r565b3572],
69	,	,	O	,	_	0	SENT_6	[p1l385t3536r565b3572],
70	CHU	NNP	PERSON	CHU	dep	115	SENT_6	[p1l584t3537r652b3565],
71	Timone	NNP	PERSON	Timone	dep	115	SENT_6	[p1l667t3537r796b3570],
72	,	,	O	,	_	0	SENT_6	[p1l667t3537r796b3570],
73	Marseille	NNP	LOCATION	Marseille	dep	115	SENT_6	[p1l813t3536r974b3570],
74	,	,	O	,	_	0	SENT_6	[p1l813t3536r974b3570],
75	France	NNP	LOCATION	France	dep	115	SENT_6	[p1l992t3537r1102b3564],
76	b	NN	O	b	dep	115	SENT_6	[p1l98t3574r111b3593],
77	Inserm	NNP	ORGANIZATION	Inserm	dep	115	SENT_6	[p1l125t3582r244b3615],
78	,	,	O	,	_	0	SENT_6	[p1l125t3582r244b3615],
79	U626	NN	O	u626	dep	115	SENT_6	[p1l259t3582r348b3615],
80	,	,	O	,	_	0	SENT_6	[p1l259t3582r348b3615],
81	Marseille	NNP	LOCATION	Marseille	dep	115	SENT_6	[p1l361t3581r522b3615],
82	,	,	O	,	_	0	SENT_6	[p1l361t3581r522b3615],
83	F-13385	NNP	O	F-13385	dep	115	SENT_6	[p1l535t3582r665b3610],
84	France	NNP	LOCATION	France	dep	115	SENT_6	[p1l674t3582r795b3615],
85	;	:	O	;	_	0	SENT_6	[p1l674t3582r795b3615],
86	Faculté	NNP	PERSON	Faculté	dep	115	SENT_6	[p1l807t3581r929b3610],
87	de	NNP	PERSON	de	dep	115	SENT_6	[p1l939t3581r978b3610],
88	Médecine	NNP	PERSON	Médecine	dep	115	SENT_6	[p1l986t3581r1153b3615],
89	,	,	O	,	_	0	SENT_6	[p1l986t3581r1153b3615],
90	Marseille	NNP	LOCATION	Marseille	dep	115	SENT_6	[p1l1165t3581r1326b3615],
91	,	,	O	,	_	0	SENT_6	[p1l1165t3581r1326b3615],
92	F-13385	NNP	O	F-13385	dep	115	SENT_6	[p1l1339t3582r1469b3610],
93	France	NNP	LOCATION	France	dep	115	SENT_6	[p1l1478t3582r1599b3615],
94	;	:	O	;	_	0	SENT_6	[p1l1478t3582r1599b3615],
95	Laboratoire	NNP	ORGANIZATION	Laboratoire	dep	115	SENT_6	[p1l1611t3581r1804b3610],
96	d'Hématologie	NNP	ORGANIZATION	d'Hématologie	dep	115	SENT_6	[p1l1814t3581r2059b3617],
97	,	,	O	,	_	0	SENT_6	[p1l1814t3581r2059b3617],
98	CHU	NNP	ORGANIZATION	CHU	dep	115	SENT_6	[p1l99t3626r167b3654],
99	Timone	NNP	ORGANIZATION	Timone	dep	115	SENT_6	[p1l179t3626r309b3660],
100	,	,	O	,	_	0	SENT_6	[p1l179t3626r309b3660],
101	Marseille	NNP	LOCATION	Marseille	dep	115	SENT_6	[p1l323t3626r485b3660],
102	,	,	O	,	_	0	SENT_6	[p1l323t3626r485b3660],
103	F-13385	NNP	O	F-13385	dep	115	SENT_6	[p1l500t3626r629b3654],
104	France	NNP	LOCATION	France	dep	115	SENT_6	[p1l640t3627r750b3654],
105	C	NNP	O	C	dep	115	SENT_6	[p1l97t3669r109b3683],
106	Laboratory	NNP	O	Laboratory	dep	115	SENT_6	[p1l124t3671r306b3707],
107	of	IN	O	of	dep	115	SENT_6	[p1l318t3671r354b3706],
108	Haematology	NNP	O	Haematology	dep	115	SENT_6	[p1l365t3671r587b3707],
109	,	,	O	,	_	0	SENT_6	[p1l365t3671r587b3707],
110	CHU	NNP	ORGANIZATION	CHU	dep	115	SENT_6	[p1l606t3672r674b3700],
111	Conception	NN	ORGANIZATION	conception	dep	115	SENT_6	[p1l689t3672r882b3707],
112	,	,	O	,	_	0	SENT_6	[p1l689t3672r882b3707],
113	Marseille	NNP	LOCATION	Marseille	dep	115	SENT_6	[p1l899t3671r1061b3705],
114	,	,	O	,	_	0	SENT_6	[p1l899t3671r1061b3705],
115	France	NNP	LOCATION	France	_	0	SENT_6	[p1l1078t3672r1188b3699],

1	Received	VBN	O	receive	_	0	SENT_7	[p2l99t43r243b72],
2	27	CD	DATE	27	dobj	1	SENT_7	[p2l258t44r296b72],
3	November	NNP	DATE	November	tmod	1	SENT_7	[p2l311t43r477b72],
4	2006	CD	DATE	2006	num	3	SENT_7	[p2l490t44r576b78],
5	;	:	O	;	_	0	SENT_7	[p2l490t44r576b78],
6	received	VBN	O	receive	parataxis	1	SENT_7	[p2l596t43r734b72],
7	in	IN	O	in	_	0	SENT_7	[p2l750t44r777b72],
8	revised	JJ	O	revised	amod	9	SENT_7	[p2l794t43r908b72],
9	form	NN	O	form	prep_in	6	SENT_7	[p2l924t43r1000b72],
10	9	CD	DATE	9	num	9	SENT_7	[p2l1015t44r1032b72],
11	January	NNP	DATE	January	tmod	9	SENT_7	[p2l1047t44r1175b79],
12	2007	CD	DATE	2007	num	11	SENT_7	[p2l1189t44r1275b78],
13	;	:	O	;	_	0	SENT_7	[p2l1189t44r1275b78],
14	accepted	VBN	O	accept	parataxis	1	SENT_7	[p2l1293t43r1442b79],
15	22	CD	DATE	22	dobj	14	SENT_7	[p2l1458t44r1494b72],
16	January	NNP	DATE	January	tmod	18	SENT_7	[p2l1509t44r1638b79],
17	2007	CD	DATE	2007	num	16	SENT_7	[p2l1651t44r1728b72],
18	Available	JJ	O	available	amod	15	SENT_7	[p2l96t89r245b118],
19	online	NN	O	online	prep	14	SENT_7	[p2l260t89r360b118],
20	6	CD	DATE	6	dep	19	SENT_7	[p2l375t90r391b118],
21	March	NNP	DATE	March	tmod	14	SENT_7	[p2l405t89r502b118],
22	2007	CD	DATE	2007	num	21	SENT_7	[p2l517t90r594b118],

1	Abstract	JJ	O	abstract	_	0	SENT_8	[p2l669t237r812b266],

1	Background	NN	O	background	_	0	SENT_9	[p2l670t329r871b365],
2	:	:	O	:	_	0	SENT_9	[p2l670t329r871b365],
3	Variability	NN	O	variability	nsubjpass	16	SENT_9	[p2l887t329r1055b365],
4	in	IN	O	in	_	0	SENT_9	[p2l1067t330r1095b357],
5	platelet	NN	O	platelet	nn	6	SENT_9	[p2l1110t329r1239b365],
6	response	NN	O	response	prep_in	3	SENT_9	[p2l1253t337r1395b365],
7	to	TO	O	to	_	0	SENT_9	[p2l1408t332r1441b358],
8	clopidogrel	NN	O	clopidogrel	prep_to	6	SENT_9	[p2l1454t329r1636b365],
9	and	CC	O	and	_	0	SENT_9	[p2l1650t329r1707b358],
10	its	PRP$	O	its	poss	12	SENT_9	[p2l1721t330r1760b358],
11	clinical	JJ	O	clinical	amod	12	SENT_9	[p2l1772t329r1889b358],
12	relevance	NN	O	relevance	prep_to	6	SENT_9	[p2l1904t329r2063b358],
13	have	VBP	O	have	aux	16	SENT_9	[p2l671t374r746b403],
14	been	VBN	O	be	auxpass	16	SENT_9	[p2l767t374r844b403],
15	well	RB	O	well	advmod	16	SENT_9	[p2l864t374r932b403],
16	described	VBN	O	describe	dep	1	SENT_9	[p2l953t374r1121b403],
17	.	.	O	.	_	0	SENT_9	[p2l953t374r1121b403],

1	However	RB	O	however	advmod	7	SENT_10	[p2l1146t375r1293b409],
2	,	,	O	,	_	0	SENT_10	[p2l1146t375r1293b409],
3	the	DT	O	the	det	5	SENT_10	[p2l1316t374r1369b403],
4	underlying	JJ	O	underlying	amod	5	SENT_10	[p2l1390t374r1561b410],
5	mechanisms	NNS	O	mechanism	nsubj	7	SENT_10	[p2l1582t374r1779b403],
6	remain	VBP	O	remain	cop	7	SENT_10	[p2l1800t375r1911b403],
7	unclear	JJ	O	unclear	_	0	SENT_10	[p2l1933t374r2059b403],
8	.	.	O	.	_	0	SENT_10	[p2l1933t374r2059b403],

1	Recently	RB	DATE	recently	advmod	13	SENT_11	[p2l672t419r817b455],
2	,	,	O	,	_	0	SENT_11	[p2l672t419r817b455],
3	the	DT	O	the	det	5	SENT_11	[p2l835t419r888b447],
4	T744C	NN	O	t744c	nn	5	SENT_11	[p2l901t419r1002b448],
5	polymorphism	NN	O	polymorphism	nsubjpass	13	SENT_11	[p2l1017t419r1245b455],
6	of	IN	O	of	_	0	SENT_11	[p2l1260t419r1293b447],
7	the	DT	O	the	det	10	SENT_11	[p2l1306t419r1359b447],
8	P2Y12	NN	O	p2y12	nn	10	SENT_11	[p2l1374t419r1470b447],
9	receptor	NN	O	receptor	nn	10	SENT_11	[p2l1487t422r1627b455],
10	gene	NN	O	gene	prep_of	5	SENT_11	[p2l1640t426r1718b455],
11	has	VBZ	O	have	aux	13	SENT_11	[p2l1733t419r1785b447],
12	been	VBN	O	be	auxpass	13	SENT_11	[p2l1800t419r1877b448],
13	associated	VBN	O	associate	_	0	SENT_11	[p2l1892t419r2061b448],
14	with	IN	O	with	_	0	SENT_11	[p2l669t464r740b493],
15	enhanced	VBN	O	enhance	amod	17	SENT_11	[p2l762t464r918b493],
16	platelet	NN	O	platelet	nn	17	SENT_11	[p2l942t464r1071b500],
17	aggregation	NN	O	aggregation	prep_with	13	SENT_11	[p2l1091t465r1283b500],
18	in	IN	O	in	_	0	SENT_11	[p2l1305t465r1333b492],
19	healthy	JJ	O	healthy	amod	20	SENT_11	[p2l1355t464r1477b500],
20	volunteers	NNS	O	volunteer	prep_in	17	SENT_11	[p2l1497t464r1680b499],
21	,	,	O	,	_	0	SENT_11	[p2l1497t464r1680b499],
22	suggesting	VBG	O	suggest	xcomp	13	SENT_11	[p2l1704t465r1873b500],
23	a	DT	O	a	det	25	SENT_11	[p2l1894t472r1911b493],
24	possible	JJ	O	possible	amod	25	SENT_11	[p2l1933t464r2063b500],
25	mechanism	NN	O	mechanism	dobj	22	SENT_11	[p2l671t509r852b538],
26	for	IN	O	for	_	0	SENT_11	[p2l866t509r914b538],
27	modulation	NN	O	modulation	prep_for	22	SENT_11	[p2l927t509r1110b538],
28	of	IN	O	of	_	0	SENT_11	[p2l1124t509r1157b538],
29	clopidogrel	NN	O	clopidogrel	nn	30	SENT_11	[p2l1169t509r1351b545],
30	response	NN	O	response	prep_of	27	SENT_11	[p2l1366t517r1518b545],
31	.	.	O	.	_	0	SENT_11	[p2l1366t517r1518b545],

1	Aim	NNP	O	Aim	_	0	SENT_12	[p2l668t554r733b582],
2	of	IN	O	of	_	0	SENT_12	[p2l746t554r782b590],
3	this	DT	O	this	det	4	SENT_12	[p2l794t554r853b582],
4	study	NN	O	study	prep_of	1	SENT_12	[p2l865t554r965b590],
5	:	:	O	:	_	0	SENT_12	[p2l865t554r965b590],
6	To	TO	O	to	aux	7	SENT_12	[p2l980t555r1016b582],
7	assess	VB	O	assess	infmod	4	SENT_12	[p2l1030t561r1127b582],
8	whether	IN	O	whether	complm	14	SENT_12	[p2l1139t554r1276b583],
9	the	DT	O	the	det	11	SENT_12	[p2l1289t554r1342b582],
10	clopidogrel	NN	O	clopidogrel	nn	11	SENT_12	[p2l1355t554r1538b590],
11	response	NN	O	response	nsubjpass	14	SENT_12	[p2l1553t561r1694b590],
12	may	MD	O	may	aux	14	SENT_12	[p2l1709t562r1775b590],
13	be	VB	O	be	auxpass	14	SENT_12	[p2l1788t554r1826b583],
14	influenced	VBN	O	influence	ccomp	7	SENT_12	[p2l1840t554r2011b582],
15	by	IN	O	by	_	0	SENT_12	[p2l2027t554r2064b590],
16	the	DT	O	the	det	20	SENT_12	[p2l670t599r723b628],
17	T744C	NN	O	t744c	nn	20	SENT_12	[p2l733t599r833b628],
18	P2Y12	NN	O	p2y12	nn	20	SENT_12	[p2l845t599r941b627],
19	gene	NN	O	gene	nn	20	SENT_12	[p2l952t606r1030b635],
20	polymorphism	NN	O	polymorphism	agent	14	SENT_12	[p2l1041t599r1268b635],
21	in	IN	O	in	_	0	SENT_12	[p2l1280t600r1307b627],
22	patients	NNS	O	patient	prep_in	20	SENT_12	[p2l1320t600r1452b635],
23	with	IN	O	with	_	0	SENT_12	[p2l1462t599r1533b628],
24	non	JJ	O	non	amod	25	SENT_12	[p2l1545t607r1601b628],
25	STelevation	NN	O	stelevation	prep_with	22	SENT_12	[p2l1613t599r1807b628],
26	acute	JJ	O	acute	amod	28	SENT_12	[p2l1819t602r1910b628],
27	coronary	JJ	O	coronary	amod	28	SENT_12	[p2l1920t607r2064b635],
28	syndrome	NN	O	syndrome	tmod	14	SENT_12	[p2l670t644r827b680],
29	(	CD	NUMBER	(	num	32	SENT_12	[p2l843t644r935b680],
30	NSTE	NNP	O	NSTE	nn	32	SENT_12	[p2l843t644r935b680],
31	ACS	NN	O	ac	nn	32	SENT_12	[p2l947t644r1032b680],
32	)	NN	O	)	dep	28	SENT_12	[p2l947t644r1032b680],
33	.	.	O	.	_	0	SENT_12	[p2l947t644r1032b680],

1	Methods	NNS	O	method	_	0	SENT_13	[p2l669t690r820b718],
2	:	:	O	:	_	0	SENT_13	[p2l669t690r820b718],
3	597	CD	NUMBER	597	num	6	SENT_13	[p2l837t690r894b718],
4	NSTE	NNP	O	NSTE	nn	6	SENT_13	[p2l915t690r997b719],
5	ACS	NN	O	ac	nn	6	SENT_13	[p2l1016t690r1078b719],
6	patients	NNS	O	patient	dep	1	SENT_13	[p2l1099t690r1237b726],
7	were	VBD	O	be	auxpass	8	SENT_13	[p2l1256t698r1339b719],
8	included	VBN	O	include	rcmod	6	SENT_13	[p2l1359t690r1503b718],
9	in	IN	O	in	_	0	SENT_13	[p2l1524t690r1552b718],
10	our	PRP$	O	we	poss	11	SENT_13	[p2l1573t698r1628b718],
11	study	NN	O	study	prep_in	8	SENT_13	[p2l1647t690r1738b726],
12	and	CC	O	and	_	0	SENT_13	[p2l1756t690r1815b718],
13	were	VBD	O	be	auxpass	14	SENT_13	[p2l1835t698r1919b719],
14	divided	VBN	O	divide	rcmod	6	SENT_13	[p2l1939t690r2062b718],
15	into	IN	O	into	_	0	SENT_13	[p2l670t736r736b764],
16	3	CD	NUMBER	3	num	17	SENT_13	[p2l763t735r778b764],
17	groups	NNS	O	group	prep_into	14	SENT_13	[p2l806t742r928b771],
18	:	:	O	:	_	0	SENT_13	[p2l806t742r928b771],
19	CC	NN	O	cc	nn	20	SENT_13	[p2l957t735r1000b764],
20	homozygotes	NNS	O	homozygote	dep	1	SENT_13	[p2l1028t735r1259b771],
21	,	,	O	,	_	0	SENT_13	[p2l1028t735r1259b771],
22	CT	NN	O	ct	nn	23	SENT_13	[p2l1289t735r1332b764],
23	heterozygotes	NNS	O	heterozygote	appos	20	SENT_13	[p2l1358t735r1599b771],
24	ad	NN	O	ad	nn	26	SENT_13	[p2l1625t735r1663b764],
25	TT	NN	O	tt	nn	26	SENT_13	[p2l1689t736r1733b763],
26	homozygotes	NNS	O	homozygote	dep	23	SENT_13	[p2l1759t735r1990b771],
27	.	.	O	.	_	0	SENT_13	[p2l1759t735r1990b771],

1	All	DT	O	all	det	2	SENT_14	[p2l2019t735r2063b764],
2	patients	NNS	O	patient	nsubj	3	SENT_14	[p2l671t781r809b816],
3	received	VBD	O	receive	_	0	SENT_14	[p2l824t780r967b809],
4	loading	VBG	O	load	xcomp	3	SENT_14	[p2l983t780r1105b816],
5	doses	NNS	O	dose	dobj	4	SENT_14	[p2l1118t780r1210b809],
6	of	IN	O	of	_	0	SENT_14	[p2l1222t780r1256b809],
7	600	CD	NUMBER	600	num	9	SENT_14	[p2l1268t780r1326b809],
8	mg	NN	O	mg	nn	9	SENT_14	[p2l1340t787r1387b816],
9	clopidogrel	NN	O	clopidogrel	prep_of	5	SENT_14	[p2l1400t780r1591b816],
10	and	CC	O	and	_	0	SENT_14	[p2l1604t780r1663b809],
11	250	CD	NUMBER	250	num	13	SENT_14	[p2l1677t780r1735b809],
12	mg	NN	O	mg	nn	13	SENT_14	[p2l1749t787r1796b816],
13	aspirin	NN	O	aspirin	conj_and	5	SENT_14	[p2l1809t781r1921b816],
14	at	IN	DURATION	at	quantmod	16	SENT_14	[p2l1936t783r1969b809],
15	least	JJS	DURATION	least	mwe	14	SENT_14	[p2l1983t780r2063b809],
16	12	CD	DURATION	12	num	17	SENT_14	[p2l672t825r707b853],
17	hours	NNS	NUMBER	hour	tmod	13	SENT_14	[p2l733t825r823b854],
18	before	IN	O	before	_	0	SENT_14	[p2l848t825r958b854],
19	blood	NN	O	blood	nn	20	SENT_14	[p2l983t825r1074b854],
20	samples	NNS	O	sample	prep_before	4	SENT_14	[p2l1099t825r1244b861],
21	.	.	O	.	_	0	SENT_14	[p2l1099t825r1244b861],

1	Clopidogrel	NNP	O	Clopidogrel	nn	2	SENT_15	[p2l1272t825r1466b861],
2	response	NN	O	response	nsubjpass	4	SENT_15	[p2l1492t833r1639b861],
3	was	VBD	O	be	auxpass	4	SENT_15	[p2l1662t833r1725b854],
4	assessed	VBN	O	assess	_	0	SENT_15	[p2l1749t825r1891b854],
5	by	IN	O	by	_	0	SENT_15	[p2l1917t825r1955b861],
6	posttreatment	NN	O	posttreatment	nn	7	SENT_15	[p2l1979t828r2061b861, p2l670t874r844b900],
7	ADP	NN	O	adp	agent	4	SENT_15	[p2l865t871r930b899],
8	10	CD	NUMBER	10	num	11	SENT_15	[p2l954t871r990b900],
9	umol/L-induced	JJ	O	umol/l-induced	amod	11	SENT_15	[p2l1012t871r1283b907],
10	platelet	NN	O	platelet	nn	11	SENT_15	[p2l1307t871r1442b907],
11	aggregation	NN	O	aggregation	dep	7	SENT_15	[p2l1463t872r1663b907],
12	(	CD	NUMBER	(	num	14	SENT_15	[p2l1688t871r1847b907],
13	ADP-Ag	NN	O	adp-ag	nn	14	SENT_15	[p2l1688t871r1847b907],
14	)	NN	O	)	dep	7	SENT_15	[p2l1688t871r1847b907],
15	,	,	O	,	_	0	SENT_15	[p2l1688t871r1847b907],
16	VASP	NN	ORGANIZATION	vasp	nn	17	SENT_15	[p2l1871t871r1951b900],
17	phosphorylation	NN	O	phosphorylation	conj_and	7	SENT_15	[p2l1974t871r2061b907, p2l671t916r864b952],
18	(	CD	NUMBER	(	num	21	SENT_15	[p2l881t917r943b952],
19	PRI	NNP	ORGANIZATION	PRI	nn	21	SENT_15	[p2l881t917r943b952],
20	VASP	NN	ORGANIZATION	vasp	nn	21	SENT_15	[p2l957t916r1050b952],
21	)	NN	O	)	dep	17	SENT_15	[p2l957t916r1050b952],
22	and	CC	O	and	_	0	SENT_15	[p2l1065t916r1123b945],
23	P-selectin	NN	O	p-selectin	nn	24	SENT_15	[p2l1139t916r1306b945],
24	expression	NN	O	expression	conj_and	7	SENT_15	[p2l1320t917r1499b952],
25	(	CD	NUMBER	(	num	26	SENT_15	[p2l1516t916r1591b952],
26	PS	NNP	O	PS	dep	24	SENT_15	[p2l1516t916r1591b952],
27	)	CD	NUMBER	)	num	26	SENT_15	[p2l1516t916r1591b952],
28	.	.	O	.	_	0	SENT_15	[p2l1516t916r1591b952],

1	Clopidogrel	NNP	O	Clopidogrel	nn	2	SENT_16	[p2l1607t916r1802b952],
2	resistance	NN	O	resistance	nsubj	3	SENT_16	[p2l1817t917r1988b945],
3	was	VBD	O	be	_	0	SENT_16	[p2l2001t924r2063b945],

1	*	NN	O	*	_	0	SENT_17	[p2l118t1049r129b1060],
2	Corresponding	VBG	O	correspond	partmod	1	SENT_17	[p2l146t1049r354b1081],
3	author	NN	O	author	dobj	2	SENT_17	[p2l366t1049r466b1075],
4	.	.	O	.	_	0	SENT_17	[p2l366t1049r466b1075],

1	Tel.	NNP	O	Tel.	_	0	SENT_18	[p2l480t1049r543b1075],
2	:	:	O	:	_	0	SENT_18	[p2l480t1049r543b1075],
3	+33 491324504	CD	NUMBER	+33 491324504	dep	1	SENT_18	[p2l619t1049r783b1080],[p2l559t1049r607b1075],
4	;	:	O	;	_	0	SENT_18	[p2l619t1049r783b1080],
5	fax	NN	O	fax	dep	1	SENT_18	[p2l797t1049r851b1075],
6	:	:	O	:	_	0	SENT_18	[p2l797t1049r851b1075],
7	+33 491254336	CD	NUMBER	+33 491254336	dep	5	SENT_18	[p2l927t1049r1090b1075],[p2l866t1049r915b1075],
8	.	.	O	.	_	0	SENT_18	[p2l927t1049r1090b1075],

1	E-mail	NN	O	e-mail	nn	2	SENT_19	[p2l147t1096r240b1122],
2	address	NN	O	address	_	0	SENT_19	[p2l251t1096r372b1122],
3	:	:	O	:	_	0	SENT_19	[p2l251t1096r372b1122],
4	Marie-Christine.Alessi@medecine.univ-mrs.fr	NN	O	marie-christine.alessi@medecine.univ-mrs.fr	nn	6	SENT_19	[p2l384t1096r1047b1124],
5	(	CD	NUMBER	(	num	6	SENT_19	[p2l1061t1096r1146b1128],
6	M.-C	NN	O	m.-c	dep	2	SENT_19	[p2l1061t1096r1146b1128],
7	.	.	O	.	_	0	SENT_19	[p2l1061t1096r1146b1128],

1	Alessi	NNP	PERSON	Alessi	nn	2	SENT_20	[p2l1160t1096r1263b1128],
2	)	NNP	O	)	_	0	SENT_20	[p2l1160t1096r1263b1128],
3	.	.	O	.	_	0	SENT_20	[p2l1160t1096r1263b1128],

1	0049-3848	CD	DURATION	0049-3848	nsubj	5	SENT_21	[p2l97t1171r261b1197],
2	/	:	O	/	punct	3	SENT_21	[p2l97t1171r261b1197],
3	S	NN	O	s	dep	1	SENT_21	[p2l266t1169r279b1200],
4	-	:	O	-	_	0	SENT_21	[p2l295t1185r302b1188],
5	see	VB	O	see	_	0	SENT_21	[p2l316t1178r364b1197],
6	front	JJ	O	front	amod	7	SENT_21	[p2l376t1171r449b1197],
7	matter	NN	O	matter	dobj	5	SENT_21	[p2l462t1174r562b1197],
8	©	CD	NUMBER	©	num	11	SENT_21	[p2l575t1174r597b1197],
9	2007	CD	DATE	2007	num	11	SENT_21	[p2l609t1171r677b1197],
10	Elsevier	NNP	ORGANIZATION	Elsevier	nn	11	SENT_21	[p2l690t1171r803b1197],
11	Ltd.	NNP	ORGANIZATION	Ltd.	dep	7	SENT_21	[p2l816t1171r870b1197],
12	.	.	O	.	_	0	SENT_21	[p2l816t1171r870b1197],

1	All	DT	O	all	det	2	SENT_22	[p2l885t1171r923b1197],
2	rights	NNS	O	rights	nsubj	3	SENT_22	[p2l937t1171r1017b1203],
3	reserved	VBN	O	reserve	_	0	SENT_22	[p2l1031t1171r1165b1197],
4	.	.	O	.	_	0	SENT_22	[p2l1031t1171r1165b1197],

1	doi	FW	O	doi	nsubj	5	SENT_23	[p2l97t1212r634b1244],
2	:10.1016	CD	NUMBER	:10.1016	dep	1	SENT_23	[p2l97t1212r634b1244],
3	/	:	O	/	punct	4	SENT_23	[p2l97t1212r634b1244],
4	j.	NN	O	j.	dep	1	SENT_23	[p2l97t1212r634b1244],
5	thromres	VBZ	O	thromre	_	0	SENT_23	[p2l97t1212r634b1244],
6	.2007.01.012	CD	NUMBER	.2007.01.012	number	7	SENT_23	[p2l97t1212r634b1244],
7	894	CD	NUMBER	894	num	9	SENT_23	[p2l98t1265r161b1297],
8	T.	NNP	O	T.	nn	9	SENT_23	[p2l1772t1266r1800b1297],
9	Cuisset	NNP	O	Cuisset	dobj	5	SENT_23	[p2l1819t1265r1948b1297],
10	et	FW	O	et	nn	11	SENT_23	[p2l1964t1268r2001b1297],
11	al.	FW	O	al.	dep	9	SENT_23	[p2l2017t1265r2059b1297],
12	.	.	O	.	_	0	SENT_23	[p2l2017t1265r2059b1297],

1	defined	VBN	O	define	_	0	SENT_24	[p2l670t1380r798b1409],
2	by	IN	O	by	_	0	SENT_24	[p2l818t1380r856b1416],
3	persistence	NN	O	persistence	prep_by	1	SENT_24	[p2l875t1381r1069b1416],
4	of	IN	O	of	_	0	SENT_24	[p2l1087t1380r1121b1409],
5	High	JJ	O	high	amod	10	SENT_24	[p2l1139t1380r1210b1416],
6	Post-treatment	JJ	O	post-treatment	amod	10	SENT_24	[p2l1231t1381r1490b1409],
7	Platelet	NN	O	platelet	nn	10	SENT_24	[p2l1509t1380r1644b1409],
8	Reactivity	NN	O	reactivity	nn	10	SENT_24	[p2l1663t1381r1833b1416],
9	(	CD	NUMBER	(	num	10	SENT_24	[p2l1853t1381r2061b1416, p2l669t1426r829b1462],
10	HPPR	NN	O	hppr	prep_of	3	SENT_24	[p2l1853t1381r2061b1416, p2l669t1426r829b1462],
11	=	JJ	O	=	amod	12	SENT_24	[p2l1853t1381r2061b1416, p2l669t1426r829b1462],
12	ADPAg	NN	O	adpag	dep	13	SENT_24	[p2l1853t1381r2061b1416, p2l669t1426r829b1462],
13	>	JJR	O	>	dobj	1	SENT_24	[p2l1853t1381r2061b1416, p2l669t1426r829b1462],
14	70	CD	PERCENT	70	number	15	SENT_24	[p2l1853t1381r2061b1416, p2l669t1426r829b1462],
15	%	NN	PERCENT	%	amod	13	SENT_24	[p2l1853t1381r2061b1416, p2l669t1426r829b1462],
16	)	CD	NUMBER	)	tmod	13	SENT_24	[p2l1853t1381r2061b1416, p2l669t1426r829b1462],
17	.	.	O	.	_	0	SENT_24	[p2l1853t1381r2061b1416, p2l669t1426r829b1462],

1	Results	NNS	O	result	_	0	SENT_25	[p2l671t1471r802b1499],
2	:	:	O	:	_	0	SENT_25	[p2l671t1471r802b1499],
3	Significant	JJ	O	significant	amod	4	SENT_25	[p2l818t1471r994b1507],
4	variability	NN	O	variability	nsubjpass	12	SENT_25	[p2l1019t1471r1190b1507],
5	in	IN	O	in	_	0	SENT_25	[p2l1215t1471r1243b1499],
6	the	DT	O	the	det	7	SENT_25	[p2l1271t1471r1324b1499],
7	distribution	NN	O	distribution	prep_in	4	SENT_25	[p2l1351t1471r1542b1500],
8	of	IN	O	of	_	0	SENT_25	[p2l1570t1471r1603b1499],
9	platelet	NN	O	platelet	nn	10	SENT_25	[p2l1629t1471r1760b1507],
10	parameters	NNS	O	parameter	prep_of	7	SENT_25	[p2l1787t1474r1977b1507],
11	was	VBD	O	be	auxpass	12	SENT_25	[p2l2002t1479r2063b1500],
12	observed	VBN	O	observe	dep	1	SENT_25	[p2l670t1516r816b1545],
13	in	IN	O	in	_	0	SENT_25	[p2l841t1517r869b1545],
14	the	DT	O	the	det	17	SENT_25	[p2l894t1516r947b1545],
15	overall	JJ	O	overall	amod	17	SENT_25	[p2l970t1516r1082b1545],
16	study	NN	O	study	nn	17	SENT_25	[p2l1106t1516r1193b1552],
17	population	NN	O	population	prep_in	12	SENT_25	[p2l1217t1516r1402b1552],
18	.	.	O	.	_	0	SENT_25	[p2l1217t1516r1402b1552],

1	No	DT	O	no	det	3	SENT_26	[p2l1430t1517r1470b1545],
2	significant	JJ	O	significant	amod	3	SENT_26	[p2l1494t1516r1664b1552],
3	difference	NN	O	difference	nsubjpass	9	SENT_26	[p2l1687t1516r1857b1545],
4	in	IN	O	in	_	0	SENT_26	[p2l1881t1517r1908b1545],
5	platelet	NN	O	platelet	nn	7	SENT_26	[p2l1934t1516r2063b1552],
6	parameter	NN	O	parameter	nn	7	SENT_26	[p2l671t1565r843b1598],
7	profiles	NNS	O	profile	prep_in	3	SENT_26	[p2l855t1562r977b1598],
8	was	VBD	O	be	auxpass	9	SENT_26	[p2l988t1570r1049b1591],
9	observed	VBN	O	observe	_	0	SENT_26	[p2l1060t1562r1206b1591],
10	within	IN	O	within	_	0	SENT_26	[p2l1218t1562r1319b1591],
11	patients	NNS	O	patient	prep_within	9	SENT_26	[p2l1333t1562r1465b1598],
12	having	VBG	O	have	partmod	11	SENT_26	[p2l1478t1562r1582b1598],
13	the	DT	O	the	det	15	SENT_26	[p2l1594t1562r1647b1590],
14	same	JJ	O	same	amod	15	SENT_26	[p2l1658t1570r1741b1590],
15	genotype	NN	O	genotype	nn	23	SENT_26	[p2l1753t1565r1914b1598],
16	,	,	O	,	_	0	SENT_26	[p2l1753t1565r1914b1598],
17	for	IN	O	for	_	0	SENT_26	[p2l1929t1562r1976b1590],
18	ADPAg	NNP	O	ADPAg	nn	20	SENT_26	[p2l1985t1562r2061b1590, p2l669t1607r709b1643],
19	(	CD	NUMBER	(	num	20	SENT_26	[p2l726t1607r880b1643],
20	p	NN	O	p	prep_for	15	SENT_26	[p2l726t1607r880b1643],
21	=	JJ	O	=	amod	23	SENT_26	[p2l726t1607r880b1643],
22	0.39	CD	NUMBER	0.39	tmod	21	SENT_26	[p2l726t1607r880b1643],
23	)	NN	O	)	dobj	12	SENT_26	[p2l726t1607r880b1643],
24	,	,	O	,	_	0	SENT_26	[p2l726t1607r880b1643],
25	PRI	NNP	ORGANIZATION	PRI	nn	26	SENT_26	[p2l900t1607r947b1635],
26	VASP	NN	ORGANIZATION	vasp	dep	32	SENT_26	[p2l963t1607r1040b1636],
27	(	CD	NUMBER	(	num	28	SENT_26	[p2l1057t1607r1200b1643],
28	p	NN	O	p	dep	26	SENT_26	[p2l1057t1607r1200b1643],
29	=	JJ	O	=	amod	30	SENT_26	[p2l1057t1607r1200b1643],
30	O.	NNP	O	O.	dep	32	SENT_26	[p2l1057t1607r1200b1643],
31	97	CD	NUMBER	97	num	32	SENT_26	[p2l1057t1607r1200b1643],
32	)	NN	O	)	dep	38	SENT_26	[p2l1057t1607r1200b1643],
33	and	CC	O	and	_	0	SENT_26	[p2l1217t1607r1274b1635],
34	PS	NNP	O	PS	nn	36	SENT_26	[p2l1291t1607r1326b1636],
35	(	CD	NUMBER	(	num	36	SENT_26	[p2l1344t1607r1498b1643],
36	p	NN	O	p	conj_and	32	SENT_26	[p2l1344t1607r1498b1643],
37	=	JJ	O	=	amod	38	SENT_26	[p2l1344t1607r1498b1643],
38	O.	NNP	O	O.	dep	40	SENT_26	[p2l1344t1607r1498b1643],
39	62	CD	NUMBER	62	num	40	SENT_26	[p2l1344t1607r1498b1643],
40	)	CD	NUMBER	)	dep	9	SENT_26	[p2l1344t1607r1498b1643],
41	.	.	O	.	_	0	SENT_26	[p2l1344t1607r1498b1643],

1	The	DT	O	the	det	3	SENT_27	[p2l1515t1607r1576b1635],
2	genotype	NN	O	genotype	nn	3	SENT_27	[p2l1591t1610r1742b1643],
3	frequencies	NNS	O	frequency	nsubj	13	SENT_27	[p2l1757t1607r1949b1643],
4	of	IN	O	of	_	0	SENT_27	[p2l1963t1607r1996b1635],
5	the	DT	O	the	det	7	SENT_27	[p2l2010t1607r2063b1635],
6	T744C	NN	O	t744c	nn	7	SENT_27	[p2l669t1653r770b1681],
7	polymorphism	NN	O	polymorphism	prep_of	3	SENT_27	[p2l798t1652r1026b1688],
8	of	IN	O	of	_	0	SENT_27	[p2l1053t1652r1086b1681],
9	the	DT	O	the	det	11	SENT_27	[p2l1111t1652r1164b1681],
10	P2Y12	NN	O	p2y12	nn	11	SENT_27	[p2l1191t1652r1288b1681],
11	gene	NN	O	gene	prep_of	7	SENT_27	[p2l1315t1659r1392b1688],
12	were	VBD	O	be	cop	13	SENT_27	[p2l1417t1660r1499b1681],
13	similar	JJ	O	similar	_	0	SENT_27	[p2l1525t1652r1636b1681],
14	in	IN	O	in	_	0	SENT_27	[p2l1661t1653r1688b1681],
15	responders	NNS	O	responder	prep_in	13	SENT_27	[p2l1716t1652r1894b1688],
16	and	CC	O	and	_	0	SENT_27	[p2l1920t1652r1977b1681],
17	non	JJ	O	non	amod	18	SENT_27	[p2l2005t1660r2062b1681],
18	responders	NNS	O	responder	prep_in	13	SENT_27	[p2l672t1698r849b1734],
19	defining	VBG	O	define	partmod	18	SENT_27	[p2l862t1698r994b1734],
20	by	IN	O	by	_	0	SENT_27	[p2l1009t1698r1045b1734],
21	HPPR	NN	O	hppr	nn	23	SENT_27	[p2l1059t1698r1144b1726],
22	(	CD	NUMBER	(	num	23	SENT_27	[p2l1158t1698r1312b1734],
23	p	NN	O	p	agent	19	SENT_27	[p2l1158t1698r1312b1734],
24	=	JJ	O	=	advmod	19	SENT_27	[p2l1158t1698r1312b1734],
25	0.75	CD	NUMBER	0.75	num	26	SENT_27	[p2l1158t1698r1312b1734],
26	)	NN	O	)	dep	24	SENT_27	[p2l1158t1698r1312b1734],
27	.	.	O	.	_	0	SENT_27	[p2l1158t1698r1312b1734],

1	Conclusion	NN	O	conclusion	_	0	SENT_28	[p2l672t1743r858b1772],
2	:	:	O	:	_	0	SENT_28	[p2l672t1743r858b1772],
3	Our	PRP$	O	we	poss	4	SENT_28	[p2l875t1743r933b1772],
4	study	NN	O	study	nsubj	7	SENT_28	[p2l945t1743r1032b1779],
5	did	VBD	O	do	aux	7	SENT_28	[p2l1044t1743r1093b1772],
6	not	RB	O	not	neg	7	SENT_28	[p2l1108t1746r1160b1772],
7	show	VB	O	show	dep	1	SENT_28	[p2l1172t1743r1254b1772],
8	any	DT	O	any	det	9	SENT_28	[p2l1266t1751r1323b1779],
9	influence	NN	O	influence	dobj	7	SENT_28	[p2l1335t1743r1487b1772],
10	of	IN	O	of	_	0	SENT_28	[p2l1500t1743r1533b1772],
11	the	DT	O	the	det	13	SENT_28	[p2l1544t1743r1597b1772],
12	T744C	NN	O	t744c	nn	13	SENT_28	[p2l1609t1743r1710b1772],
13	polymorphism	NN	O	polymorphism	prep_of	9	SENT_28	[p2l1724t1743r1951b1779],
14	of	IN	O	of	_	0	SENT_28	[p2l1966t1743r1998b1772],
15	the	DT	O	the	det	18	SENT_28	[p2l2010t1743r2063b1772],
16	P2Y12	NN	O	p2y12	nn	18	SENT_28	[p2l672t1788r768b1816],
17	receptor	NN	O	receptor	nn	18	SENT_28	[p2l788t1791r928b1824],
18	gene	NN	O	gene	prep_of	13	SENT_28	[p2l946t1795r1023b1824],
19	on	IN	O	on	_	0	SENT_28	[p2l1041t1796r1078b1817],
20	clopidogrel	NN	O	clopidogrel	nn	21	SENT_28	[p2l1097t1788r1279b1824],
21	response	NN	O	response	prep_on	7	SENT_28	[p2l1299t1796r1441b1824],
22	assessed	VBN	O	assess	partmod	21	SENT_28	[p2l1460t1788r1596b1817],
23	by	IN	O	by	_	0	SENT_28	[p2l1616t1788r1653b1824],
24	ADP-Ag	NN	O	adp-ag	agent	22	SENT_28	[p2l1669t1788r1798b1824],
25	,	,	O	,	_	0	SENT_28	[p2l1669t1788r1798b1824],
26	PRI	NNP	ORGANIZATION	PRI	nn	27	SENT_28	[p2l1820t1788r1867b1816],
27	VASP	NN	ORGANIZATION	vasp	appos	24	SENT_28	[p2l1886t1788r1964b1817],
28	or	CC	O	or	_	0	SENT_28	[p2l1980t1796r2014b1817],
29	Pselectin	NN	O	pselectin	nn	30	SENT_28	[p2l2032t1788r2061b1816, p2l670t1833r797b1861],
30	expression	NN	O	expression	conj_or	27	SENT_28	[p2l811t1833r983b1869],
31	in	IN	O	in	_	0	SENT_28	[p2l997t1833r1025b1861],
32	NSTE	NNP	O	NSTE	nn	34	SENT_28	[p2l1040t1833r1120b1862],
33	ACS	NN	O	ac	nn	34	SENT_28	[p2l1132t1833r1193b1862],
34	patients	NNS	O	patient	prep_in	27	SENT_28	[p2l1207t1833r1350b1869],
35	.	.	O	.	_	0	SENT_28	[p2l1207t1833r1350b1869],

1	©	RB	O	©	advmod	2	SENT_29	[p2l671t1881r696b1906],
2	2007	CD	DATE	2007	_	0	SENT_29	[p2l709t1878r785b1907],
3	Elsevier	NNP	ORGANIZATION	Elsevier	nn	4	SENT_29	[p2l800t1878r926b1907],
4	Ltd.	NNP	ORGANIZATION	Ltd.	dep	2	SENT_29	[p2l940t1878r1001b1907],
5	.	.	O	.	_	0	SENT_29	[p2l940t1878r1001b1907],

1	All	DT	O	all	det	2	SENT_30	[p2l1017t1878r1059b1907],
2	rights	NNS	O	rights	nsubj	3	SENT_30	[p2l1074t1878r1164b1914],
3	reserved	VBN	O	reserve	_	0	SENT_30	[p2l1178t1878r1328b1907],
4	.	.	O	.	_	0	SENT_30	[p2l1178t1878r1328b1907],

1	Introduction	NN	O	introduction	_	0	SENT_31	[p2l14t2102r647b2187],

1	Platelet	NN	O	platelet	nn	2	SENT_32	[p2l12t2341r336b2412],
2	inhibition	NN	O	inhibition	nsubj	9	SENT_32	[p2l375t2341r763b2413],
3	with	IN	O	with	_	0	SENT_32	[p2l803t2341r981b2413],
4	aspirin	NN	O	aspirin	prep_with	2	SENT_32	[p2l1023t2343r1292b2431],
5	and	CC	O	and	_	0	SENT_32	[p2l1334t2341r1477b2412],
6	clopidogrel	NN	O	clopidogrel	conj_and	4	SENT_32	[p2l1518t2341r1978b2431],
7	has	VBZ	O	have	aux	9	SENT_32	[p2l2020t2341r2150b2412],
8	significantly	RB	O	significantly	advmod	9	SENT_32	[p2l8t2454r520b2542],
9	reduced	VBN	O	reduce	_	0	SENT_32	[p2l587t2454r919b2524],
10	recurrent	JJ	O	recurrent	amod	12	SENT_32	[p2l991t2461r1385b2524],
11	ischemic	JJ	O	ischemic	amod	12	SENT_32	[p2l1450t2454r1811b2524],
12	events	NNS	O	event	dobj	9	SENT_32	[p2l1877t2461r2149b2524],
13	after	IN	O	after	mark	22	SENT_32	[p2l9t2566r214b2637],
14	non	JJ	O	non	amod	18	SENT_32	[p2l257t2585r398b2637],
15	ST	JJ	O	st	amod	18	SENT_32	[p2l445t2567r540b2638],
16	acute	JJ	O	acute	amod	18	SENT_32	[p2l571t2573r799b2637],
17	coronary	JJ	O	coronary	amod	18	SENT_32	[p2l842t2585r1203b2656],
18	syndrome	NN	O	syndrome	nsubj	22	SENT_32	[p2l1245t2566r1640b2656],
19	(	CD	NUMBER	(	num	21	SENT_32	[p2l1689t2567r1921b2656],
20	NSTE	NNP	O	NSTE	nn	21	SENT_32	[p2l1689t2567r1921b2656],
21	ACS	NNP	O	ACS	dep	18	SENT_32	[p2l1961t2567r2146b2656],
22	)	VBD	O	)	advcl	9	SENT_32	[p2l1961t2567r2146b2656],
23	[	CD	NUMBER	[	number	24	SENT_32	[p2l14t2679r230b2767],
24	1,2	CD	NUMBER	1,2	num	25	SENT_32	[p2l14t2679r230b2767],
25	]	NN	O	]	dobj	22	SENT_32	[p2l14t2679r230b2767],
26	.	.	O	.	_	0	SENT_32	[p2l14t2679r230b2767],

1	Nevertheless	RB	O	nevertheless	advmod	6	SENT_33	[p2l276t2679r828b2765],
2	,	,	O	,	_	0	SENT_33	[p2l276t2679r828b2765],
3	ischemic	JJ	O	ischemic	amod	4	SENT_33	[p2l871t2679r1226b2749],
4	events	NNS	O	event	nsubj	6	SENT_33	[p2l1260t2686r1528b2749],
5	still	RB	O	still	advmod	6	SENT_33	[p2l1562t2679r1711b2749],
6	occur	VBP	O	occur	_	0	SENT_33	[p2l1745t2698r1972b2749],
7	and	CC	O	and	_	0	SENT_33	[p2l2003t2679r2146b2749],
8	a	DT	O	a	det	10	SENT_33	[p2l9t2811r52b2863],
9	poor	JJ	O	poor	amod	10	SENT_33	[p2l93t2811r275b2881],
10	response	NN	O	response	nsubj	18	SENT_33	[p2l314t2811r670b2881],
11	to	TO	O	to	_	0	SENT_33	[p2l709t2799r791b2863],
12	antiplatelet	JJ	O	antiplatelet	amod	13	SENT_33	[p2l829t2791r1319b2881],
13	therapy	NN	O	therapy	prep_to	10	SENT_33	[p2l1357t2791r1676b2881],
14	could	MD	O	could	aux	18	SENT_33	[p2l1711t2791r1930b2863],
15	be	VB	O	be	cop	18	SENT_33	[p2l1973t2791r2068b2863],
16	a	DT	O	a	det	18	SENT_33	[p2l2106t2811r2149b2863],
17	major	JJ	O	major	amod	18	SENT_33	[p2l11t2906r253b2994],
18	factor	NN	O	factor	conj_and	6	SENT_33	[p2l279t2904r540b2975],
19	.	.	O	.	_	0	SENT_33	[p2l279t2904r540b2975],

1	Numerous	JJ	O	numerous	amod	3	SENT_34	[p2l582t2906r987b2975],
2	biological	JJ	O	biological	amod	3	SENT_34	[p2l1017t2904r1410b2994],
3	studies	NNS	O	study	nsubjpass	43	SENT_34	[p2l1440t2904r1752b2991],
4	,	,	O	,	_	0	SENT_34	[p2l1440t2904r1752b2991],
5	based	VBN	O	base	partmod	3	SENT_34	[p2l1792t2904r2022b2975],
6	on	IN	O	on	_	0	SENT_34	[p2l2053t2923r2146b2975],
7	Adenosine	NNP	LOCATION	Adenosine	nn	8	SENT_34	[p2l6t3017r447b3087],
8	DiPhosphate	NNP	O	DiPhosphate	prep_on	5	SENT_34	[p2l521t3017r1046b3105],
9	(	CD	NUMBER	(	num	10	SENT_34	[p2l1121t3017r1732b3105],
10	ADP	NN	ORGANIZATION	adp	nsubj	13	SENT_34	[p2l1121t3017r1732b3105],
11	)	SYM	O	)	dep	13	SENT_34	[p2l1121t3017r1732b3105],
12	-	:	O	-	_	0	SENT_34	[p2l1121t3017r1732b3105],
13	induced	VBN	O	induce	rcmod	8	SENT_34	[p2l1121t3017r1732b3105],
14	platelet	NN	O	platelet	nn	15	SENT_34	[p2l1808t3017r2150b3105],
15	aggregometry	NN	O	aggregometry	nsubj	17	SENT_34	[p2l9t3136r580b3217],
16	have	VBP	O	have	aux	17	SENT_34	[p2l630t3129r819b3199],
17	reported	VBN	O	report	ccomp	13	SENT_34	[p2l871t3129r1224b3217],
18	inter-individual	JJ	O	inter-individual	amod	19	SENT_34	[p2l1276t3129r1913b3199],
19	variability	NN	O	variability	dobj	17	SENT_34	[p2l1960t3130r2144b3199, p2l9t3241r270b3331],
20	in	IN	O	in	_	0	SENT_34	[p2l299t3243r368b3312],
21	platelet	NN	O	platelet	nn	22	SENT_34	[p2l405t3241r728b3331],
22	response	NN	O	response	prep_in	17	SENT_34	[p2l763t3260r1119b3331],
23	to	TO	O	to	_	0	SENT_34	[p2l1151t3248r1232b3312],
24	clopidogrel	NN	O	clopidogrel	nn	25	SENT_34	[p2l1262t3241r1722b3331],
25	[	NN	O	[	prep_to	22	SENT_34	[p2l1760t3241r1965b3331],
26	3	CD	NUMBER	3	num	27	SENT_34	[p2l1760t3241r1965b3331],
27	—	NN	O	—	dep	22	SENT_34	[p2l1760t3241r1965b3331],
28	7	CD	NUMBER	7	num	29	SENT_34	[p2l1760t3241r1965b3331],
29	]	NN	O	]	dep	27	SENT_34	[p2l1760t3241r1965b3331],
30	and	CC	O	and	_	0	SENT_34	[p2l2003t3241r2146b3312],
31	a	DT	O	a	det	32	SENT_34	[p2l9t3373r52b3424],
32	relation	NN	O	relation	conj_and	22	SENT_34	[p2l124t3354r451b3424],
33	between	IN	O	between	_	0	SENT_34	[p2l525t3354r886b3424],
34	clopidogrel	NN	O	clopidogrel	nn	35	SENT_34	[p2l957t3354r1432b3442],
35	resistance	NN	O	resistance	prep_between	32	SENT_34	[p2l1504t3355r1931b3424],
36	and	CC	O	and	_	0	SENT_34	[p2l2000t3354r2146b3424],
37	recurrence	NN	O	recurrence	conj_and	35	SENT_34	[p2l12t3485r458b3537],
38	of	IN	O	of	_	0	SENT_34	[p2l497t3466r580b3537],
39	clinical	JJ	O	clinical	amod	40	SENT_34	[p2l615t3466r908b3537],
40	outcomes	NNS	O	outcome	prep_of	32	SENT_34	[p2l948t3473r1343b3537],
41	has	VBZ	O	have	aux	43	SENT_34	[p2l1383t3466r1513b3537],
42	been	VBN	O	be	auxpass	43	SENT_34	[p2l1553t3466r1747b3537],
43	reported	VBN	O	report	dep	47	SENT_34	[p2l1792t3466r2145b3556],
44	in	IN	O	in	_	0	SENT_34	[p2l9t3580r78b3648],
45	several	JJ	O	several	amod	46	SENT_34	[p2l127t3579r419b3649],
46	studies	NNS	O	study	prep_in	43	SENT_34	[p2l466t3579r753b3649],
47	[	VBP	O	[	_	0	SENT_34	[p2l805t3579r1093b3667],
48	8	CD	NUMBER	8	num	49	SENT_34	[p2l805t3579r1093b3667],
49	—	CD	NUMBER	—	dobj	47	SENT_34	[p2l805t3579r1093b3667],
50	12	CD	NUMBER	12	num	51	SENT_34	[p2l805t3579r1093b3667],
51	]	NN	O	]	nsubj	47	SENT_34	[p2l805t3579r1093b3667],
52	.	.	O	.	_	0	SENT_34	[p2l805t3579r1093b3667],

1	In	IN	O	in	_	0	SENT_35	[p2l1152t3581r1215b3648],
2	a	DT	O	a	det	4	SENT_35	[p2l1265t3598r1308b3649],
3	previous	JJ	O	previous	amod	4	SENT_35	[p2l1358t3580r1700b3667],
4	study	NN	O	study	prep_in	7	SENT_35	[p2l1746t3579r1980b3667],
5	,	,	O	,	_	0	SENT_35	[p2l1746t3579r1980b3667],
6	we	PRP	O	we	nsubj	7	SENT_35	[p2l2032t3598r2149b3649],
7	demonstrated	VBD	O	demonstrate	_	0	SENT_35	[p2l9t3691r581b3763],
8	that	IN	O	that	_	0	SENT_35	[p2l612t3691r781b3763],
9	the	DT	O	the	det	13	SENT_35	[p2l810t3691r943b3763],
10	High	JJ	O	high	amod	13	SENT_35	[p2l974t3691r1147b3781],
11	Post	NN	O	post	nn	13	SENT_35	[p2l1181t3693r1345b3763],
12	treatment	NN	O	treatment	nn	13	SENT_35	[p2l1373t3698r1794b3763],
13	Platelet	NN	O	platelet	prep_that	7	SENT_35	[p2l1826t3691r2150b3763],

1	Reactivity	NN	O	reactivity	nn	3	SENT_36	[p3l13t20r422b108],
2	(	CD	NUMBER	(	num	3	SENT_36	[p3l478t19r751b108],
3	HPPR	NN	O	hppr	nsubj	22	SENT_36	[p3l478t19r751b108],
4	)	CD	NUMBER	)	number	5	SENT_36	[p3l478t19r751b108],
5	(	CD	NUMBER	(	num	8	SENT_36	[p3l812t18r1359b108],
6	ADP-induced	JJ	O	adp-induced	amod	8	SENT_36	[p3l812t18r1359b108],
7	platelet	NN	O	platelet	nn	8	SENT_36	[p3l1417t18r1742b108],
8	aggregation	NN	O	aggregation	dep	3	SENT_36	[p3l1794t35r2144b108, p3l9t132r165b201],
9	>	JJR	O	>	amod	3	SENT_36	[p3l210t132r454b219],
10	70	CD	PERCENT	70	num	11	SENT_36	[p3l210t132r454b219],
11	%	NN	PERCENT	%	nsubj	16	SENT_36	[p3l210t132r454b219],
12	)	CD	NUMBER	)	dep	11	SENT_36	[p3l210t132r454b219],
13	was	VBD	O	be	cop	16	SENT_36	[p3l498t150r652b201],
14	a	DT	O	a	det	16	SENT_36	[p3l696t150r738b201],
15	good	JJ	O	good	amod	16	SENT_36	[p3l783t131r973b219],
16	marker	NN	O	marker	ccomp	9	SENT_36	[p3l1023t131r1313b201],
17	of	IN	O	of	_	0	SENT_36	[p3l1355t131r1437b201],
18	low	JJ	O	low	amod	19	SENT_36	[p3l1481t131r1621b201],
19	response	NN	O	response	prep_of	16	SENT_36	[p3l1667t150r2023b219],
20	to	TO	O	to	_	0	SENT_36	[p3l2068t138r2149b201],
21	clopidogrel	NN	O	clopidogrel	prep_to	9	SENT_36	[p3l8t243r468b331],
22	correlated	VBD	O	correlate	_	0	SENT_36	[p3l527t243r954b313],
23	with	IN	O	with	_	0	SENT_36	[p3l1014t243r1192b313],
24	one-month	JJ	DURATION	one-month	amod	27	SENT_36	[p3l1253t243r1697b313],
25	recurrent	JJ	O	recurrent	amod	27	SENT_36	[p3l1762t250r2150b313],
26	ischemic	JJ	O	ischemic	amod	27	SENT_36	[p3l9t355r364b426],
27	events	NNS	O	event	prep_with	22	SENT_36	[p3l410t362r679b427],
28	after	IN	O	after	_	0	SENT_36	[p3l724t355r928b426],
29	stenting	VBG	O	stent	prepc_after	27	SENT_36	[p3l971t357r1303b445],
30	for	IN	O	for	_	0	SENT_36	[p3l1349t355r1467b426],
31	NSTE	NNP	O	NSTE	nn	32	SENT_36	[p3l1513t356r1712b427],
32	ACS	NNP	O	ACS	prep_for	29	SENT_36	[p3l1755t356r1908b427],
33	[	CD	NUMBER	[	number	34	SENT_36	[p3l1960t355r2141b445],
34	12	CD	NUMBER	12	num	35	SENT_36	[p3l1960t355r2141b445],
35	]	NN	O	]	dobj	22	SENT_36	[p3l1960t355r2141b445],
36	.	.	O	.	_	0	SENT_36	[p3l1960t355r2141b445],

1	Several	JJ	O	several	amod	2	SENT_37	[p3l9t468r308b538],
2	mechanisms	NNS	O	mechanism	nsubjpass	5	SENT_37	[p3l364t468r860b538],
3	have	VBP	O	have	aux	5	SENT_37	[p3l915t468r1104b538],
4	been	VBN	O	be	auxpass	5	SENT_37	[p3l1159t468r1353b538],
5	proposed	VBN	O	propose	_	0	SENT_37	[p3l1411t468r1780b556],
6	for	IN	O	for	_	0	SENT_37	[p3l1835t468r1953b538],
7	this	DT	O	this	det	9	SENT_37	[p3l2003t468r2150b538],
8	wide	JJ	O	wide	amod	9	SENT_37	[p3l6t580r202b652],
9	variability	NN	O	variability	prep_for	5	SENT_37	[p3l232t580r653b670],
10	in	IN	O	in	_	0	SENT_37	[p3l685t582r753b651],
11	platelet	NN	O	platelet	nn	12	SENT_37	[p3l791t580r1115b670],
12	response	NN	O	response	prep_in	9	SENT_37	[p3l1151t599r1508b670],
13	to	TO	O	to	_	0	SENT_37	[p3l1541t587r1622b651],
14	clopidogrel	NN	O	clopidogrel	prep_to	5	SENT_37	[p3l1654t580r2141b670],
15	,	,	O	,	_	0	SENT_37	[p3l1654t580r2141b670],
16	including	VBG	O	include	_	0	SENT_37	[p3l9t693r381b781],
17	polymorphisms	NNS	O	polymorphism	prep_including	5	SENT_37	[p3l411t693r1023b781],
18	in	IN	O	in	_	0	SENT_37	[p3l1051t694r1119b762],
19	platelet	NN	O	platelet	nn	21	SENT_37	[p3l1152t693r1476b781],
20	receptor	NN	O	receptor	nn	21	SENT_37	[p3l1506t700r1859b781],
21	genes	NNS	O	gene	prep_in	17	SENT_37	[p3l1883t710r2141b781],
22	.	.	O	.	_	0	SENT_37	[p3l1883t710r2141b781],

1	Recently	RB	DATE	recently	advmod	10	SENT_38	[p3l13t805r381b895],
2	,	,	O	,	_	0	SENT_38	[p3l13t805r381b895],
3	polymorphisms	NNS	O	polymorphism	nsubjpass	10	SENT_38	[p3l457t805r1072b895],
4	of	IN	O	of	_	0	SENT_38	[p3l1136t805r1219b877],
5	the	DT	O	the	det	7	SENT_38	[p3l1282t805r1415b877],
6	P2Y12	NN	O	p2y12	nn	7	SENT_38	[p3l1484t806r1726b876],
7	receptor	NN	O	receptor	prep_of	3	SENT_38	[p3l1797t812r2152b895],
8	have	VBP	O	have	aux	10	SENT_38	[p3l11t918r200b989],
9	been	VBN	O	be	auxpass	10	SENT_38	[p3l265t918r459b990],
10	associated	VBN	O	associate	_	0	SENT_38	[p3l525t918r950b989],
11	with	IN	O	with	_	0	SENT_38	[p3l1014t918r1192b990],
12	different	JJ	O	different	amod	13	SENT_38	[p3l1257t918r1626b989],
13	degrees	NNS	O	degree	prep_with	10	SENT_38	[p3l1688t918r2008b1008],
14	of	IN	O	of	_	0	SENT_38	[p3l2070t918r2153b989],
15	platelet	NN	O	platelet	nn	16	SENT_38	[p3l11t1031r336b1119],
16	aggregation	NN	O	aggregation	prep_of	13	SENT_38	[p3l371t1032r853b1119],
17	in	IN	O	in	_	0	SENT_38	[p3l891t1032r960b1100],
18	healthy	JJ	O	healthy	amod	19	SENT_38	[p3l1000t1031r1306b1119],
19	volunteers	NNS	O	volunteer	prep_in	10	SENT_38	[p3l1337t1031r1772b1101],
20	[	VBP	O	[	rcmod	19	SENT_38	[p3l1813t1031r1962b1119],
21	13	CD	NUMBER	13	num	22	SENT_38	[p3l1813t1031r1962b1119],
22	]	NN	O	]	dobj	20	SENT_38	[p3l1813t1031r1962b1119],
23	and	CC	O	and	_	0	SENT_38	[p3l2003t1031r2146b1101],
24	have	VBP	O	have	aux	26	SENT_38	[p3l11t1143r207b1213],
25	been	VBN	O	be	auxpass	26	SENT_38	[p3l278t1143r478b1213],
26	suggested	VBN	O	suggest	conj_and	20	SENT_38	[p3l550t1143r970b1231],
27	to	TO	O	to	aux	28	SENT_38	[p3l1042t1149r1126b1213],
28	modulate	VB	O	modulate	xcomp	26	SENT_38	[p3l1197t1143r1599b1213],
29	clopidogrel	NN	O	clopidogrel	nn	30	SENT_38	[p3l1668t1143r2149b1231],
30	response	NN	O	response	dobj	28	SENT_38	[p3l12t1274r394b1345],
31	.	.	O	.	_	0	SENT_38	[p3l12t1274r394b1345],

1	The	DT	O	the	det	3	SENT_39	[p3l453t1255r606b1326],
2	functional	JJ	O	functional	amod	3	SENT_39	[p3l657t1255r1074b1326],
3	role	NN	O	role	nsubjpass	18	SENT_39	[p3l1131t1255r1287b1326],
4	of	IN	O	of	_	0	SENT_39	[p3l1339t1255r1422b1326],
5	the	DT	O	the	det	8	SENT_39	[p3l1470t1255r1604b1326],
6	P2Y12	NN	O	p2y12	nn	8	SENT_39	[p3l1660t1256r1900b1326],
7	gene	NN	O	gene	nn	8	SENT_39	[p3l1955t1273r2149b1345],
8	polymorphisms	NNS	O	polymorphism	prep_of	3	SENT_39	[p3l11t1368r624b1456],
9	in	IN	O	in	_	0	SENT_39	[p3l661t1369r730b1437],
10	modulating	VBG	O	modulate	prepc_in	8	SENT_39	[p3l772t1368r1232b1456],
11	the	DT	O	the	det	12	SENT_39	[p3l1270t1368r1404b1438],
12	response	NN	O	response	dobj	10	SENT_39	[p3l1444t1387r1801b1456],
13	to	TO	O	to	_	0	SENT_39	[p3l1839t1375r1920b1438],
14	antiplatelet	JJ	O	antiplatelet	amod	15	SENT_39	[p3l1957t1369r2144b1438, p3l11t1480r336b1570],
15	drugs	NNS	O	drug	prep_to	10	SENT_39	[p3l377t1480r596b1570],
16	has	VBZ	O	have	aux	18	SENT_39	[p3l639t1480r768b1551],
17	been	VBN	O	be	auxpass	18	SENT_39	[p3l812t1480r1005b1552],
18	assessed	VBN	O	assess	_	0	SENT_39	[p3l1050t1480r1393b1551],
19	in	IN	O	in	_	0	SENT_39	[p3l1437t1482r1506b1551],
20	previous	JJ	O	previous	amod	24	SENT_39	[p3l1553t1482r1895b1570],
21	small	JJ	O	small	amod	24	SENT_39	[p3l1936t1480r2148b1551],
22	sample	NN	O	sample	nn	24	SENT_39	[p3l8t1593r297b1681],
23	size	NN	O	size	nn	24	SENT_39	[p3l346t1594r499b1663],
24	studies	NNS	O	study	prep_in	18	SENT_39	[p3l548t1593r835b1663],
25	with	IN	O	with	_	0	SENT_39	[p3l880t1593r1058b1663],
26	no	DT	O	no	det	27	SENT_39	[p3l1112t1612r1205b1663],
27	relationship	NN	O	relationship	prep_with	18	SENT_39	[p3l1257t1593r1743b1681],
28	between	IN	O	between	_	0	SENT_39	[p3l1795t1593r2146b1663],
29	P2Y12	NN	O	p2y12	nn	30	SENT_39	[p3l12t1706r257b1776],
30	polymorphisms	NNS	O	polymorphism	prep_between	27	SENT_39	[p3l329t1705r952b1795],
31	and	CC	O	and	_	0	SENT_39	[p3l1018t1705r1163b1777],
32	platelet	NN	O	platelet	nn	33	SENT_39	[p3l1236t1705r1567b1795],
33	response	NN	O	response	conj_and	27	SENT_39	[p3l1636t1725r2000b1795],
34	to	TO	O	to	_	0	SENT_39	[p3l2067t1713r2150b1777],
35	clopidogrel	NN	O	clopidogrel	prep_to	33	SENT_39	[p3l8t1818r470b1908],
36	defined	VBN	O	define	partmod	35	SENT_39	[p3l536t1818r846b1889],
37	by	IN	O	by	_	0	SENT_39	[p3l917t1818r1009b1908],
38	ADP-induced	JJ	O	adp-induced	amod	40	SENT_39	[p3l1070t1818r1593b1889],
39	aggregation	NN	O	aggregation	nn	40	SENT_39	[p3l1662t1820r2146b1908],
40	[	NN	O	[	agent	36	SENT_39	[p3l14t1931r351b2019],
41	14	CD	NUMBER	14	number	42	SENT_39	[p3l14t1931r351b2019],
42	—	CD	NUMBER	—	dep	40	SENT_39	[p3l14t1931r351b2019],
43	16	CD	NUMBER	16	num	44	SENT_39	[p3l14t1931r351b2019],
44	]	NN	O	]	dep	42	SENT_39	[p3l14t1931r351b2019],
45	.	.	O	.	_	0	SENT_39	[p3l14t1931r351b2019],

1	However	RB	O	however	advmod	7	SENT_40	[p3l416t1933r786b2017],
2	,	,	O	,	_	0	SENT_40	[p3l416t1933r786b2017],
3	these	DT	O	these	det	4	SENT_40	[p3l848t1931r1069b2001],
4	studies	NNS	O	study	nsubj	7	SENT_40	[p3l1122t1931r1410b2001],
5	did	VBD	O	do	aux	7	SENT_40	[p3l1463t1931r1585b2001],
6	not	RB	O	not	neg	7	SENT_40	[p3l1644t1938r1775b2001],
7	use	VB	O	use	_	0	SENT_40	[p3l1830t1950r1962b2001],
8	the	DT	O	the	det	17	SENT_40	[p3l2016t1931r2149b2001],
9	flow	NN	O	flow	nn	16	SENT_40	[p3l8t2043r186b2113],
10	cytometric	JJ	O	cytometric	amod	16	SENT_40	[p3l223t2044r671b2131],
11	Vasodilatator-Stimulated	JJ	O	vasodilatator-stimulated	amod	16	SENT_40	[p3l708t2043r1738b2113],
12	Phosphoprotein	NN	O	phosphoprotein	nn	16	SENT_40	[p3l1785t2043r2144b2131, p3l11t2157r304b2245],
13	(	CD	NUMBER	(	num	16	SENT_40	[p3l375t2156r627b2245],
14	VASP	NN	ORGANIZATION	vasp	nn	16	SENT_40	[p3l375t2156r627b2245],
15	)	NN	O	)	nn	16	SENT_40	[p3l375t2156r627b2245],
16	phosphorylation	NN	O	phosphorylation	nn	17	SENT_40	[p3l696t2155r1351b2245],
17	assay	NN	O	assay	dobj	7	SENT_40	[p3l1417t2174r1646b2245],
18	,	,	O	,	_	0	SENT_40	[p3l1417t2174r1646b2245],
19	which	WDT	O	which	nsubjpass	22	SENT_40	[p3l1714t2155r1952b2227],
20	has	VBZ	O	have	aux	22	SENT_40	[p3l2020t2155r2150b2226],
21	been	VBN	O	be	auxpass	22	SENT_40	[p3l11t2268r205b2338],
22	introduced	VBN	O	introduce	rcmod	17	SENT_40	[p3l255t2268r699b2338],
23	to	TO	O	to	aux	24	SENT_40	[p3l749t2275r830b2338],
24	measure	VB	O	measure	xcomp	22	SENT_40	[p3l880t2287r1224b2338],
25	specific	JJ	O	specific	amod	26	SENT_40	[p3l1271t2268r1584b2356],
26	inhibition	NN	O	inhibition	dobj	24	SENT_40	[p3l1631t2268r2021b2338],
27	of	IN	O	of	_	0	SENT_40	[p3l2070t2268r2153b2338],
28	clopidogrel	NN	O	clopidogrel	poss	31	SENT_40	[p3l8t2380r537b2470],
29	's	POS	O	's	_	0	SENT_40	[p3l8t2380r537b2470],
30	biochemical	JJ	O	biochemical	amod	31	SENT_40	[p3l607t2380r1113b2452],
31	target	NN	O	target	prep_of	26	SENT_40	[p3l1182t2387r1440b2470],
32	via	IN	O	via	_	0	SENT_40	[p3l1506t2382r1626b2451],
33	the	DT	O	the	det	35	SENT_40	[p3l1694t2380r1830b2451],
34	P2Y12	NN	O	p2y12	nn	35	SENT_40	[p3l1901t2381r2147b2451],
35	receptor	NN	O	receptor	prep_via	31	SENT_40	[p3l12t2500r365b2581],
36	and	CC	O	and	_	0	SENT_40	[p3l403t2493r546b2563],
37	used	VBN	O	use	conj_and	22	SENT_40	[p3l590t2493r770b2563],
38	heterogeneous	JJ	O	heterogeneous	amod	40	SENT_40	[p3l815t2493r1421b2581],
39	clopidogrel	NN	O	clopidogrel	nn	40	SENT_40	[p3l1460t2493r1920b2581],
40	regimen	NN	O	regimen	dobj	37	SENT_40	[p3l1963t2494r2144b2581, p3l11t2625r208b2677],
41	.	.	O	.	_	0	SENT_40	[p3l1963t2494r2144b2581, p3l11t2625r208b2677],

1	In	IN	O	in	_	0	SENT_41	[p3l260t2607r323b2676],
2	our	PRP$	O	we	poss	3	SENT_41	[p3l363t2625r498b2677],
3	study	NN	O	study	prep_in	6	SENT_41	[p3l533t2605r767b2695],
4	,	,	O	,	_	0	SENT_41	[p3l533t2605r767b2695],
5	we	PRP	O	we	nsubj	6	SENT_41	[p3l810t2625r928b2677],
6	studied	VBD	O	study	_	0	SENT_41	[p3l966t2605r1263b2677],
7	platelet	NN	O	platelet	nn	8	SENT_41	[p3l1307t2605r1632b2695],
8	response	NN	O	response	dobj	6	SENT_41	[p3l1673t2625r2029b2695],
9	to	TO	O	to	_	0	SENT_41	[p3l2068t2613r2149b2677],
10	clopidogrel	NN	O	clopidogrel	prep_to	6	SENT_41	[p3l8t2718r468b2808],
11	with	IN	O	with	_	0	SENT_41	[p3l492t2718r670b2789],
12	post-treatment	JJ	O	post-treatment	amod	14	SENT_41	[p3l701t2725r1331b2808],
13	ADP-induced	JJ	O	adp-induced	amod	14	SENT_41	[p3l1354t2718r1875b2789],
14	platelet	NN	O	platelet	prep_with	6	SENT_41	[p3l1906t2718r2144b2808, p3l12t2831r119b2901],
15	aggregation	NN	O	aggregation	nn	18	SENT_41	[p3l149t2832r631b2919],
16	(	CD	NUMBER	(	num	18	SENT_41	[p3l669t2832r1052b2919],
17	ADP-Ag	NN	O	adp-ag	nn	18	SENT_41	[p3l669t2832r1052b2919],
18	)	NN	O	)	dep	14	SENT_41	[p3l669t2832r1052b2919],
19	,	,	O	,	_	0	SENT_41	[p3l669t2832r1052b2919],
20	VASP	NN	ORGANIZATION	vasp	nn	21	SENT_41	[p3l1087t2832r1281b2901],
21	reactivity	NN	O	reactivity	dep	25	SENT_41	[p3l1311t2832r1705b2919],
22	(	CD	NUMBER	(	num	25	SENT_41	[p3l1739t2832r1888b2919],
23	PRI	NNP	ORGANIZATION	PRI	nn	25	SENT_41	[p3l1739t2832r1888b2919],
24	VASP	NN	ORGANIZATION	vasp	nn	25	SENT_41	[p3l1919t2832r2146b2919],
25	)	NN	O	)	conj_and	6	SENT_41	[p3l1919t2832r2146b2919],
26	and	CC	O	and	_	0	SENT_41	[p3l9t2943r152b3013],
27	P-selectin	NN	O	p-selectin	nn	28	SENT_41	[p3l194t2943r595b3013],
28	expression	NN	O	expression	conj_and	6	SENT_41	[p3l633t2944r1064b3031],
29	and	CC	O	and	_	0	SENT_41	[p3l1103t2943r1246b3013],
30	the	DT	O	the	det	31	SENT_41	[p3l1285t2943r1418b3013],
31	aim	NN	O	aim	nsubj	35	SENT_41	[p3l1453t2944r1598b3013],
32	of	IN	O	of	_	0	SENT_41	[p3l1635t2943r1718b3013],
33	this	DT	O	this	det	34	SENT_41	[p3l1750t2943r1897b3013],
34	study	NN	O	study	prep_of	31	SENT_41	[p3l1931t2943r2151b3031],
35	was	VBD	O	be	conj_and	6	SENT_41	[p3l6t3073r159b3125],
36	to	TO	O	to	aux	37	SENT_41	[p3l225t3061r306b3125],
37	evaluate	VB	O	evaluate	xcomp	35	SENT_41	[p3l371t3054r728b3125],
38	influence	NN	O	influence	dobj	37	SENT_41	[p3l794t3054r1177b3125],
39	of	IN	O	of	_	0	SENT_41	[p3l1242t3054r1325b3125],
40	the	DT	O	the	det	43	SENT_41	[p3l1387t3054r1520b3125],
41	T744C	NN	O	t744c	nn	43	SENT_41	[p3l1583t3055r1836b3125],
42	P2Y12	NN	O	p2y12	nn	43	SENT_41	[p3l1906t3055r2147b3124],
43	polymorphism	NN	O	polymorphism	prep_of	38	SENT_41	[p3l11t3167r583b3257],
44	on	IN	O	on	_	0	SENT_41	[p3l623t3186r716b3238],
45	clopidogrel	NN	O	clopidogrel	nn	46	SENT_41	[p3l755t3167r1215b3257],
46	responsiveness	NN	O	responsiveness	prep_on	37	SENT_41	[p3l1256t3169r1861b3257],
47	in	IN	O	in	_	0	SENT_41	[p3l1898t3169r1967b3238],
48	597	CD	NUMBER	597	num	49	SENT_41	[p3l2009t3168r2150b3238],
49	patients	NNS	O	patient	prep_in	37	SENT_41	[p3l11t3282r345b3370],
50	with	IN	O	with	_	0	SENT_41	[p3l367t3280r545b3351],
51	NSTE	NN	O	nste	nn	52	SENT_41	[p3l577t3281r777b3351],
52	ACS	NN	O	ac	prep_with	49	SENT_41	[p3l799t3281r951b3352],
53	receiving	VBG	O	receive	xcomp	37	SENT_41	[p3l981t3281r1353b3370],
54	a	DT	O	a	det	57	SENT_41	[p3l1378t3299r1421b3351],
55	high	JJ	O	high	amod	57	SENT_41	[p3l1449t3280r1613b3370],
56	loading	NN	O	loading	nn	57	SENT_41	[p3l1645t3280r1939b3370],
57	dose	NN	O	dose	dobj	53	SENT_41	[p3l1964t3280r2149b3351],
58	of	IN	O	of	_	0	SENT_41	[p3l8t3393r91b3463],
59	600	CD	NUMBER	600	num	60	SENT_41	[p3l122t3393r263b3463],
60	mg	NN	O	mg	prep_of	57	SENT_41	[p3l299t3410r416b3481],
61	of	IN	O	of	_	0	SENT_41	[p3l449t3393r532b3463],
62	clopidogrel	NN	O	clopidogrel	prep_of	60	SENT_41	[p3l561t3393r1047b3481],
63	.	.	O	.	_	0	SENT_41	[p3l561t3393r1047b3481],

1	Materials	NNPS	O	Materials	_	0	SENT_42	[p3l7t3631r477b3717],
2	and	CC	O	and	_	0	SENT_42	[p3l522t3631r704b3716],
3	methods	NNS	O	method	conj_and	1	SENT_42	[p3l754t3631r1191b3716],

1	Study	NNP	O	Study	_	0	SENT_43	[p4l10t75r274b174],
2	population	NN	O	population	dep	1	SENT_43	[p4l314t75r815b174],

1	Consecutive	JJ	O	consecutive	amod	2	SENT_44	[p4l9t309r495b378],
2	patients	NNS	O	patient	nsubj	23	SENT_44	[p4l538t309r865b396],
3	admitted	VBN	O	admit	partmod	2	SENT_44	[p4l904t308r1269b378],
4	for	IN	O	for	_	0	SENT_44	[p4l1312t308r1428b378],
5	NSTE	NNP	O	NSTE	nn	6	SENT_44	[p4l1470t309r1666b378],
6	ACS	NNP	O	ACS	prep_for	3	SENT_44	[p4l1704t309r1854b378],
7	to	TO	O	to	_	0	SENT_44	[p4l1896t315r1977b378],
8	the	DT	O	the	det	9	SENT_44	[p4l2017t308r2149b378],
9	Department	NNP	ORGANIZATION	Department	prep_to	3	SENT_44	[p4l12t422r493b510],
10	of	IN	ORGANIZATION	of	_	0	SENT_44	[p4l545t420r627b492],
11	Cardiology	NNP	ORGANIZATION	Cardiology	prep_of	9	SENT_44	[p4l677t420r1105b510],
12	at	IN	O	at	_	0	SENT_44	[p4l1155t427r1236b492],
13	the	DT	O	the	det	15	SENT_44	[p4l1288t420r1420b492],
14	Timone	NNP	O	Timone	nn	15	SENT_44	[p4l1470t422r1769b492],
15	Hospital	NNP	O	Hospital	prep_at	3	SENT_44	[p4l1826t420r2149b510],
16	between	IN	O	between	_	0	SENT_44	[p4l11t533r356b605],
17	October	NNP	DATE	October	prep_between	15	SENT_44	[p4l398t533r722b605],
18	2004	CD	DATE	2004	num	17	SENT_44	[p4l758t534r947b604],
19	and	CC	O	and	_	0	SENT_44	[p4l984t533r1125b604],
20	June	NNP	DATE	June	prep_between	15	SENT_44	[p4l1164t535r1354b604],
21	2006	CD	DATE	2006	num	20	SENT_44	[p4l1390t534r1579b605],
22	were	VBD	O	be	cop	23	SENT_44	[p4l1614t552r1815b605],
23	eligible	JJ	O	eligible	_	0	SENT_44	[p4l1853t533r2149b623],
24	for	IN	O	for	_	0	SENT_44	[p4l8t646r125b716],
25	this	DT	O	this	det	27	SENT_44	[p4l160t646r304b716],
26	prospective	JJ	O	prospective	amod	27	SENT_44	[p4l342t647r808b734],
27	study	NN	O	study	prep_for	23	SENT_44	[p4l845t646r1072b734],
28	.	.	O	.	_	0	SENT_44	[p4l845t646r1072b734],

1	NSTE	NNP	ORGANIZATION	NSTE	nn	2	SENT_45	[p4l1122t647r1319b716],
2	ACS	NNP	ORGANIZATION	ACS	nsubjpass	4	SENT_45	[p4l1352t647r1503b716],
3	was	VBD	O	be	auxpass	4	SENT_45	[p4l1539t665r1690b716],
4	defined	VBN	O	define	_	0	SENT_45	[p4l1726t646r2028b716],
5	as	IN	O	as	_	0	SENT_45	[p4l2069t665r2149b716],
6	clinical	JJ	O	clinical	amod	7	SENT_45	[p4l8t758r295b829],
7	symptoms	NNS	O	symptom	npadvmod	55	SENT_45	[p4l326t765r730b848],
8	compatible	JJ	O	compatible	amod	7	SENT_45	[p4l758t758r1212b848],
9	with	IN	O	with	_	0	SENT_45	[p4l1241t758r1416b829],
10	acute	JJ	O	acute	amod	12	SENT_45	[p4l1450t765r1673b829],
11	myocardial	JJ	O	myocardial	amod	12	SENT_45	[p4l1707t758r2149b848],
12	ischemia	NN	O	ischemia	prep_with	8	SENT_45	[p4l9t871r360b941],
13	within	IN	O	within	prep	8	SENT_45	[p4l379t871r628b941],
14	12	CD	NUMBER	12	num	15	SENT_45	[p4l657t872r743b940],
15	h	NN	O	h	dep	32	SENT_45	[p4l767t871r807b940],
16	before	IN	O	before	_	0	SENT_45	[p4l833t871r1095b941],
17	admission	NN	O	admission	prep_before	15	SENT_45	[p4l1114t871r1503b941],
18	and	CC	O	and	_	0	SENT_45	[p4l1527t871r1668b941],
19	at	IN	O	at	quantmod	21	SENT_45	[p4l1692t878r1773b941],
20	least	JJS	O	least	mwe	19	SENT_45	[p4l1795t871r1985b941],
21	one	CD	NUMBER	one	conj_and	15	SENT_45	[p4l2004t890r2149b941],
22	of	IN	O	of	_	0	SENT_45	[p4l8t983r92b1055],
23	the	DT	O	the	det	24	SENT_45	[p4l154t983r288b1055],
24	following	NN	O	following	prep_of	21	SENT_45	[p4l353t983r763b1073],
25	:	:	O	:	_	0	SENT_45	[p4l353t983r763b1073],
26	a	DT	O	a	det	28	SENT_45	[p4l836t1003r879b1055],
27	new	JJ	O	new	amod	28	SENT_45	[p4l947t1003r1114b1055],
28	finding	NN	O	finding	dep	21	SENT_45	[p4l1175t983r1462b1073],
29	of	IN	O	of	_	0	SENT_45	[p4l1527t983r1610b1055],
30	ST-segment	NN	O	st-segment	prep_of	28	SENT_45	[p4l1672t984r2148b1073],
31	depression	NN	O	depression	dep	32	SENT_45	[p4l9t1096r434b1186],
32	>	JJR	O	>	dep	35	SENT_45	[p4l459t1097r695b1167],
33	0.05	CD	NUMBER	0.05	num	34	SENT_45	[p4l459t1097r695b1167],
34	m	NN	O	m	dep	32	SENT_45	[p4l722t1098r856b1183],
35	\	CD	NUMBER	\	dep	13	SENT_45	[p4l722t1098r856b1183],
36	/	:	O	/	punct	35	SENT_45	[p4l722t1098r856b1183],
37	,	,	O	,	_	0	SENT_45	[p4l722t1098r856b1183],
38	transient	JJ	O	transient	amod	39	SENT_45	[p4l888t1098r1250b1167],
39	(	NN	O	(	dep	45	SENT_45	[p4l1279t1097r1461b1185],
40	<	JJR	O	<	dep	39	SENT_45	[p4l1279t1097r1461b1185],
41	20	CD	DURATION	20	num	42	SENT_45	[p4l1279t1097r1461b1185],
42	min	NN	DURATION	min	dep	45	SENT_45	[p4l1487t1098r1661b1186],
43	)	CD	NUMBER	)	num	45	SENT_45	[p4l1487t1098r1661b1186],
44	ST-segment	NN	O	st-segment	nn	45	SENT_45	[p4l1688t1097r2149b1186],
45	elevation	NN	O	elevation	dep	50	SENT_45	[p4l8t1209r381b1279],
46	>	JJR	O	>	dep	45	SENT_45	[p4l423t1210r597b1279],
47	O.	NNP	O	O.	nn	49	SENT_45	[p4l423t1210r597b1279],
48	1	CD	NUMBER	1	num	49	SENT_45	[p4l423t1210r597b1279],
49	m	NN	O	m	dep	46	SENT_45	[p4l655t1211r789b1295],
50	\	CD	NUMBER	\	dep	35	SENT_45	[p4l655t1211r789b1295],
51	/	:	O	/	punct	50	SENT_45	[p4l655t1211r789b1295],
52	,	,	O	,	_	0	SENT_45	[p4l655t1211r789b1295],
53	T-wave	JJ	O	t-wave	amod	54	SENT_45	[p4l835t1211r1122b1279],
54	inversion	NN	O	inversion	dep	50	SENT_45	[p4l1163t1210r1520b1279],
55	>	JJR	O	>	prep_as	4	SENT_45	[p4l1562t1210r1748b1279],
56	O.	NNP	O	O.	nn	58	SENT_45	[p4l1562t1210r1748b1279],
57	3	CD	NUMBER	3	num	58	SENT_45	[p4l1562t1210r1748b1279],
58	mV	NN	O	mv	dobj	4	SENT_45	[p4l1794t1211r1921b1279],
59	in	IN	O	in	_	0	SENT_45	[p4l1958t1210r2025b1278],
60	at	IN	O	at	quantmod	62	SENT_45	[p4l2069t1216r2149b1279],
61	least	JJS	O	least	mwe	60	SENT_45	[p4l12t1320r201b1391],
62	two	CD	NUMBER	two	num	63	SENT_45	[p4l227t1327r376b1391],
63	leads	NNS	O	lead	prep_in	58	SENT_45	[p4l406t1320r635b1406],
64	,	,	O	,	_	0	SENT_45	[p4l406t1320r635b1406],
65	elevated	JJ	O	elevated	amod	66	SENT_45	[p4l667t1320r1016b1391],
66	levels	NNS	O	level	conj_or	58	SENT_45	[p4l1048t1320r1275b1391],
67	of	IN	O	of	_	0	SENT_45	[p4l1299t1320r1381b1391],
68	cardiac	JJ	O	cardiac	amod	69	SENT_45	[p4l1403t1320r1695b1391],
69	markers	NNS	O	marker	prep_of	66	SENT_45	[p4l1724t1320r2043b1391],
70	or	CC	O	or	_	0	SENT_45	[p4l2068t1340r2151b1391],
71	coronary	JJ	O	coronary	amod	73	SENT_45	[p4l8t1452r363b1523],
72	artery	NN	O	artery	nn	73	SENT_45	[p4l384t1440r631b1523],
73	disease	NN	O	disease	conj_or	58	SENT_45	[p4l651t1433r943b1504],
74	as	IN	O	as	mark	75	SENT_45	[p4l967t1452r1046b1504],
75	documented	VBN	O	document	dep	73	SENT_45	[p4l1069t1433r1569b1504],
76	by	IN	O	by	_	0	SENT_45	[p4l1597t1433r1688b1523],
77	a	DT	O	a	det	78	SENT_45	[p4l1709t1452r1752b1504],
78	history	NN	O	history	prep_by	75	SENT_45	[p4l1778t1433r2051b1523],
79	of	IN	O	of	_	0	SENT_45	[p4l2070t1433r2152b1504],
80	catheterization	NN	O	catheterization	prep_of	78	SENT_45	[p4l8t1546r656b1632],
81	,	,	O	,	_	0	SENT_45	[p4l8t1546r656b1632],
82	revascularization	NN	O	revascularization	prep_of	78	SENT_45	[p4l709t1546r1392b1616],
83	or	CC	O	or	_	0	SENT_45	[p4l1437t1565r1519b1616],
84	myocardial	JJ	O	myocardial	amod	85	SENT_45	[p4l1561t1546r2002b1634],
85	infarction	NN	O	infarction	prep_of	78	SENT_45	[p4l2045t1547r2144b1615, p4l8t1659r350b1730],
86	.	.	O	.	_	0	SENT_45	[p4l2045t1547r2144b1615, p4l8t1659r350b1730],

1	The	DT	O	the	det	3	SENT_46	[p4l411t1659r562b1730],
2	exclusion	NN	O	exclusion	nn	3	SENT_46	[p4l615t1659r985b1730],
3	criteria	NNS	O	criterion	nsubj	6	SENT_46	[p4l1043t1661r1338b1730],
4	were	VBD	O	be	cop	6	SENT_46	[p4l1391t1678r1593b1730],
5	a	DT	O	a	det	6	SENT_46	[p4l1647t1678r1690b1730],
6	history	NN	O	history	_	0	SENT_46	[p4l1747t1659r2020b1749],
7	of	IN	O	of	_	0	SENT_46	[p4l2071t1659r2152b1730],
8	bleeding	VBG	O	bleed	prepc_of	6	SENT_46	[p4l11t1771r353b1859],
9	diathesis	NN	O	diathesis	dep	24	SENT_46	[p4l379t1771r757b1857],
10	,	,	O	,	_	0	SENT_46	[p4l379t1771r757b1857],
11	persistent	JJ	O	persistent	amod	13	SENT_46	[p4l793t1772r1191b1859],
12	STelevation	NN	O	stelevation	nn	13	SENT_46	[p4l1216t1771r1694b1841],
13	ACS	NN	ORGANIZATION	ac	appos	9	SENT_46	[p4l1719t1772r1896b1857],
14	,	,	O	,	_	0	SENT_46	[p4l1719t1772r1896b1857],
15	NYHA	NN	O	nyha	nn	16	SENT_46	[p4l1932t1772r2151b1841],
16	class	NN	O	class	appos	9	SENT_46	[p4l8t1883r196b1955],
17	IV	CD	NUMBER	iv	dep	16	SENT_46	[p4l233t1885r313b1970],
18	,	,	O	,	_	0	SENT_46	[p4l233t1885r313b1970],
19	Percutaneous	JJ	O	percutaneous	amod	21	SENT_46	[p4l356t1885r894b1955],
20	Coronary	JJ	O	coronary	amod	21	SENT_46	[p4l926t1884r1289b1973],
21	Intervention	NN	O	intervention	appos	9	SENT_46	[p4l1323t1885r1810b1955],
22	(	CD	NUMBER	(	num	23	SENT_46	[p4l1850t1884r2034b1973],
23	PCI	NN	O	pcus	dep	24	SENT_46	[p4l1850t1884r2034b1973],
24	)	CD	NUMBER	)	dep	28	SENT_46	[p4l1850t1884r2034b1973],
25	or	CC	O	or	_	0	SENT_46	[p4l2068t1903r2151b1955],
26	coronary	JJ	O	coronary	amod	27	SENT_46	[p4l8t2015r363b2086],
27	bypass	NN	O	bypass	dep	28	SENT_46	[p4l397t1996r657b2086],
28	grafting	VBG	O	graft	dep	66	SENT_46	[p4l691t1996r1005b2086],
29	(	CD	NUMBER	(	num	31	SENT_46	[p4l1045t1997r1320b2086],
30	CABG	NN	ORGANIZATION	cabg	nn	31	SENT_46	[p4l1045t1997r1320b2086],
31	)	NN	O	)	dobj	28	SENT_46	[p4l1045t1997r1320b2086],
32	<	JJR	O	<	amod	31	SENT_46	[p4l1355t1997r1460b2067],
33	3	CD	DURATION	3	num	34	SENT_46	[p4l1355t1997r1460b2067],
34	months	NNS	NUMBER	month	tmod	32	SENT_46	[p4l1500t1996r1816b2083],
35	,	,	O	,	_	0	SENT_46	[p4l1500t1996r1816b2083],
36	contraindications	NNS	O	contraindication	npadvmod	43	SENT_46	[p4l1856t2003r2144b2067, p4l9t2109r446b2179],
37	to	TO	O	to	_	0	SENT_46	[p4l499t2116r579b2179],
38	antiplatelet	JJ	O	antiplatelet	amod	39	SENT_46	[p4l633t2109r1112b2197],
39	therapy	NN	O	therapy	prep_to	36	SENT_46	[p4l1165t2109r1489b2197],
40	,	,	O	,	_	0	SENT_46	[p4l1165t2109r1489b2197],
41	platelet	NN	O	platelet	nn	42	SENT_46	[p4l1553t2109r1871b2197],
42	count	NN	O	count	appos	39	SENT_46	[p4l1923t2116r2149b2179],
43	<	JJR	O	<	dep	32	SENT_46	[p4l7t2222r212b2293],
44	1OO	CD	NUMBER	1oo	num	45	SENT_46	[p4l7t2222r212b2293],
45	G	NN	O	g	dep	32	SENT_46	[p4l243t2222r341b2293],
46	/	:	O	/	punct	47	SENT_46	[p4l243t2222r341b2293],
47	L	NN	O	l	dep	31	SENT_46	[p4l356t2223r418b2308],
48	,	,	O	,	_	0	SENT_46	[p4l356t2223r418b2308],
49	creatinin	NN	O	creatinin	nn	50	SENT_46	[p4l458t2223r816b2293],
50	clearance	NN	O	clearance	appos	47	SENT_46	[p4l850t2221r1242b2293],
51	<	JJR	O	<	dep	50	SENT_46	[p4l1272t2222r1426b2293],
52	25	CD	NUMBER	25	num	53	SENT_46	[p4l1272t2222r1426b2293],
53	mL	NN	O	ml	dep	47	SENT_46	[p4l1462t2223r1618b2292],
54	/	:	O	/	punct	47	SENT_46	[p4l1462t2223r1618b2292],
55	min	NN	DURATION	min	nn	56	SENT_46	[p4l1633t2223r1807b2311],
56	)	NN	O	)	dep	28	SENT_46	[p4l1633t2223r1807b2311],
57	and	CC	O	and	_	0	SENT_46	[p4l1842t2221r1982b2293],
58	use	NN	O	use	conj_and	56	SENT_46	[p4l2019t2241r2149b2293],
59	of	IN	O	of	_	0	SENT_46	[p4l8t2334r91b2405],
60	GP	NN	O	gp	nn	63	SENT_46	[p4l112t2334r441b2406],
61	|	CD	NUMBER	|	num	63	SENT_46	[p4l112t2334r441b2406],
62	|	NN	O	|	nn	63	SENT_46	[p4l112t2334r441b2406],
63	b	NN	O	b	prep_of	56	SENT_46	[p4l112t2334r441b2406],
64	|	CD	NUMBER	|	num	65	SENT_46	[p4l112t2334r441b2406],
65	|	CD	NUMBER	|	nsubj	66	SENT_46	[p4l112t2334r441b2406],
66	|	VBD	O	|	ccomp	8	SENT_46	[p4l112t2334r441b2406],
67	a	DT	O	a	det	68	SENT_46	[p4l112t2334r441b2406],
68	antagonist	NN	O	antagonist	dobj	66	SENT_46	[p4l466t2336r887b2424],
69	before	IN	O	before	_	0	SENT_46	[p4l913t2334r1174b2406],
70	the	DT	O	the	det	71	SENT_46	[p4l1199t2334r1331b2405],
71	procedure	NN	O	procedure	prep_before	66	SENT_46	[p4l1359t2334r1791b2424],
72	.	.	O	.	_	0	SENT_46	[p4l1359t2334r1791b2424],

1	Patients	NNS	O	patient	nsubj	2	SENT_47	[p4l1828t2336r2149b2405],
2	received	VBD	O	receive	_	0	SENT_47	[p4l12t2447r352b2517],
3	a	DT	O	a	det	7	SENT_47	[p4l399t2466r442b2517],
4	600	CD	NUMBER	600	num	7	SENT_47	[p4l487t2448r627b2517],
5	mg	NN	O	mg	nn	7	SENT_47	[p4l672t2464r787b2535],
6	loading	NN	O	loading	nn	7	SENT_47	[p4l835t2447r1122b2535],
7	dose	NN	O	dose	dobj	2	SENT_47	[p4l1165t2447r1348b2517],
8	of	IN	O	of	_	0	SENT_47	[p4l1390t2447r1471b2517],
9	clopidogrel	NN	O	clopidogrel	prep_of	7	SENT_47	[p4l1512t2447r1960b2535],
10	and	CC	O	and	_	0	SENT_47	[p4l2005t2447r2145b2517],
11	250	CD	NUMBER	250	num	12	SENT_47	[p4l8t2560r149b2630],
12	mg	NN	O	mg	dobj	2	SENT_47	[p4l209t2576r323b2649],
13	of	IN	O	of	_	0	SENT_47	[p4l381t2559r462b2630],
14	aspirin	NN	O	aspirin	prep_of	12	SENT_47	[p4l516t2561r779b2649],
15	at	IN	O	at	quantmod	17	SENT_47	[p4l840t2566r919b2630],
16	least	JJS	O	least	mwe	15	SENT_47	[p4l980t2559r1169b2630],
17	12	CD	NUMBER	12	num	18	SENT_47	[p4l1231t2560r1316b2629],
18	h	NN	O	h	npadvmod	2	SENT_47	[p4l1377t2559r1417b2629],
19	before	IN	O	before	_	0	SENT_47	[p4l1480t2559r1741b2630],
20	coronary	JJ	O	coronary	amod	21	SENT_47	[p4l1797t2578r2152b2649],
21	angiography	NN	O	angiography	prep_before	2	SENT_47	[p4l9t2672r499b2760],
22	and	CC	O	and	_	0	SENT_47	[p4l556t2672r696b2742],
23	blood	NN	O	blood	nn	24	SENT_47	[p4l760t2672r976b2742],
24	samples	NNS	O	sample	conj_and	21	SENT_47	[p4l1037t2672r1382b2760],
25	.	.	O	.	_	0	SENT_47	[p4l1037t2672r1382b2760],

1	For	IN	O	for	_	0	SENT_48	[p4l1451t2674r1578b2742],
2	all	DT	O	all	det	3	SENT_48	[p4l1633t2672r1728b2742],
3	patients	NNS	O	patient	prep_for	7	SENT_48	[p4l1790t2673r2142b2760],
4	,	,	O	,	_	0	SENT_48	[p4l1790t2673r2142b2760],
5	anticoagulation	NN	O	anticoagulation	nsubjpass	7	SENT_48	[p4l9t2784r634b2874],
6	was	VBD	O	be	auxpass	7	SENT_48	[p4l660t2804r811b2856],
7	begun	VBN	O	begin	_	0	SENT_48	[p4l840t2784r1076b2874],
8	before	IN	O	before	_	0	SENT_48	[p4l1108t2784r1369b2856],
9	coronary	JJ	O	coronary	amod	10	SENT_48	[p4l1395t2804r1750b2874],
10	angiography	NN	O	angiography	prep_before	7	SENT_48	[p4l1773t2786r2144b2874, p4l11t2898r152b2988],
11	in	IN	O	in	_	0	SENT_48	[p4l175t2900r243b2969],
12	the	DT	O	the	det	15	SENT_48	[p4l270t2898r401b2969],
13	intensive	JJ	O	intensive	amod	15	SENT_48	[p4l425t2900r788b2969],
14	care	NN	O	care	nn	15	SENT_48	[p4l812t2917r986b2969],
15	unit	NN	O	unit	prep_in	10	SENT_48	[p4l1013t2900r1167b2969],
16	and	CC	O	and	_	0	SENT_48	[p4l1192t2898r1332b2969],
17	performed	VBN	O	perform	conj_and	7	SENT_48	[p4l1362t2898r1782b2988],
18	with	IN	O	with	_	0	SENT_48	[p4l1807t2898r1981b2969],
19	low	JJ	O	low	amod	26	SENT_48	[p4l2012t2898r2150b2969],
20	molecular	JJ	O	molecular	amod	26	SENT_48	[p4l11t3010r414b3080],
21	weight	NN	O	weight	nn	26	SENT_48	[p4l435t3010r709b3098],
22	heparin	NN	O	heparin	nn	26	SENT_48	[p4l739t3010r1038b3098],
23	(	NN	O	(	nn	26	SENT_48	[p4l1073t3011r1495b3098],
24	enoxapari	NN	O	enoxaparus	nn	26	SENT_48	[p4l1073t3011r1495b3098],
25	n	NN	O	n	nn	26	SENT_48	[p4l1506t3012r1606b3098],
26	)	NN	O	)	prep_with	17	SENT_48	[p4l1506t3012r1606b3098],
27	,	,	O	,	_	0	SENT_48	[p4l1506t3012r1606b3098],
28	or	CC	O	or	_	0	SENT_48	[p4l1641t3029r1724b3080],
29	unfractionated	JJ	O	unfractionated	amod	30	SENT_48	[p4l1751t3010r2144b3080, p4l11t3122r236b3194],
30	heparin	NN	O	heparin	conj_or	7	SENT_48	[p4l272t3122r570b3212],
31	in	IN	O	in	_	0	SENT_48	[p4l604t3124r672b3193],
32	patients	NNS	O	patient	prep_in	30	SENT_48	[p4l707t3124r1034b3212],
33	over	IN	O	over	_	0	SENT_48	[p4l1062t3142r1239b3194],
34	75	CD	DURATION	75	num	35	SENT_48	[p4l1267t3124r1356b3194],
35	years	NNS	NUMBER	year	prep_over	32	SENT_48	[p4l1386t3142r1599b3212],
36	or	CC	O	or	_	0	SENT_48	[p4l1627t3142r1711b3194],
37	with	IN	O	with	_	0	SENT_48	[p4l1736t3122r1911b3194],
38	renal	JJ	O	renal	amod	39	SENT_48	[p4l1948t3122r2149b3194],
39	insufficiency	NN	O	insufficiency	prep_with	30	SENT_48	[p4l9t3235r531b3325],
40	.	.	O	.	_	0	SENT_48	[p4l9t3235r531b3325],

1	The	DT	O	the	det	3	SENT_49	[p4l561t3235r711b3306],
2	study	NN	O	study	nn	3	SENT_49	[p4l735t3235r951b3325],
3	protocol	NN	O	protocol	nsubjpass	5	SENT_49	[p4l975t3235r1308b3325],
4	was	VBD	O	be	auxpass	5	SENT_49	[p4l1329t3254r1480b3307],
5	approved	VBN	O	approve	_	0	SENT_49	[p4l1504t3235r1875b3325],
6	by	IN	O	by	_	0	SENT_49	[p4l1905t3235r1996b3325],
7	the	DT	O	the	det	9	SENT_49	[p4l2017t3235r2149b3306],
8	ethics	NNS	O	ethic	nn	9	SENT_49	[p4l8t3348r247b3418],
9	committee	NN	O	committee	agent	5	SENT_49	[p4l268t3349r707b3418],
10	of	IN	O	of	_	0	SENT_49	[p4l729t3348r811b3418],
11	our	PRP$	O	we	poss	12	SENT_49	[p4l828t3367r961b3418],
12	institution	NN	O	institution	prep_of	9	SENT_49	[p4l980t3349r1419b3434],
13	,	,	O	,	_	0	SENT_49	[p4l980t3349r1419b3434],
14	and	CC	O	and	_	0	SENT_49	[p4l1449t3348r1590b3418],
15	patients	NNS	O	patient	nsubj	16	SENT_49	[p4l1618t3349r1944b3436],
16	gave	VBD	O	give	conj_and	5	SENT_49	[p4l1965t3365r2149b3436],
17	written	VBN	O	write	dep	16	SENT_49	[p4l7t3463r303b3532],
18	informed	VBN	O	inform	amod	19	SENT_49	[p4l336t3461r696b3532],
19	consent	NN	O	consent	dobj	17	SENT_49	[p4l729t3468r1041b3532],
20	for	IN	O	for	_	0	SENT_49	[p4l1070t3461r1187b3532],
21	participation	NN	O	participation	prep_for	19	SENT_49	[p4l1216t3463r1757b3551],
22	.	.	O	.	_	0	SENT_49	[p4l1216t3463r1757b3551],

1	Blood	NN	O	blood	nn	2	SENT_50	[p4l13t3659r268b3738],
2	samples	NNS	O	sample	_	0	SENT_50	[p4l311t3659r685b3758],

1	Blood	NN	O	blood	nn	2	SENT_51	[p5l12t114r229b184],
2	samples	NNS	O	sample	nsubjpass	8	SENT_51	[p5l282t114r603b202],
3	for	IN	O	for	_	0	SENT_51	[p5l651t114r768b184],
4	testing	NN	O	testing	nn	6	SENT_51	[p5l815t115r1092b202],
5	platelet	NN	O	platelet	nn	6	SENT_51	[p5l1143t114r1462b202],
6	reactivity	NN	O	reactivity	prep_for	2	SENT_51	[p5l1514t115r1903b202],
7	were	VBD	O	be	auxpass	8	SENT_51	[p5l1947t133r2150b184],
8	drawn	VBN	O	draw	_	0	SENT_51	[p5l9t226r255b297],
9	in	IN	O	in	_	0	SENT_51	[p5l318t228r387b297],
10	the	DT	O	the	det	12	SENT_51	[p5l449t226r581b297],
11	catheterization	NN	O	catheterization	nn	12	SENT_51	[p5l639t226r1264b297],
12	laboratory	NN	O	laboratory	prep_in	8	SENT_51	[p5l1329t226r1748b316],
13	from	IN	O	from	_	0	SENT_51	[p5l1805t226r1992b297],
14	an	DT	O	a	det	16	SENT_51	[p5l2055t245r2146b297],
15	arterial	JJ	O	arterial	amod	16	SENT_51	[p5l9t338r310b408],
16	sheath	NN	O	sheath	prep_from	8	SENT_51	[p5l348t338r612b408],
17	before	IN	O	before	_	0	SENT_51	[p5l656t338r919b408],
18	the	DT	O	the	det	20	SENT_51	[p5l956t338r1088b408],
19	coronary	JJ	O	coronary	amod	20	SENT_51	[p5l1126t357r1481b426],
20	angiography	NN	O	angiography	prep_before	8	SENT_51	[p5l1517t338r2023b426],
21	,	,	O	,	_	0	SENT_51	[p5l1517t338r2023b426],
22	at	IN	O	at	advmod	20	SENT_51	[p5l2068t345r2150b408],

1	Role	NN	O	role	_	0	SENT_52	[p5l99t501r174b533],
2	of	IN	O	of	_	0	SENT_52	[p5l190t501r226b533],
3	the	DT	O	the	det	5	SENT_52	[p5l241t501r300b533],
4	T744C	NN	O	t744c	nn	5	SENT_52	[p5l315t501r426b533],
5	polymorphism	NN	O	polymorphism	prep_of	1	SENT_52	[p5l444t501r697b541],
6	of	IN	O	of	_	0	SENT_52	[p5l714t501r751b533],
7	the	DT	O	the	det	9	SENT_52	[p5l766t501r824b533],
8	P2Y12	NN	O	p2y12	nn	9	SENT_52	[p5l842t501r949b532],
9	gene	NN	O	gene	prep_of	5	SENT_52	[p5l966t509r1051b541],
10	on	IN	O	on	_	0	SENT_52	[p5l1067t509r1108b533],
11	a	DT	O	a	det	13	SENT_52	[p5l1126t509r1145b533],
12	600-mg	JJ	O	600-mg	amod	13	SENT_52	[p5l1162t501r1294b541],
13	dose	NN	O	dose	prep_on	9	SENT_52	[p5l1310t501r1392b533],
14	of	IN	O	of	_	0	SENT_52	[p5l1408t501r1444b533],
15	clopidogrel	NN	O	clopidogrel	prep_of	13	SENT_52	[p5l1459t501r1662b541],
16	in	IN	O	in	_	0	SENT_52	[p5l1678t502r1709b532],
17	597	CD	NUMBER	597	num	18	SENT_52	[p5l1728t501r1789b533],
18	patients	NNS	O	patient	prep_in	15	SENT_52	[p5l1806t502r1953b541],
19	895	CD	NUMBER	895	dep	1	SENT_52	[p5l2000t501r2061b533],

1	least	JJS	O	least	conj_and	1	SENT_53	[p5l12t704r193b772],
2	12	CD	NUMBER	12	num	3	SENT_53	[p5l233t705r313b771],
3	h	NN	O	h	npadvmod	1	SENT_53	[p5l352t704r389b771],
4	after	IN	O	after	_	0	SENT_53	[p5l427t704r618b772],
5	the	DT	O	the	det	7	SENT_53	[p5l651t704r776b772],
6	loading	VBG	O	load	amod	7	SENT_53	[p5l813t704r1088b789],
7	dose	NN	O	dose	prep_after	3	SENT_53	[p5l1122t704r1296b772],
8	of	IN	O	of	_	0	SENT_53	[p5l1329t704r1408b772],
9	clopidogrel	NN	O	clopidogrel	prep_of	1	SENT_53	[p5l1438t704r1866b789],
10	and	CC	O	and	_	0	SENT_53	[p5l1902t704r2036b772],
11	aspirin	NN	O	aspirin	prep_of	1	SENT_53	[p5l10t813r263b897],
12	and	CC	O	and	_	0	SENT_53	[p5l325t812r461b879],
13	before	IN	O	before	_	0	SENT_53	[p5l525t812r775b879],
14	administration	NN	O	administration	prep_before	1	SENT_53	[p5l835t812r1397b879],
15	of	IN	O	of	_	0	SENT_53	[p5l1458t812r1537b879],
16	tirofiban	NN	O	tirofiban	prep_of	14	SENT_53	[p5l1593t812r1925b879],
17	if	IN	O	if	mark	18	SENT_53	[p5l1987t812r2043b879],
18	needed	VBN	O	need	dep	14	SENT_53	[p5l12t919r317b986],
19	.	.	O	.	_	0	SENT_53	[p5l12t919r317b986],

1	The	DT	O	the	det	4	SENT_54	[p5l381t919r526b986],
2	initial	JJ	O	initial	amod	4	SENT_54	[p5l584t919r807b986],
3	first	JJ	ORDINAL	first	amod	4	SENT_54	[p5l865t919r1021b986],
4	blood	NN	O	blood	nsubjpass	20	SENT_54	[p5l1082t919r1290b986],
5	millimetres	NNS	O	millimetre	nsubjpass	7	SENT_54	[p5l1353t919r1792b986],
6	were	VBD	O	be	auxpass	7	SENT_54	[p5l1847t937r2040b986],
7	discarded	VBN	O	discard	rcmod	4	SENT_54	[p5l9t1025r376b1093],
8	to	TO	O	to	aux	9	SENT_54	[p5l429t1032r507b1093],
9	avoid	VB	O	avoid	xcomp	7	SENT_54	[p5l556t1025r757b1093],
10	platelet	NN	O	platelet	nn	11	SENT_54	[p5l812t1025r1115b1110],
11	activation	NN	O	activation	dobj	9	SENT_54	[p5l1165t1027r1546b1093],
12	induced	VBN	O	induce	partmod	11	SENT_54	[p5l1600t1025r1899b1093],
13	by	IN	O	by	_	0	SENT_54	[p5l1955t1025r2042b1110],
14	needle	NN	O	needle	nn	15	SENT_54	[p5l12t1132r270b1199],
15	puncture	NN	O	puncture	agent	12	SENT_54	[p5l298t1138r642b1217],
16	and	CC	O	and	_	0	SENT_54	[p5l668t1132r803b1199],
17	blood	NN	O	blood	agent	12	SENT_54	[p5l835t1132r1041b1199],
18	was	VBD	O	be	auxpass	20	SENT_54	[p5l1068t1150r1211b1199],
19	immediately	RB	O	immediately	advmod	20	SENT_54	[p5l1239t1132r1723b1217],
20	collected	VBN	O	collect	_	0	SENT_54	[p5l1746t1132r2035b1199, p5l9t1240r99b1307],
21	in	IN	O	in	_	0	SENT_54	[p5l146t1241r211b1306],
22	a	DT	O	a	det	24	SENT_54	[p5l258t1258r299b1307],
23	vacutainer	NN	O	vacutainer	nn	24	SENT_54	[p5l342t1241r755b1307],
24	tube	NN	O	tube	prep_in	20	SENT_54	[p5l797t1240r971b1307],
25	containing	VBG	O	contain	xcomp	20	SENT_54	[p5l1015t1241r1416b1324],
26	3.8	CD	PERCENT	3.8	number	27	SENT_54	[p5l1463t1241r1633b1307],
27	%	NN	PERCENT	%	amod	29	SENT_54	[p5l1463t1241r1633b1307],
28	trisodium	NN	O	trisodium	nn	29	SENT_54	[p5l1677t1240r2037b1307],
29	citrate	NN	O	citrate	dobj	25	SENT_54	[p5l9t1348r292b1428],
30	,	,	O	,	_	0	SENT_54	[p5l9t1348r292b1428],
31	filled	VBN	O	fill	conj_and	20	SENT_54	[p5l337t1346r533b1414],
32	to	TO	O	to	_	0	SENT_54	[p5l574t1353r651b1414],
33	capacity	NN	O	capacity	prep_to	31	SENT_54	[p5l687t1348r1025b1431],
34	,	,	O	,	_	0	SENT_54	[p5l687t1348r1025b1431],
35	and	CC	O	and	_	0	SENT_54	[p5l1070t1346r1205b1414],
36	sent	VBD	O	send	conj_and	20	SENT_54	[p5l1245t1353r1406b1414],
37	immediately	RB	O	immediately	advmod	36	SENT_54	[p5l1443t1346r1927b1431],
38	to	TO	O	to	_	0	SENT_54	[p5l1962t1353r2040b1414],
39	the	DT	O	the	det	41	SENT_54	[p5l9t1454r135b1521],
40	haemostasis	NN	O	haemostasis	nn	41	SENT_54	[p5l166t1454r628b1521],
41	laboratory	NN	O	laboratory	prep_to	36	SENT_54	[p5l658t1454r1067b1538],
42	.	.	O	.	_	0	SENT_54	[p5l658t1454r1067b1538],

1	Platelet	NN	O	platelet	nn	2	SENT_55	[p5l13t1651r360b1726],
2	aggregation	NN	O	aggregation	_	0	SENT_55	[p5l399t1653r920b1745],

1	The	DT	O	the	det	3	SENT_56	[p5l7t1881r150b1949],
2	blood-citrate	JJ	O	blood-citrate	amod	3	SENT_56	[p5l189t1881r692b1949],
3	mixture	NN	O	mixture	nsubjpass	5	SENT_56	[p5l730t1883r1027b1949],
4	was	VBD	O	be	auxpass	5	SENT_56	[p5l1060t1900r1204b1949],
5	centrifuged	VBN	O	centrifuge	_	0	SENT_56	[p5l1239t1881r1681b1966],
6	at	IN	O	at	_	0	SENT_56	[p5l1720t1888r1797b1949],
7	120	CD	NUMBER	120	num	8	SENT_56	[p5l1837t1882r1964b1949],
8	g	NN	O	g	prep_at	5	SENT_56	[p5l2000t1898r2039b1966],
9	for	IN	O	for	_	0	SENT_56	[p5l9t1988r120b2055],
10	5	CD	DURATION	5	num	11	SENT_56	[p5l159t1990r195b2055],
11	min	NN	DURATION	min	prep_for	8	SENT_56	[p5l239t1990r401b2055],
12	.	.	O	.	_	0	SENT_56	[p5l239t1990r401b2055],

1	The	DT	O	the	det	4	SENT_57	[p5l446t1988r589b2055],
2	resulting	VBG	O	result	amod	4	SENT_57	[p5l632t1988r963b2073],
3	platelet-rich	JJ	O	platelet-rich	amod	4	SENT_57	[p5l1004t1988r1483b2073],
4	plasma	NN	O	plasma	nsubjpass	28	SENT_57	[p5l1528t1988r1794b2073],
5	(	CD	NUMBER	(	num	7	SENT_57	[p5l1838t1989r2036b2073],
6	PRP	NN	O	prp	nn	7	SENT_57	[p5l1838t1989r2036b2073],
7	)	NN	O	)	nsubjpass	9	SENT_57	[p5l1838t1989r2036b2073],
8	was	VBD	O	be	auxpass	9	SENT_57	[p5l7t2114r151b2163],
9	kept	VBN	O	keep	rcmod	4	SENT_57	[p5l176t2096r344b2180],
10	at	IN	O	at	_	0	SENT_57	[p5l366t2102r443b2163],
11	room	NN	O	room	nn	12	SENT_57	[p5l468t2114r658b2163],
12	temperature	NN	O	temperature	prep_at	9	SENT_57	[p5l683t2102r1173b2180],
13	for	IN	O	for	_	0	SENT_57	[p5l1195t2096r1306b2163],
14	use	NN	O	use	prep_for	12	SENT_57	[p5l1328t2114r1451b2163],
15	within	IN	O	within	_	0	SENT_57	[p5l1472t2096r1710b2163],
16	1	CD	NUMBER	1	num	17	SENT_57	[p5l1741t2097r1764b2162],
17	h.	NN	O	h.	prep_within	9	SENT_57	[p5l1803t2096r1868b2163],
18	The	DT	O	the	det	20	SENT_57	[p5l1896t2096r2039b2163],
19	platelet	NN	O	platelet	nn	20	SENT_57	[p5l12t2202r315b2287],
20	count	NN	O	count	dep	17	SENT_57	[p5l336t2209r552b2270],
21	was	VBD	O	be	auxpass	22	SENT_57	[p5l571t2221r715b2270],
22	determined	VBN	O	determine	_	0	SENT_57	[p5l737t2202r1182b2270],
23	in	IN	O	in	_	0	SENT_57	[p5l1207t2204r1272b2269],
24	the	DT	O	the	det	26	SENT_57	[p5l1297t2202r1422b2270],
25	PRP	NN	O	prp	nn	26	SENT_57	[p5l1447t2204r1587b2269],
26	sample	NN	O	sample	prep_in	22	SENT_57	[p5l1610t2202r1880b2287],
27	and	CC	O	and	_	0	SENT_57	[p5l1902t2202r2036b2270],
28	adjusted	VBN	O	adjust	conj_and	22	SENT_57	[p5l10t2309r341b2393],
29	to	TO	O	to	_	0	SENT_57	[p5l368t2316r446b2376],
30	2.5	CD	NUMBER	2.5	num	31	SENT_57	[p5l469t2310r586b2376],
31	x108	CD	NUMBER	x108	prep_to	28	SENT_57	[p5l606t2302r782b2376],
32	mL	NN	O	ml	nn	33	SENT_57	[p5l812t2303r996b2375],
33	“	NN	O	“	dobj	22	SENT_57	[p5l812t2303r996b2375],
34	with	IN	O	with	_	0	SENT_57	[p5l1030t2309r1197b2376],
35	homologous	JJ	O	homologous	amod	37	SENT_57	[p5l1227t2309r1678b2393],
36	plateletpoor	NN	O	plateletpoor	nn	37	SENT_57	[p5l1706t2309r2036b2393, p5l12t2434r183b2500],
37	plasma	NN	O	plasma	prep_with	22	SENT_57	[p5l224t2415r490b2500],
38	(	CD	NUMBER	(	num	40	SENT_57	[p5l536t2417r759b2500],
39	PPP	NN	ORGANIZATION	ppp	nn	40	SENT_57	[p5l536t2417r759b2500],
40	)	NN	O	)	dep	37	SENT_57	[p5l536t2417r759b2500],
41	.	.	O	.	_	0	SENT_57	[p5l536t2417r759b2500],

1	Platelets	NNS	O	platelet	nsubjpass	3	SENT_58	[p5l812t2415r1149b2483],
2	were	VBD	O	be	auxpass	3	SENT_58	[p5l1187t2434r1379b2483],
3	stimulated	VBN	O	stimulate	_	0	SENT_58	[p5l1420t2415r1828b2483],
4	with	IN	O	with	_	0	SENT_58	[p5l1870t2415r2037b2483],
5	ADP	NN	O	adp	prep_with	3	SENT_58	[p5l7t2523r158b2589],
6	(	CD	NUMBER	(	number	7	SENT_58	[p5l186t2523r301b2606],
7	10	CD	NUMBER	10	num	10	SENT_58	[p5l186t2523r301b2606],
8	umoll	NN	O	umoll	nn	10	SENT_58	[p5l325t2522r554b2606],
9	L	NN	O	l	nn	10	SENT_58	[p5l568t2524r632b2606],
10	)	NN	O	)	tmod	3	SENT_58	[p5l568t2524r632b2606],
11	and	CC	O	and	_	0	SENT_58	[p5l659t2522r793b2589],
12	aggregation	NN	O	aggregation	conj_and	10	SENT_58	[p5l820t2524r1269b2607],
13	was	VBD	O	be	auxpass	14	SENT_58	[p5l1294t2540r1438b2589],
14	assessed	VBN	O	assess	rcmod	10	SENT_58	[p5l1460t2522r1780b2589],
15	with	IN	O	with	_	0	SENT_58	[p5l1805t2522r1972b2589],
16	a	DT	O	a	det	18	SENT_58	[p5l1998t2540r2039b2589],
17	PAP4	NN	O	pap4	nn	18	SENT_58	[p5l12t2631r191b2696],
18	Aggregometer	NNP	O	Aggregometer	prep_with	14	SENT_58	[p5l210t2631r757b2714],
19	(	CD	NUMBER	(	num	18	SENT_58	[p5l783t2630r1100b2714],
20	Biodata	NNP	ORGANIZATION	Biodata	nn	27	SENT_58	[p5l783t2630r1100b2714],
21	Corporation	NNP	ORGANIZATION	Corporation	nn	27	SENT_58	[p5l1123t2631r1603b2714],
22	,	,	O	,	_	0	SENT_58	[p5l1123t2631r1603b2714],
23	Wellcome	NNP	ORGANIZATION	Wellcome	appos	27	SENT_58	[p5l1630t2630r2032b2712],
24	,	,	O	,	_	0	SENT_58	[p5l1630t2630r2032b2712],
25	Paris	NNP	LOCATION	Paris	appos	27	SENT_58	[p5l12t2738r212b2818],
26	,	,	O	,	_	0	SENT_58	[p5l12t2738r212b2818],
27	France	NNP	LOCATION	France	dep	10	SENT_58	[p5l275t2738r587b2821],
28	)	CD	NUMBER	)	num	27	SENT_58	[p5l275t2738r587b2821],
29	.	.	O	.	_	0	SENT_58	[p5l275t2738r587b2821],

1	Aggregation	NN	O	aggregation	nsubjpass	3	SENT_59	[p5l644t2737r1103b2821],
2	was	VBD	O	be	auxpass	3	SENT_59	[p5l1155t2755r1299b2804],
3	expressed	VBN	O	express	_	0	SENT_59	[p5l1351t2736r1731b2821],
4	as	IN	O	as	_	0	SENT_59	[p5l1786t2755r1863b2804],
5	the	DT	O	the	det	8	SENT_59	[p5l1914t2736r2039b2804],
6	maximal	JJ	O	maximal	amod	8	SENT_59	[p5l12t2843r334b2910],
7	percentage	NN	O	percentage	nn	8	SENT_59	[p5l381t2850r814b2928],
8	change	NN	O	change	prep_as	3	SENT_59	[p5l857t2843r1129b2928],
9	in	IN	O	in	_	0	SENT_59	[p5l1172t2845r1237b2910],
10	light	JJ	O	light	amod	11	SENT_59	[p5l1286t2843r1454b2928],
11	transmittance	NN	O	transmittance	prep_in	8	SENT_59	[p5l1498t2845r2039b2910],
12	from	IN	O	from	_	0	SENT_59	[p5l9t2951r187b3018],
13	baseline	NN	O	baseline	prep_from	3	SENT_59	[p5l219t2951r533b3018],
14	with	IN	O	with	_	0	SENT_59	[p5l557t2951r725b3018],
15	PPP	NN	ORGANIZATION	ppp	prep_with	3	SENT_59	[p5l757t2952r895b3017],
16	as	IN	O	as	_	0	SENT_59	[p5l919t2969r995b3018],
17	reference	NN	O	reference	prep_as	15	SENT_59	[p5l1025t2951r1420b3018],
18	.	.	O	.	_	0	SENT_59	[p5l1025t2951r1420b3018],

1	Here	RB	O	here	advmod	3	SENT_60	[p5l1458t2953r1637b3018],
2	we	PRP	O	we	nsubj	3	SENT_60	[p5l1661t2969r1773b3018],
3	report	VBP	O	report	_	0	SENT_60	[p5l1802t2957r2039b3035],
4	data	NNS	O	datum	dobj	3	SENT_60	[p5l9t3057r178b3125],
5	on	IN	O	on	_	0	SENT_60	[p5l226t3076r313b3125],
6	maximal	JJ	O	maximal	amod	7	SENT_60	[p5l365t3057r687b3125],
7	intensity	NN	O	intensity	prep_on	3	SENT_60	[p5l735t3059r1070b3142],
8	of	IN	O	of	_	0	SENT_60	[p5l1114t3057r1192b3125],
9	platelet	NN	O	platelet	nn	10	SENT_60	[p5l1238t3057r1540b3142],
10	aggregation	NN	O	aggregation	prep_of	7	SENT_60	[p5l1586t3059r2036b3142],
11	with	IN	O	with	_	0	SENT_60	[p5l7t3165r174b3232],
12	ADP	NN	ORGANIZATION	adp	nn	13	SENT_60	[p5l202t3166r353b3231],
13	concentration	NN	O	concentration	prep_with	10	SENT_60	[p5l382t3166r943b3232],
14	.	.	O	.	_	0	SENT_60	[p5l382t3166r943b3232],

1	The	DT	O	the	det	2	SENT_61	[p5l978t3165r1121b3232],
2	coefficient	NN	O	coefficient	nsubj	15	SENT_61	[p5l1150t3165r1567b3232],
3	of	IN	O	of	_	0	SENT_61	[p5l1595t3165r1674b3232],
4	variation	NN	O	variation	prep_of	2	SENT_61	[p5l1696t3166r2036b3232],
5	of	IN	O	of	_	0	SENT_61	[p5l9t3271r87b3339],
6	maximal	JJ	O	maximal	amod	7	SENT_61	[p5l107t3271r430b3339],
7	intensity	NN	O	intensity	prep_of	4	SENT_61	[p5l452t3273r787b3356],
8	of	IN	O	of	_	0	SENT_61	[p5l806t3271r885b3339],
9	platelet	NN	O	platelet	nn	10	SENT_61	[p5l905t3271r1207b3356],
10	aggregation	NN	O	aggregation	prep_of	7	SENT_61	[p5l1228t3273r1678b3356],
11	with	IN	O	with	_	0	SENT_61	[p5l1700t3271r1867b3339],
12	ADP	NN	ORGANIZATION	adp	prep_with	10	SENT_61	[p5l1888t3272r2039b3338],
13	was	VBD	O	be	cop	15	SENT_61	[p5l7t3396r151b3445],
14	6.5	CD	PERCENT	6.5	num	15	SENT_61	[p5l198t3379r392b3446],
15	%	NN	PERCENT	%	_	0	SENT_61	[p5l198t3379r392b3446],
16	.	.	O	.	_	0	SENT_61	[p5l198t3379r392b3446],

1	We	PRP	O	we	nsubj	2	SENT_62	[p5l445t3380r562b3445],
2	analyzed	VBD	O	analyze	_	0	SENT_62	[p5l609t3378r946b3463],
3	clopidogrel	NN	O	clopidogrel	nn	4	SENT_62	[p5l996t3378r1423b3463],
4	responsiveness	NN	O	responsiveness	dobj	2	SENT_62	[p5l1475t3380r2040b3463],
5	using	VBG	O	use	xcomp	2	SENT_62	[p5l11t3487r203b3570],
6	post-treatment	JJ	O	post-treatment	amod	9	SENT_62	[p5l236t3492r823b3570],
7	ADP-induced	JJ	O	adp-induced	amod	9	SENT_62	[p5l852t3486r1339b3553],
8	platelet	NN	O	platelet	nn	9	SENT_62	[p5l1375t3486r1677b3570],
9	aggregation	NN	O	aggregation	dobj	5	SENT_62	[p5l1708t3502r2035b3570, p5l9t3594r181b3660],
10	.	.	O	.	_	0	SENT_62	[p5l1708t3502r2035b3570, p5l9t3594r181b3660],

1	Clopidogrel	NNP	O	Clopidogrel	nn	2	SENT_63	[p5l232t3592r669b3677],
2	resistance	NN	O	resistance	nsubjpass	4	SENT_63	[p5l715t3594r1100b3660],
3	was	VBD	O	be	auxpass	4	SENT_63	[p5l1140t3611r1284b3660],
4	defined	VBN	O	define	_	0	SENT_63	[p5l1326t3592r1615b3660],
5	by	IN	O	by	_	0	SENT_63	[p5l1662t3592r1748b3677],
6	persistence	NN	O	persistence	agent	4	SENT_63	[p5l1792t3594r2036b3677, p5l9t3705r226b3766],
7	of	IN	O	of	_	0	SENT_63	[p5l284t3699r362b3766],
8	High	JJ	O	high	amod	11	SENT_63	[p5l421t3699r583b3784],
9	Post-treatment	JJ	O	post-treatment	amod	11	SENT_63	[p5l647t3701r1232b3766],
10	Platelet	NN	O	platelet	nn	11	SENT_63	[p5l1294t3699r1597b3766],
11	Reactivity	NN	O	reactivity	prep_of	6	SENT_63	[p5l1658t3700r2042b3784],

1	(	RB	O	(	dep	5	SENT_64	[p6l14t19r859b102],
2	HPPR	NN	O	hppr	nn	4	SENT_64	[p6l14t19r859b102],
3	=	JJ	O	=	amod	4	SENT_64	[p6l14t19r859b102],
4	ADP-Ag	NN	O	adp-ag	dep	5	SENT_64	[p6l14t19r859b102],
5	>	JJR	O	>	_	0	SENT_64	[p6l14t19r859b102],
6	70	CD	PERCENT	70	number	7	SENT_64	[p6l14t19r859b102],
7	%	NN	PERCENT	%	amod	5	SENT_64	[p6l14t19r859b102],
8	)	CD	NUMBER	)	dep	5	SENT_64	[p6l14t19r859b102],
9	,	,	O	,	_	0	SENT_64	[p6l14t19r859b102],
10	as	IN	O	as	amod	11	SENT_64	[p6l895t36r972b85],
11	previously	RB	DATE	previously	appos	5	SENT_64	[p6l1002t18r1391b102],
12	described	VBN	O	describe	partmod	11	SENT_64	[p6l1416t18r1786b85],
13	[	NN	O	[	nn	15	SENT_64	[p6l1822t18r1991b102],
14	12	CD	NUMBER	12	num	15	SENT_64	[p6l1822t18r1991b102],
15	]	NN	O	]	dobj	12	SENT_64	[p6l1822t18r1991b102],
16	.	.	O	.	_	0	SENT_64	[p6l1822t18r1991b102],

1	VASP	NN	ORGANIZATION	vasp	nn	2	SENT_65	[p6l7t216r225b290],
2	phosphorylation	NN	O	phosphorylation	_	0	SENT_65	[p6l266t215r989b309],

1	To	TO	O	to	aux	2	SENT_66	[p6l7t447r95b512],
2	determine	VB	O	determine	purpcl	12	SENT_66	[p6l160t445r587b512],
3	the	DT	O	the	det	6	SENT_66	[p6l652t445r784b512],
4	VASP	NN	ORGANIZATION	vasp	nn	6	SENT_66	[p6l846t446r1039b512],
5	phosphorylation	NN	O	phosphorylation	nn	6	SENT_66	[p6l1106t445r1766b530],
6	state	NN	O	state	dobj	2	SENT_66	[p6l1833t451r2039b512],
7	of	IN	O	of	_	0	SENT_66	[p6l9t553r89b620],
8	whole	JJ	O	whole	amod	9	SENT_66	[p6l146t553r386b620],
9	blood	NN	O	blood	prep_of	6	SENT_66	[p6l450t553r695b635],
10	,	,	O	,	_	0	SENT_66	[p6l450t553r695b635],
11	we	PRP	O	we	nsubj	12	SENT_66	[p6l762t571r875b620],
12	used	VBD	O	use	_	0	SENT_66	[p6l940t553r1115b620],
13	a	DT	O	a	det	17	SENT_66	[p6l1181t571r1221b620],
14	standardized	JJ	O	standardized	amod	17	SENT_66	[p6l1284t553r1802b620],
15	flow	NN	O	flow	nn	17	SENT_66	[p6l1867t553r2041b620],
16	cytometric	JJ	O	cytometric	amod	17	SENT_66	[p6l9t661r455b744],
17	assay	NN	O	assay	dobj	12	SENT_66	[p6l519t678r731b744],
18	[	CD	NUMBER	[	num	21	SENT_66	[p6l798t659r1153b744],
19	Platelet	NN	O	platelet	nn	21	SENT_66	[p6l798t659r1153b744],
20	VASP	NN	ORGANIZATION	vasp	nn	21	SENT_66	[p6l1214t660r1498b741],
21	®	NN	O	®	dep	17	SENT_66	[p6l1214t660r1498b741],
22	;	:	O	;	_	0	SENT_66	[p6l1214t660r1498b741],
23	Diagnostica	NNP	PERSON	Diagnostica	nn	27	SENT_66	[p6l1573t661r2038b744],
24	Stago	NNP	PERSON	Stago	nn	27	SENT_66	[p6l10t766r221b850],
25	(	NNP	O	(	nn	27	SENT_66	[p6l281t767r699b850],
26	Biocytex	NNP	O	Biocytex	nn	27	SENT_66	[p6l281t767r699b850],
27	)	NNP	O	)	dep	17	SENT_66	[p6l281t767r699b850],
28	,	,	O	,	_	0	SENT_66	[p6l281t767r699b850],
29	Asnieres	NNP	O	Asnieres	appos	27	SENT_66	[p6l760t761r1109b847],
30	,	,	O	,	_	0	SENT_66	[p6l760t761r1109b847],
31	France	NNP	LOCATION	France	nn	32	SENT_66	[p6l1177t765r1493b850],
32	]	NNP	O	]	appos	27	SENT_66	[p6l1177t765r1493b850],
33	,	,	O	,	_	0	SENT_66	[p6l1177t765r1493b850],
34	which	WDT	O	which	nsubj	37	SENT_66	[p6l1554t765r1780b833],
35	is	VBZ	O	be	cop	37	SENT_66	[p6l1839t767r1894b832],
36	an	DT	O	a	det	37	SENT_66	[p6l1950t784r2036b832],
37	adaptation	NN	O	adaptation	rcmod	32	SENT_66	[p6l10t873r431b957],
38	of	IN	O	of	_	0	SENT_66	[p6l485t873r563b940],
39	the	DT	O	the	det	40	SENT_66	[p6l612t873r739b940],
40	method	NN	O	method	prep_of	37	SENT_66	[p6l793t873r1084b940],
41	of	IN	O	of	_	0	SENT_66	[p6l1139t873r1218b940],
42	Schwarz	NNP	PERSON	Schwarz	prep_of	40	SENT_66	[p6l1266t873r1608b940],
43	.	.	O	.	_	0	SENT_66	[p6l1266t873r1608b940],

1	Briefly	RB	O	briefly	advmod	8	SENT_67	[p6l1672t873r1938b957],
2	,	,	O	,	_	0	SENT_67	[p6l1672t873r1938b957],
3	a	DT	O	a	nsubjpass	20	SENT_67	[p6l1998t891r2039b940],
4	citrated	VBN	O	citrate	partmod	3	SENT_67	[p6l9t979r319b1047],
5	blood	NN	O	blood	nn	6	SENT_67	[p6l361t979r569b1047],
6	sample	NN	O	sample	dobj	4	SENT_67	[p6l608t979r882b1064],
7	was	VBD	O	be	auxpass	8	SENT_67	[p6l916t998r1062b1047],
8	incubated	VBN	O	incubate	_	0	SENT_67	[p6l1098t979r1483b1047],
9	with	IN	O	with	_	0	SENT_67	[p6l1521t979r1689b1047],
10	PGE1	NN	O	pge1	prep_with	8	SENT_67	[p6l1732t980r1912b1047],
11	or	CC	O	or	_	0	SENT_67	[p6l1962t998r2042b1047],
12	with	IN	O	with	_	0	SENT_67	[p6l7t1087r176b1154],
13	PGE1	NN	O	pge1	conj_or	10	SENT_67	[p6l241t1088r422b1154],
14	and	CC	O	and	_	0	SENT_67	[p6l495t1087r630b1154],
15	ADP	NN	ORGANIZATION	adp	conj_and	13	SENT_67	[p6l690t1088r842b1153],
16	for	IN	O	for	_	0	SENT_67	[p6l901t1087r1013b1154],
17	10	CD	DURATION	10	num	18	SENT_67	[p6l1075t1088r1158b1154],
18	min	NN	DURATION	min	prep_for	8	SENT_67	[p6l1219t1088r1355b1153],
19	and	CC	O	and	_	0	SENT_67	[p6l1418t1087r1553b1154],
20	fixed	VBN	O	fix	conj_and	8	SENT_67	[p6l1615t1087r1807b1154],
21	with	IN	O	with	_	0	SENT_67	[p6l1867t1087r2036b1154],
22	paraformaldehyde	NN	O	paraformaldehyde	prep_with	20	SENT_67	[p6l12t1193r752b1278],
23	,	,	O	,	_	0	SENT_67	[p6l12t1193r752b1278],
24	after	IN	O	after	_	0	SENT_67	[p6l800t1193r994b1261],
25	which	WDT	O	which	rel	29	SENT_67	[p6l1029t1193r1254b1261],
26	the	DT	O	the	det	27	SENT_67	[p6l1297t1193r1423b1261],
27	platelets	NNS	O	platelet	nsubj	29	SENT_67	[p6l1466t1193r1808b1278],
28	were	VBD	O	be	cop	29	SENT_67	[p6l1845t1212r2039b1261],
29	permeabilized	JJ	O	permeabilized	rcmod	22	SENT_67	[p6l12t1300r566b1385],
30	with	IN	O	with	_	0	SENT_67	[p6l607t1300r776b1367],
31	non-ionic	JJ	O	non-ionic	amod	32	SENT_67	[p6l823t1301r1180b1367],
32	detergent	NN	O	detergent	prep_with	29	SENT_67	[p6l1222t1300r1633b1385],
33	.	.	O	.	_	0	SENT_67	[p6l1222t1300r1633b1385],

1	The	DT	O	the	det	2	SENT_68	[p6l1679t1300r1824b1367],
2	cells	NNS	O	cell	nsubjpass	4	SENT_68	[p6l1864t1300r2039b1367],
3	were	VBD	O	be	auxpass	4	SENT_68	[p6l7t1426r201b1475],
4	labelled	VBN	O	label	_	0	SENT_68	[p6l241t1408r550b1475],
5	with	IN	O	with	_	0	SENT_68	[p6l588t1408r756b1475],
6	a	DT	O	a	det	9	SENT_68	[p6l796t1426r837b1475],
7	primary	JJ	O	primary	amod	9	SENT_68	[p6l877t1409r1178b1492],
8	monoclonal	JJ	O	monoclonal	amod	9	SENT_68	[p6l1215t1408r1661b1475],
9	antibody	NN	O	antibody	prep_with	4	SENT_68	[p6l1699t1408r2040b1492],
10	against	IN	O	against	_	0	SENT_68	[p6l10t1516r291b1599],
11	serine	NN	O	serine	nn	13	SENT_68	[p6l351t1516r591b1582],
12	239-phosphorylated	JJ	O	239-phosphorylated	amod	13	SENT_68	[p6l652t1514r1439b1599],
13	VASP	NN	ORGANIZATION	vasp	prep_against	9	SENT_68	[p6l1501t1515r1688b1582],
14	(	CD	NUMBER	(	num	16	SENT_68	[p6l1754t1515r2031b1599],
15	16C2	NN	O	16c2	nn	16	SENT_68	[p6l1754t1515r2031b1599],
16	)	NN	O	)	dep	13	SENT_68	[p6l1754t1515r2031b1599],
17	,	,	O	,	_	0	SENT_68	[p6l1754t1515r2031b1599],
18	followed	VBN	O	follow	partmod	13	SENT_68	[p6l9t1621r347b1689],
19	by	IN	O	by	_	0	SENT_68	[p6l412t1621r499b1706],
20	a	DT	O	a	det	22	SENT_68	[p6l558t1639r599b1688],
21	secondary	JJ	O	secondary	amod	22	SENT_68	[p6l659t1621r1056b1706],
22	fluorescein	NN	O	fluorescein	agent	18	SENT_68	[p6l1113t1621r1547b1688],
23	isothiocyanate-conjugated	JJ	O	isothiocyanate-conjugated	amod	25	SENT_68	[p6l1610t1621r2035b1706, p6l12t1729r656b1813],
24	polyclonal	JJ	O	polyclonal	amod	25	SENT_68	[p6l719t1729r1114b1813],
25	goat	NN	O	goat	tmod	18	SENT_68	[p6l1172t1735r1341b1813],
26	antimouse	JJ	O	antimouse	amod	27	SENT_68	[p6l1397t1730r1799b1796],
27	antibody	NN	O	antibody	dep	25	SENT_68	[p6l1857t1730r2035b1796, p6l12t1835r222b1920],
28	.	.	O	.	_	0	SENT_68	[p6l1857t1730r2035b1796, p6l12t1835r222b1920],

1	The	DT	O	the	det	3	SENT_69	[p6l294t1835r446b1903],
2	total	JJ	O	total	amod	3	SENT_69	[p6l513t1835r711b1903],
3	duration	NN	O	duration	nsubj	17	SENT_69	[p6l779t1835r1130b1903],
4	of	IN	O	of	_	0	SENT_69	[p6l1198t1835r1280b1903],
5	the	DT	O	the	det	6	SENT_69	[p6l1343t1835r1478b1903],
6	preparation	NN	O	preparation	prep_of	3	SENT_69	[p6l1546t1837r2036b1920],
7	according	VBG	O	accord	_	0	SENT_69	[p6l10t1943r387b2027],
8	to	TO	O	to	prepc_according_to	17	SENT_69	[p6l408t1949r486b2010],
9	the	DT	O	the	det	10	SENT_69	[p6l507t1943r633b2010],
10	procedure	NN	O	procedure	pobj	17	SENT_69	[p6l656t1943r1052b2027],
11	described	VBN	O	describe	partmod	10	SENT_69	[p6l1073t1943r1448b2010],
12	by	IN	O	by	_	0	SENT_69	[p6l1474t1943r1562b2027],
13	the	DT	O	the	det	14	SENT_69	[p6l1581t1943r1708b2010],
14	supplier	NN	O	supplier	agent	11	SENT_69	[p6l1728t1943r2041b2027],
15	did	VBD	O	do	aux	17	SENT_69	[p6l9t2049r125b2117],
16	not	RB	O	not	neg	17	SENT_69	[p6l158t2056r282b2117],
17	exceed	VB	O	exceed	_	0	SENT_69	[p6l308t2049r583b2117],
18	30	CD	DURATION	30	num	19	SENT_69	[p6l615t2050r702b2117],
19	min	NN	DURATION	min	dobj	17	SENT_69	[p6l732t2051r895b2117],
20	.	.	O	.	_	0	SENT_69	[p6l732t2051r895b2117],

1	Analyses	NNS	O	analysis	nsubjpass	3	SENT_70	[p6l928t2049r1262b2134],
2	were	VBD	O	be	auxpass	3	SENT_70	[p6l1287t2068r1481b2117],
3	performed	VBN	O	perform	_	0	SENT_70	[p6l1511t2049r1918b2134],
4	on	IN	O	on	_	0	SENT_70	[p6l1948t2068r2036b2117],
5	EPICS	NNS	O	epic	nn	7	SENT_70	[p6l12t2157r220b2223],
6	XL-MCL	NN	O	xl-mcl	nn	7	SENT_70	[p6l241t2157r527b2223],
7	flow	NN	O	flow	prep_on	3	SENT_70	[p6l547t2156r716b2223],
8	cytometer	NN	O	cytometer	tmod	3	SENT_70	[p6l736t2162r1143b2241],
9	(	CD	NUMBER	(	num	8	SENT_70	[p6l1168t2156r1542b2240],
10	Beckman	NNP	PERSON	Beckman	nn	15	SENT_70	[p6l1168t2156r1542b2240],
11	Coultronics	NNP	PERSON	Coultronics	nn	15	SENT_70	[p6l1568t2156r2031b2238],
12	,	,	O	,	_	0	SENT_70	[p6l1568t2156r2031b2238],
13	Margency	NNP	PERSON	Margency	appos	15	SENT_70	[p6l7t2266r392b2348],
14	,	,	O	,	_	0	SENT_70	[p6l7t2266r392b2348],
15	France	NNP	LOCATION	France	dep	8	SENT_70	[p6l463t2266r778b2348],
16	)	CD	NUMBER	)	num	15	SENT_70	[p6l463t2266r778b2348],
17	.	.	O	.	_	0	SENT_70	[p6l463t2266r778b2348],

1	The	DT	O	the	det	3	SENT_71	[p6l844t2264r989b2331],
2	platelet	NN	O	platelet	nn	3	SENT_71	[p6l1051t2264r1359b2348],
3	population	NN	O	population	nsubjpass	5	SENT_71	[p6l1421t2264r1834b2348],
4	was	VBD	O	be	auxpass	5	SENT_71	[p6l1894t2282r2039b2331],
5	identified	VBN	O	identify	_	0	SENT_71	[p6l9t2370r388b2438],
6	from	IN	O	from	_	0	SENT_71	[p6l429t2370r610b2438],
7	its	PRP$	O	its	poss	8	SENT_71	[p6l651t2372r742b2438],
8	forward	JJ	O	forward	prep_from	5	SENT_71	[p6l780t2370r1083b2438],
9	and	CC	O	and	_	0	SENT_71	[p6l1125t2370r1261b2438],
10	side	JJ	O	side	amod	12	SENT_71	[p6l1303t2370r1456b2438],
11	scatter	NN	O	scatter	nn	12	SENT_71	[p6l1494t2377r1770b2438],
12	distribution	NN	O	distribution	nsubjpass	17	SENT_71	[p6l1807t2370r2035b2438, p6l12t2477r255b2545],
13	and	CC	O	and	_	0	SENT_71	[p6l295t2477r431b2544],
14	10000	CD	NUMBER	10000	num	15	SENT_71	[p6l477t2478r709b2544],
15	platelets	NNS	O	platelet	conj_and	12	SENT_71	[p6l748t2477r1091b2562],
16	were	VBD	O	be	auxpass	17	SENT_71	[p6l1126t2495r1320b2544],
17	gated	VBN	O	gate	conj_and	5	SENT_71	[p6l1357t2477r1600b2562],
18	.	.	O	.	_	0	SENT_71	[p6l1357t2477r1600b2562],

1	A	DT	O	a	det	8	SENT_72	[p6l1642t2478r1695b2544],
2	platelet	NN	O	platelet	nn	8	SENT_72	[p6l1731t2477r2039b2562],
3	reactivity	NN	O	reactivity	nn	8	SENT_72	[p6l12t2586r387b2669],
4	index	NN	O	index	nn	8	SENT_72	[p6l416t2585r628b2652],
5	(	CD	NUMBER	(	num	8	SENT_72	[p6l663t2586r804b2669],
6	PRI	NNP	ORGANIZATION	PRI	nn	8	SENT_72	[p6l663t2586r804b2669],
7	VASP	NN	ORGANIZATION	vasp	nn	8	SENT_72	[p6l838t2586r1052b2669],
8	)	NN	O	)	_	0	SENT_72	[p6l838t2586r1052b2669],
9	was	VBD	O	be	auxpass	10	SENT_72	[p6l1084t2603r1229b2652],
10	calculated	VBN	O	calculate	partmod	8	SENT_72	[p6l1259t2585r1665b2652],
11	from	IN	O	from	_	0	SENT_72	[p6l1699t2585r1879b2652],
12	the	DT	O	the	det	15	SENT_72	[p6l1913t2585r2039b2652],
13	median	JJ	O	median	amod	15	SENT_72	[p6l12t2691r296b2759],
14	fluorescence	NN	O	fluorescence	nn	15	SENT_72	[p6l359t2691r866b2759],
15	intensity	NN	O	intensity	prep_from	10	SENT_72	[p6l927t2693r1275b2776],
16	(	CD	NUMBER	(	num	17	SENT_72	[p6l1338t2693r1526b2776],
17	MFI	NNP	ORGANIZATION	MFI	dobj	10	SENT_72	[p6l1338t2693r1526b2776],
18	)	CD	NUMBER	)	num	17	SENT_72	[p6l1338t2693r1526b2776],
19	of	IN	O	of	_	0	SENT_72	[p6l1589t2691r1668b2759],
20	samples	NNS	O	sample	prep_of	17	SENT_72	[p6l1725t2691r2040b2776],
21	incubated	VBN	O	incubate	partmod	20	SENT_72	[p6l9t2799r395b2866],
22	with	IN	O	with	_	0	SENT_72	[p6l428t2799r597b2866],
23	PGE1	NN	O	pge1	prep_with	21	SENT_72	[p6l636t2800r816b2866],
24	or	CC	O	or	_	0	SENT_72	[p6l862t2817r942b2866],
25	PGE1	NN	O	pge1	conj_or	23	SENT_72	[p6l975t2800r1155b2866],
26	and	CC	O	and	_	0	SENT_72	[p6l1201t2799r1337b2866],
27	ADP	NN	O	adp	conj_and	23	SENT_72	[p6l1370t2800r1522b2865],
28	according	VBG	O	accord	_	0	SENT_72	[p6l1552t2799r1929b2883],
29	to	TO	O	to	prepc_according_to	10	SENT_72	[p6l1962t2805r2039b2866],
30	the	DT	O	the	det	31	SENT_72	[p6l59t3203r189b3272],
31	formUla	NN	O	formulum	pobj	10	SENT_72	[p6l239t3203r578b3272],
32	:	:	O	:	_	0	SENT_72	[p6l239t3203r578b3272],
33	P	NN	O	p	nn	34	SENT_72	[p6l641t3205r755b3272],
34	iV	NN	O	iv	dobj	10	SENT_72	[p6l641t3205r755b3272],
35	*	SYM	O	*	dep	34	SENT_72	[p6l641t3205r755b3272],
36	-	:	O	-	_	0	SENT_72	[p6l808t3204r999b3273],
37	uV	NN	O	uv	nn	38	SENT_72	[p6l808t3204r999b3273],
38	*	NN	O	*	dep	8	SENT_72	[p6l808t3204r999b3273],
39	=	JJ	O	=	quantmod	41	SENT_72	[p6l1017t3203r2134b3299],
40	[	CD	NUMBER	[	number	41	SENT_72	[p6l1017t3203r2134b3299],
41	(	CD	NUMBER	(	num	45	SENT_72	[p6l1017t3203r2134b3299],
42	MF	NN	O	mf	nn	45	SENT_72	[p6l1017t3203r2134b3299],
43	|	NN	O	|	nn	45	SENT_72	[p6l1017t3203r2134b3299],
44	(	CD	NUMBER	(	num	45	SENT_72	[p6l1017t3203r2134b3299],
45	pGE1	NN	O	pge1	dep	38	SENT_72	[p6l1017t3203r2134b3299],
46	)	CD	NUMBER	)	number	47	SENT_72	[p6l1017t3203r2134b3299],
47	‘	CD	NUMBER	‘	num	51	SENT_72	[p6l1017t3203r2134b3299],
48	MF	NN	O	mf	nn	51	SENT_72	[p6l1017t3203r2134b3299],
49	|	NN	O	|	nn	51	SENT_72	[p6l1017t3203r2134b3299],
50	(	CD	NUMBER	(	num	51	SENT_72	[p6l1017t3203r2134b3299],
51	pGE1	NN	O	pge1	dep	38	SENT_72	[p6l1017t3203r2134b3299],
52	+	CC	O	+	_	0	SENT_72	[p6l1017t3203r2134b3299],
53	ADp	NN	O	adp	conj_+	38	SENT_72	[p6l1017t3203r2134b3299],
54	)	CD	NUMBER	)	num	53	SENT_72	[p6l1017t3203r2134b3299],
55	/	:	O	/	punct	59	SENT_72	[p6l1017t3203r2134b3299],
56	MFIPGE1	NN	O	mfipge1	nn	59	SENT_72	[p6l56t3312r375b3400],
57	]	NN	O	]	nn	59	SENT_72	[p6l56t3312r375b3400],
58	X	NN	O	x	nn	59	SENT_72	[p6l400t3333r438b3371],
59	6V	NN	O	6v	dep	53	SENT_72	[p6l463t3313r620b3381],
60	*	CD	NUMBER	*	dep	59	SENT_72	[p6l463t3313r620b3381],

1	Flow	NN	O	flow	nn	2	SENT_73	[p6l63t3526r280b3603],
2	cytometry	NN	O	cytometry	_	0	SENT_73	[p6l316t3533r797b3623],

1	The	DT	O	the	det	3	SENT_74	[p7l56t72r209b141],
2	surface	NN	O	surface	nn	3	SENT_74	[p7l240t72r540b141],
3	expression	NN	O	expression	nsubj	17	SENT_74	[p7l571t73r1006b158],
4	of	IN	O	of	_	0	SENT_74	[p7l1040t72r1122b141],
5	the	DT	O	the	det	10	SENT_74	[p7l1150t72r1284b141],
6	internal	JJ	O	internal	amod	10	SENT_74	[p7l1316t72r1641b141],
7	alphagranule	JJ	O	alphagranule	amod	10	SENT_74	[p7l1673t72r2147b158, p7l61t181r182b249],
8	membrane	NN	O	membrane	nn	10	SENT_74	[p7l214t181r651b249],
9	protein	NN	O	protein	nn	10	SENT_74	[p7l683t182r978b267],
10	P-selectin	NN	MISC	p-selectin	prep_of	3	SENT_74	[p7l1014t181r1419b249],
11	expressed	VBN	O	express	partmod	10	SENT_74	[p7l1451t181r1859b267],
12	on	IN	O	on	_	0	SENT_74	[p7l1892t199r1985b249],
13	the	DT	O	the	det	14	SENT_74	[p7l2017t181r2151b249],
14	surface	NN	O	surface	prep_on	11	SENT_74	[p7l58t289r360b359],
15	of	IN	O	of	_	0	SENT_74	[p7l387t289r470b359],
16	ADP	NN	ORGANIZATION	adp	prep_of	14	SENT_74	[p7l492t290r652b358],
17	activated	VBD	O	activate	_	0	SENT_74	[p7l677t289r1065b359],
18	platelets	NNS	O	platelet	nsubjpass	20	SENT_74	[p7l1099t289r1464b377],
19	was	VBD	O	be	auxpass	20	SENT_74	[p7l1489t308r1642b359],
20	determined	VBN	O	determine	ccomp	17	SENT_74	[p7l1671t289r2149b359],
21	by	IN	O	by	_	0	SENT_74	[p7l61t400r153b486],
22	flow	NN	O	flow	nn	23	SENT_74	[p7l185t400r364b469],
23	cytometry	NN	O	cytometry	agent	20	SENT_74	[p7l396t406r823b486],
24	with	IN	O	with	_	0	SENT_74	[p7l854t400r1032b469],
25	monoclonal	JJ	O	monoclonal	amod	26	SENT_74	[p7l1073t400r1546b469],
26	antibody	NN	O	antibody	prep_with	20	SENT_74	[p7l1582t400r1958b486],
27	.	.	O	.	_	0	SENT_74	[p7l1582t400r1958b486],

1	The	DT	O	the	det	3	SENT_75	[p7l1999t400r2151b469],
2	following	VBG	O	follow	amod	3	SENT_75	[p7l58t508r439b596],
3	antibodies	NNS	O	antibody	nsubjpass	5	SENT_75	[p7l467t508r898b577],
4	were	VBD	O	be	auxpass	5	SENT_75	[p7l923t527r1128b577],
5	used	VBN	O	use	_	0	SENT_75	[p7l1158t508r1368b577],
6	:	:	O	:	_	0	SENT_75	[p7l1158t508r1368b577],
7	anti-CD62P	JJ	O	anti-cd62p	amod	11	SENT_75	[p7l1405t509r1862b578],
8	(	NN	O	(	nn	11	SENT_75	[p7l1895t508r2146b595, p7l61t638r227b688],
9	Beckman	NNP	ORGANIZATION	Beckman	nn	11	SENT_75	[p7l1895t508r2146b595, p7l61t638r227b688],
10	Coulter	NNP	ORGANIZATION	Coulter	nn	11	SENT_75	[p7l273t619r580b688],
11	INC	NNP	ORGANIZATION	INC	dep	27	SENT_75	[p7l626t620r783b703],
12	,	,	O	,	_	0	SENT_75	[p7l626t620r783b703],
13	Fullerton	NNP	ORGANIZATION	Fullerton	dep	27	SENT_75	[p7l838t619r1239b703],
14	,	,	O	,	_	0	SENT_75	[p7l838t619r1239b703],
15	California	NNP	LOCATION	California	dep	27	SENT_75	[p7l1290t619r1721b703],
16	,	,	O	,	_	0	SENT_75	[p7l1290t619r1721b703],
17	USA	NNP	LOCATION	USA	dep	27	SENT_75	[p7l1776t620r1959b705],
18	)	CD	NUMBER	)	num	17	SENT_75	[p7l1776t620r1959b705],
19	and	CC	O	and	_	0	SENT_75	[p7l2006t619r2149b688],
20	antimouse	JJ	O	antimouse	amod	23	SENT_75	[p7l59t729r484b797],
21	goat	NN	O	goat	nn	23	SENT_75	[p7l528t734r706b815],
22	|	NN	O	|	nn	23	SENT_75	[p7l754t728r876b815],
23	gG	NN	O	gg	dep	27	SENT_75	[p7l754t728r876b815],
24	FITC	NN	O	fitc	dep	27	SENT_75	[p7l926t728r1101b797],
25	(	CD	NUMBER	(	num	24	SENT_75	[p7l1151t729r1607b815],
26	antimouse	JJ	O	antimouse	amod	27	SENT_75	[p7l1151t729r1607b815],
27	goat	NN	O	goat	dep	29	SENT_75	[p7l1651t734r1828b815],
28	|	NN	O	|	dep	27	SENT_75	[p7l1877t728r1998b815],
29	gG	NN	O	gg	dep	5	SENT_75	[p7l1877t728r1998b815],
30	labelled	VBN	O	label	partmod	29	SENT_75	[p7l2049t727r2147b797, p7l61t837r312b907],
31	with	IN	O	with	_	0	SENT_75	[p7l359t837r537b907],
32	fluorescein	NN	O	fluorescein	nn	33	SENT_75	[p7l587t837r1044b907],
33	isothiocyanate	NN	O	isothiocyanate	prep_with	30	SENT_75	[p7l1093t837r1727b925],
34	;	:	O	;	_	0	SENT_75	[p7l1093t837r1727b925],
35	Beckman	NNP	ORGANIZATION	Beckman	nn	37	SENT_75	[p7l1785t837r2148b907],
36	Coulter	NNP	ORGANIZATION	Coulter	nn	37	SENT_75	[p7l59t948r366b1017],
37	INC	NNP	ORGANIZATION	INC	dep	29	SENT_75	[p7l417t949r575b1032],
38	,	,	O	,	_	0	SENT_75	[p7l417t949r575b1032],
39	Fullerton	NNP	ORGANIZATION	Fullerton	nn	43	SENT_75	[p7l635t948r1037b1032],
40	,	,	O	,	_	0	SENT_75	[p7l635t948r1037b1032],
41	California	NNP	LOCATION	California	appos	43	SENT_75	[p7l1094t948r1525b1032],
42	,	,	O	,	_	0	SENT_75	[p7l1094t948r1525b1032],
43	USA	NNP	LOCATION	USA	appos	37	SENT_75	[p7l1585t949r1798b1034],
44	)	CD	NUMBER	)	num	43	SENT_75	[p7l1585t949r1798b1034],
45	.	.	O	.	_	0	SENT_75	[p7l1585t949r1798b1034],

1	Briefly	RB	O	briefly	advmod	5	SENT_76	[p7l1859t948r2143b1034],
2	,	,	O	,	_	0	SENT_76	[p7l1859t948r2143b1034],
3	PRP	NN	O	prp	nsubjpass	5	SENT_76	[p7l62t1058r210b1124],
4	was	VBD	O	be	auxpass	5	SENT_76	[p7l255t1075r408b1126],
5	diluted	VBN	O	dilute	_	0	SENT_76	[p7l455t1057r745b1125],
6	1/10	CD	NUMBER	1/10	dobj	5	SENT_76	[p7l802t1057r986b1125],
7	in	IN	O	in	_	0	SENT_76	[p7l1034t1058r1102b1125],
8	tyrode	NN	O	tyrode	nn	10	SENT_76	[p7l1153t1057r1421b1143],
9	albumine	NN	O	albumine	nn	10	SENT_76	[p7l1469t1057r1849b1125],
10	buffer	NN	O	buffer	prep_in	5	SENT_76	[p7l1899t1057r2153b1125],
11	(	CD	NUMBER	(	num	12	SENT_76	[p7l64t1167r268b1253],
12	0.25	CD	NUMBER	0.25	dep	10	SENT_76	[p7l64t1167r268b1253],
13	103	CD	NUMBER	103	num	14	SENT_76	[p7l314t1159r439b1235],
14	mL	NN	O	ml	dep	12	SENT_76	[p7l483t1159r723b1253],
15	“	CD	NUMBER	“	num	16	SENT_76	[p7l483t1159r723b1253],
16	)	NN	O	)	dep	14	SENT_76	[p7l483t1159r723b1253],
17	and	CC	O	and	_	0	SENT_76	[p7l766t1166r908b1235],
18	gently	RB	O	gently	conj_and	12	SENT_76	[p7l950t1166r1208b1253],
19	mixed	JJ	O	mixed	dep	18	SENT_76	[p7l1247t1166r1520b1235],
20	.	.	O	.	_	0	SENT_76	[p7l1247t1166r1520b1235],

1	Both	DT	O	both	det	4	SENT_77	[p7l1570t1166r1750b1235],
2	antibody	NN	O	antibody	nn	4	SENT_77	[p7l1792t1166r2154b1253],
3	anti-CD62P	JJ	O	anti-cd62p	amod	4	SENT_77	[p7l59t1277r516b1345],
4	(	NN	O	(	nsubjpass	24	SENT_77	[p7l555t1277r677b1362],
5	10	CD	NUMBER	10	num	6	SENT_77	[p7l555t1277r677b1362],
6	uL	NN	O	ul	dep	4	SENT_77	[p7l711t1278r806b1361],
7	of	IN	O	of	_	0	SENT_77	[p7l838t1276r920b1345],
8	dilution	NN	O	dilution	nn	10	SENT_77	[p7l950t1276r1266b1345],
9	1/10	CD	NUMBER	1/10	num	10	SENT_77	[p7l1308t1277r1525b1362],
10	)	NN	O	)	prep_of	6	SENT_77	[p7l1308t1277r1525b1362],
11	and	CC	O	and	_	0	SENT_77	[p7l1562t1276r1704b1345],
12	ADP	NN	O	adp	nsubjpass	24	SENT_77	[p7l1738t1277r1898b1344],
13	(	CD	NUMBER	(	num	12	SENT_77	[p7l1937t1276r2150b1362],
14	final	JJ	O	final	amod	18	SENT_77	[p7l1937t1276r2150b1362],
15	concentration	NN	O	concentration	amod	18	SENT_77	[p7l58t1386r636b1454],
16	10	CD	NUMBER	10	number	15	SENT_77	[p7l700t1385r786b1454],
17	umol/mL	NN	O	umol/ml	nn	18	SENT_77	[p7l844t1384r1251b1472],
18	)	NN	O	)	dep	12	SENT_77	[p7l844t1384r1251b1472],
19	or	CC	O	or	_	0	SENT_77	[p7l1309t1403r1393b1454],
20	tyrode	NN	O	tyrode	nn	22	SENT_77	[p7l1446t1384r1714b1472],
21	albumine	NN	O	albumine	nn	22	SENT_77	[p7l1770t1384r2151b1454],
22	buffer	NN	O	buffer	dep	12	SENT_77	[p7l61t1495r315b1564],
23	were	VBD	O	be	auxpass	24	SENT_77	[p7l351t1514r556b1564],
24	added	VBN	O	add	_	0	SENT_77	[p7l597t1495r844b1564],
25	to	TO	O	to	_	0	SENT_77	[p7l888t1501r969b1564],
26	10	CD	NUMBER	10	num	27	SENT_77	[p7l1016t1496r1102b1564],
27	uL	NN	O	ul	prep_to	24	SENT_77	[p7l1144t1497r1240b1580],
28	of	IN	O	of	_	0	SENT_77	[p7l1277t1495r1360b1564],
29	diluted	VBN	O	dilute	amod	30	SENT_77	[p7l1398t1495r1688b1564],
30	PRP	NN	O	prp	prep_of	27	SENT_77	[p7l1735t1496r1893b1564],
31	.	.	O	.	_	0	SENT_77	[p7l1735t1496r1893b1564],

1	After	IN	O	after	_	0	SENT_78	[p7l1939t1495r2154b1564],
2	incubation	NN	O	incubation	prep_after	26	SENT_78	[p7l59t1603r493b1673],
3	in	IN	O	in	_	0	SENT_78	[p7l545t1605r614b1672],
4	the	DT	O	the	det	8	SENT_78	[p7l666t1603r799b1673],
5	dark	JJ	O	dark	amod	8	SENT_78	[p7l847t1603r1029b1673],
6	at	IN	O	at	_	0	SENT_78	[p7l1076t1610r1156b1673],
7	room	NN	O	room	prep_at	5	SENT_78	[p7l1207t1622r1409b1673],
8	temperature	NN	O	temperature	prep_in	2	SENT_78	[p7l1461t1610r1987b1691],
9	for	IN	O	for	_	0	SENT_78	[p7l2035t1603r2154b1673],
10	15	CD	DURATION	15	num	11	SENT_78	[p7l64t1715r148b1783],
11	min	NN	DURATION	min	prep_for	8	SENT_78	[p7l187t1715r361b1798],
12	,	,	O	,	_	0	SENT_78	[p7l187t1715r361b1798],
13	10	CD	NUMBER	10	num	14	SENT_78	[p7l409t1714r495b1783],
14	uL	NN	O	ul	nsubjpass	26	SENT_78	[p7l530t1715r627b1800],
15	of	IN	O	of	_	0	SENT_78	[p7l658t1713r740b1783],
16	antimouse	JJ	O	antimouse	amod	21	SENT_78	[p7l772t1715r1199b1783],
17	goat	NN	O	goat	nn	21	SENT_78	[p7l1233t1720r1412b1801],
18	|	NN	O	|	nn	21	SENT_78	[p7l1450t1714r1572b1801],
19	gG	NN	O	gg	nn	21	SENT_78	[p7l1450t1714r1572b1801],
20	FITC	NN	O	fitc	nn	21	SENT_78	[p7l1613t1714r1787b1783],
21	(	NN	O	(	prep_of	14	SENT_78	[p7l1828t1713r2148b1801],
22	diluted	VBN	O	dilute	amod	21	SENT_78	[p7l1828t1713r2148b1801],
23	1/10	CD	NUMBER	1/10	number	24	SENT_78	[p7l64t1825r281b1910],
24	)	CD	NUMBER	)	dep	22	SENT_78	[p7l64t1825r281b1910],
25	were	VBD	O	be	auxpass	26	SENT_78	[p7l313t1843r518b1893],
26	added	VBN	O	add	_	0	SENT_78	[p7l550t1824r797b1893],
27	and	CC	O	and	_	0	SENT_78	[p7l833t1824r975b1893],
28	again	RB	O	again	advmod	29	SENT_78	[p7l1010t1825r1225b1910],
29	incubated	VBN	O	incubate	conj_and	26	SENT_78	[p7l1260t1824r1669b1893],
30	in	IN	O	in	_	0	SENT_78	[p7l1704t1825r1773b1892],
31	the	DT	O	the	det	35	SENT_78	[p7l1808t1824r1941b1893],
32	dark	JJ	O	dark	amod	35	SENT_78	[p7l1973t1824r2154b1893],
33	at	IN	O	at	_	0	SENT_78	[p7l59t1939r139b2001],
34	room	NN	O	room	prep_at	32	SENT_78	[p7l188t1951r389b2001],
35	temperature	NN	O	temperature	prep_in	29	SENT_78	[p7l437t1939r963b2019],
36	for	IN	O	for	_	0	SENT_78	[p7l1008t1933r1126b2001],
37	15	CD	DURATION	15	num	38	SENT_78	[p7l1174t1934r1259b2001],
38	min	NN	DURATION	min	prep_for	35	SENT_78	[p7l1309t1934r1482b2001],
39	.	.	O	.	_	0	SENT_78	[p7l1309t1934r1482b2001],

1	Scatter	NNP	O	Scatter	nn	2	SENT_79	[p7l1536t1933r1836b2002],
2	signals	NNS	O	signal	nsubjpass	7	SENT_79	[p7l1879t1933r2152b2019],
3	and	CC	O	and	_	0	SENT_79	[p7l59t2041r201b2111],
4	fluorescence	NN	O	fluorescence	nn	5	SENT_79	[p7l262t2041r793b2111],
5	intensity	NN	O	intensity	conj_and	2	SENT_79	[p7l852t2043r1215b2129],
6	were	VBD	O	be	auxpass	7	SENT_79	[p7l1269t2060r1474b2111],
7	analyzed	VBN	O	analyze	_	0	SENT_79	[p7l1532t2041r1894b2129],
8	on	IN	O	on	_	0	SENT_79	[p7l1955t2060r2048b2111],
9	a	DT	O	a	det	12	SENT_79	[p7l2109t2060r2151b2111],
10	EPICS	NN	O	epic	nn	12	SENT_79	[p7l62t2153r281b2221],
11	XL-MCL	NN	O	xl-mcl	nn	12	SENT_79	[p7l325t2153r627b2221],
12	flow	NN	O	flow	prep_on	7	SENT_79	[p7l669t2152r848b2221],
13	cytometer	NN	O	cytometer	tmod	7	SENT_79	[p7l890t2158r1322b2238],
14	(	CD	NUMBER	(	num	13	SENT_79	[p7l1369t2152r1765b2238],
15	Beckman	NNP	PERSON	Beckman	nn	20	SENT_79	[p7l1369t2152r1765b2238],
16	Coultronics	NNP	PERSON	Coultronics	nn	20	SENT_79	[p7l1813t2152r2147b2221, p7l61t2262r249b2345],
17	,	,	O	,	_	0	SENT_79	[p7l1813t2152r2147b2221, p7l61t2262r249b2345],
18	Margency	NNP	PERSON	Margency	appos	20	SENT_79	[p7l324t2262r748b2348],
19	,	,	O	,	_	0	SENT_79	[p7l324t2262r748b2348],
20	France	NNP	LOCATION	France	dep	13	SENT_79	[p7l828t2262r1178b2348],
21	)	CD	NUMBER	)	num	20	SENT_79	[p7l828t2262r1178b2348],
22	.	.	O	.	_	0	SENT_79	[p7l828t2262r1178b2348],

1	The	DT	O	the	det	3	SENT_80	[p7l1253t2260r1409b2330],
2	light-scattering	JJ	O	light-scattering	amod	3	SENT_80	[p7l1482t2260r2152b2348],
3	properties	NNS	O	property	nsubj	8	SENT_80	[p7l61t2372r486b2457],
4	projected	VBN	O	project	partmod	3	SENT_80	[p7l531t2371r933b2457],
5	on	IN	O	on	_	0	SENT_80	[p7l978t2390r1070b2440],
6	a	DT	O	a	det	7	SENT_80	[p7l1116t2390r1158b2440],
7	scattergram	NN	O	scattergram	prep_on	4	SENT_80	[p7l1201t2377r1700b2457],
8	identified	VBD	O	identify	_	0	SENT_80	[p7l1746t2371r2149b2440],
9	the	DT	O	the	det	11	SENT_80	[p7l59t2479r192b2549],
10	platelet	NN	O	platelet	nn	11	SENT_80	[p7l248t2479r575b2567],
11	cluster	NN	O	cluster	dobj	8	SENT_80	[p7l628t2479r926b2549],
12	.	.	O	.	_	0	SENT_80	[p7l628t2479r926b2549],

1	Fluorescence	NN	O	fluorescence	nn	2	SENT_81	[p7l991t2479r1533b2549],
2	intensity	NN	O	intensity	nsubjpass	4	SENT_81	[p7l1586t2481r1950b2567],
3	was	VBD	O	be	auxpass	4	SENT_81	[p7l1999t2498r2152b2549],
4	expressed	VBN	O	express	_	0	SENT_81	[p7l58t2589r466b2677],
5	on	IN	O	on	_	0	SENT_81	[p7l504t2608r596b2659],
6	individual	JJ	O	individual	amod	7	SENT_81	[p7l633t2589r1038b2659],
7	cyto-histograms	NNS	O	cyto-histogram	prep_on	4	SENT_81	[p7l1073t2589r1762b2677],
8	,	,	O	,	_	0	SENT_81	[p7l1073t2589r1762b2677],
9	with	IN	O	with	_	0	SENT_81	[p7l1802t2589r1980b2659],
10	the	DT	O	the	det	11	SENT_81	[p7l2017t2589r2151b2659],
11	region	NN	O	region	prep_with	4	SENT_81	[p7l62t2701r313b2786],
12	of	IN	O	of	_	0	SENT_81	[p7l373t2700r455b2769],
13	interest	NN	O	interest	prep_of	11	SENT_81	[p7l510t2701r835b2769],
14	limited	VBN	O	limit	partmod	13	SENT_81	[p7l895t2700r1183b2769],
15	to	TO	O	to	_	0	SENT_81	[p7l1244t2706r1325b2769],
16	the	DT	O	the	det	18	SENT_81	[p7l1382t2700r1516b2769],
17	platelet	NN	O	platelet	nn	18	SENT_81	[p7l1576t2700r1903b2786],
18	cluster	NN	O	cluster	prep_to	14	SENT_81	[p7l1960t2700r2147b2769, p7l59t2815r195b2877],
19	.	.	O	.	_	0	SENT_81	[p7l1960t2700r2147b2769, p7l59t2815r195b2877],

1	The	DT	O	the	det	2	SENT_82	[p7l269t2809r423b2877],
2	mean	NN	O	mean	nsubjpass	10	SENT_82	[p7l494t2827r712b2877],
3	channel	NN	O	channel	nn	8	SENT_82	[p7l783t2809r1109b2877],
4	fluorescence	NN	O	fluorescence	nn	8	SENT_82	[p7l1178t2809r1716b2878],
5	intensity	NN	O	intensity	nn	8	SENT_82	[p7l1785t2810r2153b2895],
6	(	CD	NUMBER	(	num	8	SENT_82	[p7l64t2919r262b3005],
7	MFI	NNP	ORGANIZATION	MFI	nn	8	SENT_82	[p7l64t2919r262b3005],
8	)	NN	O	)	dep	2	SENT_82	[p7l64t2919r262b3005],
9	was	VBD	O	be	auxpass	10	SENT_82	[p7l313t2936r467b2987],
10	used	VBN	O	use	_	0	SENT_82	[p7l519t2917r701b2987],
11	as	IN	O	as	_	0	SENT_82	[p7l754t2936r835b2987],
12	an	DT	O	a	det	13	SENT_82	[p7l885t2936r976b2987],
13	index	NN	O	index	prep_as	10	SENT_82	[p7l1029t2917r1255b2987],
14	of	IN	O	of	_	0	SENT_82	[p7l1303t2917r1386b2987],
15	antibody	NN	O	antibody	nn	16	SENT_82	[p7l1433t2917r1798b3005],
16	binding	NN	O	binding	prep_of	13	SENT_82	[p7l1849t2917r2152b3005],
17	and	CC	O	and	_	0	SENT_82	[p7l59t3028r202b3097],
18	P-selectin	NN	O	p-selectin	nn	20	SENT_82	[p7l246t3028r656b3097],
19	surface	NN	O	surface	nn	20	SENT_82	[p7l696t3028r1000b3097],
20	expression	NN	O	expression	prep_of	13	SENT_82	[p7l1037t3029r1506b3114],
21	.	.	O	.	_	0	SENT_82	[p7l1037t3029r1506b3114],

1	Genotyping	VBG	O	genotype	_	0	SENT_83	[p7l59t3242r587b3336],

1	Genomic	JJ	O	genomic	amod	2	SENT_84	[p7l59t3468r409b3537],
2	DNA	NN	O	dna	nsubjpass	4	SENT_84	[p7l449t3468r611b3537],
3	was	VBD	O	be	auxpass	4	SENT_84	[p7l638t3486r788b3537],
4	extracted	VBN	O	extract	_	0	SENT_84	[p7l823t3467r1212b3537],
5	from	IN	O	from	_	0	SENT_84	[p7l1252t3467r1438b3537],
6	peripheral	JJ	O	peripheral	amod	8	SENT_84	[p7l1480t3467r1893b3555],
7	blood	NN	O	blood	nn	8	SENT_84	[p7l1933t3467r2148b3537],
8	leukocytes	NNS	O	leukocyte	prep_from	4	SENT_84	[p7l62t3578r487b3664],
9	by	IN	O	by	_	0	SENT_84	[p7l532t3578r622b3664],
10	the	DT	O	the	det	12	SENT_84	[p7l662t3578r793b3647],
11	salting-out	NN	O	salting-out	nn	12	SENT_84	[p7l835t3578r1268b3664],
12	method	NN	O	method	agent	4	SENT_84	[p7l1313t3578r1642b3647],
13	.	.	O	.	_	0	SENT_84	[p7l1313t3578r1642b3647],

1	Genotyping	VBG	O	genotype	csubjpass	11	SENT_85	[p7l1693t3579r2151b3664],
2	for	IN	O	for	_	0	SENT_85	[p7l58t3687r174b3755],
3	the	DT	O	the	det	5	SENT_85	[p7l203t3687r333b3755],
4	T744C	NN	O	t744c	nn	5	SENT_85	[p7l362t3687r609b3756],
5	polymorphism	NN	O	polymorphism	prep_for	1	SENT_85	[p7l645t3687r1204b3773],
6	of	IN	O	of	_	0	SENT_85	[p7l1238t3687r1319b3755],
7	the	DT	O	the	det	9	SENT_85	[p7l1348t3687r1478b3755],
8	P2Y12	NN	O	p2y12	nn	9	SENT_85	[p7l1513t3687r1749b3755],
9	gene	NN	O	gene	prep_of	5	SENT_85	[p7l1783t3703r1972b3773],
10	was	VBD	O	be	auxpass	11	SENT_85	[p7l2002t3705r2152b3756],
11	performed	VBN	O	perform	_	0	SENT_85	[p8l61t18r480b106],
12	by	IN	O	by	_	0	SENT_85	[p8l507t18r597b106],
13	allele-specific	JJ	O	allele-specific	amod	14	SENT_85	[p8l617t18r1184b106],
14	PCR	NN	O	pcr	agent	11	SENT_85	[p8l1209t19r1384b103],
15	,	,	O	,	_	0	SENT_85	[p8l1209t19r1384b103],
16	two	CD	NUMBER	two	num	18	SENT_85	[p8l1413t25r1561b88],
17	allele-specific	JJ	O	allele-specific	amod	18	SENT_85	[p8l1582t18r2150b106],
18	primers	NNS	O	primer	appos	14	SENT_85	[p8l61t130r363b216],
19	by	IN	O	by	_	0	SENT_85	[p8l407t128r497b216],
20	reaction	NN	O	reaction	agent	11	SENT_85	[p8l539t130r894b197],
21	.	.	O	.	_	0	SENT_85	[p8l539t130r894b197],

1	The	DT	O	the	det	4	SENT_86	[p8l942t128r1091b197],
2	PCR	NN	O	pcr	nn	4	SENT_86	[p8l1136t129r1289b198],
3	reactions	NNS	O	reaction	nn	4	SENT_86	[p8l1330t130r1697b197],
4	conditions	NNS	O	condition	nsubj	5	SENT_86	[p8l1738t128r2151b197],
5	were	VBD	O	be	_	0	SENT_86	[p8l56t257r256b308],
6	as	IN	O	as	dep	7	SENT_86	[p8l293t257r373b308],
7	follows	VBZ	O	follow	advcl	5	SENT_86	[p8l408t238r693b308],
8	(	NN	O	(	nsubj	61	SENT_86	[p8l734t238r878b326],
9	for	IN	O	for	_	0	SENT_86	[p8l734t238r878b326],
10	one	CD	NUMBER	one	num	12	SENT_86	[p8l911t257r1055b308],
11	reaction	NN	O	reaction	nn	12	SENT_86	[p8l1095t240r1484b326],
12	)	NN	O	)	prep_for	8	SENT_86	[p8l1095t240r1484b326],
13	:	:	O	:	_	0	SENT_86	[p8l1095t240r1484b326],
14	200	CD	NUMBER	200	num	15	SENT_86	[p8l1528t239r1667b308],
15	nM	NN	O	nm	dep	12	SENT_86	[p8l1706t240r1815b308],
16	of	IN	O	of	_	0	SENT_86	[p8l1850t238r1930b308],
17	each	DT	O	each	det	20	SENT_86	[p8l1963t238r2148b308],
18	primer	NN	O	primer	nn	20	SENT_86	[p8l61t350r329b435],
19	(	NN	O	(	nn	20	SENT_86	[p8l366t350r826b435],
20	lnvitrogen	NN	O	lnvitrogen	prep_of	15	SENT_86	[p8l366t350r826b435],
21	,	,	O	,	_	0	SENT_86	[p8l366t350r826b435],
22	USA	NNP	LOCATION	USA	appos	8	SENT_86	[p8l872t350r1046b433],
23	,	,	O	,	_	0	SENT_86	[p8l872t350r1046b433],
24	CA	NNP	LOCATION	CA	nn	25	SENT_86	[p8l1089t350r1250b435],
25	)	NNP	O	)	appos	8	SENT_86	[p8l1089t350r1250b435],
26	,	,	O	,	_	0	SENT_86	[p8l1089t350r1250b435],
27	200	CD	NUMBER	200	num	28	SENT_86	[p8l1292t350r1430b418],
28	uM	NN	O	um	appos	8	SENT_86	[p8l1466t351r1579b434],
29	of	IN	O	of	_	0	SENT_86	[p8l1611t349r1692b418],
30	each	DT	O	each	det	33	SENT_86	[p8l1722t349r1906b418],
31	dNTP	NN	O	dntp	nn	33	SENT_86	[p8l1943t349r2151b418],
32	(	NN	O	(	nn	33	SENT_86	[p8l64t459r524b545],
33	lnvitrogen	NN	O	lnvitrogen	prep_of	28	SENT_86	[p8l64t459r524b545],
34	,	,	O	,	_	0	SENT_86	[p8l64t459r524b545],
35	USA	NNP	LOCATION	USA	appos	8	SENT_86	[p8l558t458r732b542],
36	,	,	O	,	_	0	SENT_86	[p8l558t458r732b542],
37	CA	NNP	O	CA	nn	38	SENT_86	[p8l762t458r924b545],
38	)	NNP	O	)	appos	8	SENT_86	[p8l762t458r924b545],
39	,	,	O	,	_	0	SENT_86	[p8l762t458r924b545],
40	60	CD	NUMBER	60	num	41	SENT_86	[p8l954t458r1044b527],
41	ng	NN	O	ng	appos	8	SENT_86	[p8l1068t474r1156b545],
42	of	IN	O	of	_	0	SENT_86	[p8l1178t457r1258b527],
43	genomic	JJ	O	genomic	amod	44	SENT_86	[p8l1277t459r1612b545],
44	DNA	NN	MISC	dna	prep_of	41	SENT_86	[p8l1638t458r1823b542],
45	,	,	O	,	_	0	SENT_86	[p8l1638t458r1823b542],
46	0.3	CD	NUMBER	0.3	num	47	SENT_86	[p8l1852t458r1973b527],
47	U	NN	O	u	appos	8	SENT_86	[p8l2001t459r2048b527],
48	of	IN	O	of	_	0	SENT_86	[p8l2073t457r2154b527],
49	Taq	NN	O	taq	nn	50	SENT_86	[p8l56t569r191b655],
50	polymerase	NN	O	polymerase	prep_of	47	SENT_86	[p8l245t567r704b655],
51	(	CD	NUMBER	(	num	52	SENT_86	[p8l759t567r1129b655],
52	Qbiotaq	NN	O	qbiotaq	dep	47	SENT_86	[p8l759t567r1129b655],
53	,	,	O	,	_	0	SENT_86	[p8l759t567r1129b655],
54	Quantum	NNP	O	Quantum	appos	8	SENT_86	[p8l1187t568r1577b652],
55	,	,	O	,	_	0	SENT_86	[p8l1187t568r1577b652],
56	MP	NNP	O	MP	nn	57	SENT_86	[p8l1632t569r1745b637],
57	Biomedicals	NNP	O	Biomedicals	appos	8	SENT_86	[p8l1798t567r2146b637, p8l58t678r235b762],
58	,	,	O	,	_	0	SENT_86	[p8l1798t567r2146b637, p8l58t678r235b762],
59	USA	NNP	LOCATION	USA	appos	8	SENT_86	[p8l302t679r476b762],
60	,	,	O	,	_	0	SENT_86	[p8l302t679r476b762],
61	CA	NNP	LOCATION	CA	xcomp	7	SENT_86	[p8l539t679r672b764],
62	)	CD	NUMBER	)	num	61	SENT_86	[p8l539t679r672b764],
63	with	IN	O	with	_	0	SENT_86	[p8l728t678r902b747],
64	its	PRP$	O	its	poss	66	SENT_86	[p8l960t679r1054b747],
65	supplied	VBN	O	supply	amod	66	SENT_86	[p8l1109t678r1442b764],
66	buffer	NN	O	buffer	prep_with	61	SENT_86	[p8l1503t678r1750b747],
67	(	CD	NUMBER	(	dep	66	SENT_86	[p8l1808t679r1958b764],
68	3.5	CD	NUMBER	3.5	num	71	SENT_86	[p8l1808t679r1958b764],
69	mM	NN	O	mm	nn	71	SENT_86	[p8l2018t680r2153b747],
70	MgCl2	NN	O	mgcl2	nn	71	SENT_86	[p8l56t787r352b873],
71	)	NN	O	)	nsubj	7	SENT_86	[p8l56t787r352b873],
72	.	.	O	.	_	0	SENT_86	[p8l56t787r352b873],

1	The	DT	O	the	det	3	SENT_87	[p8l410t787r560b855],
2	PCR	NN	MISC	pcr	nn	3	SENT_87	[p8l615t787r768b856],
3	products	NNS	O	product	nsubjpass	5	SENT_87	[p8l819t787r1165b873],
4	were	VBD	O	be	auxpass	5	SENT_87	[p8l1215t805r1415b856],
5	visualised	VBN	O	visualise	_	0	SENT_87	[p8l1465t787r1853b855],
6	on	IN	O	on	_	0	SENT_87	[p8l1908t805r1999b855],
7	2	CD	PERCENT	2	number	8	SENT_87	[p8l2054t787r2151b855],
8	%	NN	PERCENT	%	amod	10	SENT_87	[p8l2054t787r2151b855],
9	agarose	NN	O	agarose	nn	10	SENT_87	[p8l59t912r374b983],
10	gels	NNS	O	gel	prep_on	5	SENT_87	[p8l437t895r595b983],
11	stained	VBN	O	stain	partmod	10	SENT_87	[p8l657t895r954b965],
12	with	IN	O	with	_	0	SENT_87	[p8l1018t895r1196b965],
13	0.2	CD	NUMBER	0.2	num	15	SENT_87	[p8l1262t896r1387b965],
14	pg/mL	NN	O	pg/ml	nn	15	SENT_87	[p8l1454t897r1723b983],
15	Ethidium	NN	O	ethidium	prep_with	11	SENT_87	[p8l1788t895r2149b965],
16	Bromide	NN	O	bromide	nn	18	SENT_87	[p8l62t1005r391b1074],
17	(	NN	O	(	nn	18	SENT_87	[p8l428t1007r888b1093],
18	lnvitrogen	NN	O	lnvitrogen	dep	15	SENT_87	[p8l428t1007r888b1093],
19	,	,	O	,	_	0	SENT_87	[p8l428t1007r888b1093],
20	USA	NNP	LOCATION	USA	appos	15	SENT_87	[p8l931t1006r1105b1090],
21	,	,	O	,	_	0	SENT_87	[p8l931t1006r1105b1090],
22	CA	NNP	O	CA	nn	23	SENT_87	[p8l1145t1006r1306b1092],
23	)	NNP	O	)	appos	20	SENT_87	[p8l1145t1006r1306b1092],
24	.	.	O	.	_	0	SENT_87	[p8l1145t1006r1306b1092],

1	We	PRP	O	we	nsubj	2	SENT_88	[p8l1343t1007r1464b1074],
2	used	VBD	O	use	_	0	SENT_88	[p8l1498t1005r1673b1074],
3	the	DT	O	the	dep	2	SENT_88	[p8l1708t1005r1838b1074],
4	following	VBG	O	follow	xcomp	2	SENT_88	[p8l1869t1005r2146b1074, p8l59t1117r175b1203],
5	primers	NNS	O	primer	dobj	4	SENT_88	[p8l200t1117r527b1203],
6	:	:	O	:	_	0	SENT_88	[p8l200t1117r527b1203],
7	forward	RB	O	forward	advmod	8	SENT_88	[p8l557t1115r868b1185],
8	primer	NN	O	primer	dep	5	SENT_88	[p8l897t1117r1187b1203],
9	:	:	O	:	_	0	SENT_88	[p8l897t1117r1187b1203],
10	5	CD	NUMBER	5	dep	8	SENT_88	[p8l1221t1116r1476b1185],
11	’	SYM	O	’	dep	8	SENT_88	[p8l1221t1116r1476b1185],
12	-	:	O	-	_	0	SENT_88	[p8l1221t1116r1476b1185],
13	TAA	NN	ORGANIZATION	taa	nn	17	SENT_88	[p8l1221t1116r1476b1185],
14	gTg	NN	O	gtg	nn	17	SENT_88	[p8l1495t1117r1634b1203],
15	CTA	NNP	O	CTA	nn	17	SENT_88	[p8l1657t1116r1807b1185],
16	CAT	NNP	O	CAT	nn	17	SENT_88	[p8l1827t1116r1976b1185],
17	TCA	NNP	O	TCA	dep	5	SENT_88	[p8l1993t1116r2154b1185],
18	TT	NN	O	tt	nn	19	SENT_88	[p8l56t1228r213b1294],
19	|	NN	O	|	dep	17	SENT_88	[p8l56t1228r213b1294],
20	'	''	O	'	_	0	SENT_88	[p8l56t1228r213b1294],
21	ATC-3	NN	O	atc-3	nn	22	SENT_88	[p8l231t1227r515b1310],
22	’	NN	O	’	dep	5	SENT_88	[p8l231t1227r515b1310],
23	,	,	O	,	_	0	SENT_88	[p8l231t1227r515b1310],
24	reverse	JJ	O	reverse	amod	25	SENT_88	[p8l557t1244r850b1295],
25	primer	NN	O	primer	appos	22	SENT_88	[p8l883t1227r1173b1312],
26	:	:	O	:	_	0	SENT_88	[p8l883t1227r1173b1312],
27	5	CD	NUMBER	5	dep	25	SENT_88	[p8l1215t1227r1461b1295],
28	’	SYM	O	’	dep	25	SENT_88	[p8l1215t1227r1461b1295],
29	-	:	O	-	_	0	SENT_88	[p8l1215t1227r1461b1295],
30	TAT	NN	ORGANIZATION	tat	nn	31	SENT_88	[p8l1215t1227r1461b1295],
31	Agg	NN	O	agg	dep	25	SENT_88	[p8l1477t1227r1621b1312],
32	TTA	NNP	O	TTA	nn	38	SENT_88	[p8l1648t1227r1799b1294],
33	TTA	NNP	O	TTA	nn	38	SENT_88	[p8l1815t1227r1966b1294],
34	CCA	NNP	O	CCA	nn	38	SENT_88	[p8l1994t1227r2153b1295],
35	CAA	NNP	O	CAA	nn	38	SENT_88	[p8l59t1335r218b1404],
36	TAg	NN	O	tag	nn	38	SENT_88	[p8l236t1335r378b1422],
37	g-3	NN	O	g-3	nn	38	SENT_88	[p8l410t1335r586b1422],
38	’	NN	O	’	dep	31	SENT_88	[p8l410t1335r586b1422],
39	,	,	O	,	_	0	SENT_88	[p8l410t1335r586b1422],
40	allele	NN	O	allele	dep	25	SENT_88	[p8l626t1334r849b1404],
41	specific	JJ	O	specific	amod	43	SENT_88	[p8l881t1334r1189b1422],
42	forward	RB	O	forward	advmod	43	SENT_88	[p8l1221t1334r1532b1404],
43	primer	NN	O	primer	dep	40	SENT_88	[p8l1571t1336r1862b1422],
44	:	:	O	:	_	0	SENT_88	[p8l1571t1336r1862b1422],
45	5	CD	NUMBER	5	dep	43	SENT_88	[p8l1905t1336r2151b1422],
46	’	SYM	O	’	dep	43	SENT_88	[p8l1905t1336r2151b1422],
47	-	:	O	-	_	0	SENT_88	[p8l1905t1336r2151b1422],
48	gTg	NN	O	gtg	dep	40	SENT_88	[p8l1905t1336r2151b1422],
49	AAA	NNP	O	AAA	nn	56	SENT_88	[p8l56t1445r217b1513],
50	TAA	NNP	O	TAA	nn	56	SENT_88	[p8l244t1445r396b1513],
51	AAA	NNP	O	AAA	nn	56	SENT_88	[p8l431t1445r592b1513],
52	gAT	NNP	O	gAT	nn	56	SENT_88	[p8l631t1445r772b1532],
53	TAC	NNP	O	TAC	nn	56	SENT_88	[p8l808t1445r957b1514],
54	AAA	NNP	O	AAA	nn	56	SENT_88	[p8l996t1445r1158b1513],
55	C-3	NN	O	c-3	nn	56	SENT_88	[p8l1196t1445r1351b1514],
56	’	NN	O	’	dep	48	SENT_88	[p8l1196t1445r1351b1514],
57	and	CC	O	and	_	0	SENT_88	[p8l1396t1444r1536b1514],
58	allele	NN	O	allele	dep	25	SENT_88	[p8l1581t1444r1803b1514],
59	specific	JJ	O	specific	amod	61	SENT_88	[p8l1844t1444r2151b1532],
60	reverse	JJ	O	reverse	amod	61	SENT_88	[p8l62t1573r355b1624],
61	primer	NN	O	primer	dep	58	SENT_88	[p8l393t1556r683b1641],
62	:	:	O	:	_	0	SENT_88	[p8l393t1556r683b1641],
63	5	CD	NUMBER	5	dep	61	SENT_88	[p8l730t1556r983b1641],
64	’	SYM	O	’	dep	61	SENT_88	[p8l730t1556r983b1641],
65	-	:	O	-	_	0	SENT_88	[p8l730t1556r983b1641],
66	'	''	O	'	_	0	SENT_88	[p8l730t1556r983b1641],
67	|	NN	O	|	dep	5	SENT_88	[p8l730t1556r983b1641],
68	'	''	O	'	_	0	SENT_88	[p8l730t1556r983b1641],
69	|	NN	O	|	dep	67	SENT_88	[p8l730t1556r983b1641],
70	'	''	O	'	_	0	SENT_88	[p8l730t1556r983b1641],
71	g	NN	O	g	nn	72	SENT_88	[p8l730t1556r983b1641],
72	ggA	NN	O	gga	dep	5	SENT_88	[p8l1019t1556r1162b1641],
73	A	NN	O	a	nn	75	SENT_88	[p8l1192t1556r1343b1623],
74	'	''	O	'	_	0	SENT_88	[p8l1192t1556r1343b1623],
75	|	NN	O	|	dep	72	SENT_88	[p8l1192t1556r1343b1623],
76	'	''	O	'	_	0	SENT_88	[p8l1192t1556r1343b1623],
77	|	NN	O	|	nn	79	SENT_88	[p8l1192t1556r1343b1623],
78	'	''	O	'	_	0	SENT_88	[p8l1192t1556r1343b1623],
79	TgA	NN	O	tga	dep	5	SENT_88	[p8l1373t1556r1525b1641],
80	AAT	NN	O	aat	nn	83	SENT_88	[p8l1555t1556r1707b1623],
81	gAC	NN	O	gac	nn	83	SENT_88	[p8l1740t1556r1888b1641],
82	AT-3	NN	O	at-3	nn	83	SENT_88	[p8l1922t1556r2143b1624],
83	’	NN	O	’	dep	79	SENT_88	[p8l1922t1556r2143b1624],
84	.	.	O	.	_	0	SENT_88	[p8l1922t1556r2143b1624],

1	The	DT	O	the	det	2	SENT_89	[p8l56t1664r206b1732],
2	size	NN	O	size	nsubj	15	SENT_89	[p8l234t1665r384b1732],
3	of	IN	O	of	_	0	SENT_89	[p8l412t1664r493b1732],
4	the	DT	O	the	det	7	SENT_89	[p8l518t1664r648b1732],
5	different	JJ	O	different	amod	7	SENT_89	[p8l676t1664r1036b1732],
6	PCR	NN	O	pcr	nn	7	SENT_89	[p8l1068t1664r1221b1733],
7	products	NNS	O	product	prep_of	2	SENT_89	[p8l1247t1664r1593b1750],
8	generated	VBN	O	generate	partmod	7	SENT_89	[p8l1622t1664r2029b1750],
9	by	IN	O	by	_	0	SENT_89	[p8l2063t1664r2154b1750],
10	the	DT	O	the	det	12	SENT_89	[p8l59t1772r189b1842],
11	allele-specific	JJ	O	allele-specific	amod	12	SENT_89	[p8l220t1772r787b1860],
12	PCR	NN	O	pcr	agent	8	SENT_89	[p8l822t1773r974b1842],
13	were	VBD	O	be	cop	15	SENT_89	[p8l998t1791r1199b1842],
14	246	CD	NUMBER	246	num	15	SENT_89	[p8l1229t1773r1367b1842],
15	bp	NN	O	bp	dep	31	SENT_89	[p8l1400t1772r1520b1860],
16	,	,	O	,	_	0	SENT_89	[p8l1400t1772r1520b1860],
17	116	CD	NUMBER	116	num	18	SENT_89	[p8l1563t1773r1695b1842],
18	bp	NN	O	bp	dep	31	SENT_89	[p8l1729t1772r1848b1860],
19	,	,	O	,	_	0	SENT_89	[p8l1729t1772r1848b1860],
20	169	CD	NUMBER	169	num	21	SENT_89	[p8l1892t1773r2023b1842],
21	bp	NN	O	bp	dep	31	SENT_89	[p8l2057t1772r2151b1860],
22	and	CC	O	and	_	0	SENT_89	[p8l9t2160r145b2228],
23	the	DT	O	the	det	24	SENT_89	[p8l170t2160r296b2228],
24	Tm	NN	MISC	tm	dep	31	SENT_89	[p8l316t2162r435b2227],
25	used	VBN	O	use	partmod	24	SENT_89	[p8l462t2160r633b2228],
26	was	VBD	O	be	cop	31	SENT_89	[p8l656t2179r801b2228],
27	56	CD	NUMBER	56	num	31	SENT_89	[p8l826t2161r910b2228],
28	°	CD	NUMBER	°	num	31	SENT_89	[p8l942t2161r962b2180],
29	C.	NNP	O	C.	nn	31	SENT_89	[p8l980t2161r1051b2228],
30	The	NNP	O	The	nn	31	SENT_89	[p8l1079t2160r1224b2228],
31	C	NNP	O	C	_	0	SENT_89	[p8l1246t2161r1293b2228],
32	allele	NN	O	allele	nsubj	39	SENT_89	[p8l1317t2160r1532b2228],
33	of	IN	O	of	_	0	SENT_89	[p8l1554t2160r1633b2228],
34	the	DT	O	the	det	36	SENT_89	[p8l1652t2160r1778b2228],
35	T744C	NN	O	t744c	nn	36	SENT_89	[p8l1798t2161r2038b2228],
36	polymorphism	NN	O	polymorphism	prep_of	32	SENT_89	[p8l11t2268r553b2353],
37	is	VBZ	O	be	cop	39	SENT_89	[p8l595t2270r651b2335],
38	a	DT	O	a	det	39	SENT_89	[p8l690t2286r730b2335],
39	constituent	NN	O	constituent	rcmod	31	SENT_89	[p8l768t2270r1215b2335],
40	of	IN	O	of	_	0	SENT_89	[p8l1253t2268r1331b2335],
41	the	DT	O	the	det	43	SENT_89	[p8l1366t2268r1493b2335],
42	minor	JJ	O	minor	amod	43	SENT_89	[p8l1534t2270r1757b2335],
43	haplotype	NN	O	haplotype	prep_of	39	SENT_89	[p8l1796t2268r2034b2353, p8l9t2381r180b2459],
44	of	IN	O	of	_	0	SENT_89	[p8l215t2375r293b2442],
45	the	DT	O	the	det	46	SENT_89	[p8l325t2375r452b2442],
46	P2Y12	NN	O	p2y12	prep_of	43	SENT_89	[p8l491t2376r719b2441],
47	previously	RB	DATE	previously	advmod	48	SENT_89	[p8l759t2375r1155b2459],
48	described	VBN	O	describe	partmod	46	SENT_89	[p8l1188t2375r1563b2442],
49	by	IN	O	by	_	0	SENT_89	[p8l1604t2375r1692b2459],
50	Fontana	NNP	PERSON	Fontana	agent	48	SENT_89	[p8l1728t2377r2037b2442],
51	et	FW	O	et	nn	53	SENT_89	[p8l8t2488r87b2549],
52	al.	FW	O	al.	nn	53	SENT_89	[p8l122t2481r214b2549],
53	[	FW	O	[	dobj	48	SENT_89	[p8l262t2481r434b2566],
54	13	CD	NUMBER	13	num	55	SENT_89	[p8l262t2481r434b2566],
55	]	NN	O	]	nsubj	31	SENT_89	[p8l262t2481r434b2566],
56	.	.	O	.	_	0	SENT_89	[p8l262t2481r434b2566],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_90	[p8l479t2483r791b2549],
2	were	VBD	O	be	auxpass	3	SENT_90	[p8l823t2500r1017b2549],
3	divided	VBN	O	divide	_	0	SENT_90	[p8l1052t2481r1334b2549],
4	into	IN	O	into	_	0	SENT_90	[p8l1371t2483r1522b2549],
5	3	CD	NUMBER	3	num	6	SENT_90	[p8l1558t2482r1595b2549],
6	groups	NNS	O	group	prep_into	3	SENT_90	[p8l1632t2498r1887b2566],
7	according	VBG	O	accord	_	0	SENT_90	[p8l1921t2500r2034b2549, p8l8t2588r296b2673],
8	to	TO	O	to	prepc_according_to	3	SENT_90	[p8l332t2594r409b2655],
9	the	DT	O	the	det	10	SENT_90	[p8l444t2588r571b2655],
10	genotype	NN	O	genotype	pobj	3	SENT_90	[p8l606t2594r990b2673],
11	:	:	O	:	_	0	SENT_90	[p8l606t2594r990b2673],
12	CC	NN	O	cc	nn	13	SENT_90	[p8l1034t2589r1133b2655],
13	homozygotes	NNS	O	homozygote	dep	10	SENT_90	[p8l1172t2588r1702b2673],
14	,	,	O	,	_	0	SENT_90	[p8l1172t2588r1702b2673],
15	CT	NN	O	ct	nn	16	SENT_90	[p8l1745t2589r1847b2655],
16	heterozygotes	NNS	O	heterozygote	dep	10	SENT_90	[p8l1882t2588r2034b2655, p8l8t2702r430b2780],
17	and	CC	O	and	_	0	SENT_90	[p8l460t2696r595b2763],
18	TT	NN	O	tt	nn	19	SENT_90	[p8l625t2698r727b2762],
19	homozygotes	NNS	O	homozygote	conj_and	13	SENT_90	[p8l756t2696r1286b2780],
20	.	.	O	.	_	0	SENT_90	[p8l756t2696r1286b2780],

1	Statistical	JJ	O	statistical	amod	2	SENT_91	[p8l9t2889r451b2964],
2	analysis	NN	O	analysis	_	0	SENT_91	[p8l491t2889r839b2983],

1	Statistical	JJ	MISC	statistical	amod	2	SENT_92	[p8l9t3119r391b3186],
2	analysis	NN	O	analysis	nsubjpass	4	SENT_92	[p8l440t3119r736b3203],
3	was	VBD	O	be	auxpass	4	SENT_92	[p8l781t3137r925b3186],
4	performed	VBN	O	perform	_	0	SENT_92	[p8l975t3119r1376b3203],
5	using	VBG	O	use	xcomp	4	SENT_92	[p8l1428t3120r1620b3203],
6	Graphpad	NNP	O	Graphpad	nn	7	SENT_92	[p8l1667t3119r2036b3203],
7	Prism	NNP	O	Prism	dobj	5	SENT_92	[p8l12t3227r212b3293],
8	Software	NNP	O	Software	dep	7	SENT_92	[p8l264t3225r607b3293],
9	(	CD	NUMBER	(	num	8	SENT_92	[p8l661t3227r727b3310],
10	v	LS	O	v	dep	8	SENT_92	[p8l661t3227r727b3310],
11	4.00	CD	NUMBER	4.00	num	8	SENT_92	[p8l773t3226r964b3307],
12	;	:	O	;	_	0	SENT_92	[p8l773t3226r964b3307],
13	Graphpad	NNP	O	Graphpad	nn	14	SENT_92	[p8l1022t3225r1390b3310],
14	Software	NNP	O	Software	dep	7	SENT_92	[p8l1443t3225r1808b3307],
15	,	,	O	,	_	0	SENT_92	[p8l1443t3225r1808b3307],
16	Inc	NNP	ORGANIZATION	Inc	appos	14	SENT_92	[p8l1871t3227r2031b3310],
17	)	CD	NUMBER	)	num	16	SENT_92	[p8l1871t3227r2031b3310],
18	.	.	O	.	_	0	SENT_92	[p8l1871t3227r2031b3310],

1	Continuous	JJ	O	continuous	amod	2	SENT_93	[p8l9t3333r433b3400],
2	variables	NNS	O	variable	nsubjpass	4	SENT_93	[p8l470t3332r816b3399],
3	are	VBP	O	be	auxpass	4	SENT_93	[p8l856t3350r978b3399],
4	expressed	VBN	O	express	_	0	SENT_93	[p8l1017t3332r1396b3417],
5	as	IN	O	as	_	0	SENT_93	[p8l1439t3350r1516b3399],
6	mean	JJ	O	mean	amod	8	SENT_93	[p8l1557t3334r1863b3399],
7	:1	CD	NUMBER	:1	num	8	SENT_93	[p8l1557t3334r1863b3399],
8	SD	NN	O	sd	prep_as	4	SENT_93	[p8l1916t3333r2031b3400],
9	.	.	O	.	_	0	SENT_93	[p8l1916t3333r2031b3400],

1	Categorical	JJ	O	categorical	amod	2	SENT_94	[p8l9t3440r445b3524],
2	variables	NNS	O	variable	nsubjpass	4	SENT_94	[p8l488t3440r834b3507],
3	are	VBP	O	be	auxpass	4	SENT_94	[p8l878t3458r1000b3507],
4	expressed	VBN	O	express	_	0	SENT_94	[p8l1044t3440r1422b3524],
5	as	IN	O	as	_	0	SENT_94	[p8l1471t3458r1547b3507],
6	frequencies	NNS	O	frequency	prep_as	4	SENT_94	[p8l1590t3440r2039b3524],
7	and	CC	O	and	_	0	SENT_94	[p8l9t3547r143b3614],
8	percentages	NNS	O	percentage	prep_as	4	SENT_94	[p8l189t3553r679b3631],
9	.	.	O	.	_	0	SENT_94	[p8l189t3553r679b3631],

1	Comparisons	NNS	O	comparison	nsubjpass	6	SENT_95	[p8l727t3547r1209b3631],
2	between	IN	O	between	_	0	SENT_95	[p8l1252t3547r1580b3614],
3	the	DT	O	the	det	4	SENT_95	[p8l1624t3547r1748b3614],
4	groups	NNS	O	group	prep_between	1	SENT_95	[p8l1789t3563r2039b3631],
5	were	VBD	O	be	auxpass	6	SENT_95	[p8l6t3671r199b3719],
6	made	VBN	O	make	_	0	SENT_95	[p8l226t3652r434b3719],
7	with	IN	O	with	_	0	SENT_95	[p8l456t3652r623b3719],
8	the	DT	O	the	det	10	SENT_95	[p8l651t3652r775b3719],
9	X2	NN	O	x2	nn	10	SENT_95	[p8l801t3646r879b3736],
10	test	NN	O	test	prep_with	6	SENT_95	[p8l907t3659r1054b3719],
11	for	IN	O	for	_	0	SENT_95	[p8l1078t3652r1189b3719],
12	categorical	JJ	O	categorical	amod	13	SENT_95	[p8l1211t3652r1639b3737],
13	variables	NNS	O	variable	prep_for	10	SENT_95	[p8l1662t3652r2031b3719],
14	.	.	O	.	_	0	SENT_95	[p8l1662t3652r2031b3719],

1	Mean	NN	O	mean	nn	2	SENT_96	[p9l6t20r204b85],
2	levels	NNS	O	level	nsubjpass	4	SENT_96	[p9l240t18r455b85],
3	were	VBD	O	be	auxpass	4	SENT_96	[p9l482t36r674b85],
4	compared	VBN	O	compare	_	0	SENT_96	[p9l702t18r1080b103],
5	using	VBG	O	use	xcomp	4	SENT_96	[p9l1115t20r1306b103],
6	the	DT	O	the	det	8	SENT_96	[p9l1336t18r1461b85],
7	Mann-Whitney	JJ	O	mann-whitney	amod	8	SENT_96	[p9l1488t18r2040b103],
8	test	NN	O	test	dobj	5	SENT_96	[p9l9t131r155b192],
9	for	IN	O	for	_	0	SENT_96	[p9l177t125r287b192],
10	continuous	JJ	O	continuous	amod	11	SENT_96	[p9l306t126r722b192],
11	variables	NNS	O	variable	prep_for	5	SENT_96	[p9l741t125r1110b192],
12	.	.	O	.	_	0	SENT_96	[p9l741t125r1110b192],

1	Allele	NN	O	allele	nn	2	SENT_97	[p9l1137t125r1357b192],
2	frequencies	NNS	O	frequency	nsubjpass	4	SENT_97	[p9l1379t125r1827b209],
3	were	VBD	O	be	auxpass	4	SENT_97	[p9l1847t143r2039b192],
4	estimated	VBN	O	estimate	_	0	SENT_97	[p9l8t232r395b299],
5	by	IN	O	by	_	0	SENT_97	[p9l459t232r546b316],
6	gene-counting	NN	O	gene-counting	agent	4	SENT_97	[p9l603t233r1156b316],
7	and	CC	O	and	_	0	SENT_97	[p9l1215t232r1351b299],
8	departure	NN	O	departure	nsubjpass	13	SENT_97	[p9l1412t232r1798b316],
9	from	IN	O	from	_	0	SENT_97	[p9l1857t232r2036b299],
10	Hardy-Weinberg	JJ	LOCATION	hardy-weinberg	amod	11	SENT_97	[p9l12t338r627b422],
11	equilibrium	NN	O	equilibrium	prep_from	8	SENT_97	[p9l671t338r1108b422],
12	was	VBD	O	be	auxpass	13	SENT_97	[p9l1154t356r1298b405],
13	tested	VBN	O	test	conj_and	4	SENT_97	[p9l1343t338r1582b405],
14	using	VBG	O	use	xcomp	13	SENT_97	[p9l1633t339r1825b422],
15	a	DT	O	a	det	17	SENT_97	[p9l1871t356r1911b405],
16	X2	NN	O	x2	nn	17	SENT_97	[p9l1958t331r2036b421],
17	test	NN	O	test	dobj	14	SENT_97	[p9l9t451r179b511],
18	.	.	O	.	_	0	SENT_97	[p9l9t451r179b511],

1	Allele	NN	O	allele	nn	2	SENT_98	[p9l240t444r461b511],
2	frequencies	NNS	O	frequency	nsubjpass	4	SENT_98	[p9l517t444r965b529],
3	were	VBD	O	be	auxpass	4	SENT_98	[p9l1020t462r1212b511],
4	compared	VBN	O	compare	_	0	SENT_98	[p9l1267t444r1646b529],
5	between	IN	O	between	_	0	SENT_98	[p9l1708t444r2036b511],
6	responders	NNS	O	responder	prep_between	4	SENT_98	[p9l12t551r427b635],
7	and	CC	O	and	_	0	SENT_98	[p9l463t551r597b618],
8	non	JJ	O	non	amod	9	SENT_98	[p9l640t569r772b618],
9	responders	NNS	O	responder	prep_between	4	SENT_98	[p9l815t551r1230b635],
10	by	IN	O	by	_	0	SENT_98	[p9l1269t551r1356b635],
11	use	NN	O	use	agent	4	SENT_98	[p9l1393t569r1517b618],
12	of	IN	O	of	_	0	SENT_98	[p9l1552t551r1631b618],
13	a	DT	O	a	det	15	SENT_98	[p9l1664t569r1705b618],
14	X2	NN	O	x2	nn	15	SENT_98	[p9l1742t544r1821b634],
15	test	NN	O	test	prep_of	11	SENT_98	[p9l1860t558r2031b618],
16	.	.	O	.	_	0	SENT_98	[p9l1860t558r2031b618],

1	Values	NNS	O	value	nsubjpass	7	SENT_99	[p9l6t658r260b725],
2	of	IN	O	of	_	0	SENT_99	[p9l322t658r401b725],
3	p	NN	O	p	prep_of	1	SENT_99	[p9l457t658r751b742],
4	<	JJR	O	<	dep	3	SENT_99	[p9l457t658r751b742],
5	0.05	CD	NUMBER	0.05	dep	4	SENT_99	[p9l457t658r751b742],
6	were	VBD	O	be	auxpass	7	SENT_99	[p9l813t676r1011b725],
7	considered	VBN	O	consider	_	0	SENT_99	[p9l1073t658r1506b725],
8	statistically	RB	O	statistically	advmod	9	SENT_99	[p9l1570t658r2041b742],
9	significant	JJ	O	significant	acomp	7	SENT_99	[p9l8t764r428b849],
10	.	.	O	.	_	0	SENT_99	[p9l8t764r428b849],

1	Results	NNS	O	result	_	0	SENT_100	[p9l13t951r356b1032],

1	Population	NNP	O	Population	_	0	SENT_101	[p9l12t1190r482b1284],

1	From	IN	O	from	_	0	SENT_102	[p9l12t1413r202b1478],
2	October	NNP	DATE	October	prep_from	21	SENT_102	[p9l229t1411r544b1479],
3	2004	CD	DATE	2004	num	2	SENT_102	[p9l565t1412r747b1478],
4	to	TO	O	to	_	0	SENT_102	[p9l770t1418r848b1478],
5	June	NNP	DATE	June	prep_to	2	SENT_102	[p9l871t1413r1053b1478],
6	2006	CD	DATE	2006	num	5	SENT_102	[p9l1077t1412r1282b1493],
7	,	,	O	,	_	0	SENT_102	[p9l1077t1412r1282b1493],
8	a	DT	O	a	det	9	SENT_102	[p9l1314t1429r1355b1478],
9	total	NN	O	total	nsubjpass	21	SENT_102	[p9l1380t1411r1564b1478],
10	of	IN	O	of	_	0	SENT_102	[p9l1588t1411r1667b1478],
11	597	CD	NUMBER	597	num	14	SENT_102	[p9l1690t1412r1823b1479],
12	NSTE	NNP	O	NSTE	nn	14	SENT_102	[p9l1849t1412r2038b1479],
13	ACS	NN	ORGANIZATION	ac	nn	14	SENT_102	[p9l6t1520r150b1586],
14	patients	NNS	O	patient	prep_of	9	SENT_102	[p9l197t1520r513b1603],
15	who	WP	O	who	nsubj	16	SENT_102	[p9l553t1519r712b1586],
16	fulfilled	VBD	O	fulfil	rcmod	14	SENT_102	[p9l755t1519r1061b1586],
17	the	DT	O	the	det	19	SENT_102	[p9l1108t1519r1234b1586],
18	enrollment	NN	O	enrollment	nn	19	SENT_102	[p9l1277t1519r1708b1586],
19	criteria	NNS	O	criterion	dobj	16	SENT_102	[p9l1750t1520r2037b1586],
20	were	VBD	O	be	auxpass	21	SENT_102	[p9l6t1644r200b1693],
21	included	VBN	O	include	_	0	SENT_102	[p9l248t1625r578b1693],
22	in	IN	O	in	_	0	SENT_102	[p9l628t1627r693b1692],
23	our	PRP$	O	we	poss	24	SENT_102	[p9l742t1644r870b1693],
24	study	NN	O	study	prep_in	21	SENT_102	[p9l915t1625r1136b1710],
25	.	.	O	.	_	0	SENT_102	[p9l915t1625r1136b1710],

1	All	DT	O	all	det	2	SENT_103	[p9l1189t1625r1290b1693],
2	patients	NNS	O	patient	nsubj	3	SENT_103	[p9l1340t1627r1655b1710],
3	received	VBD	O	receive	_	0	SENT_103	[p9l1706t1625r2035b1693],
4	600	CD	NUMBER	600	num	5	SENT_103	[p9l9t1733r143b1800],
5	mg	NN	O	mg	dobj	3	SENT_103	[p9l175t1749r285b1817],
6	of	IN	O	of	_	0	SENT_103	[p9l313t1733r392b1800],
7	clopidogrel	NN	O	clopidogrel	prep_of	5	SENT_103	[p9l417t1733r852b1817],
8	and	CC	O	and	_	0	SENT_103	[p9l883t1733r1019b1800],
9	250	CD	NUMBER	250	num	10	SENT_103	[p9l1050t1733r1184b1800],
10	mg	NN	O	mg	dobj	3	SENT_103	[p9l1216t1749r1326b1817],
11	of	IN	O	of	_	0	SENT_103	[p9l1355t1733r1434b1800],
12	aspirin	NN	O	aspirin	prep_of	10	SENT_103	[p9l1459t1734r1715b1817],
13	at	IN	O	at	quantmod	15	SENT_103	[p9l1747t1739r1824b1800],
14	least	JJS	O	least	mwe	13	SENT_103	[p9l1855t1733r2039b1800],
15	12	CD	NUMBER	12	num	16	SENT_103	[p9l14t1840r94b1906],
16	h	NN	O	h	npadvmod	3	SENT_103	[p9l158t1839r196b1906],
17	before	IN	O	before	_	0	SENT_103	[p9l261t1839r514b1907],
18	coronary	JJ	O	coronary	amod	19	SENT_103	[p9l573t1858r916b1924],
19	angiography	NN	O	angiography	prep_before	3	SENT_103	[p9l973t1839r1461b1924],
20	.	.	O	.	_	0	SENT_103	[p9l973t1839r1461b1924],

1	Demographic	JJ	MISC	demographic	amod	2	SENT_104	[p9l1532t1839r2038b1924],
2	data	NNS	O	datum	nsubjpass	8	SENT_104	[p9l8t1946r180b2013],
3	of	IN	O	of	_	0	SENT_104	[p9l222t1946r300b2013],
4	the	DT	O	the	det	6	SENT_104	[p9l339t1946r465b2013],
5	studied	VBN	O	study	amod	6	SENT_104	[p9l507t1946r789b2013],
6	population	NN	O	population	prep_of	2	SENT_104	[p9l837t1946r1249b2031],
7	are	VBP	O	be	auxpass	8	SENT_104	[p9l1293t1964r1417b2013],
8	summarized	VBN	O	summarize	_	0	SENT_104	[p9l1458t1946r1925b2013],
9	in	IN	O	in	_	0	SENT_104	[p9l1970t1948r2036b2012],
10	Table	NNP	O	Table	prep_in	8	SENT_104	[p9l6t2054r214b2121],
11	1	CD	NUMBER	1	num	10	SENT_104	[p9l257t2055r317b2121],
12	.	.	O	.	_	0	SENT_104	[p9l257t2055r317b2121],

1	The	DT	O	the	det	3	SENT_105	[p9l360t2054r505b2121],
2	mean	JJ	O	mean	amod	3	SENT_105	[p9l545t2072r751b2121],
3	time	NN	O	time	nsubj	13	SENT_105	[p9l791t2055r967b2121],
4	between	IN	O	between	_	0	SENT_105	[p9l1007t2054r1340b2121],
5	the	DT	O	the	det	7	SENT_105	[p9l1381t2054r1507b2121],
6	loading	VBG	O	load	amod	7	SENT_105	[p9l1548t2054r1826b2138],
7	dose	NN	O	dose	prep_between	3	SENT_105	[p9l1864t2054r2038b2121],
8	and	CC	O	and	_	0	SENT_105	[p9l9t2160r145b2228],
9	blood	NN	O	blood	nn	10	SENT_105	[p9l182t2160r391b2228],
10	sampling	NN	O	sampling	prep_between	3	SENT_105	[p9l426t2160r769b2245],
11	was	VBD	O	be	cop	13	SENT_105	[p9l799t2179r945b2228],
12	18.2:2.4	CD	NUMBER	18.2:2.4	num	13	SENT_105	[p9l981t2161r1337b2228],
13	h.	NN	O	h.	_	0	SENT_105	[p9l1371t2160r1436b2228],

1	Platelet	NN	O	platelet	nn	2	SENT_106	[p9l12t2351r360b2426],
2	parameters	NNS	O	parameter	_	0	SENT_106	[p9l401t2358r911b2445],

1	ADP-Ag	NN	O	adp-ag	nn	4	SENT_107	[p9l6t2582r288b2666],
2	and	CC	O	and	_	0	SENT_107	[p9l326t2581r461b2648],
3	P-selectin	NN	O	p-selectin	nn	4	SENT_107	[p9l505t2581r886b2648],
4	expression	NN	O	expression	nsubjpass	6	SENT_107	[p9l926t2583r1334b2666],
5	were	VBD	O	be	auxpass	6	SENT_107	[p9l1372t2599r1567b2648],
6	assessed	VBN	O	assess	_	0	SENT_107	[p9l1605t2581r1930b2648],
7	in	IN	O	in	_	0	SENT_107	[p9l1970t2583r2036b2648],
8	all	DT	O	all	det	9	SENT_107	[p9l9t2688r101b2755],
9	patients	NNS	O	patient	prep_in	6	SENT_107	[p9l152t2689r492b2772],
10	.	.	O	.	_	0	SENT_107	[p9l152t2689r492b2772],

1	For	IN	O	for	_	0	SENT_108	[p9l552t2690r674b2755],
2	technical	JJ	O	technical	amod	3	SENT_108	[p9l720t2688r1078b2755],
3	reasons	NNS	O	reason	prep_for	8	SENT_108	[p9l1131t2706r1442b2770],
4	,	,	O	,	_	0	SENT_108	[p9l1131t2706r1442b2770],
5	PRI	NNP	ORGANIZATION	PRI	nn	6	SENT_108	[p9l1501t2689r1612b2754],
6	VASP	NN	ORGANIZATION	vasp	nsubjpass	8	SENT_108	[p9l1663t2689r1848b2755],
7	was	VBD	O	be	auxpass	8	SENT_108	[p9l1894t2706r2039b2755],
8	assessed	VBN	O	assess	_	0	SENT_108	[p9l9t2794r334b2862],
9	in	IN	O	in	_	0	SENT_108	[p9l369t2796r434b2861],
10	454	CD	NUMBER	454	num	11	SENT_108	[p9l467t2796r605b2862],
11	patients	NNS	O	patient	prep_in	8	SENT_108	[p9l638t2796r978b2879],
12	.	.	O	.	_	0	SENT_108	[p9l638t2796r978b2879],

1	Table	NNP	O	Table	nsubj	4	SENT_109	[p9l60t3040r256b3101],
2	1	CD	NUMBER	1	num	4	SENT_109	[p9l292t3042r315b3100],
3	Baseline	NN	O	baseline	nn	4	SENT_109	[p9l441t3041r729b3101],
4	characteristics	NNS	O	characteristic	_	0	SENT_109	[p9l757t3041r1276b3101],
5	of	IN	O	of	_	0	SENT_109	[p9l1304t3041r1375b3101],
6	the	DT	O	the	det	8	SENT_109	[p9l1401t3041r1515b3101],
7	population	NN	O	population	nn	8	SENT_109	[p9l1546t3041r1917b3117],
8	Age	NN	O	age	prep_of	4	SENT_109	[p9l60t3174r194b3241],
9	,	,	O	,	_	0	SENT_109	[p9l60t3174r194b3241],
10	years	NNS	DURATION	year	nsubj	11	SENT_109	[p9l223t3188r388b3241],
11	(	VBP	O	(	rcmod	4	SENT_109	[p9l417t3174r764b3241],
12	mean	NN	O	mean	dobj	11	SENT_109	[p9l417t3174r764b3241],
13	:	:	O	:	_	0	SENT_109	[p9l417t3174r764b3241],
14	SD	NN	O	sd	dep	4	SENT_109	[p9l417t3174r764b3241],
15	)	CD	NUMBER	)	number	16	SENT_109	[p9l417t3174r764b3241],
16	64.7	CD	NUMBER	64.7	dep	14	SENT_109	[p9l1698t3174r1875b3227],
17	:	:	O	:	_	0	SENT_109	[p9l1698t3174r1875b3227],
18	12	CD	NUMBER	12	num	19	SENT_109	[p9l1894t3174r1958b3227],
19	Men	NN	O	man	nn	26	SENT_109	[p9l60t3264r205b3328],
20	,	,	O	,	_	0	SENT_109	[p9l60t3264r205b3328],
21	n	NN	O	n	appos	19	SENT_109	[p9l237t3277r272b3316],
22	(	CD	PERCENT	(	num	23	SENT_109	[p9l301t3263r385b3330],
23	%	NN	PERCENT	%	dep	21	SENT_109	[p9l301t3263r385b3330],
24	)	CD	NUMBER	)	number	25	SENT_109	[p9l301t3263r385b3330],
25	456	CD	NUMBER	456	num	23	SENT_109	[p9l1696t3263r1804b3317],
26	(	NN	O	(	dep	4	SENT_109	[p9l1834t3264r1950b3330],
27	75	CD	NUMBER	75	num	30	SENT_109	[p9l1834t3264r1950b3330],
28	)	NN	O	)	nn	30	SENT_109	[p9l1834t3264r1950b3330],
29	Risk	NN	O	risk	nn	30	SENT_109	[p9l65t3352r185b3406],
30	factors	NNS	O	factor	dobj	4	SENT_109	[p9l208t3352r444b3418],
31	,	,	O	,	_	0	SENT_109	[p9l208t3352r444b3418],
32	n	NN	O	n	dobj	4	SENT_109	[p9l476t3366r510b3405],
33	(	CD	PERCENT	(	num	34	SENT_109	[p9l540t3352r623b3419],
34	%	NN	PERCENT	%	dep	32	SENT_109	[p9l540t3352r623b3419],
35	)	CD	NUMBER	)	dep	34	SENT_109	[p9l540t3352r623b3419],

1	Current	JJ	DATE	current	amod	4	SENT_110	[p9l133t3441r371b3494],
2	smoker	NN	O	smoker	nn	4	SENT_110	[p9l396t3440r629b3506],
3	,	,	O	,	_	0	SENT_110	[p9l396t3440r629b3506],
4	n	NN	O	n	dep	9	SENT_110	[p9l661t3455r696b3494],
5	(	CD	PERCENT	(	num	6	SENT_110	[p9l725t3441r809b3508],
6	%	NN	PERCENT	%	dep	4	SENT_110	[p9l725t3441r809b3508],
7	)	CD	NUMBER	)	dep	9	SENT_110	[p9l725t3441r809b3508],
8	264	CD	NUMBER	264	num	9	SENT_110	[p9l1697t3441r1805b3494],
9	(	NN	O	(	dep	19	SENT_110	[p9l1834t3441r1950b3508],
10	44	CD	NUMBER	44	number	11	SENT_110	[p9l1834t3441r1950b3508],
11	)	CD	NUMBER	)	num	12	SENT_110	[p9l1834t3441r1950b3508],
12	Hypertension	NN	O	hypertension	dep	9	SENT_110	[p9l135t3531r565b3597],
13	,	,	O	,	_	0	SENT_110	[p9l135t3531r565b3597],
14	n	NN	O	n	appos	12	SENT_110	[p9l598t3544r633b3583],
15	(	CD	PERCENT	(	num	16	SENT_110	[p9l662t3530r746b3597],
16	%	NN	PERCENT	%	dep	14	SENT_110	[p9l662t3530r746b3597],
17	)	CD	NUMBER	)	number	18	SENT_110	[p9l662t3530r746b3597],
18	337	CD	NUMBER	337	num	16	SENT_110	[p9l1699t3530r1806b3583],
19	(	NN	O	(	dep	30	SENT_110	[p9l1834t3530r1950b3597],
20	56	CD	NUMBER	56	num	19	SENT_110	[p9l1834t3530r1950b3597],
21	)	CD	NUMBER	)	num	23	SENT_110	[p9l1834t3530r1950b3597],
22	Diabetes	NNP	MISC	Diabetes	nn	23	SENT_110	[p9l135t3619r403b3673],
23	mellitus	NN	O	mellitus	dep	19	SENT_110	[p9l430t3619r698b3684],
24	,	,	O	,	_	0	SENT_110	[p9l430t3619r698b3684],
25	n	NN	O	n	appos	23	SENT_110	[p9l730t3633r765b3672],
26	(	CD	PERCENT	(	num	27	SENT_110	[p9l794t3619r878b3686],
27	%	NN	PERCENT	%	dep	25	SENT_110	[p9l794t3619r878b3686],
28	)	CD	NUMBER	)	number	29	SENT_110	[p9l794t3619r878b3686],
29	170	CD	NUMBER	170	num	27	SENT_110	[p9l1701t3619r1805b3673],
30	(	NN	O	(	dep	32	SENT_110	[p9l1834t3619r1950b3686],
31	28	CD	NUMBER	28	num	30	SENT_110	[p9l1834t3619r1950b3686],
32	)	NN	O	)	_	0	SENT_110	[p9l1834t3619r1950b3686],

1	Dyslipidemia	NNP	PERSON	Dyslipidemia	_	0	SENT_111	[p10l135t18r549b86],
2	,	,	O	,	_	0	SENT_111	[p10l135t18r549b86],
3	n	NN	O	n	appos	1	SENT_111	[p10l581t32r616b71],
4	(	CD	PERCENT	(	num	5	SENT_111	[p10l646t18r730b85],
5	%	NN	PERCENT	%	nn	33	SENT_111	[p10l646t18r730b85],
6	)	CD	NUMBER	)	num	8	SENT_111	[p10l646t18r730b85],
7	323	CD	NUMBER	323	num	8	SENT_111	[p10l1699t18r1802b72],
8	(	NN	O	(	dep	5	SENT_111	[p10l1834t19r1950b85],
9	54	CD	NUMBER	54	number	10	SENT_111	[p10l1834t19r1950b85],
10	)	CD	NUMBER	)	num	12	SENT_111	[p10l1834t19r1950b85],
11	Famillial	JJ	O	famillial	amod	12	SENT_111	[p10l135t106r401b160],
12	history	NN	O	history	dep	8	SENT_111	[p10l429t106r651b174],
13	,	,	O	,	_	0	SENT_111	[p10l429t106r651b174],
14	n	NN	O	n	appos	8	SENT_111	[p10l683t121r717b160],
15	(	CD	PERCENT	(	num	16	SENT_111	[p10l747t107r830b174],
16	%	NN	PERCENT	%	dep	14	SENT_111	[p10l747t107r830b174],
17	)	CD	NUMBER	)	number	18	SENT_111	[p10l747t107r830b174],
18	199	CD	NUMBER	199	num	16	SENT_111	[p10l1701t107r1804b160],
19	(	NN	O	(	amod	24	SENT_111	[p10l1834t107r1950b174],
20	33	CD	NUMBER	33	num	19	SENT_111	[p10l1834t107r1950b174],
21	)	CD	NUMBER	)	num	23	SENT_111	[p10l1834t107r1950b174],
22	Body	NN	O	body	nn	23	SENT_111	[p10l64t195r212b263],
23	mass	NN	O	mass	dep	19	SENT_111	[p10l237t210r384b249],
24	index	NN	O	index	dep	14	SENT_111	[p10l410t195r579b249],
25	(	CD	NUMBER	(	num	26	SENT_111	[p10l608t196r954b263],
26	mean	NN	O	mean	dep	24	SENT_111	[p10l608t196r954b263],
27	:	:	O	:	_	0	SENT_111	[p10l608t196r954b263],
28	SD	NN	O	sd	dep	8	SENT_111	[p10l608t196r954b263],
29	)	CD	NUMBER	)	number	30	SENT_111	[p10l608t196r954b263],
30	26.9:4.3	CD	NUMBER	26.9:4.3	num	31	SENT_111	[p10l1697t196r1983b250],
31	Medications	NNS	MISC	medication	dep	28	SENT_111	[p10l60t285r451b350],
32	,	,	O	,	_	0	SENT_111	[p10l60t285r451b350],
33	n	NN	O	n	dep	3	SENT_111	[p10l483t299r518b338],
34	(	CD	PERCENT	(	num	35	SENT_111	[p10l547t285r631b352],
35	%	NN	PERCENT	%	dep	1	SENT_111	[p10l547t285r631b352],
36	)	CD	NUMBER	)	dep	35	SENT_111	[p10l547t285r631b352],

1	Statins	NNS	MISC	statin	_	0	SENT_112	[p10l133t374r363b440],
2	,	,	O	,	_	0	SENT_112	[p10l133t374r363b440],
3	n	NN	O	n	appos	1	SENT_112	[p10l396t388r431b427],
4	(	CD	PERCENT	(	num	5	SENT_112	[p10l459t374r543b442],
5	%	NN	PERCENT	%	dep	3	SENT_112	[p10l459t374r543b442],
6	)	CD	NUMBER	)	number	7	SENT_112	[p10l459t374r543b442],
7	337	CD	NUMBER	337	num	5	SENT_112	[p10l1699t374r1806b428],
8	(	NN	O	(	dep	3	SENT_112	[p10l1834t375r1950b442],
9	56	CD	NUMBER	56	number	10	SENT_112	[p10l1834t375r1950b442],
10	)	CD	NUMBER	)	num	11	SENT_112	[p10l1834t375r1950b442],
11	Beta-blocker	NN	O	beta-blocker	dep	8	SENT_112	[p10l135t462r545b528],
12	,	,	O	,	_	0	SENT_112	[p10l135t462r545b528],
13	n	NN	O	n	appos	1	SENT_112	[p10l577t477r611b516],
14	(	CD	PERCENT	(	num	15	SENT_112	[p10l640t463r724b530],
15	%	NN	PERCENT	%	dep	13	SENT_112	[p10l640t463r724b530],
16	)	CD	NUMBER	)	number	17	SENT_112	[p10l640t463r724b530],
17	274	CD	NUMBER	274	num	15	SENT_112	[p10l1697t463r1805b516],
18	(	NN	O	(	dep	1	SENT_112	[p10l1834t463r1950b530],
19	50	CD	NUMBER	50	number	20	SENT_112	[p10l1834t463r1950b530],
20	)	CD	NUMBER	)	dep	18	SENT_112	[p10l1834t463r1950b530],

1	T.	NNP	O	T.	_	0	SENT_113	[p10l1505t724r1567b791],
2	Cuisset	NNP	O	Cuisset	prep	1	SENT_113	[p10l1611t723r1895b792],
3	et	FW	O	et	nn	4	SENT_113	[p10l1930t729r2012b791],
4	al.	FW	O	al.	dep	2	SENT_113	[p10l2048t722r2142b791],
5	.	.	O	.	_	0	SENT_113	[p10l2048t722r2142b791],
6	"	''	O	"	punct	1	SENT_113	[p10l259t1393r329b1440],

1	T5	NN	O	t5	_	0	SENT_114	[p10l259t1393r329b1440],

1	Number	NN	O	number	nn	3	SENT_115	[p10l135t1576r182b1816],
2	nf	NN	O	nf	nn	3	SENT_115	[p10l132t1493r182b1553],
3	patients	NNS	O	patient	_	0	SENT_115	[p10l135t1227r196b1470],
4	25	CD	NUMBER	25	dep	3	SENT_115	[p10l262t1802r329b1849],

1	D-1	NN	O	d-1	nn	3	SENT_116	[p10l491t2069r581b2102],
2	|	NN	O	|	nn	3	SENT_116	[p10l491t2069r581b2102],
3	ﬂ	NN	O	ﬂ	_	0	SENT_116	[p10l491t2069r581b2102],
4	‘	CD	NUMBER	‘	num	5	SENT_116	[p10l634t2069r751b2102],
5	Iﬂ	NN	O	iﬂ	dep	3	SENT_116	[p10l634t2069r751b2102],
6	!	.	O	!	_	0	SENT_116	[p10l634t2069r751b2102],

1	-20	CD	NUMBER	-20	num	2	SENT_117	[p10l634t2069r751b2102],
2	21	CD	NUMBER	21	nsubj	6	SENT_117	[p10l790t2069r904b2102],
3	]	NN	O	]	advmod	6	SENT_117	[p10l790t2069r904b2102],
4	-3	CD	NUMBER	-3	dep	6	SENT_117	[p10l790t2069r904b2102],
5	'	''	O	'	_	0	SENT_117	[p10l790t2069r904b2102],
6	l.	NN	O	l.	_	0	SENT_117	[p10l790t2069r904b2102],
7	'	''	O	'	_	0	SENT_117	[p10l790t2069r904b2102],
8	l	NN	O	l	prep	6	SENT_117	[p10l790t2069r904b2102],
9	SD-4D	NN	O	sd-4d	nn	10	SENT_117	[p10l944t2069r1060b2102],
10	IIUI-5	NN	O	iiui-5	dep	8	SENT_117	[p10l1100t2069r1216b2102],
11	|	CD	NUMBER	|	number	12	SENT_117	[p10l1100t2069r1216b2102],
12	]	CD	NUMBER	]	dobj	6	SENT_117	[p10l1100t2069r1216b2102],
13	50-ED	JJ	O	50-ed	amod	14	SENT_117	[p10l1256t2069r1372b2102],
14	El	NNP	O	El	dep	12	SENT_117	[p10l1409t2069r1526b2102],
15	]	SYM	O	]	dep	12	SENT_117	[p10l1409t2069r1526b2102],
16	-	:	O	-	_	0	SENT_117	[p10l1409t2069r1526b2102],
17	?	.	O	?	_	0	SENT_117	[p10l1409t2069r1526b2102],

1	I	PRP	O	I	_	0	SENT_118	[p10l1409t2069r1526b2102],
2	]	VBP	O	]	rcmod	1	SENT_118	[p10l1409t2069r1526b2102],
3	'	''	O	'	_	0	SENT_118	[p10l1565t2069r1682b2102],
4	r	NN	O	r	dobj	2	SENT_118	[p10l1565t2069r1682b2102],
5	"	''	O	"	punct	4	SENT_118	[p10l1565t2069r1682b2102],
6	'	''	O	'	_	0	SENT_118	[p10l1565t2069r1682b2102],
7	ﬂ	JJ	O	ﬂ	amod	11	SENT_118	[p10l1565t2069r1682b2102],
8	~	NN	O	~	nn	11	SENT_118	[p10l1565t2069r1682b2102],
9	'	''	O	'	_	0	SENT_118	[p10l1565t2069r1682b2102],
10	Bﬂ	NN	O	bﬂ	nn	11	SENT_118	[p10l1565t2069r1682b2102],
11	ED-9	NN	O	ed-9	dep	2	SENT_118	[p10l1722t2069r1838b2102],
12	|	CD	NUMBER	|	num	14	SENT_118	[p10l1722t2069r1838b2102],
13	]	CD	NUMBER	]	num	14	SENT_118	[p10l1722t2069r1838b2102],
14	ED-10D	NN	O	ed-10d	dep	1	SENT_118	[p10l1864t2069r2005b2102],

1	.	.	O	.	_	0	SENT_119	[p10l1040t2145r1283b2208],

1	A	DT	O	a	det	3	SENT_120	[p10l1040t2145r1283b2208],
2	\	NN	O	\	nn	3	SENT_120	[p10l1040t2145r1283b2208],
3	D	NN	O	d	_	0	SENT_120	[p10l1040t2145r1283b2208],
4	‘	CD	NUMBER	‘	number	5	SENT_120	[p10l1040t2145r1283b2208],
5	*	CD	NUMBER	*	num	6	SENT_120	[p10l1040t2145r1283b2208],
6	PaAg	NN	O	paag	dep	3	SENT_120	[p10l1040t2145r1283b2208],
7	(	CD	PERCENT	(	num	8	SENT_120	[p10l1309t2145r1406b2208],
8	%	NN	PERCENT	%	dep	6	SENT_120	[p10l1309t2145r1406b2208],
9	)	CD	NUMBER	)	dep	3	SENT_120	[p10l1309t2145r1406b2208],

1	Number	NN	O	number	_	0	SENT_121	[p10l135t2847r182b3087],
2	of	IN	O	of	_	0	SENT_121	[p10l132t2764r182b2824],
3	patients	NNS	O	patient	prep_of	1	SENT_121	[p10l135t2497r196b2741],

1	=	JJ	O	=	amod	2	SENT_122	[p10l488t3343r581b3376],
2	|	NN	O	|	_	0	SENT_122	[p10l488t3343r581b3376],
3	.	.	O	.	_	0	SENT_122	[p10l488t3343r581b3376],
4	'	''	O	'	_	0	SENT_122	[p10l488t3343r581b3376],

1	I	PRP	O	I	dep	10	SENT_123	[p10l488t3343r581b3376],
2	'	''	O	'	_	0	SENT_123	[p10l488t3343r581b3376],
3	--	:	O	--	_	0	SENT_123	[p10l488t3343r581b3376],
4	1	CD	NUMBER	1	dep	1	SENT_123	[p10l488t3343r581b3376],
5	=	JJ	O	=	amod	6	SENT_123	[p10l488t3343r581b3376],
6	ﬂ	NN	O	ﬂ	dep	1	SENT_123	[p10l488t3343r581b3376],
7	'	''	O	'	_	0	SENT_123	[p10l488t3343r581b3376],
8	1	CD	NUMBER	1	nsubj	10	SENT_123	[p10l634t3343r748b3376],
9	|	CD	NUMBER	|	dep	10	SENT_123	[p10l634t3343r748b3376],
10	I	PRP	O	I	_	0	SENT_123	[p10l634t3343r748b3376],
11	'	''	O	'	_	0	SENT_123	[p10l634t3343r748b3376],
12	.	.	O	.	_	0	SENT_123	[p10l634t3343r748b3376],
13	'	''	O	'	_	0	SENT_123	[p10l634t3343r748b3376],

1	.	.	O	.	_	0	SENT_124	[p10l634t3343r748b3376],

1	|	NN	O	|	_	0	SENT_125	[p10l634t3343r748b3376],
2	-210	CD	NUMBER	-210	num	3	SENT_125	[p10l634t3343r748b3376],
3	2	CD	NUMBER	2	dep	1	SENT_125	[p10l787t3343r904b3376],
4	!	.	O	!	_	0	SENT_125	[p10l787t3343r904b3376],

1	}	NN	O	}	_	0	SENT_126	[p10l787t3343r904b3376],
2	-3	CD	NUMBER	-3	num	3	SENT_126	[p10l787t3343r904b3376],
3	!!	NN	O	!!	dep	1	SENT_126	[p10l787t3343r904b3376],

1	EH-4	NN	O	eh-4	_	0	SENT_127	[p10l943t3343r1060b3376],
2	'	''	O	'	_	0	SENT_127	[p10l943t3343r1060b3376],
3	-	:	O	-	_	0	SENT_127	[p10l943t3343r1060b3376],
4	IE	JJ	O	ie	amod	6	SENT_127	[p10l943t3343r1060b3376],
5	4	CD	NUMBER	4	tmod	4	SENT_127	[p10l1100t3343r1216b3376],
6	|	NN	O	|	dep	1	SENT_127	[p10l1100t3343r1216b3376],
7	]	CD	NUMBER	]	num	9	SENT_127	[p10l1100t3343r1216b3376],
8	-5	CD	NUMBER	-5	num	9	SENT_127	[p10l1100t3343r1216b3376],
9	|	NN	O	|	dep	6	SENT_127	[p10l1100t3343r1216b3376],
10	!	.	O	!	_	0	SENT_127	[p10l1100t3343r1216b3376],

1	51	CD	NUMBER	51	_	0	SENT_128	[p10l1256t3343r1372b3376],
2	]	SYM	O	]	dep	5	SENT_128	[p10l1256t3343r1372b3376],
3	-	:	O	-	_	0	SENT_128	[p10l1256t3343r1372b3376],
4	BID	NNP	O	BID	nn	5	SENT_128	[p10l1256t3343r1372b3376],
5	El	NNP	O	El	dep	1	SENT_128	[p10l1409t3342r1526b3376],
6	]	SYM	O	]	dep	5	SENT_128	[p10l1409t3342r1526b3376],
7	-	:	O	-	_	0	SENT_128	[p10l1409t3342r1526b3376],
8	Tl	NN	O	tl	nn	11	SENT_128	[p10l1409t3342r1526b3376],
9	]	CD	NUMBER	]	num	11	SENT_128	[p10l1409t3342r1526b3376],
10	TD-GED	NN	O	td-ged	nn	11	SENT_128	[p10l1565t3343r1682b3376],
11	ED	NN	O	ed	dep	1	SENT_128	[p10l1722t3343r1838b3376],
12	-	:	O	-	_	0	SENT_128	[p10l1722t3343r1838b3376],
13	‘	CD	NUMBER	‘	num	15	SENT_128	[p10l1722t3343r1838b3376],
14	SD	NN	O	sd	nn	15	SENT_128	[p10l1722t3343r1838b3376],
15	ED-1	NN	O	ed-1	dep	11	SENT_128	[p10l1864t3343r2008b3376],
16	&	CC	O	&	_	0	SENT_128	[p10l1864t3343r2008b3376],
17	0	CD	NUMBER	0	dep	11	SENT_128	[p10l1864t3343r2008b3376],

1	PHII	CD	NUMBER	phii	num	2	SENT_129	[p10l1023t3426r1123b3473],
2	VASP	NN	O	vasp	_	0	SENT_129	[p10l1146t3423r1320b3473],
3	(	CD	NUMBER	(	num	4	SENT_129	[p10l1342t3423r1439b3486],
4	°	NN	O	°	dep	2	SENT_129	[p10l1342t3423r1439b3486],
5	.	.	O	.	_	0	SENT_129	[p10l1342t3423r1439b3486],

1	»	NN	O	»	_	0	SENT_130	[p10l1342t3423r1439b3486],
2	.	.	O	.	_	0	SENT_130	[p10l1342t3423r1439b3486],

1	a	DT	O	a	det	2	SENT_131	[p10l1342t3423r1439b3486],
2	)	NN	O	)	_	0	SENT_131	[p10l1342t3423r1439b3486],

1	B	NN	O	b	_	0	SENT_132	[p11l225t380r296b427],
2	an	DT	O	a	dep	1	SENT_132	[p11l295t380r329b427],

1	Nlumber	NNP	O	Nlumber	_	0	SENT_133	[p11l135t626r182b866],
2	of	IN	O	of	_	0	SENT_133	[p11l132t546r182b604],
3	patients	NNS	O	patient	prep_of	1	SENT_133	[p11l135t277r196b521],
4	3	CD	NUMBER	3	num	5	SENT_133	[p11l228t720r297b770],
5	G	NN	O	g	dep	1	SENT_133	[p11l298t720r329b770],

1	M1	NN	O	m1	nn	3	SENT_134	[p11l475t1118r565b1152],
2	0.1-0	CD	NUMBER	0.1-0	num	3	SENT_134	[p11l614t1118r744b1152],
3	.2	NN	NUMBER	.2	_	0	SENT_134	[p11l614t1118r744b1152],
4	11.2-11	CD	NUMBER	11.2-11	num	5	SENT_134	[p11l770t1118r901b1152],
5	.3	NN	NUMBER	.3	dep	3	SENT_134	[p11l770t1118r901b1152],
6	-11.3	CD	NUMBER	-11.3	dep	5	SENT_134	[p11l924t1118r1057b1152],
7	-	:	O	-	_	0	SENT_134	[p11l924t1118r1057b1152],
8	u.	NN	O	u.	dep	5	SENT_134	[p11l924t1118r1057b1152],
9	4	CD	NUMBER	4	num	10	SENT_134	[p11l924t1118r1057b1152],
10	0.4-0	CD	NUMBER	0.4-0	dep	8	SENT_134	[p11l1080t1118r1213b1152],
11	.5	CD	NUMBER	.5	number	12	SENT_134	[p11l1080t1118r1213b1152],
12	9.54.5	CD	NUMBER	9.54.5	dep	3	SENT_134	[p11l1236t1118r1366b1152],
13	0.5-0	CD	NUMBER	0.5-0	num	15	SENT_134	[p11l1392t1118r1525b1152],
14	.7	CD	NUMBER	.7	num	15	SENT_134	[p11l1392t1118r1525b1152],
15	n..7-n	NN	O	n..7-n	dep	12	SENT_134	[p11l1549t1118r1679b1152],
16	.	.	O	.	_	0	SENT_134	[p11l1549t1118r1679b1152],

1	.	.	O	.	_	0	SENT_135	[p11l1549t1118r1679b1152],

1	s	NNS	O	s	_	0	SENT_136	[p11l1549t1118r1679b1152],
2	n	NN	O	n	nn	3	SENT_136	[p11l1705t1118r1835b1152],
3	»	NN	O	»	dep	1	SENT_136	[p11l1705t1118r1835b1152],
4	.	.	O	.	_	0	SENT_136	[p11l1705t1118r1835b1152],

1	a.	IN	O	a.	_	0	SENT_137	[p11l1705t1118r1835b1152],
2	u	FW	O	u	nn	3	SENT_137	[p11l1705t1118r1835b1152],
3	»	FW	O	»	pobj	1	SENT_137	[p11l1705t1118r1835b1152],
4	.	.	O	.	_	0	SENT_137	[p11l1705t1118r1835b1152],

1	a	DT	O	a	det	2	SENT_138	[p11l1705t1118r1835b1152],
2	vn.a-1	NN	O	vn.a-1	_	0	SENT_138	[p11l1858t1118r1991b1152],
3	.	.	O	.	_	0	SENT_138	[p11l1858t1118r1991b1152],

1	u	NN	O	u	_	0	SENT_139	[p11l1858t1118r1991b1152],

1	P-Selectin	NN	O	p-selectin	nn	2	SENT_140	[p11l711t1185r1014b1235],
2	mtpression	NN	O	mtpression	_	0	SENT_140	[p11l1037t1185r1376b1245],
3	(	CD	NUMBER	(	num	4	SENT_140	[p11l1402t1185r1512b1245],
4	AU	NN	O	au	dep	2	SENT_140	[p11l1402t1185r1512b1245],
5	at	IN	O	at	_	0	SENT_140	[p11l1535t1185r1596b1232],
6	MHI	NNP	O	MHI	prep_at	4	SENT_140	[p11l1622t1185r1748b1245],
7	)	CD	NUMBER	)	num	6	SENT_140	[p11l1622t1185r1748b1245],

1	Figure	NNP	O	Figure	nn	3	SENT_141	[p11l60t1345r284b1418],
2	1	CD	NUMBER	1	num	3	SENT_141	[p11l322t1345r343b1402],
3	Distribution	NN	O	distribution	_	0	SENT_141	[p11l473t1344r868b1403],
4	of	IN	O	of	_	0	SENT_141	[p11l900t1344r969b1403],
5	platelet	NN	O	platelet	nn	6	SENT_141	[p11l998t1344r1268b1418],
6	parameters	NNS	O	parameter	prep_of	3	SENT_141	[p11l1299t1349r1689b1418],
7	in	IN	O	in	_	0	SENT_141	[p11l1718t1345r1775b1402],
8	the	DT	O	the	det	10	SENT_141	[p11l1808t1344r1919b1403],
9	whole	JJ	O	whole	amod	10	SENT_141	[p11l1947t1344r2151b1403],
10	population	NN	O	population	prep_in	3	SENT_141	[p11l59t1445r445b1519],
11	.	.	O	.	_	0	SENT_141	[p11l59t1445r445b1519],

1	We	PRP	O	we	nsubj	2	SENT_142	[p11l166t1663r287b1731],
2	observed	VBD	O	observe	_	0	SENT_142	[p11l313t1661r672b1731],
3	high	JJ	O	high	amod	5	SENT_142	[p11l705t1661r866b1749],
4	interindividual	JJ	O	interindividual	amod	5	SENT_142	[p11l897t1661r1486b1731],
5	variability	NN	O	variability	nsubj	12	SENT_142	[p11l1512t1661r1924b1749],
6	of	IN	O	of	_	0	SENT_142	[p11l1950t1661r2030b1731],
7	all	PDT	O	all	predet	8	SENT_142	[p11l2055t1661r2150b1731],
8	the	DT	O	the	prep_of	5	SENT_142	[p11l58t1772r188b1841],
9	studied	VBN	O	study	partmod	5	SENT_142	[p11l233t1772r525b1841],
10	platelet	NN	O	platelet	nn	11	SENT_142	[p11l574t1772r892b1858],
11	parameters	NNS	O	parameter	dobj	9	SENT_142	[p11l938t1778r1396b1858],
12	(	VBP	O	(	ccomp	2	SENT_142	[p11l1446t1773r1614b1858],
13	Fig	NN	O	fig	dobj	12	SENT_142	[p11l1446t1773r1614b1858],
14	.	.	O	.	_	0	SENT_142	[p11l1446t1773r1614b1858],

1	1	CD	NUMBER	1	_	0	SENT_143	[p11l1672t1773r1768b1858],
2	)	NN	O	)	dep	1	SENT_143	[p11l1672t1773r1768b1858],
3	.	.	O	.	_	0	SENT_143	[p11l1672t1773r1768b1858],

1	Maximal	JJ	O	maximal	amod	2	SENT_144	[p11l1818t1772r2149b1841],
2	intensity	NN	O	intensity	nsubj	5	SENT_144	[p11l58t1882r410b1968],
3	of	IN	O	of	_	0	SENT_144	[p11l434t1880r514b1950],
4	ADP-Ag	NN	O	adp-ag	prep_of	2	SENT_144	[p11l534t1881r824b1968],
5	varied	VBD	O	vary	_	0	SENT_144	[p11l847t1880r1097b1950],
6	from	IN	O	from	_	0	SENT_144	[p11l1125t1880r1311b1950],
7	o	NN	O	o	prep_from	5	SENT_144	[p11l1339t1881r1383b1950],
8	to	TO	O	to	_	0	SENT_144	[p11l1408t1887r1488b1950],
9	100	CD	PERCENT	100	num	10	SENT_144	[p11l1519t1881r1706b1950],
10	%	NN	PERCENT	%	prep_to	5	SENT_144	[p11l1519t1881r1706b1950],
11	with	IN	O	with	_	0	SENT_144	[p11l1730t1880r1904b1950],
12	mean	JJ	O	mean	amod	13	SENT_144	[p11l1935t1899r2148b1950],
13	value	NN	O	value	prep_with	10	SENT_144	[p11l55t1990r276b2059],
14	of	IN	O	of	_	0	SENT_144	[p11l340t1990r422b2059],
15	56	CD	NUMBER	56	prep_of	13	SENT_144	[p11l487t1991r633b2060],
16	:	:	O	:	_	0	SENT_144	[p11l487t1991r633b2060],
17	19	CD	PERCENT	19	num	18	SENT_144	[p11l658t1991r825b2059],
18	%	NN	PERCENT	%	dep	13	SENT_144	[p11l658t1991r825b2059],
19	.	.	O	.	_	0	SENT_144	[p11l658t1991r825b2059],

1	For	IN	O	for	_	0	SENT_145	[p11l901t1992r1029b2059],
2	PRI	NNP	ORGANIZATION	PRI	nn	3	SENT_145	[p11l1095t1991r1212b2059],
3	VASP	NN	ORGANIZATION	vasp	prep_for	12	SENT_145	[p11l1279t1991r1471b2060],
4	and	CC	O	and	_	0	SENT_145	[p11l1534t1990r1675b2059],
5	P-selectin	NN	O	p-selectin	nn	6	SENT_145	[p11l1748t1990r2148b2059],
6	expression	NN	O	expression	prep_for	12	SENT_145	[p11l57t2102r507b2187],
7	,	,	O	,	_	0	SENT_145	[p11l57t2102r507b2187],
8	values	NNS	O	value	nsubj	12	SENT_145	[p11l547t2101r800b2170],
9	were	VBD	O	be	cop	12	SENT_145	[p11l831t2120r1031b2170],
10	also	RB	O	also	advmod	12	SENT_145	[p11l1065t2101r1220b2170],
11	very	RB	O	very	advmod	12	SENT_145	[p11l1251t2120r1426b2187],
12	variables	NNS	O	variable	_	0	SENT_145	[p11l1456t2101r1844b2185],
13	,	,	O	,	_	0	SENT_145	[p11l1456t2101r1844b2185],
14	from	IN	O	from	_	0	SENT_145	[p11l1885t2101r2071b2170],
15	1	CD	NUMBER	1	number	17	SENT_145	[p11l2113t2102r2136b2169],
16	to	TO	O	to	dep	17	SENT_145	[p11l58t2216r138b2279],
17	95	CD	PERCENT	95	num	18	SENT_145	[p11l168t2210r313b2279],
18	%	NN	PERCENT	%	prep_from	12	SENT_145	[p11l168t2210r313b2279],
19	and	CC	O	and	_	0	SENT_145	[p11l345t2209r484b2279],
20	from	IN	O	from	_	0	SENT_145	[p11l518t2209r703b2279],
21	0.15	CD	NUMBER	0.15	number	23	SENT_145	[p11l736t2210r906b2279],
22	to	TO	NUMBER	to	dep	23	SENT_145	[p11l939t2216r1019b2279],
23	1.8	CD	NUMBER	1.8	num	24	SENT_145	[p11l1055t2210r1172b2279],
24	UA	NN	LOCATION	ua	conj_and	18	SENT_145	[p11l1207t2210r1315b2279],
25	with	IN	O	with	_	0	SENT_145	[p11l1336t2209r1510b2279],
26	mean	NN	O	mean	nn	27	SENT_145	[p11l1546t2228r1759b2279],
27	values	NNS	O	value	prep_with	24	SENT_145	[p11l1790t2209r2043b2279],
28	of	IN	O	of	_	0	SENT_145	[p11l2073t2209r2154b2279],
29	54:23	CD	PERCENT	54:23	num	30	SENT_145	[p11l60t2320r369b2389],
30	%	NN	PERCENT	%	prep_of	27	SENT_145	[p11l60t2320r369b2389],
31	and	CC	O	and	_	0	SENT_145	[p11l395t2319r534b2388],
32	0.36	CD	NUMBER	0.36	num	33	SENT_145	[p11l562t2320r733b2389],
33	10.18	CD	NUMBER	10.18	prep_of	27	SENT_145	[p11l753t2320r980b2389],
34	UA	NNP	ORGANIZATION	UA	dep	12	SENT_145	[p11l1010t2320r1117b2389],
35	respectively	RB	O	respectively	advmod	12	SENT_145	[p11l1143t2319r1645b2407],
36	.	.	O	.	_	0	SENT_145	[p11l1143t2319r1645b2407],

1	Distribution	NN	O	distribution	_	0	SENT_146	[p11l1682t2319r2147b2389],

1	Table	NNP	O	Table	nn	3	SENT_147	[p11l110t2573r312b2636],
2	2	CD	NUMBER	2	num	3	SENT_147	[p11l345t2574r385b2635],
3	Results	NNS	O	result	_	0	SENT_147	[p11l505t2573r753b2636],
4	of	IN	O	of	_	0	SENT_147	[p11l807t2573r880b2636],
5	platelet	NN	O	platelet	nn	6	SENT_147	[p11l934t2573r1219b2652],
6	testing	NN	O	testing	prep_of	3	SENT_147	[p11l1274t2575r1521b2652],
7	according	VBG	O	accord	_	0	SENT_147	[p11l1576t2573r1927b2652],
8	to	TO	O	to	prepc_according_to	3	SENT_147	[p11l1981t2579r2053b2636],
9	genotype	NN	O	genotype	pobj	3	SENT_147	[p11l113t2679r447b2752],
10	of	IN	O	of	_	0	SENT_147	[p11l501t2674r574b2736],
11	T744C	NN	O	t744c	nn	12	SENT_147	[p11l623t2674r846b2737],
12	polymorphism	NN	O	polymorphism	prep_of	9	SENT_147	[p11l904t2673r1407b2752],
13	of	IN	O	of	_	0	SENT_147	[p11l1463t2674r1536b2736],
14	P2Y12	NN	O	p2y12	nn	16	SENT_147	[p11l1591t2674r1803b2736],
15	Polymorphism	NN	O	polymorphism	nn	16	SENT_147	[p11l116t2812r616b2891],
16	ADP	NN	O	adp	prep_of	12	SENT_147	[p11l648t2813r816b2874],
17	-	:	O	-	_	0	SENT_147	[p11l648t2813r816b2874],
18	p	NN	O	p	dep	16	SENT_147	[p11l899t2830r945b2892],
19	PRI	NNP	ORGANIZATION	PRI	nn	22	SENT_147	[p11l1085t2814r1189b2874],
20	p	NN	O	p	nn	22	SENT_147	[p11l1331t2830r1377b2892],
21	P-selectin	NN	O	p-selectin	nn	22	SENT_147	[p11l1517t2812r1870b2875],
22	p	NN	O	p	dep	18	SENT_147	[p11l1915t2830r1960b2892],

1	Ag	NN	O	ag	nn	3	SENT_148	[p11l647t2914r735b2992],
2	VASP	NN	ORGANIZATION	vasp	nn	3	SENT_148	[p11l1080t2913r1251b2976],
3	expression	NN	O	expression	_	0	SENT_148	[p11l1513t2914r1893b2992],
4	(	CD	PERCENT	(	num	5	SENT_148	[p11l655t3015r905b3093],
5	%	NN	PERCENT	%	dep	3	SENT_148	[p11l655t3015r905b3093],
6	:	:	O	:	_	0	SENT_148	[p11l655t3015r905b3093],
7	SD	NN	O	sd	dep	3	SENT_148	[p11l655t3015r905b3093],
8	)	CD	PERCENT	)	number	9	SENT_148	[p11l655t3015r905b3093],
9	(	CD	PERCENT	(	num	10	SENT_148	[p11l1087t3015r1337b3093],
10	%	NN	PERCENT	%	dep	7	SENT_148	[p11l1087t3015r1337b3093],
11	:	:	O	:	_	0	SENT_148	[p11l1087t3015r1337b3093],
12	SD	NN	O	sd	dep	3	SENT_148	[p11l1087t3015r1337b3093],
13	)	CD	NUMBER	)	num	15	SENT_148	[p11l1087t3015r1337b3093],
14	(	CD	NUMBER	(	num	15	SENT_148	[p11l1519t3015r1821b3093],
15	AU	NN	O	au	dep	12	SENT_148	[p11l1519t3015r1821b3093],
16	:	:	O	:	_	0	SENT_148	[p11l1519t3015r1821b3093],
17	SD	NN	O	sd	nn	18	SENT_148	[p11l1519t3015r1821b3093],
18	)	NN	O	)	dep	15	SENT_148	[p11l1519t3015r1821b3093],

1	T744C	NN	O	t744c	_	0	SENT_149	[p11l110t3216r308b3271],

1	CC	NN	O	cc	dep	10	SENT_150	[p11l186t3306r268b3361],
2	59116	CD	NUMBER	59116	num	3	SENT_150	[p11l652t3306r855b3361],
3	0.39	CD	NUMBER	0.39	dep	1	SENT_150	[p11l902t3306r1039b3361],
4	52:23	CD	NUMBER	52:23	number	5	SENT_150	[p11l1084t3306r1284b3361],
5	0.97	CD	NUMBER	0.97	dep	3	SENT_150	[p11l1335t3306r1473b3361],
6	0.39	CD	NUMBER	0.39	num	7	SENT_150	[p11l1513t3306r1849b3361],
7	i0	NN	O	i0	dep	10	SENT_150	[p11l1513t3306r1849b3361],
8	.17	CD	NUMBER	.17	num	10	SENT_150	[p11l1513t3306r1849b3361],
9	0.62	CD	NUMBER	0.62	num	10	SENT_150	[p11l1918t3306r2054b3361],
10	CT	NN	O	ct	dep	18	SENT_150	[p11l186t3396r270b3450],
11	58119	CD	NUMBER	58119	number	12	SENT_150	[p11l652t3396r854b3450],
12	54:23	CD	NUMBER	54:23	dep	10	SENT_150	[p11l1084t3396r1284b3450],
13	0.37	CD	NUMBER	0.37	num	14	SENT_150	[p11l1513t3396r1848b3450],
14	i0	NN	O	i0	dep	12	SENT_150	[p11l1513t3396r1848b3450],
15	.16	CD	NUMBER	.16	dep	12	SENT_150	[p11l1513t3396r1848b3450],
16	"	``	O	"	punct	15	SENT_150	[p11l184t3487r268b3540],
17	IT	PRP	O	it	dep	15	SENT_150	[p11l184t3487r268b3540],
18	56:19	CD	NUMBER	56:19	dep	20	SENT_150	[p11l652t3486r854b3541],
19	54:23	CD	NUMBER	54:23	num	20	SENT_150	[p11l1084t3486r1284b3540],
20	0.36:0.18	CD	NUMBER	0.36:0.18	_	0	SENT_150	[p11l1513t3486r1848b3541],

1	Role	NN	O	role	_	0	SENT_151	[p11l98t3697r173b3729],
2	of	IN	O	of	_	0	SENT_151	[p11l189t3697r225b3729],
3	the	DT	O	the	det	5	SENT_151	[p11l240t3697r299b3729],
4	T744C	NN	O	t744c	nn	5	SENT_151	[p11l314t3697r426b3729],
5	polymorphism	NN	O	polymorphism	prep_of	1	SENT_151	[p11l444t3697r696b3737],
6	of	IN	O	of	_	0	SENT_151	[p11l713t3697r750b3729],
7	the	DT	O	the	det	9	SENT_151	[p11l765t3697r824b3729],
8	P2Y12	NN	O	p2y12	nn	9	SENT_151	[p11l841t3697r948b3728],
9	gene	NN	O	gene	prep_of	5	SENT_151	[p11l965t3705r1051b3737],
10	on	IN	O	on	_	0	SENT_151	[p11l1067t3705r1108b3729],
11	a	DT	O	a	det	13	SENT_151	[p11l1126t3706r1145b3729],
12	600-mg	JJ	O	600-mg	amod	13	SENT_151	[p11l1161t3697r1293b3737],
13	dose	NN	O	dose	prep_on	9	SENT_151	[p11l1310t3697r1391b3729],
14	of	IN	O	of	_	0	SENT_151	[p11l1407t3697r1444b3729],
15	clopidogrel	NN	O	clopidogrel	prep_of	13	SENT_151	[p11l1458t3697r1661b3737],
16	in	IN	O	in	_	0	SENT_151	[p11l1678t3698r1708b3728],
17	597	CD	NUMBER	597	num	18	SENT_151	[p11l1727t3697r1789b3729],
18	patients	NNS	O	patient	prep_in	15	SENT_151	[p11l1805t3698r1953b3737],
19	897	CD	NUMBER	897	dep	1	SENT_151	[p11l1999t3697r2062b3729],

1	Table	NNP	O	Table	dep	9	SENT_152	[p12l59t111r255b172],
2	3	CD	NUMBER	3	num	4	SENT_152	[p12l284t113r320b172],
3	Genotype	NN	O	genotype	nn	4	SENT_152	[p12l436t113r773b188],
4	frequencies	NNS	O	frequency	dep	1	SENT_152	[p12l799t112r1211b188],
5	in	IN	O	in	_	0	SENT_152	[p12l1237t113r1296b171],
6	responders	NNS	O	responder	prep_in	4	SENT_152	[p12l1327t112r1707b188],
7	(	CD	NUMBER	(	num	8	SENT_152	[p12l1739t113r1831b188],
8	R	NN	O	r	dep	9	SENT_152	[p12l1739t113r1831b188],
9	)	NN	O	)	dep	13	SENT_152	[p12l1739t113r1831b188],
10	and	CC	O	and	_	0	SENT_152	[p12l1860t112r1982b172],
11	non	JJ	O	non	amod	12	SENT_152	[p12l64t230r184b273],
12	responders	NNS	O	responder	dep	13	SENT_152	[p12l219t213r599b289],
13	(	VBP	O	(	_	0	SENT_152	[p12l631t214r775b289],
14	NR	NN	MISC	nr	nn	15	SENT_152	[p12l631t214r775b289],
15	)	NN	O	)	dobj	13	SENT_152	[p12l631t214r775b289],

1	T744C	NN	O	t744c	nn	4	SENT_153	[p12l59t349r275b408],
2	P2Y12	NN	O	p2y12	nn	4	SENT_153	[p12l310t349r517b407],
3	GF	NN	O	gf	nn	4	SENT_153	[p12l687t349r780b408],
4	NR	NN	O	nr	_	0	SENT_153	[p12l812t349r924b421],
5	,	,	O	,	_	0	SENT_153	[p12l812t349r924b421],
6	n	NN	O	n	appos	4	SENT_153	[p12l963t364r1002b407],
7	(	CD	PERCENT	(	num	8	SENT_153	[p12l1037t348r1131b424],
8	%	NN	PERCENT	%	dep	6	SENT_153	[p12l1037t348r1131b424],
9	)	CD	NUMBER	)	num	11	SENT_153	[p12l1037t348r1131b424],
10	GF	NN	ORGANIZATION	gf	nn	11	SENT_153	[p12l1270t349r1362b408],
11	R	NN	ORGANIZATION	r	dep	4	SENT_153	[p12l1395t349r1455b421],
12	,	,	O	,	_	0	SENT_153	[p12l1395t349r1455b421],
13	n	NN	O	n	appos	11	SENT_153	[p12l1494t364r1533b407],
14	(	CD	PERCENT	(	num	15	SENT_153	[p12l1569t348r1663b424],
15	%	NN	PERCENT	%	npadvmod	20	SENT_153	[p12l1569t348r1663b424],
16	)	CD	NUMBER	)	num	19	SENT_153	[p12l1569t348r1663b424],
17	P	NN	O	p	nn	19	SENT_153	[p12l1851t349r1896b407],
18	Polymorphism	NN	O	polymorphism	nn	19	SENT_153	[p12l65t444r549b520],
19	ADP-Ag	NN	O	adp-ag	dep	15	SENT_153	[p12l684t445r1134b520],
20	>	JJR	O	>	amod	13	SENT_153	[p12l684t445r1134b520],
21	70	CD	PERCENT	70	number	22	SENT_153	[p12l684t445r1134b520],
22	%	NN	PERCENT	%	num	23	SENT_153	[p12l684t445r1134b520],
23	ADP-Ag	NN	O	adp-ag	npadvmod	24	SENT_153	[p12l1267t445r1717b520],
24	<	JJR	O	<	dep	20	SENT_153	[p12l1267t445r1717b520],
25	70	CD	PERCENT	70	num	26	SENT_153	[p12l1267t445r1717b520],
26	%	NN	PERCENT	%	dep	20	SENT_153	[p12l1267t445r1717b520],

1	cc	NN	O	cc	nn	3	SENT_154	[p12l62t579r142b633],
2	10	CD	NUMBER	10	num	3	SENT_154	[p12l728t579r881b647],
3	(	NN	O	(	dep	11	SENT_154	[p12l728t579r881b647],
4	2	CD	NUMBER	2	number	5	SENT_154	[p12l728t579r881b647],
5	)	CD	NUMBER	)	dep	3	SENT_154	[p12l728t579r881b647],
6	3	CD	NUMBER	3	dep	5	SENT_154	[p12l1345t579r1463b646],
7	(	NN	O	(	dep	11	SENT_154	[p12l1345t579r1463b646],
8	2	CD	NUMBER	2	num	7	SENT_154	[p12l1345t579r1463b646],
9	)	CD	NUMBER	)	num	11	SENT_154	[p12l1345t579r1463b646],
10	0.75	CD	NUMBER	0.75	num	11	SENT_154	[p12l1852t579r1983b633],
11	CT	NN	O	ct	dep	15	SENT_154	[p12l62t668r143b722],
12	96	CD	NUMBER	96	number	13	SENT_154	[p12l724t668r918b736],
13	(	CD	NUMBER	(	dep	11	SENT_154	[p12l724t668r918b736],
14	22	CD	NUMBER	22	dep	13	SENT_154	[p12l724t668r918b736],
15	)	NN	O	)	dep	18	SENT_154	[p12l724t668r918b736],
16	29	CD	NUMBER	29	num	15	SENT_154	[p12l1306t668r1501b736],
17	(	CD	NUMBER	(	num	18	SENT_154	[p12l1306t668r1501b736],
18	2o	NN	O	2o	dep	20	SENT_154	[p12l1306t668r1501b736],
19	)	CD	NUMBER	)	num	20	SENT_154	[p12l1306t668r1501b736],
20	TT	NN	O	tt	dep	22	SENT_154	[p12l59t758r141b810],
21	347	CD	NUMBER	347	num	22	SENT_154	[p12l688t757r918b825],
22	(	NN	O	(	dep	24	SENT_154	[p12l688t757r918b825],
23	76	CD	NUMBER	76	num	24	SENT_154	[p12l688t757r918b825],
24	)	NN	O	)	dep	26	SENT_154	[p12l688t757r918b825],
25	112	CD	NUMBER	112	num	26	SENT_154	[p12l1273t757r1501b825],
26	(	NN	O	(	dep	28	SENT_154	[p12l1273t757r1501b825],
27	78	CD	NUMBER	78	num	28	SENT_154	[p12l1273t757r1501b825],
28	)	NN	O	)	_	0	SENT_154	[p12l1273t757r1501b825],

1	of	IN	O	of	_	0	SENT_155	[p12l9t1053r87b1120],
2	ADP-Ag	NN	O	adp-ag	prep_of	4	SENT_155	[p12l105t1054r387b1138],
3	was	VBD	O	be	cop	4	SENT_155	[p12l409t1071r554b1120],
4	consistent	JJ	O	consistent	_	0	SENT_155	[p12l577t1054r975b1120],
5	with	IN	O	with	prep	4	SENT_155	[p12l997t1053r1166b1120],
6	a	DT	O	a	det	10	SENT_155	[p12l1193t1071r1233b1120],
7	normal	JJ	O	normal	amod	10	SENT_155	[p12l1260t1053r1553b1135],
8	,	,	O	,	_	0	SENT_155	[p12l1260t1053r1553b1135],
9	bell-shaped	JJ	O	bell-shaped	amod	10	SENT_155	[p12l1587t1053r2036b1138],
10	distribution	NN	O	distribution	nsubj	4	SENT_155	[p12l9t1161r487b1243],
11	,	,	O	,	_	0	SENT_155	[p12l9t1161r487b1243],
12	while	IN	O	while	mark	20	SENT_155	[p12l535t1161r746b1228],
13	distribution	NN	O	distribution	nsubj	20	SENT_155	[p12l787t1161r1237b1228],
14	of	IN	O	of	_	0	SENT_155	[p12l1282t1161r1361b1228],
15	PRI	NNP	ORGANIZATION	PRI	nn	16	SENT_155	[p12l1403t1162r1514b1227],
16	VASP	NN	ORGANIZATION	vasp	prep_of	13	SENT_155	[p12l1558t1162r1743b1228],
17	and	CC	O	and	_	0	SENT_155	[p12l1782t1161r1917b1228],
18	Pselectin	NN	O	pselectin	nn	19	SENT_155	[p12l1966t1162r2035b1227, p12l9t1267r311b1335],
19	expression	NN	O	expression	prep_of	13	SENT_155	[p12l361t1269r770b1352],
20	were	VBD	O	be	dep	10	SENT_155	[p12l818t1286r1012b1335],
21	not	RB	O	not	neg	20	SENT_155	[p12l1062t1274r1210b1335],
22	.	.	O	.	_	0	SENT_155	[p12l1062t1274r1210b1335],

1	The	DT	O	the	det	2	SENT_156	[p12l1263t1267r1408b1335],
2	rate	NN	O	rate	nsubj	20	SENT_156	[p12l1458t1274r1614b1335],
3	of	IN	O	of	_	0	SENT_156	[p12l1661t1267r1740b1335],
4	persistence	NN	O	persistence	prep_of	2	SENT_156	[p12l1786t1269r2034b1352, p12l9t1380r228b1441],
5	of	IN	O	of	_	0	SENT_156	[p12l260t1374r338b1441],
6	HPPR	NN	O	hppr	prep_of	4	SENT_156	[p12l370t1375r572b1441],
7	(	CD	NUMBER	(	num	8	SENT_156	[p12l606t1375r1160b1459],
8	ADP-Ag	NN	O	adp-ag	npadvmod	9	SENT_156	[p12l606t1375r1160b1459],
9	>	JJR	O	>	amod	6	SENT_156	[p12l606t1375r1160b1459],
10	70	CD	PERCENT	70	num	11	SENT_156	[p12l606t1375r1160b1459],
11	%	NN	PERCENT	%	dep	9	SENT_156	[p12l606t1375r1160b1459],
12	)	CD	NUMBER	)	tmod	4	SENT_156	[p12l606t1375r1160b1459],
13	was	VBD	O	be	cop	20	SENT_156	[p12l1193t1392r1338b1441],
14	24	CD	PERCENT	24	num	15	SENT_156	[p12l1369t1375r1510b1441],
15	%	NN	PERCENT	%	nn	20	SENT_156	[p12l1369t1375r1510b1441],
16	(	CD	NUMBER	(	num	17	SENT_156	[p12l1547t1376r1673b1458],
17	n	NN	O	n	dep	15	SENT_156	[p12l1547t1376r1673b1458],
18	=	JJ	O	=	amod	20	SENT_156	[p12l1547t1376r1673b1458],
19	143	CD	NUMBER	143	tmod	18	SENT_156	[p12l1696t1375r1882b1458],
20	)	NN	O	)	_	0	SENT_156	[p12l1696t1375r1882b1458],
21	.	.	O	.	_	0	SENT_156	[p12l1696t1375r1882b1458],

1	All	DT	O	all	det	3	SENT_157	[p12l113t1482r215b1549],
2	platelet	NN	O	platelet	nn	3	SENT_157	[p12l248t1482r555b1566],
3	parameters	NNS	O	parameter	nsubjpass	6	SENT_157	[p12l587t1488r1032b1566],
4	studied	VBN	O	study	partmod	3	SENT_157	[p12l1061t1482r1344b1549],
5	were	VBD	O	be	auxpass	6	SENT_157	[p12l1374t1500r1568b1549],
6	correlated	VBN	O	correlate	_	0	SENT_157	[p12l1598t1482r2031b1549],
7	.	.	O	.	_	0	SENT_157	[p12l1598t1482r2031b1549],

1	The	DT	O	the	det	3	SENT_158	[p12l7t1588r152b1656],
2	strongest	JJS	O	strongest	amod	3	SENT_158	[p12l205t1595r564b1673],
3	correlation	NN	O	correlation	nsubj	19	SENT_158	[p12l616t1588r1045b1656],
4	observed	VBN	O	observe	partmod	3	SENT_158	[p12l1101t1588r1449b1656],
5	was	VBD	O	be	cop	19	SENT_158	[p12l1503t1607r1648b1656],
6	between	IN	O	between	_	0	SENT_158	[p12l1702t1588r2036b1656],
7	ADP-Ag	NN	O	adp-ag	nn	10	SENT_158	[p12l6t1697r289b1780],
8	and	CC	O	and	_	0	SENT_158	[p12l337t1696r473b1763],
9	PRI	NNP	ORGANIZATION	PRI	nn	10	SENT_158	[p12l528t1697r639b1762],
10	VASP	NN	ORGANIZATION	vasp	prep_between	19	SENT_158	[p12l690t1696r875b1763],
11	(	CD	NUMBER	(	num	12	SENT_158	[p12l929t1696r1252b1780],
12	r	NN	O	r	npadvmod	18	SENT_158	[p12l929t1696r1252b1780],
13	=	JJ	O	=	amod	12	SENT_158	[p12l929t1696r1252b1780],
14	O.	NNP	O	O.	tmod	13	SENT_158	[p12l929t1696r1252b1780],
15	64	CD	NUMBER	64	num	14	SENT_158	[p12l929t1696r1252b1780],
16	,	,	O	,	_	0	SENT_158	[p12l929t1696r1252b1780],
17	p	NN	O	p	appos	14	SENT_158	[p12l1304t1696r1667b1780],
18	<	JJR	O	<	amod	10	SENT_158	[p12l1304t1696r1667b1780],
19	0.001	CD	NUMBER	0.001	_	0	SENT_158	[p12l1304t1696r1667b1780],
20	,	,	O	,	_	0	SENT_158	[p12l1304t1696r1667b1780],
21	n	NN	O	n	appos	19	SENT_158	[p12l1724t1697r2031b1780],
22	=	JJ	O	=	quantmod	23	SENT_158	[p12l1724t1697r2031b1780],
23	454	CD	NUMBER	454	num	24	SENT_158	[p12l1724t1697r2031b1780],
24	)	NN	O	)	dep	21	SENT_158	[p12l1724t1697r2031b1780],
25	.	.	O	.	_	0	SENT_158	[p12l1724t1697r2031b1780],

1	There	EX	O	there	expl	2	SENT_159	[p12l7t1802r234b1870],
2	were	VBD	O	be	_	0	SENT_159	[p12l262t1821r456b1870],
3	also	RB	O	also	advmod	2	SENT_159	[p12l485t1802r635b1870],
4	significant	JJ	O	significant	amod	5	SENT_159	[p12l664t1802r1069b1887],
5	correlations	NNS	O	correlation	nsubj	2	SENT_159	[p12l1098t1802r1565b1870],
6	between	IN	O	between	_	0	SENT_159	[p12l1597t1802r1930b1870],
7	Pselectin	NN	O	pselectin	nn	8	SENT_159	[p12l1966t1804r2035b1869, p12l9t1909r311b1976],
8	expression	NN	O	expression	prep_between	5	SENT_159	[p12l353t1911r761b1994],
9	and	CC	O	and	_	0	SENT_159	[p12l803t1909r938b1976],
10	ADP-Ag	JJ	O	adp-ag	amod	12	SENT_159	[p12l977t1910r1259b1994],
11	(	NN	O	(	nn	12	SENT_159	[p12l1303t1910r1626b1994],
12	r	NN	O	r	conj_and	5	SENT_159	[p12l1303t1910r1626b1994],
13	=	JJ	O	=	amod	18	SENT_159	[p12l1303t1910r1626b1994],
14	O.	NNP	O	O.	tmod	13	SENT_159	[p12l1303t1910r1626b1994],
15	50	CD	NUMBER	50	num	14	SENT_159	[p12l1303t1910r1626b1994],
16	,	,	O	,	_	0	SENT_159	[p12l1303t1910r1626b1994],
17	p	NN	O	p	appos	14	SENT_159	[p12l1669t1910r2031b1994],
18	<	JJR	O	<	dep	12	SENT_159	[p12l1669t1910r2031b1994],
19	0.001	CD	NUMBER	0.001	dep	12	SENT_159	[p12l1669t1910r2031b1994],
20	,	,	O	,	_	0	SENT_159	[p12l1669t1910r2031b1994],
21	n	NN	O	n	conj_and	5	SENT_159	[p12l10t2018r289b2101],
22	=	JJ	O	=	amod	33	SENT_159	[p12l10t2018r289b2101],
23	597	CD	NUMBER	597	num	24	SENT_159	[p12l10t2018r289b2101],
24	)	NN	O	)	nn	33	SENT_159	[p12l10t2018r289b2101],
25	and	CC	O	and	_	0	SENT_159	[p12l328t2017r464b2084],
26	between	IN	O	between	nn	33	SENT_159	[p12l505t2017r837b2084],
27	P-selectin	NN	MISC	p-selectin	nn	28	SENT_159	[p12l880t2017r1260b2084],
28	expression	NN	O	expression	pobj	26	SENT_159	[p12l1298t2018r1707b2101],
29	and	CC	O	and	_	0	SENT_159	[p12l1745t2017r1881b2084],
30	PRI	NNP	ORGANIZATION	PRI	nn	31	SENT_159	[p12l1923t2018r2034b2083],
31	VASP	NN	ORGANIZATION	vasp	pobj	26	SENT_159	[p12l7t2124r191b2191],
32	(	CD	NUMBER	(	num	31	SENT_159	[p12l229t2124r552b2208],
33	r	NN	O	r	dep	21	SENT_159	[p12l229t2124r552b2208],
34	=	JJ	O	=	amod	33	SENT_159	[p12l229t2124r552b2208],
35	0.58	CD	NUMBER	0.58	tmod	34	SENT_159	[p12l229t2124r552b2208],
36	,	,	O	,	_	0	SENT_159	[p12l229t2124r552b2208],
37	p	NN	O	p	dep	38	SENT_159	[p12l588t2124r951b2208],
38	<	JJR	O	<	nsubj	2	SENT_159	[p12l588t2124r951b2208],
39	0.001	CD	NUMBER	0.001	dep	38	SENT_159	[p12l588t2124r951b2208],
40	,	,	O	,	_	0	SENT_159	[p12l588t2124r951b2208],
41	n	NN	O	n	nsubj	2	SENT_159	[p12l991t2125r1298b2208],
42	=	JJ	O	=	quantmod	43	SENT_159	[p12l991t2125r1298b2208],
43	454	CD	NUMBER	454	num	44	SENT_159	[p12l991t2125r1298b2208],
44	)	NN	O	)	dep	41	SENT_159	[p12l991t2125r1298b2208],
45	.	.	O	.	_	0	SENT_159	[p12l991t2125r1298b2208],

1	Genetic	JJ	O	genetic	amod	2	SENT_160	[p12l10t2322r356b2396],
2	polymorphism	NN	O	polymorphism	_	0	SENT_160	[p12l397t2320r1027b2415],
3	and	CC	O	and	_	0	SENT_160	[p12l1069t2320r1227b2395],
4	platelet	NN	O	platelet	nn	5	SENT_160	[p12l1270t2320r1618b2415],
5	parameters	NNS	O	parameter	conj_and	2	SENT_160	[p12l11t2442r522b2529],

1	The	DT	O	the	det	3	SENT_161	[p12l7t2655r154b2723],
2	allele	NN	O	allele	nn	3	SENT_161	[p12l213t2655r434b2723],
3	frequencies	NNS	O	frequency	nsubj	4	SENT_161	[p12l493t2655r958b2740],
4	were	VBD	O	be	dep	16	SENT_161	[p12l1015t2674r1211b2723],
5	in	IN	O	in	_	0	SENT_161	[p12l1271t2657r1337b2722],
6	Hardy-Weinberg	JJ	LOCATION	hardy-weinberg	amod	7	SENT_161	[p12l1403t2655r2039b2740],
7	equilibrium	NN	O	equilibrium	prep_in	4	SENT_161	[p12l9t2762r462b2847],
8	and	CC	O	and	_	0	SENT_161	[p12l490t2762r626b2829],
9	similar	JJ	O	similar	prep_in	4	SENT_161	[p12l653t2762r922b2829],
10	to	TO	O	to	_	0	SENT_161	[p12l943t2768r1022b2829],
11	that	DT	O	that	prep_to	4	SENT_161	[p12l1046t2762r1209b2829],
12	observed	VBN	O	observe	partmod	11	SENT_161	[p12l1232t2762r1586b2829],
13	in	IN	O	in	_	0	SENT_161	[p12l1614t2764r1680b2829],
14	previous	JJ	O	previous	amod	15	SENT_161	[p12l1709t2763r2040b2847],
15	reports	NNS	O	report	prep_in	12	SENT_161	[p12l12t2876r294b2954],
16	[	VBP	O	[	_	0	SENT_161	[p12l348t2870r672b2954],
17	13	CD	NUMBER	13	num	18	SENT_161	[p12l348t2870r672b2954],
18	—	CD	NUMBER	—	dobj	16	SENT_161	[p12l348t2870r672b2954],
19	16	CD	NUMBER	16	num	20	SENT_161	[p12l348t2870r672b2954],
20	]	NN	O	]	nsubj	16	SENT_161	[p12l348t2870r672b2954],
21	.	.	O	.	_	0	SENT_161	[p12l348t2870r672b2954],

1	In	IN	O	in	_	0	SENT_162	[p12l733t2872r793b2936],
2	the	DT	O	the	det	4	SENT_162	[p12l845t2870r974b2937],
3	whole	JJ	O	whole	amod	4	SENT_162	[p12l1020t2870r1257b2937],
4	population	NN	O	population	prep_in	20	SENT_162	[p12l1308t2870r1728b2954],
5	of	IN	O	of	_	0	SENT_162	[p12l1779t2870r1858b2937],
6	597	CD	NUMBER	597	num	7	SENT_162	[p12l1906t2871r2040b2937],
7	patients	NNS	O	patient	prep_of	4	SENT_162	[p12l12t2978r359b3061],
8	,	,	O	,	_	0	SENT_162	[p12l12t2978r359b3061],
9	the	DT	O	the	det	11	SENT_162	[p12l412t2976r540b3044],
10	genotype	NN	O	genotype	nn	11	SENT_162	[p12l585t2983r950b3061],
11	distribution	NN	O	distribution	nsubj	20	SENT_162	[p12l996t2976r1456b3044],
12	of	IN	O	of	_	0	SENT_162	[p12l1503t2976r1582b3044],
13	the	DT	O	the	det	15	SENT_162	[p12l1625t2976r1753b3044],
14	T744C	NN	O	t744c	nn	15	SENT_162	[p12l1795t2977r2039b3044],
15	polymorphism	NN	O	polymorphism	prep_of	11	SENT_162	[p12l12t3083r563b3168],
16	of	IN	O	of	_	0	SENT_162	[p12l594t3083r673b3150],
17	the	DT	O	the	det	19	SENT_162	[p12l697t3083r825b3150],
18	P2Y12	NN	O	p2y12	nn	19	SENT_162	[p12l856t3084r1088b3150],
19	gene	NN	O	gene	prep_of	15	SENT_162	[p12l1118t3100r1305b3168],
20	was	VBD	O	be	_	0	SENT_162	[p12l1330t3101r1477b3151],
21	as	IN	O	as	mark	22	SENT_162	[p12l1504t3101r1582b3150],
22	follows	VBZ	O	follow	advcl	20	SENT_162	[p12l1609t3083r1915b3151],
23	:	:	O	:	_	0	SENT_162	[p12l1609t3083r1915b3151],
24	13	CD	NUMBER	13	num	25	SENT_162	[p12l1956t3084r2036b3150],
25	patients	NNS	O	patient	nsubj	32	SENT_162	[p12l12t3192r334b3275],
26	(	IN	O	(	_	0	SENT_162	[p12l397t3192r551b3275],
27	2	CD	PERCENT	2	num	28	SENT_162	[p12l397t3192r551b3275],
28	%	NN	PERCENT	%	prep_(	25	SENT_162	[p12l397t3192r551b3275],
29	)	CD	NUMBER	)	dep	28	SENT_162	[p12l397t3192r551b3275],
30	were	VBD	O	be	cop	32	SENT_162	[p12l611t3209r807b3258],
31	CC	NN	O	cc	nn	32	SENT_162	[p12l866t3192r967b3258],
32	homozygotes	NNS	O	homozygote	dep	22	SENT_162	[p12l1029t3191r1568b3275],
33	,	,	O	,	_	0	SENT_162	[p12l1029t3191r1568b3275],
34	125	CD	PERCENT	125	number	35	SENT_162	[p12l1640t3192r1769b3258],
35	(	CD	PERCENT	(	appos	32	SENT_162	[p12l1835t3192r2036b3275],
36	21	CD	PERCENT	21	num	37	SENT_162	[p12l1835t3192r2036b3275],
37	%	NN	PERCENT	%	dep	35	SENT_162	[p12l1835t3192r2036b3275],
38	)	CD	NUMBER	)	nsubj	41	SENT_162	[p12l1835t3192r2036b3275],
39	were	VBD	O	be	cop	41	SENT_162	[p12l7t3316r204b3365],
40	CT	NN	O	ct	nn	41	SENT_162	[p12l260t3298r362b3365],
41	heterozygotes	NNS	O	heterozygote	dep	32	SENT_162	[p12l419t3297r980b3382],
42	and	CC	O	and	_	0	SENT_162	[p12l1036t3297r1173b3365],
43	459	CD	PERCENT	459	number	44	SENT_162	[p12l1230t3298r1367b3365],
44	(	CD	PERCENT	(	dep	32	SENT_162	[p12l1430t3298r1631b3382],
45	77	CD	PERCENT	77	num	46	SENT_162	[p12l1430t3298r1631b3382],
46	%	NN	PERCENT	%	dep	44	SENT_162	[p12l1430t3298r1631b3382],
47	)	CD	NUMBER	)	nsubj	50	SENT_162	[p12l1430t3298r1631b3382],
48	were	VBD	O	be	cop	50	SENT_162	[p12l1688t3316r1885b3365],
49	TT	NN	O	tt	nn	50	SENT_162	[p12l1939t3299r2042b3364],
50	homozygotes	NNS	O	homozygote	dep	32	SENT_162	[p12l12t3385r551b3469],
51	.	.	O	.	_	0	SENT_162	[p12l12t3385r551b3469],

1	No	DT	O	no	det	3	SENT_163	[p12l120t3493r216b3559],
2	significant	JJ	O	significant	amod	3	SENT_163	[p12l253t3491r658b3576],
3	difference	NN	O	difference	dep	9	SENT_163	[p12l695t3491r1101b3559],
4	in	IN	O	in	_	0	SENT_163	[p12l1139t3493r1204b3558],
5	platelet	NN	O	platelet	nn	7	SENT_163	[p12l1248t3491r1555b3576],
6	parameters	NNS	O	parameter	nn	7	SENT_163	[p12l1595t3498r2039b3576],
7	profiles	NNS	O	profile	prep_in	3	SENT_163	[p12l12t3599r303b3684],
8	was	VBD	O	be	auxpass	9	SENT_163	[p12l327t3617r472b3666],
9	observed	VBN	O	observe	_	0	SENT_163	[p12l498t3599r846b3666],
10	within	IN	O	within	_	0	SENT_163	[p12l874t3599r1116b3666],
11	patients	NNS	O	patient	prep_within	9	SENT_163	[p12l1149t3601r1464b3684],
12	with	IN	O	with	_	0	SENT_163	[p12l1488t3599r1657b3666],
13	the	DT	O	the	det	15	SENT_163	[p12l1687t3599r1814b3666],
14	same	JJ	O	same	amod	15	SENT_163	[p12l1841t3617r2039b3666],
15	genotype	NN	O	genotype	prep_with	9	SENT_163	[p12l10t3712r394b3790],
16	,	,	O	,	_	0	SENT_163	[p12l10t3712r394b3790],
17	for	IN	O	for	_	0	SENT_163	[p12l437t3706r549b3773],
18	ADP-Ag	JJ	O	adp-ag	amod	20	SENT_163	[p12l580t3707r863b3790],
19	(	NN	O	(	nn	20	SENT_163	[p12l904t3707r1272b3791],
20	p	NN	O	p	prep_for	9	SENT_163	[p12l904t3707r1272b3791],
21	=	JJ	O	=	amod	20	SENT_163	[p12l904t3707r1272b3791],
22	0.39	CD	NUMBER	0.39	num	23	SENT_163	[p12l904t3707r1272b3791],
23	)	NN	O	)	tmod	21	SENT_163	[p12l904t3707r1272b3791],
24	,	,	O	,	_	0	SENT_163	[p12l904t3707r1272b3791],
25	PRI	NNP	ORGANIZATION	PRI	nn	26	SENT_163	[p12l1320t3707r1431b3772],
26	VASP	NN	ORGANIZATION	vasp	appos	23	SENT_163	[p12l1469t3707r1653b3773],
27	(	CD	NUMBER	(	num	28	SENT_163	[p12l1695t3707r2036b3791],
28	p	NN	O	p	npadvmod	29	SENT_163	[p12l1695t3707r2036b3791],
29	=	JJ	O	=	amod	20	SENT_163	[p12l1695t3707r2036b3791],
30	0.97	CD	NUMBER	0.97	num	31	SENT_163	[p12l1695t3707r2036b3791],
31	)	NN	O	)	nsubjpass	9	SENT_163	[p12l1695t3707r2036b3791],

1	and	CC	O	and	cc	4	SENT_164	[p13l10t17r145b85],
2	PS	NNP	O	PS	nn	4	SENT_164	[p13l183t18r266b85],
3	(	CD	NUMBER	(	num	4	SENT_164	[p13l304t18r645b102],
4	p	NN	O	p	_	0	SENT_164	[p13l304t18r645b102],
5	=	JJ	O	=	dep	4	SENT_164	[p13l304t18r645b102],
6	O.	NNP	O	O.	iobj	5	SENT_164	[p13l304t18r645b102],
7	62	CD	NUMBER	62	num	6	SENT_164	[p13l304t18r645b102],
8	)	CD	NUMBER	)	number	9	SENT_164	[p13l304t18r645b102],
9	(	CD	NUMBER	(	num	10	SENT_164	[p13l685t17r918b102],
10	Table	NNP	O	Table	dobj	5	SENT_164	[p13l685t17r918b102],
11	2	CD	NUMBER	2	num	10	SENT_164	[p13l950t18r1049b102],
12	)	CD	NUMBER	)	dep	4	SENT_164	[p13l950t18r1049b102],
13	.	.	O	.	_	0	SENT_164	[p13l950t18r1049b102],

1	Defining	VBG	O	define	partmod	21	SENT_165	[p13l120t124r437b209],
2	clopidogrel	NN	O	clopidogrel	nn	3	SENT_165	[p13l484t124r920b209],
3	resistance	NN	O	resistance	dobj	1	SENT_165	[p13l970t126r1362b191],
4	with	IN	O	with	_	0	SENT_165	[p13l1407t124r1576b192],
5	ADP-Ag	NN	O	adp-ag	prep_with	1	SENT_165	[p13l1623t125r1905b209],
6	by	IN	O	by	_	0	SENT_165	[p13l1954t124r2041b209],
7	HPPR	NN	O	hppr	agent	1	SENT_165	[p13l12t233r236b314],
8	,	,	O	,	_	0	SENT_165	[p13l12t233r236b314],
9	the	DT	O	the	det	11	SENT_165	[p13l275t232r402b299],
10	genotype	NN	O	genotype	nn	11	SENT_165	[p13l433t238r793b316],
11	frequencies	NNS	O	frequency	nsubj	21	SENT_165	[p13l824t232r1281b316],
12	of	IN	O	of	_	0	SENT_165	[p13l1312t232r1390b299],
13	the	DT	O	the	det	15	SENT_165	[p13l1418t232r1545b299],
14	T744C	NN	O	t744c	nn	15	SENT_165	[p13l1573t233r1813b299],
15	polymorphism	NN	O	polymorphism	prep_of	11	SENT_165	[p13l1848t232r2035b316, p13l12t338r388b423],
16	of	IN	O	of	_	0	SENT_165	[p13l440t338r519b406],
17	the	DT	O	the	det	19	SENT_165	[p13l565t338r692b406],
18	P2Y12	NN	O	p2y12	nn	19	SENT_165	[p13l745t339r974b405],
19	gene	NN	O	gene	prep_of	15	SENT_165	[p13l1025t355r1209b423],
20	were	VBD	O	be	cop	21	SENT_165	[p13l1257t357r1451b406],
21	similar	JJ	O	similar	dep	27	SENT_165	[p13l1500t338r1763b406],
22	in	IN	O	in	_	0	SENT_165	[p13l1811t340r1876b405],
23	responders	NNS	O	responder	prep_in	21	SENT_165	[p13l1932t357r2035b406, p13l9t446r352b530],
24	and	CC	O	and	_	0	SENT_165	[p13l384t446r520b513],
25	non	JJ	O	non	amod	26	SENT_165	[p13l557t464r691b513],
26	responders	NNS	O	responder	conj_and	23	SENT_165	[p13l728t446r1151b530],
27	(	VBP	O	(	_	0	SENT_165	[p13l1187t446r1528b530],
28	p	NN	O	p	dobj	27	SENT_165	[p13l1187t446r1528b530],
29	=	JJ	O	=	amod	30	SENT_165	[p13l1187t446r1528b530],
30	O.	NNP	O	O.	nsubj	27	SENT_165	[p13l1187t446r1528b530],
31	75	CD	NUMBER	75	dep	30	SENT_165	[p13l1187t446r1528b530],
32	)	CD	NUMBER	)	number	33	SENT_165	[p13l1187t446r1528b530],
33	(	CD	NUMBER	(	num	36	SENT_165	[p13l1569t446r1802b530],
34	Table	NNP	O	Table	nn	36	SENT_165	[p13l1569t446r1802b530],
35	3	CD	NUMBER	3	num	36	SENT_165	[p13l1836t446r1933b530],
36	)	NN	O	)	dep	31	SENT_165	[p13l1836t446r1933b530],
37	.	.	O	.	_	0	SENT_165	[p13l1836t446r1933b530],

1	Discussion	NN	O	discussion	_	0	SENT_166	[p13l14t648r507b727],

1	The	DT	O	the	det	3	SENT_167	[p13l7t874r155b942],
2	present	JJ	DATE	present	amod	3	SENT_167	[p13l193t881r492b959],
3	study	NN	O	study	nsubj	4	SENT_167	[p13l527t874r741b959],
4	confirmed	VBD	O	confirm	_	0	SENT_167	[p13l774t874r1181b942],
5	that	IN	O	that	complm	24	SENT_167	[p13l1219t874r1383b942],
6	in	IN	O	in	_	0	SENT_167	[p13l1418t876r1485b941],
7	a	DT	O	a	det	9	SENT_167	[p13l1524t893r1564b942],
8	broad	JJ	O	broad	amod	9	SENT_167	[p13l1602t874r1824b942],
9	population	NN	O	population	prep_in	24	SENT_167	[p13l1865t893r2036b959, p13l11t981r286b1048],
10	of	IN	O	of	_	0	SENT_167	[p13l323t981r402b1048],
11	NSTE	NNP	O	NSTE	nn	13	SENT_167	[p13l437t982r630b1049],
12	ACS	NN	ORGANIZATION	ac	nn	13	SENT_167	[p13l662t982r809b1049],
13	patients	NNS	O	patient	prep_of	9	SENT_167	[p13l846t983r1198b1066],
14	,	,	O	,	_	0	SENT_167	[p13l846t983r1198b1066],
15	the	DT	O	the	det	17	SENT_167	[p13l1240t981r1369b1048],
16	T744C	NN	O	t744c	nn	17	SENT_167	[p13l1401t982r1647b1049],
17	polymorphism	NN	O	polymorphism	nsubj	24	SENT_167	[p13l1684t981r2035b1066, p13l12t1089r255b1173],
18	of	IN	O	of	_	0	SENT_167	[p13l310t1089r394b1156],
19	the	DT	O	the	det	21	SENT_167	[p13l443t1089r581b1156],
20	P2Y12	NN	O	p2y12	nn	21	SENT_167	[p13l637t1090r888b1155],
21	gene	NN	O	gene	prep_of	17	SENT_167	[p13l942t1105r1143b1173],
22	does	VBZ	O	do	aux	24	SENT_167	[p13l1196t1089r1389b1156],
23	not	RB	O	not	neg	24	SENT_167	[p13l1443t1095r1578b1156],
24	modulate	VB	O	modulate	ccomp	4	SENT_167	[p13l1632t1089r2038b1156],
25	clopidogrelresponsiveness	NN	O	clopidogrelresponsiveness	dobj	24	SENT_167	[p13l9t1195r1094b1280],
26	.	.	O	.	_	0	SENT_167	[p13l9t1195r1094b1280],

1	Numerous	JJ	O	numerous	amod	3	SENT_168	[p13l120t1305r504b1370],
2	biological	JJ	O	biological	amod	3	SENT_168	[p13l535t1303r907b1387],
3	studies	NNS	O	study	nsubj	17	SENT_168	[p13l937t1303r1234b1385],
4	,	,	O	,	_	0	SENT_168	[p13l937t1303r1234b1385],
5	based	VBN	O	base	partmod	3	SENT_168	[p13l1272t1303r1490b1370],
6	on	IN	O	on	_	0	SENT_168	[p13l1522t1321r1610b1370],
7	Adenosine	NNP	LOCATION	Adenosine	nn	8	SENT_168	[p13l1639t1303r2039b1370],
8	DiPhosphate	NNP	O	DiPhosphate	prep_on	5	SENT_168	[p13l12t1409r487b1494],
9	(	CD	NUMBER	(	num	10	SENT_168	[p13l539t1409r1091b1494],
10	ADP	NN	ORGANIZATION	adp	nsubj	13	SENT_168	[p13l539t1409r1091b1494],
11	)	SYM	O	)	dep	13	SENT_168	[p13l539t1409r1091b1494],
12	-	:	O	-	_	0	SENT_168	[p13l539t1409r1091b1494],
13	induced	VBN	O	induce	rcmod	8	SENT_168	[p13l539t1409r1091b1494],
14	platelet	NN	O	platelet	nn	15	SENT_168	[p13l1144t1409r1451b1494],
15	aggregometry	NN	O	aggregometry	dobj	13	SENT_168	[p13l1499t1416r2040b1494],
16	have	VBP	O	have	aux	17	SENT_168	[p13l12t1517r191b1584],
17	reported	VBN	O	report	dep	37	SENT_168	[p13l247t1517r582b1602],
18	variability	NN	O	variability	dobj	17	SENT_168	[p13l635t1517r1034b1602],
19	in	IN	O	in	_	0	SENT_168	[p13l1085t1518r1150b1584],
20	platelet	NN	O	platelet	nn	21	SENT_168	[p13l1208t1517r1515b1602],
21	response	NN	O	response	prep_in	17	SENT_168	[p13l1571t1535r1909b1602],
22	to	TO	O	to	_	0	SENT_168	[p13l1962t1523r2039b1584],
23	clopidogrel	NN	O	clopidogrel	nn	24	SENT_168	[p13l9t1624r445b1708],
24	[	NN	O	[	prep_to	21	SENT_168	[p13l507t1624r734b1708],
25	3	CD	NUMBER	3	num	26	SENT_168	[p13l507t1624r734b1708],
26	—	NN	O	—	dep	21	SENT_168	[p13l507t1624r734b1708],
27	7	CD	NUMBER	7	num	28	SENT_168	[p13l507t1624r734b1708],
28	]	NN	O	]	dep	26	SENT_168	[p13l507t1624r734b1708],
29	,	,	O	,	_	0	SENT_168	[p13l507t1624r734b1708],
30	and	CC	O	and	_	0	SENT_168	[p13l798t1624r933b1691],
31	its	PRP$	O	its	poss	33	SENT_168	[p13l993t1625r1084b1691],
32	clinical	JJ	O	clinical	amod	33	SENT_168	[p13l1139t1624r1418b1691],
33	relevance	NN	O	relevance	prep_in	17	SENT_168	[p13l1479t1624r1857b1691],
34	has	VBZ	O	have	aux	37	SENT_168	[p13l1916t1624r2039b1691],
35	been	VBN	O	be	auxpass	37	SENT_168	[p13l12t1730r195b1798],
36	well	RB	O	well	advmod	37	SENT_168	[p13l230t1730r392b1798],
37	investigated	VBN	O	investigate	_	0	SENT_168	[p13l427t1730r904b1815],
38	[	NN	O	[	dobj	37	SENT_168	[p13l946t1730r1219b1815],
39	8	CD	NUMBER	8	num	42	SENT_168	[p13l946t1730r1219b1815],
40	—	NN	O	—	nn	42	SENT_168	[p13l946t1730r1219b1815],
41	12	CD	NUMBER	12	num	42	SENT_168	[p13l946t1730r1219b1815],
42	]	NN	O	]	nsubjpass	37	SENT_168	[p13l946t1730r1219b1815],
43	.	.	O	.	_	0	SENT_168	[p13l946t1730r1219b1815],

1	These	DT	O	these	det	2	SENT_169	[p13l1258t1730r1486b1798],
2	findings	NNS	O	finding	nsubj	4	SENT_169	[p13l1520t1730r1824b1815],
3	have	VBP	O	have	aux	4	SENT_169	[p13l1860t1730r2039b1798],
4	underlined	VBN	O	underline	_	0	SENT_169	[p13l11t1837r427b1904],
5	the	DT	O	the	det	6	SENT_169	[p13l487t1837r614b1904],
6	need	NN	O	need	dobj	4	SENT_169	[p13l673t1837r857b1904],
7	to	TO	O	to	aux	8	SENT_169	[p13l917t1844r994b1904],
8	optimize	VB	O	optimize	xcomp	4	SENT_169	[p13l1051t1839r1392b1922],
9	antithrombotic	JJ	O	antithrombotic	amod	10	SENT_169	[p13l1449t1837r2038b1905],
10	treatment	NN	O	treatment	dobj	8	SENT_169	[p13l9t1951r409b2012],
11	at	IN	O	at	_	0	SENT_169	[p13l449t1951r526b2012],
12	the	DT	O	the	det	13	SENT_169	[p13l566t1945r692b2012],
13	time	NN	O	time	prep_at	8	SENT_169	[p13l732t1946r908b2012],
14	of	IN	O	of	_	0	SENT_169	[p13l948t1945r1026b2012],
15	PCI	NNP	O	PCI	prep_of	13	SENT_169	[p13l1066t1946r1209b2027],
16	,	,	O	,	_	0	SENT_169	[p13l1066t1946r1209b2027],
17	in	IN	O	in	_	0	SENT_169	[p13l1256t1946r1321b2011],
18	high-risk	JJ	O	high-risk	amod	19	SENT_169	[p13l1367t1945r1699b2029],
19	settings	NNS	O	setting	prep_in	4	SENT_169	[p13l1737t1946r2039b2029],
20	such	JJ	O	such	_	0	SENT_169	[p13l9t2051r177b2119],
21	as	IN	O	as	_	0	SENT_169	[p13l207t2070r284b2119],
22	ACS	NN	O	ac	prep_such_as	19	SENT_169	[p13l308t2052r477b2119],
23	.	.	O	.	_	0	SENT_169	[p13l308t2052r477b2119],

1	Several	JJ	O	several	amod	2	SENT_170	[p13l513t2051r796b2119],
2	studies	NNS	O	study	nsubj	4	SENT_170	[p13l825t2051r1097b2119],
3	already	RB	O	already	advmod	4	SENT_170	[p13l1124t2051r1415b2136],
4	showed	VBD	O	show	_	0	SENT_170	[p13l1440t2051r1727b2119],
5	benefit	NN	O	benefit	dobj	4	SENT_170	[p13l1759t2051r2039b2119],
6	of	IN	O	of	_	0	SENT_170	[p13l9t2159r87b2226],
7	higher	JJR	O	higher	amod	8	SENT_170	[p13l129t2159r373b2243],
8	clopidogrel	NN	O	clopidogrel	prep_of	5	SENT_170	[p13l413t2159r848b2243],
9	loading	VBG	O	load	partmod	8	SENT_170	[p13l896t2159r1175b2243],
10	dose	NN	O	dose	dobj	9	SENT_170	[p13l1217t2159r1392b2226],
11	on	IN	O	on	_	0	SENT_170	[p13l1435t2177r1523b2226],
12	platelet	NN	O	platelet	nn	13	SENT_170	[p13l1570t2159r1878b2243],
13	aggregation	NN	O	aggregation	prep_on	9	SENT_170	[p13l1921t2175r2035b2243, p13l59t2565r436b2651],

1	with	IN	O	with	_	0	SENT_171	[p13l481t2563r656b2633],
2	decreased	VBN	O	decrease	amod	3	SENT_171	[p13l703t2563r1110b2633],
3	rates	NNS	O	rate	pobj	1	SENT_171	[p13l1162t2570r1359b2633],
4	of	IN	O	of	_	0	SENT_171	[p13l1403t2563r1484b2633],
5	non	JJ	O	non	amod	6	SENT_171	[p13l1528t2582r1665b2633],
6	responders	NNS	O	responder	prep_of	3	SENT_171	[p13l1716t2563r2151b2651],
7	and	CC	O	and	_	0	SENT_171	[p13l59t2673r199b2742],
8	platelet	NN	O	platelet	nn	9	SENT_171	[p13l232t2673r549b2761],
9	reactivity	NN	O	reactivity	pobj	1	SENT_171	[p13l580t2674r966b2761],
10	[	CD	NUMBER	[	number	11	SENT_171	[p13l999t2673r1327b2761],
11	17	CD	NUMBER	17	num	12	SENT_171	[p13l999t2673r1327b2761],
12	—	NN	O	—	dep	9	SENT_171	[p13l999t2673r1327b2761],
13	21	CD	NUMBER	21	num	14	SENT_171	[p13l999t2673r1327b2761],
14	]	NN	O	]	dep	9	SENT_171	[p13l999t2673r1327b2761],
15	.	.	O	.	_	0	SENT_171	[p13l999t2673r1327b2761],

1	Others	NNS	O	other	nsubj	2	SENT_172	[p13l1364t2673r1628b2743],
2	demonstrated	VBD	O	demonstrate	_	0	SENT_172	[p13l1655t2673r2146b2742, p13l58t2784r151b2853],
3	the	DT	O	the	det	4	SENT_172	[p13l201t2784r332b2853],
4	superiority	NN	O	superiority	dobj	2	SENT_172	[p13l378t2785r815b2870],
5	of	IN	O	of	_	0	SENT_172	[p13l859t2784r940b2853],
6	600	CD	NUMBER	600	num	7	SENT_172	[p13l984t2785r1122b2853],
7	mg	NN	O	mg	prep_of	4	SENT_172	[p13l1172t2801r1285b2870],
8	of	IN	O	of	_	0	SENT_172	[p13l1332t2784r1413b2853],
9	clopidogrel	NN	O	clopidogrel	prep_of	7	SENT_172	[p13l1456t2784r1906b2870],
10	compared	VBN	O	compare	_	0	SENT_172	[p13l1953t2803r2147b2853, p13l61t2892r285b2980],
11	with	IN	O	with	prepc_compared_with	2	SENT_172	[p13l346t2892r521b2962],
12	a	DT	O	a	det	16	SENT_172	[p13l586t2911r628b2962],
13	standard	JJ	O	standard	amod	16	SENT_172	[p13l689t2892r1036b2962],
14	300	CD	NUMBER	300	num	16	SENT_172	[p13l1102t2893r1239b2962],
15	mg	NN	O	mg	nn	16	SENT_172	[p13l1303t2910r1416b2980],
16	regimen	NN	O	regimen	pobj	2	SENT_172	[p13l1481t2894r1802b2980],
17	on	IN	O	on	_	0	SENT_172	[p13l1866t2911r1957b2962],
18	the	DT	O	the	det	19	SENT_172	[p13l2021t2892r2151b2962],
19	incidence	NN	O	incidence	prep_on	16	SENT_172	[p13l59t3003r445b3072],
20	of	IN	O	of	_	0	SENT_172	[p13l475t3003r556b3072],
21	periprocedural	JJ	O	periprocedural	amod	22	SENT_172	[p13l585t3003r1179b3091],
22	elevation	NN	O	elevation	prep_of	19	SENT_172	[p13l1210t3003r1582b3072],
23	of	IN	O	of	_	0	SENT_172	[p13l1615t3003r1696b3072],
24	markers	NNS	O	marker	prep_of	22	SENT_172	[p13l1725t3003r2044b3072],
25	of	IN	O	of	_	0	SENT_172	[p13l2073t3003r2154b3072],
26	myocardial	JJ	O	myocardial	amod	28	SENT_172	[p13l61t3113r502b3199],
27	necrosis	NN	O	necrosis	nn	28	SENT_172	[p13l544t3114r864b3182],
28	[	NN	O	[	prep_of	24	SENT_172	[p13l908t3113r1054b3199],
29	22	CD	NUMBER	22	number	30	SENT_172	[p13l908t3113r1054b3199],
30	]	CD	NUMBER	]	dep	28	SENT_172	[p13l908t3113r1054b3199],
31	or	CC	O	or	_	0	SENT_172	[p13l1098t3132r1180b3182],
32	clinical	JJ	O	clinical	amod	33	SENT_172	[p13l1215t3113r1502b3182],
33	prognosis	NN	O	prognosis	conj_or	28	SENT_172	[p13l1544t3114r1915b3199],
34	after	IN	O	after	_	0	SENT_172	[p13l1954t3113r2154b3182],
35	stenting	VBG	O	stent	prepc_after	33	SENT_172	[p13l58t3223r384b3309],
36	for	IN	O	for	_	0	SENT_172	[p13l414t3221r529b3291],
37	NSTE	NNP	O	NSTE	nn	38	SENT_172	[p13l560t3222r755b3291],
38	ACS	NNP	O	ACS	prep_for	35	SENT_172	[p13l782t3222r932b3291],
39	[	CD	NUMBER	[	number	40	SENT_172	[p13l968t3221r1145b3309],
40	23	CD	NUMBER	23	num	41	SENT_172	[p13l968t3221r1145b3309],
41	]	NN	O	]	dep	35	SENT_172	[p13l968t3221r1145b3309],
42	.	.	O	.	_	0	SENT_172	[p13l968t3221r1145b3309],

1	However	RB	O	however	advmod	12	SENT_173	[p13l1186t3223r1548b3306],
2	,	,	O	,	_	0	SENT_173	[p13l1186t3223r1548b3306],
3	a	DT	O	a	det	6	SENT_173	[p13l1586t3240r1628b3291],
4	residual	JJ	O	residual	amod	6	SENT_173	[p13l1662t3221r1975b3291],
5	15	CD	PERCENT	15	num	6	SENT_173	[p13l2011t3222r2151b3291],
6	%	NN	PERCENT	%	nsubj	12	SENT_173	[p13l2011t3222r2151b3291],
7	of	IN	O	of	_	0	SENT_173	[p13l58t3332r139b3400],
8	poor	JJ	O	poor	amod	9	SENT_173	[p13l183t3350r362b3418],
9	responders	NNS	O	responder	prep_of	6	SENT_173	[p13l408t3332r844b3418],
10	to	TO	O	to	_	0	SENT_173	[p13l889t3338r969b3400],
11	clopidogrel	NN	O	clopidogrel	prep_to	9	SENT_173	[p13l1014t3332r1464b3418],
12	remain	VBP	O	remain	_	0	SENT_173	[p13l1513t3333r1786b3400],
13	[	JJ	O	[	amod	19	SENT_173	[p13l1840t3332r2018b3418],
14	23	CD	NUMBER	23	num	19	SENT_173	[p13l1840t3332r2018b3418],
15	]	NN	O	]	nn	19	SENT_173	[p13l1840t3332r2018b3418],
16	,	,	O	,	_	0	SENT_173	[p13l1840t3332r2018b3418],
17	so	RB	O	so	advmod	18	SENT_173	[p13l2071t3350r2152b3400],
18	alternative	JJ	O	alternative	amod	19	SENT_173	[p13l59t3440r511b3510],
19	treatments	NNS	O	treatment	nsubjpass	21	SENT_173	[p13l577t3447r1033b3510],
20	are	VBP	O	be	auxpass	21	SENT_173	[p13l1098t3459r1227b3510],
21	required	VBN	O	require	ccomp	12	SENT_173	[p13l1296t3440r1665b3528],
22	.	.	O	.	_	0	SENT_173	[p13l1296t3440r1665b3528],

1	First	RB	ORDINAL	first	advmod	14	SENT_174	[p13l1743t3442r1946b3525],
2	,	,	O	,	_	0	SENT_174	[p13l1743t3442r1946b3525],
3	the	DT	O	the	det	6	SENT_174	[p13l2019t3440r2150b3510],
4	periprocedural	JJ	O	periprocedural	amod	6	SENT_174	[p13l61t3550r655b3638],
5	period	NN	O	period	nn	6	SENT_174	[p13l714t3550r965b3638],
6	use	NN	O	use	nsubj	14	SENT_174	[p13l1027t3569r1155b3619],
7	of	IN	O	of	_	0	SENT_174	[p13l1211t3550r1292b3619],
8	GP	NN	O	gp	nn	11	SENT_174	[p13l1345t3550r1674b3620],
9	|	CD	NUMBER	|	num	11	SENT_174	[p13l1345t3550r1674b3620],
10	|	NN	O	|	nn	11	SENT_174	[p13l1345t3550r1674b3620],
11	b	NN	O	b	prep_of	6	SENT_174	[p13l1345t3550r1674b3620],
12	|	CD	NUMBER	|	number	13	SENT_174	[p13l1345t3550r1674b3620],
13	|	CD	NUMBER	|	num	11	SENT_174	[p13l1345t3550r1674b3620],
14	|	VBD	O	|	_	0	SENT_174	[p13l1345t3550r1674b3620],
15	a	DT	O	a	det	16	SENT_174	[p13l1345t3550r1674b3620],
16	antagonist	NN	O	antagonist	nsubj	19	SENT_174	[p13l1731t3552r2151b3638],
17	might	MD	O	might	aux	19	SENT_174	[p13l61t3661r287b3747],
18	be	VB	O	be	cop	19	SENT_174	[p13l314t3661r407b3730],
19	beneficial	JJ	O	beneficial	ccomp	14	SENT_174	[p13l434t3661r830b3730],
20	in	IN	O	in	_	0	SENT_174	[p13l857t3662r924b3729],
21	these	DT	O	these	det	22	SENT_174	[p13l951t3661r1168b3730],
22	patients	NNS	O	patient	prep_in	19	SENT_174	[p13l1195t3662r1546b3747],
23	.	.	O	.	_	0	SENT_174	[p13l1195t3662r1546b3747],

1	A	DT	O	a	det	3	SENT_175	[p13l1576t3662r1630b3729],
2	recent	JJ	O	recent	amod	3	SENT_175	[p13l1656t3667r1914b3730],
3	study	NN	O	study	nsubj	4	SENT_175	[p13l1938t3661r2153b3747],
4	demonstrated	VBD	O	demonstrate	_	0	SENT_175	[p14l58t18r618b88],
5	the	DT	O	the	det	27	SENT_175	[p14l665t18r796b88],
6	lower	JJR	O	lower	amod	8	SENT_175	[p14l843t18r1066b88],
7	clinical	JJ	O	clinical	amod	8	SENT_175	[p14l1107t18r1394b88],
8	events	NNS	O	event	dep	27	SENT_175	[p14l1439t25r1702b88],
9	rate	NN	O	rate	amod	19	SENT_175	[p14l1748t25r1909b88],
10	after	IN	O	after	_	0	SENT_175	[p14l1954t18r2154b88],
11	administration	NN	O	administration	prep_after	9	SENT_175	[p14l59t128r643b198],
12	of	IN	O	of	_	0	SENT_175	[p14l676t128r757b198],
13	abciximab	NN	O	abciximab	prep_of	11	SENT_175	[p14l784t128r1194b198],
14	in	IN	O	in	_	0	SENT_175	[p14l1225t130r1292b197],
15	higher	JJR	O	higher	amod	18	SENT_175	[p14l1328t128r1579b216],
16	risk	NN	O	risk	nn	18	SENT_175	[p14l1610t128r1748b198],
17	NSTE	NN	O	nste	nn	18	SENT_175	[p14l1778t129r1974b198],
18	ACS	NN	O	ac	prep_in	9	SENT_175	[p14l2001t129r2151b198],
19	patients	NNS	O	patient	npadvmod	8	SENT_175	[p14l61t240r388b325],
20	in	IN	O	in	_	0	SENT_175	[p14l451t240r519b307],
21	spite	NN	O	spite	prep_in	8	SENT_175	[p14l585t240r780b325],
22	of	IN	O	of	_	0	SENT_175	[p14l844t239r924b308],
23	a	DT	O	a	det	25	SENT_175	[p14l985t258r1027b308],
24	600	CD	NUMBER	600	num	25	SENT_175	[p14l1092t240r1230b308],
25	mg	NN	O	mg	prep_of	8	SENT_175	[p14l1296t256r1410b325],
26	loading	NN	O	loading	nn	27	SENT_175	[p14l1477t239r1765b325],
27	dose	NN	O	dose	dobj	4	SENT_175	[p14l1829t239r2010b308],
28	of	IN	O	of	_	0	SENT_175	[p14l2074t239r2154b308],
29	clopidogrel	NN	O	clopidogrel	prep_of	27	SENT_175	[p14l58t347r507b435],
30	[	CD	NUMBER	[	num	29	SENT_175	[p14l557t347r734b435],
31	24	CD	NUMBER	24	num	32	SENT_175	[p14l557t347r734b435],
32	]	NN	O	]	dep	29	SENT_175	[p14l557t347r734b435],
33	.	.	O	.	_	0	SENT_175	[p14l557t347r734b435],

1	Secondly	RB	O	secondly	advmod	10	SENT_176	[p14l785t347r1156b435],
2	,	,	O	,	_	0	SENT_176	[p14l785t347r1156b435],
3	the	DT	O	the	det	4	SENT_176	[p14l1206t347r1337b417],
4	emergence	NN	O	emergence	nsubj	10	SENT_176	[p14l1379t365r1825b435],
5	of	IN	O	of	_	0	SENT_176	[p14l1868t347r1949b417],
6	new	JJ	O	new	amod	7	SENT_176	[p14l1991t366r2153b417],
7	ADP-antagonists	NNS	O	adp-antagonist	prep_of	4	SENT_176	[p14l56t459r709b544],
8	might	MD	O	might	aux	10	SENT_176	[p14l755t458r981b544],
9	be	VB	O	be	cop	10	SENT_176	[p14l1027t458r1119b526],
10	helpful	JJ	O	helpful	dep	22	SENT_176	[p14l1165t458r1444b544],
11	in	IN	O	in	_	0	SENT_176	[p14l1489t459r1556b525],
12	these	DT	O	these	det	14	SENT_176	[p14l1603t458r1819b526],
13	clinical	JJ	O	clinical	amod	14	SENT_176	[p14l1862t458r2150b526],
14	settings	NNS	O	setting	prep_in	22	SENT_176	[p14l58t568r371b654],
15	and	CC	O	and	_	0	SENT_176	[p14l406t566r546b636],
16	a	DT	O	a	det	19	SENT_176	[p14l584t585r626b636],
17	recent	JJ	O	recent	amod	19	SENT_176	[p14l665t573r924b636],
18	biological	JJ	O	biological	amod	19	SENT_176	[p14l961t566r1345b654],
19	study	NN	O	study	conj_and	14	SENT_176	[p14l1381t566r1597b654],
20	have	VBP	O	have	aux	22	SENT_176	[p14l1633t566r1817b636],
21	already	RB	O	already	advmod	22	SENT_176	[p14l1853t566r2153b654],
22	demonstrated	VBN	O	demonstrate	_	0	SENT_176	[p14l58t676r618b745],
23	the	DT	O	the	det	25	SENT_176	[p14l668t676r798b745],
24	biological	JJ	O	biological	amod	25	SENT_176	[p14l847t676r1231b764],
25	superiority	NN	O	superiority	dobj	22	SENT_176	[p14l1277t677r1714b764],
26	of	IN	O	of	_	0	SENT_176	[p14l1757t676r1838b745],
27	CS-467	NN	MISC	cs-467	prep_of	25	SENT_176	[p14l1880t677r2152b746],
28	over	IN	O	over	_	0	SENT_176	[p14l58t806r235b856],
29	clopidogrel	NN	O	clopidogrel	prep_over	22	SENT_176	[p14l265t787r714b873],
30	[	CD	NUMBER	[	num	29	SENT_176	[p14l754t787r931b873],
31	25	CD	NUMBER	25	num	32	SENT_176	[p14l754t787r931b873],
32	]	NN	O	]	nsubj	22	SENT_176	[p14l754t787r931b873],
33	.	.	O	.	_	0	SENT_176	[p14l754t787r931b873],

1	Several	JJ	O	several	amod	2	SENT_177	[p14l169t895r462b965],
2	mechanisms	NNS	O	mechanism	nsubjpass	5	SENT_177	[p14l500t895r985b965],
3	have	VBP	O	have	aux	5	SENT_177	[p14l1022t895r1207b965],
4	been	VBN	O	be	auxpass	5	SENT_177	[p14l1245t895r1434b965],
5	proposed	VBN	O	propose	_	0	SENT_177	[p14l1474t895r1835b983],
6	for	IN	O	for	_	0	SENT_177	[p14l1872t895r1988b965],
7	the	DT	O	the	det	9	SENT_177	[p14l2021t895r2151b965],
8	wide	JJ	O	wide	amod	9	SENT_177	[p14l56t1005r248b1074],
9	variability	NN	O	variability	prep_for	5	SENT_177	[p14l290t1005r702b1093],
10	in	IN	O	in	_	0	SENT_177	[p14l746t1007r813b1074],
11	clopidogrel	NN	O	clopidogrel	nn	12	SENT_177	[p14l860t1005r1310b1093],
12	response	NN	O	response	prep_in	9	SENT_177	[p14l1359t1024r1733b1093],
13	,	,	O	,	_	0	SENT_177	[p14l1359t1024r1733b1093],
14	including	VBG	O	include	_	0	SENT_177	[p14l1787t1005r2151b1093],
15	non	JJ	O	non	amod	21	SENT_177	[p14l61t1135r199b1185],
16	compliance	NN	O	compliance	nn	21	SENT_177	[p14l244t1116r731b1202],
17	,	,	O	,	_	0	SENT_177	[p14l244t1116r731b1202],
18	drug	NN	O	drug	dep	21	SENT_177	[p14l782t1116r1196b1202],
19	—	CD	NUMBER	—	num	21	SENT_177	[p14l782t1116r1196b1202],
20	drug	NN	O	drug	nn	21	SENT_177	[p14l782t1116r1196b1202],
21	interactions	NNS	O	interaction	prep_including	9	SENT_177	[p14l1239t1117r1722b1185],
22	and	CC	O	and	_	0	SENT_177	[p14l1765t1116r1905b1185],
23	polymorphisms	NNS	O	polymorphism	prep_for	5	SENT_177	[p14l1954t1116r2146b1202, p14l61t1224r488b1312],
24	in	IN	O	in	_	0	SENT_177	[p14l542t1226r610b1293],
25	platelet	NN	O	platelet	nn	27	SENT_177	[p14l670t1224r987b1312],
26	receptor	NN	O	receptor	nn	27	SENT_177	[p14l1044t1231r1389b1312],
27	genes	NNS	O	gene	prep_in	23	SENT_177	[p14l1442t1242r1693b1312],
28	.	.	O	.	_	0	SENT_177	[p14l1442t1242r1693b1312],

1	The	DT	O	the	det	3	SENT_178	[p14l1753t1224r1903b1294],
2	main	JJ	O	main	amod	3	SENT_178	[p14l1960t1226r2148b1294],
3	targets	NNS	O	target	nsubj	4	SENT_178	[p14l59t1341r342b1421],
4	involve	VBP	O	involve	_	0	SENT_178	[p14l391t1335r677b1404],
5	in	IN	O	in	_	0	SENT_178	[p14l725t1336r792b1402],
6	clopidogrel	NN	O	clopidogrel	prep_in	13	SENT_178	[p14l844t1335r1293b1421],
7	antiplatelet	JJ	O	antiplatelet	amod	8	SENT_178	[p14l1344t1335r1823b1421],
8	effects	NNS	O	effect	nsubj	13	SENT_178	[p14l1871t1335r2151b1403],
9	are	VBP	O	be	cop	13	SENT_178	[p14l59t1462r186b1513],
10	the	DT	O	the	det	13	SENT_178	[p14l212t1443r342b1513],
11	hepatic	JJ	O	hepatic	amod	13	SENT_178	[p14l369t1443r667b1531],
12	cytochrome	NN	O	cytochrome	nn	13	SENT_178	[p14l692t1443r1167b1531],
13	P450	NN	O	p450	ccomp	4	SENT_178	[p14l1196t1444r1382b1513],
14	which	WDT	O	which	nsubj	15	SENT_178	[p14l1404t1443r1637b1513],
15	metabolizes	VBZ	O	metabolize	rcmod	13	SENT_178	[p14l1668t1443r2151b1513],
16	clopidogrel	NN	O	clopidogrel	dobj	15	SENT_178	[p14l58t1553r507b1641],
17	into	IN	O	into	_	0	SENT_178	[p14l531t1555r687b1622],
18	its	PRP$	O	its	poss	20	SENT_178	[p14l709t1555r803b1622],
19	active	JJ	O	active	amod	20	SENT_178	[p14l825t1554r1069b1622],
20	metabolite	NN	O	metabolite	prep_into	15	SENT_178	[p14l1094t1553r1561b1638],
21	,	,	O	,	_	0	SENT_178	[p14l1094t1553r1561b1638],
22	and	CC	O	and	_	0	SENT_178	[p14l1592t1553r1731b1622],
23	the	DT	O	the	det	27	SENT_178	[p14l1757t1553r1888b1622],
24	P2Y12	NN	O	p2y12	nn	27	SENT_178	[p14l1913t1554r2149b1622],
25	ADP	NN	O	adp	nn	27	SENT_178	[p14l56t1665r212b1732],
26	platelet	NN	O	platelet	nn	27	SENT_178	[p14l237t1664r554b1750],
27	receptor	NN	O	receptor	conj_and	13	SENT_178	[p14l579t1670r936b1750],
28	.	.	O	.	_	0	SENT_178	[p14l579t1670r936b1750],

1	Because	IN	O	because	mark	7	SENT_179	[p14l969t1665r1291b1733],
2	the	DT	O	the	det	4	SENT_179	[p14l1312t1664r1443b1733],
3	P2Y12	NN	O	p2y12	nn	4	SENT_179	[p14l1468t1665r1703b1732],
4	receptor	NN	O	receptor	nsubjpass	7	SENT_179	[p14l1729t1670r2075b1750],
5	is	VBZ	O	be	auxpass	7	SENT_179	[p14l2095t1665r2152b1733],
6	mainly	RB	O	mainly	advmod	7	SENT_179	[p14l61t1772r326b1860],
7	expressed	VBN	O	express	advcl	17	SENT_179	[p14l355t1772r752b1860],
8	on	IN	O	on	_	0	SENT_179	[p14l787t1791r878b1842],
9	blood	NN	O	blood	nn	10	SENT_179	[p14l916t1772r1131b1842],
10	platelets	NNS	O	platelet	prep_on	7	SENT_179	[p14l1169t1772r1547b1860],
11	,	,	O	,	_	0	SENT_179	[p14l1169t1772r1547b1860],
12	it	PRP	O	it	nsubj	17	SENT_179	[p14l1587t1774r1644b1842],
13	has	VBZ	O	have	aux	17	SENT_179	[p14l1678t1772r1805b1842],
14	become	VBN	O	become	cop	17	SENT_179	[p14l1839t1772r2151b1842],
15	an	DT	O	a	det	17	SENT_179	[p14l59t1901r148b1951],
16	attractive	JJ	O	attractive	amod	17	SENT_179	[p14l182t1884r583b1951],
17	target	NN	O	target	_	0	SENT_179	[p14l614t1889r861b1970],
18	for	IN	O	for	_	0	SENT_179	[p14l891t1882r1007b1951],
19	antagonists	NNS	O	antagonist	prep_for	17	SENT_179	[p14l1036t1884r1518b1970],
20	,	,	O	,	_	0	SENT_179	[p14l1036t1884r1518b1970],
21	like	IN	O	like	_	0	SENT_179	[p14l1560t1882r1700b1951],
22	thienopyridine	NN	O	thienopyridine	prep_like	17	SENT_179	[p14l1731t1882r2146b1970, p14l59t1993r281b2062],
23	.	.	O	.	_	0	SENT_179	[p14l1731t1882r2146b1970, p14l59t1993r281b2062],

1	Since	IN	O	since	_	0	SENT_180	[p14l328t1994r537b2062],
2	cloning	NN	O	cloning	prep_since	22	SENT_180	[p14l575t1993r863b2079],
3	of	IN	O	of	_	0	SENT_180	[p14l901t1993r982b2062],
4	the	DT	O	the	det	7	SENT_180	[p14l1018t1993r1148b2062],
5	P2Y12	NN	O	p2y12	nn	7	SENT_180	[p14l1190t1994r1426b2061],
6	receptor	NN	O	receptor	nn	7	SENT_180	[p14l1470t1999r1815b2079],
7	gene	NN	O	gene	prep_of	2	SENT_180	[p14l1852t2009r2042b2079],
8	in	IN	O	in	_	0	SENT_180	[p14l2081t1994r2148b2061],
9	2001	CD	DATE	2001	num	10	SENT_180	[p14l58t2102r231b2171],
10	[	CD	NUMBER	[	prep_in	7	SENT_180	[p14l309t2101r486b2189],
11	26	CD	NUMBER	26	num	12	SENT_180	[p14l309t2101r486b2189],
12	]	NN	O	]	nsubjpass	22	SENT_180	[p14l309t2101r486b2189],
13	,	,	O	,	_	0	SENT_180	[p14l309t2101r486b2189],
14	five	CD	NUMBER	five	num	16	SENT_180	[p14l552t2101r701b2171],
15	genetic	JJ	O	genetic	amod	16	SENT_180	[p14l760t2103r1057b2189],
16	polymorphisms	NNS	O	polymorphism	appos	12	SENT_180	[p14l1118t2101r1716b2189],
17	of	IN	O	of	_	0	SENT_180	[p14l1775t2101r1855b2171],
18	P2Y12	NN	O	p2y12	nn	19	SENT_180	[p14l1913t2102r2149b2170],
19	receptor	NN	O	receptor	prep_of	16	SENT_180	[p14l62t2218r407b2298],
20	have	VBP	O	have	aux	22	SENT_180	[p14l436t2212r620b2280],
21	been	VBN	O	be	auxpass	22	SENT_180	[p14l651t2212r841b2280],
22	described	VBN	O	describe	_	0	SENT_180	[p14l872t2212r1258b2281],
23	in	IN	O	in	_	0	SENT_180	[p14l1289t2213r1356b2280],
24	a	DT	O	a	det	25	SENT_180	[p14l1388t2230r1429b2280],
25	cohort	NN	O	cohort	prep_in	22	SENT_180	[p14l1458t2212r1718b2280],
26	of	IN	O	of	_	0	SENT_180	[p14l1745t2212r1826b2280],
27	healthy	JJ	O	healthy	amod	28	SENT_180	[p14l1853t2212r2153b2298],
28	donors	NNS	O	donor	prep_of	25	SENT_180	[p14l59t2320r324b2390],
29	[	VBP	O	[	dep	28	SENT_180	[p14l382t2320r559b2408],
30	13	CD	NUMBER	13	num	31	SENT_180	[p14l382t2320r559b2408],
31	]	CD	NUMBER	]	dobj	29	SENT_180	[p14l382t2320r559b2408],
32	.	.	O	.	_	0	SENT_180	[p14l382t2320r559b2408],

1	Four	CD	NUMBER	four	nsubj	5	SENT_181	[p14l623t2322r799b2390],
2	of	IN	O	of	_	0	SENT_181	[p14l848t2320r928b2390],
3	these	DT	O	these	det	4	SENT_181	[p14l978t2320r1194b2390],
4	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_181	[p14l1250t2320r1848b2408],
5	are	VBP	O	be	_	0	SENT_181	[p14l1901t2339r2028b2390],
6	in	IN	O	in	_	0	SENT_181	[p14l2081t2322r2148b2389],
7	complete	JJ	O	complete	amod	9	SENT_181	[p14l58t2430r436b2518],
8	linkage	NN	O	linkage	nn	9	SENT_181	[p14l481t2430r765b2518],
9	disequilibrium	NN	O	disequilibrium	prep_in	5	SENT_181	[p14l807t2430r1378b2518],
10	giving	VBG	O	give	partmod	9	SENT_181	[p14l1423t2432r1656b2518],
11	rise	NN	O	rise	dobj	10	SENT_181	[p14l1701t2431r1840b2499],
12	to	TO	O	to	_	0	SENT_181	[p14l1882t2437r1962b2499],
13	two	CD	NUMBER	two	num	14	SENT_181	[p14l2003t2437r2151b2499],
14	haplotypes	NNS	O	haplotype	prep_to	10	SENT_181	[p14l61t2541r521b2627],
15	:	:	O	:	_	0	SENT_181	[p14l61t2541r521b2627],
16	H1	NN	O	h1	dep	9	SENT_181	[p14l554t2542r639b2609],
17	and	CC	O	and	_	0	SENT_181	[p14l675t2541r815b2610],
18	H2	NN	O	h2	conj_and	16	SENT_181	[p14l844t2542r967b2610],
19	.	.	O	.	_	0	SENT_181	[p14l844t2542r967b2610],

1	Further	RB	O	further	advmod	5	SENT_182	[p14l1001t2541r1311b2625],
2	,	,	O	,	_	0	SENT_182	[p14l1001t2541r1311b2625],
3	it	PRP	O	it	nsubjpass	5	SENT_182	[p14l1340t2542r1398b2610],
4	was	VBD	O	be	auxpass	5	SENT_182	[p14l1417t2560r1567b2610],
5	demonstrated	VBN	O	demonstrate	_	0	SENT_182	[p14l1588t2541r2148b2610],
6	that	IN	O	that	complm	16	SENT_182	[p14l59t2649r224b2719],
7	maximal	JJ	O	maximal	amod	9	SENT_182	[p14l267t2649r605b2719],
8	platelet	NN	O	platelet	nn	9	SENT_182	[p14l649t2649r966b2737],
9	aggregation	NN	O	aggregation	nsubjpass	16	SENT_182	[p14l1008t2651r1479b2737],
10	induced	VBN	O	induce	partmod	9	SENT_182	[p14l1523t2649r1836b2719],
11	by	IN	O	by	_	0	SENT_182	[p14l1884t2649r1974b2737],
12	low	JJ	O	low	amod	14	SENT_182	[p14l2016t2649r2153b2719],
13	ADP	NN	ORGANIZATION	adp	nn	14	SENT_182	[p14l56t2760r212b2828],
14	concentrations	NNS	O	concentration	agent	10	SENT_182	[p14l242t2761r843b2828],
15	was	VBD	O	be	auxpass	16	SENT_182	[p14l871t2778r1021b2828],
16	increased	VBN	O	increase	ccomp	5	SENT_182	[p14l1050t2759r1432b2828],
17	in	IN	O	in	_	0	SENT_182	[p14l1466t2760r1533b2828],
18	H1	NN	O	h1	prep_in	16	SENT_182	[p14l1569t2761r1653b2828],
19	/	:	O	/	punct	21	SENT_182	[p14l1678t2760r1821b2828],
20	H2	NN	O	h2	nn	21	SENT_182	[p14l1678t2760r1821b2828],
21	heterozygotes	NNS	O	heterozygote	dep	18	SENT_182	[p14l1855t2759r2146b2828, p14l57t2876r384b2956],
22	,	,	O	,	_	0	SENT_182	[p14l1855t2759r2146b2828, p14l57t2876r384b2956],

1	and	CC	O	and	cc	6	SENT_183	[p14l438t2870r578b2939],
2	the	DT	O	the	det	4	SENT_183	[p14l626t2870r757b2939],
3	highest	JJS	O	highest	amod	4	SENT_183	[p14l805t2870r1091b2956],
4	values	NNS	O	value	nsubjpass	6	SENT_183	[p14l1134t2870r1387b2939],
5	were	VBD	O	be	auxpass	6	SENT_183	[p14l1430t2889r1630b2939],
6	recorded	VBN	O	record	_	0	SENT_183	[p14l1678t2870r2032b2939],
7	in	IN	O	in	_	0	SENT_183	[p14l2081t2871r2148b2938],
8	H2/H2	NN	O	h2/h2	nn	9	SENT_183	[p14l62t2979r314b3047],
9	homozygotes	NNS	O	homozygote	prep_in	6	SENT_183	[p14l344t2978r890b3066],
10	.	.	O	.	_	0	SENT_183	[p14l344t2978r890b3066],

1	Besides	IN	O	besides	advmod	12	SENT_184	[p14l927t2978r1245b3063],
2	,	,	O	,	_	0	SENT_184	[p14l927t2978r1245b3063],
3	the	DT	O	the	det	5	SENT_184	[p14l1278t2978r1409b3048],
4	ADP-induced	JJ	O	adp-induced	amod	5	SENT_184	[p14l1431t2978r1941b3048],
5	drop	NN	O	drop	nsubjpass	12	SENT_184	[p14l1970t2978r2151b3066],
6	in	IN	O	in	_	0	SENT_184	[p14l59t3090r126b3156],
7	cytosolic	JJ	O	cytosolic	amod	9	SENT_184	[p14l166t3089r519b3175],
8	cAMP	NN	O	camp	nn	9	SENT_184	[p14l557t3090r766b3158],
9	level	NN	O	level	prep_in	5	SENT_184	[p14l807t3089r996b3157],
10	was	VBD	O	be	auxpass	12	SENT_184	[p14l1032t3107r1182b3158],
11	more	RBR	O	more	advmod	12	SENT_184	[p14l1222t3107r1424b3157],
12	enhanced	VBN	O	enhance	_	0	SENT_184	[p14l1461t3089r1846b3157],
13	in	IN	O	in	_	0	SENT_184	[p14l1887t3090r1954b3156],
14	carriers	NNS	O	carrier	prep_in	12	SENT_184	[p14l1994t3107r2146b3157, p14l62t3199r237b3267],
15	of	IN	O	of	_	0	SENT_184	[p14l270t3197r350b3267],
16	H2	NN	O	h2	nn	17	SENT_184	[p14l385t3198r482b3266],
17	haplotype	NN	O	haplotype	prep_of	14	SENT_184	[p14l520t3197r918b3285],
18	[	CD	NUMBER	[	number	19	SENT_184	[p14l959t3197r1136b3285],
19	13	CD	NUMBER	13	num	20	SENT_184	[p14l959t3197r1136b3285],
20	]	NN	O	]	dep	17	SENT_184	[p14l959t3197r1136b3285],
21	.	.	O	.	_	0	SENT_184	[p14l959t3197r1136b3285],

1	So	RB	O	so	advmod	2	SENT_185	[p14l1178t3198r1266b3267],
2	far	RB	O	far	advmod	8	SENT_185	[p14l1299t3197r1425b3282],
3	,	,	O	,	_	0	SENT_185	[p14l1299t3197r1425b3282],
4	there	EX	O	there	expl	8	SENT_185	[p14l1467t3197r1683b3267],
5	has	VBZ	O	have	aux	8	SENT_185	[p14l1719t3197r1846b3267],
6	been	VBN	O	be	cop	8	SENT_185	[p14l1882t3197r2072b3267],
7	a	DT	O	a	det	8	SENT_185	[p14l2109t3216r2151b3267],
8	lack	NN	O	lack	_	0	SENT_185	[p14l62t3307r221b3376],
9	of	IN	O	of	_	0	SENT_185	[p14l245t3307r325b3376],
10	information	NN	O	information	prep_of	8	SENT_185	[p14l348t3307r818b3376],
11	whether	IN	O	whether	complm	13	SENT_185	[p14l845t3307r1183b3376],
12	the	DT	O	the	det	13	SENT_185	[p14l1207t3307r1337b3376],
13	H1	NN	O	h1	dep	8	SENT_185	[p14l1367t3309r1452b3376],
14	/	:	O	/	punct	13	SENT_185	[p14l1477t3309r1508b3376],
15	H2	NN	O	h2	nn	16	SENT_185	[p14l1522t3308r1619b3376],
16	haplotype	NN	O	haplotype	nsubj	20	SENT_185	[p14l1650t3307r2048b3395],
17	of	IN	O	of	_	0	SENT_185	[p14l2074t3307r2154b3376],
18	P2Y12	NN	O	p2y12	nn	19	SENT_185	[p14l62t3419r298b3486],
19	receptor	NN	O	receptor	prep_of	16	SENT_185	[p14l333t3424r678b3504],
20	affects	VBZ	O	affect	dep	13	SENT_185	[p14l706t3418r984b3487],
21	platelet	NN	O	platelet	nn	22	SENT_185	[p14l1016t3418r1333b3504],
22	sensitivity	NN	O	sensitivity	dobj	20	SENT_185	[p14l1362t3419r1772b3504],
23	to	TO	O	to	_	0	SENT_185	[p14l1800t3424r1880b3487],
24	P2Y12	NN	O	p2y12	nn	25	SENT_185	[p14l1913t3419r2149b3486],
25	inhibitors	NNS	O	inhibitor	prep_to	20	SENT_185	[p14l59t3526r464b3596],
26	.	.	O	.	_	0	SENT_185	[p14l59t3526r464b3596],

1	Recents	NNP	O	Recents	nn	2	SENT_186	[p14l517t3528r825b3596],
2	publications	NNS	O	publication	nsubj	4	SENT_186	[p14l869t3526r1356b3614],
3	have	VBP	O	have	aux	4	SENT_186	[p14l1400t3526r1584b3596],
4	explored	VBN	O	explore	_	0	SENT_186	[p14l1625t3526r1976b3614],
5	the	DT	O	the	det	6	SENT_186	[p14l2021t3526r2151b3596],
6	relationship	NN	O	relationship	dobj	4	SENT_186	[p14l62t3636r536b3724],
7	between	IN	O	between	_	0	SENT_186	[p14l571t3636r915b3705],
8	these	DT	O	these	det	11	SENT_186	[p14l949t3636r1165b3705],
9	P2Y12	NN	O	p2y12	nn	11	SENT_186	[p14l1200t3637r1436b3705],
10	gene	NN	O	gene	nn	11	SENT_186	[p14l1469t3653r1659b3724],
11	polymorphisms	NNS	O	polymorphism	prep_between	6	SENT_186	[p14l1694t3636r2146b3724, p15l59t19r228b87],

1	and	CC	O	and	dep	3	SENT_187	[p15l267t18r407b87],
2	platelet	NN	O	platelet	nn	3	SENT_187	[p15l452t18r770b104],
3	response	NN	O	response	_	0	SENT_187	[p15l812t37r1160b104],
4	to	TO	O	to	_	0	SENT_187	[p15l1200t24r1280b87],
5	clopidogrel	NN	O	clopidogrel	prep_to	3	SENT_187	[p15l1319t18r1768b104],
6	[	CD	NUMBER	[	number	7	SENT_187	[p15l1814t18r2143b104],
7	14	CD	NUMBER	14	num	8	SENT_187	[p15l1814t18r2143b104],
8	—	NN	O	—	dep	5	SENT_187	[p15l1814t18r2143b104],
9	16	CD	NUMBER	16	num	10	SENT_187	[p15l1814t18r2143b104],
10	]	NN	O	]	dep	8	SENT_187	[p15l1814t18r2143b104],
11	.	.	O	.	_	0	SENT_187	[p15l1814t18r2143b104],

1	No	DT	O	no	det	2	SENT_188	[p15l62t128r160b196],
2	relationship	NN	O	relationship	nsubjpass	12	SENT_188	[p15l200t126r675b214],
3	between	IN	O	between	_	0	SENT_188	[p15l714t126r1058b196],
4	genotype	NN	O	genotype	nn	5	SENT_188	[p15l1097t133r1468b214],
5	distribution	NN	O	distribution	prep_between	2	SENT_188	[p15l1505t126r1969b196],
6	and	CC	O	and	_	0	SENT_188	[p15l2008t126r2148b196],
7	platelet	NN	O	platelet	nn	8	SENT_188	[p15l61t237r378b323],
8	response	NN	O	response	prep_between	2	SENT_188	[p15l426t255r775b323],
9	to	TO	O	to	_	0	SENT_188	[p15l821t243r901b305],
10	clopidogrel	NN	O	clopidogrel	prep_to	5	SENT_188	[p15l945t237r1395b323],
11	were	VBD	O	be	auxpass	12	SENT_188	[p15l1438t255r1638b306],
12	reported	VBN	O	report	_	0	SENT_188	[p15l1687t237r2032b323],
13	in	IN	O	in	_	0	SENT_188	[p15l2081t238r2148b305],
14	these	DT	O	these	det	15	SENT_188	[p15l59t345r275b415],
15	studies	NNS	O	study	prep_in	12	SENT_188	[p15l329t345r609b415],
16	that	WDT	O	that	nsubj	17	SENT_188	[p15l663t345r828b415],
17	measured	VBD	O	measure	rcmod	15	SENT_188	[p15l884t345r1268b415],
18	a	DT	O	a	det	19	SENT_188	[p15l1326t364r1367b415],
19	variation	NN	O	variation	dobj	17	SENT_188	[p15l1418t347r1775b415],
20	of	IN	O	of	_	0	SENT_188	[p15l1832t345r1913b415],
21	ADPinduced	JJ	O	adpinduced	amod	22	SENT_188	[p15l1960t346r2147b414, p15l59t455r372b524],
22	aggregation	NN	O	aggregation	prep_of	19	SENT_188	[p15l408t457r879b543],
23	from	IN	O	from	_	0	SENT_188	[p15l913t455r1099b524],
24	a	DT	O	a	det	26	SENT_188	[p15l1134t474r1176b524],
25	baseline	NN	O	baseline	nn	26	SENT_188	[p15l1211t455r1540b524],
26	value	NN	O	value	prep_from	17	SENT_188	[p15l1570t455r1812b524],
27	.	.	O	.	_	0	SENT_188	[p15l1570t455r1812b524],

1	However	RB	O	however	advmod	7	SENT_189	[p15l1855t457r2146b524, p15l58t585r152b650],
2	,	,	O	,	_	0	SENT_189	[p15l1855t457r2146b524, p15l58t585r152b650],
3	several	JJ	O	several	amod	4	SENT_189	[p15l203t566r488b635],
4	issues	NNS	O	issue	nsubjpass	7	SENT_189	[p15l533t567r763b635],
5	can	MD	O	can	aux	7	SENT_189	[p15l806t585r941b635],
6	be	VB	O	be	auxpass	7	SENT_189	[p15l990t566r1083b635],
7	raised	VBN	O	raise	_	0	SENT_189	[p15l1130t566r1364b635],
8	regarding	VBG	O	regard	_	0	SENT_189	[p15l1415t566r1793b652],
9	this	DT	O	this	det	10	SENT_189	[p15l1837t566r1981b635],
10	approach	NN	O	approach	prep_regarding	7	SENT_189	[p15l2024t585r2146b652, p15l61t674r328b762],
11	of	IN	O	of	_	0	SENT_189	[p15l370t674r451b744],
12	defining	VBG	O	define	prepc_of	10	SENT_189	[p15l487t674r813b762],
13	clopidogrel	NN	O	clopidogrel	nn	14	SENT_189	[p15l852t674r1301b762],
14	responsiveness	NN	O	responsiveness	dobj	12	SENT_189	[p15l1345t676r1937b762],
15	with	IN	O	with	_	0	SENT_189	[p15l1973t674r2148b744],
16	variation	NN	O	variation	prep_with	12	SENT_189	[p15l56t787r413b854],
17	from	IN	O	from	_	0	SENT_189	[p15l459t785r645b854],
18	a	DT	O	a	det	20	SENT_189	[p15l691t804r733b854],
19	baseline	NN	O	baseline	nn	20	SENT_189	[p15l780t785r1109b854],
20	value	NN	O	value	prep_from	12	SENT_189	[p15l1150t785r1392b854],
21	.	.	O	.	_	0	SENT_189	[p15l1150t785r1392b854],

1	First	RB	ORDINAL	first	advmod	6	SENT_190	[p15l1447t787r1646b869],
2	,	,	O	,	_	0	SENT_190	[p15l1447t787r1646b869],
3	it	PRP	O	it	nsubj	6	SENT_190	[p15l1697t787r1754b854],
4	does	VBZ	O	do	aux	6	SENT_190	[p15l1797t785r1979b854],
5	not	RB	O	not	neg	6	SENT_190	[p15l2024t791r2151b854],
6	take	VB	O	take	_	0	SENT_190	[p15l59t895r233b964],
7	into	IN	O	into	_	0	SENT_190	[p15l274t896r430b964],
8	account	NN	O	account	nn	10	SENT_190	[p15l470t901r788b964],
9	absolute	JJ	O	absolute	amod	10	SENT_190	[p15l827t895r1169b964],
10	levels	NNS	O	level	prep_into	6	SENT_190	[p15l1212t895r1439b964],
11	of	IN	O	of	_	0	SENT_190	[p15l1478t895r1559b964],
12	pre	JJ	O	pre	prep_of	10	SENT_190	[p15l1599t914r1726b981],
13	and	CC	O	and	_	0	SENT_190	[p15l1767t895r1907b964],
14	posttreatment	NN	O	posttreatment	nn	16	SENT_190	[p15l1953t901r2146b981, p15l59t1010r471b1073],
15	platelet	NN	O	platelet	nn	16	SENT_190	[p15l512t1003r830b1091],
16	activity	NN	O	activity	conj_and	12	SENT_190	[p15l868t1005r1172b1091],
17	and	CC	O	and	_	0	SENT_190	[p15l1209t1003r1349b1073],
18	it	PRP	O	it	nsubj	20	SENT_190	[p15l1391t1005r1448b1073],
19	is	VBZ	O	be	cop	20	SENT_190	[p15l1486t1005r1543b1073],
20	unsuitable	JJ	O	unsuitable	conj_and	6	SENT_190	[p15l1584t1003r2000b1073],
21	for	IN	O	for	_	0	SENT_190	[p15l2038t1003r2154b1073],
22	daily	JJ	SET	daily	amod	24	SENT_190	[p15l59t1114r252b1200],
23	clinical	JJ	O	clinical	amod	24	SENT_190	[p15l271t1114r558b1183],
24	practice	NN	O	practice	prep_for	20	SENT_190	[p15l584t1115r913b1200],
25	as	IN	O	as	mark	32	SENT_190	[p15l936t1132r1015b1182],
26	the	DT	O	the	det	27	SENT_190	[p15l1037t1114r1167b1182],
27	majority	NN	O	majority	nsubj	32	SENT_190	[p15l1192t1115r1535b1200],
28	of	IN	O	of	_	0	SENT_190	[p15l1554t1114r1635b1182],
29	ACS	NN	ORGANIZATION	ac	nn	30	SENT_190	[p15l1651t1114r1800b1183],
30	patients	NNS	O	patient	prep_of	27	SENT_190	[p15l1826t1115r2152b1200],
31	are	VBP	O	be	cop	32	SENT_190	[p15l10t1520r134b1569],
32	urgently-treated	JJ	O	urgently-treated	advcl	20	SENT_190	[p15l170t1501r818b1586],
33	or	CC	O	or	cc	32	SENT_190	[p15l856t1520r935b1569],
34	already	RB	O	already	advmod	32	SENT_190	[p15l967t1501r1258b1586],
35	on	IN	O	on	_	0	SENT_190	[p15l1290t1520r1378b1569],
36	chronic	JJ	O	chronic	amod	38	SENT_190	[p15l1415t1501r1701b1569],
37	antiplatelet	JJ	O	antiplatelet	amod	38	SENT_190	[p15l1735t1501r2035b1586, p15l10t1608r198b1675],
38	therapy	NN	O	therapy	prep_on	32	SENT_190	[p15l233t1608r548b1693],
39	.	.	O	.	_	0	SENT_190	[p15l233t1608r548b1693],

1	Moreover	RB	O	moreover	advmod	5	SENT_191	[p15l588t1610r965b1690],
2	,	,	O	,	_	0	SENT_191	[p15l588t1610r965b1690],
3	previous	JJ	O	previous	amod	4	SENT_191	[p15l1009t1609r1334b1693],
4	studies	NNS	O	study	nsubj	20	SENT_191	[p15l1368t1608r1640b1675],
5	showed	VBD	O	show	_	0	SENT_191	[p15l1674t1608r1961b1675],
6	a	DT	O	a	det	7	SENT_191	[p15l1999t1626r2039b1675],
7	correlation	NN	O	correlation	dobj	5	SENT_191	[p15l9t1716r453b1783],
8	between	IN	O	between	_	0	SENT_191	[p15l521t1716r863b1783],
9	clopidogrel	NN	O	clopidogrel	nn	10	SENT_191	[p15l928t1716r1379b1800],
10	responsiveness	NN	O	responsiveness	prep_between	7	SENT_191	[p15l1445t1717r2040b1800],
11	defined	VBN	O	define	partmod	10	SENT_191	[p15l9t1822r303b1890],
12	by	IN	O	by	_	0	SENT_191	[p15l356t1822r444b1907],
13	baseline	NN	O	baseline	nn	14	SENT_191	[p15l492t1822r811b1890],
14	value	NN	O	value	agent	11	SENT_191	[p15l857t1822r1067b1890],
15	and	CC	O	and	_	0	SENT_191	[p15l1115t1822r1251b1890],
16	ADP-induced	JJ	O	adp-induced	amod	18	SENT_191	[p15l1299t1822r1794b1890],
17	posttreatment	NN	O	posttreatment	nn	18	SENT_191	[p15l1847t1829r2035b1907, p15l10t1936r410b1997],
18	reactivity	NN	O	reactivity	agent	11	SENT_191	[p15l453t1932r828b2015],
19	and	CC	O	and	_	0	SENT_191	[p15l866t1930r1001b1997],
20	proposed	VBD	O	propose	conj_and	5	SENT_191	[p15l1047t1930r1397b2015],
21	post-treatment	JJ	O	post-treatment	amod	23	SENT_191	[p15l1442t1936r2039b2015],
22	platelet	NN	O	platelet	nn	23	SENT_191	[p15l12t2037r320b2121],
23	reactivity	NN	O	reactivity	dobj	20	SENT_191	[p15l365t2038r740b2121],
24	as	IN	O	as	_	0	SENT_191	[p15l781t2055r858b2104],
25	a	DT	O	a	det	27	SENT_191	[p15l900t2055r940b2104],
26	better	JJR	O	better	amod	27	SENT_191	[p15l986t2037r1231b2104],
27	estimate	NN	O	estimate	prep_as	20	SENT_191	[p15l1271t2038r1613b2104],
28	of	IN	O	of	_	0	SENT_191	[p15l1656t2037r1734b2104],
29	thrombotic	JJ	O	thrombotic	amod	33	SENT_191	[p15l1774t2037r2035b2104, p15l12t2143r205b2211],
30	risk	NN	O	risk	nn	33	SENT_191	[p15l238t2143r371b2211],
31	[	NN	O	[	nn	33	SENT_191	[p15l404t2143r576b2228],
32	27	CD	NUMBER	27	num	33	SENT_191	[p15l404t2143r576b2228],
33	]	NN	O	]	prep_of	27	SENT_191	[p15l404t2143r576b2228],
34	.	.	O	.	_	0	SENT_191	[p15l404t2143r576b2228],

1	In	IN	O	in	_	0	SENT_192	[p15l122t2252r182b2317],
2	the	DT	O	the	det	4	SENT_192	[p15l250t2251r378b2318],
3	present	JJ	DATE	present	amod	4	SENT_192	[p15l445t2257r745b2335],
4	study	NN	O	study	prep_in	7	SENT_192	[p15l808t2251r1035b2335],
5	,	,	O	,	_	0	SENT_192	[p15l808t2251r1035b2335],
6	we	PRP	O	we	nsubj	7	SENT_192	[p15l1105t2269r1217b2318],
7	decided	VBD	O	decide	_	0	SENT_192	[p15l1281t2251r1593b2318],
8	to	TO	O	to	aux	9	SENT_192	[p15l1660t2257r1739b2318],
9	assess	VB	O	assess	xcomp	7	SENT_192	[p15l1803t2269r2040b2318],
10	clopidogrel	NN	O	clopidogrel	nn	11	SENT_192	[p15l9t2357r445b2442],
11	responsiveness	NN	O	responsiveness	dobj	9	SENT_192	[p15l508t2359r1082b2442],
12	with	IN	O	with	_	0	SENT_192	[p15l1137t2357r1306b2425],
13	one	CD	NUMBER	one	num	15	SENT_192	[p15l1367t2376r1506b2425],
14	single	JJ	O	single	amod	15	SENT_192	[p15l1564t2357r1787b2442],
15	posttreatment	NN	O	posttreatment	prep_with	9	SENT_192	[p15l1847t2364r2035b2442, p15l10t2470r410b2531],
16	blood	NN	O	blood	nn	17	SENT_192	[p15l438t2464r647b2531],
17	sample	NN	O	sample	dep	15	SENT_192	[p15l675t2464r949b2549],
18	after	IN	O	after	_	0	SENT_192	[p15l975t2464r1169b2531],
19	a	DT	O	a	det	23	SENT_192	[p15l1192t2482r1233b2531],
20	600	CD	NUMBER	600	num	23	SENT_192	[p15l1259t2465r1393b2532],
21	mg	NN	O	mg	nn	23	SENT_192	[p15l1421t2480r1532b2549],
22	loading	NN	O	loading	nn	23	SENT_192	[p15l1560t2464r1839b2549],
23	dose	NN	O	dose	prep_after	9	SENT_192	[p15l1865t2464r2039b2531],
24	of	IN	O	of	_	0	SENT_192	[p15l9t2572r88b2639],
25	clopidogrel	NN	O	clopidogrel	prep_of	23	SENT_192	[p15l122t2572r584b2656],
26	,	,	O	,	_	0	SENT_192	[p15l122t2572r584b2656],
27	regarding	VBG	O	regard	_	0	SENT_192	[p15l634t2572r1001b2656],
28	its	PRP$	O	its	poss	29	SENT_192	[p15l1040t2573r1131b2639],
29	biological	JJ	O	biological	prep_regarding	23	SENT_192	[p15l1171t2572r1544b2656],
30	and	CC	O	and	_	0	SENT_192	[p15l1583t2572r1719b2639],
31	clinical	JJ	O	clinical	amod	33	SENT_192	[p15l1760t2572r2038b2639],
32	benefit	NN	O	benefit	nn	33	SENT_192	[p15l12t2678r292b2746],
33	[	NN	O	[	prep_regarding	23	SENT_192	[p15l352t2678r671b2763],
34	17	CD	NUMBER	17	number	35	SENT_192	[p15l352t2678r671b2763],
35	—	CD	NUMBER	—	dep	29	SENT_192	[p15l352t2678r671b2763],
36	23	CD	NUMBER	23	num	37	SENT_192	[p15l352t2678r671b2763],
37	]	NN	O	]	dep	35	SENT_192	[p15l352t2678r671b2763],
38	.	.	O	.	_	0	SENT_192	[p15l352t2678r671b2763],

1	Using	VBG	O	use	partmod	13	SENT_193	[p15l737t2680r940b2763],
2	ADP-Ag	NN	O	adp-ag	dobj	1	SENT_193	[p15l992t2679r1298b2763],
3	,	,	O	,	_	0	SENT_193	[p15l992t2679r1298b2763],
4	PRI	NNP	ORGANIZATION	PRI	nn	5	SENT_193	[p15l1365t2680r1476b2745],
5	VASP	NN	ORGANIZATION	vasp	conj_and	2	SENT_193	[p15l1533t2679r1718b2746],
6	and	CC	O	and	_	0	SENT_193	[p15l1769t2678r1905b2746],
7	Pselectin	NN	PERSON	pselectin	nn	8	SENT_193	[p15l1966t2680r2035b2745, p15l9t2785r312b2852],
8	expression	NN	O	expression	dobj	1	SENT_193	[p15l340t2786r777b2870],
9	,	,	O	,	_	0	SENT_193	[p15l340t2786r777b2870],
10	we	PRP	O	we	nsubj	13	SENT_193	[p15l808t2803r919b2852],
11	did	VBD	O	do	aux	13	SENT_193	[p15l945t2785r1061b2852],
12	not	RB	O	not	neg	13	SENT_193	[p15l1092t2791r1215b2852],
13	find	VB	O	find	_	0	SENT_193	[p15l1240t2785r1388b2852],
14	any	DT	O	any	det	15	SENT_193	[p15l1417t2803r1552b2870],
15	relationship	NN	O	relationship	dobj	13	SENT_193	[p15l1579t2785r2039b2870],
16	between	IN	O	between	_	0	SENT_193	[p15l12t2893r345b2960],
17	the	DT	O	the	det	19	SENT_193	[p15l406t2893r533b2960],
18	T744C	NN	O	t744c	nn	19	SENT_193	[p15l587t2894r827b2960],
19	polymorphism	NN	O	polymorphism	prep_between	15	SENT_193	[p15l888t2893r1430b2977],
20	of	IN	O	of	_	0	SENT_193	[p15l1490t2893r1568b2960],
21	the	DT	O	the	det	23	SENT_193	[p15l1622t2893r1749b2960],
22	P2Y12	NN	O	p2y12	nn	23	SENT_193	[p15l1809t2894r2038b2959],
23	gene	NN	O	gene	prep_of	19	SENT_193	[p15l10t3016r194b3084],
24	and	CC	O	and	_	0	SENT_193	[p15l245t2999r380b3067],
25	the	DT	O	the	det	27	SENT_193	[p15l435t2999r562b3067],
26	clopidogrel	NN	O	clopidogrel	nn	27	SENT_193	[p15l611t2999r1047b3084],
27	responsiveness	NN	O	responsiveness	conj_and	19	SENT_193	[p15l1103t3001r1677b3084],
28	in	IN	O	in	_	0	SENT_193	[p15l1728t3001r1793b3066],
29	NSTE	NNP	O	NSTE	nn	31	SENT_193	[p15l1850t3000r2039b3067],
30	ACS	NN	O	ac	nn	31	SENT_193	[p15l7t3107r151b3174],
31	patients	NNS	O	patient	prep_in	27	SENT_193	[p15l201t3108r542b3191],
32	.	.	O	.	_	0	SENT_193	[p15l201t3108r542b3191],

1	This	DT	O	this	det	2	SENT_194	[p15l594t3107r752b3174],
2	finding	NN	O	finding	nsubj	3	SENT_194	[p15l798t3107r1066b3191],
3	suggests	VBZ	O	suggest	_	0	SENT_194	[p15l1113t3113r1436b3191],
4	that	IN	O	that	complm	13	SENT_194	[p15l1482t3107r1642b3174],
5	the	DT	O	the	det	6	SENT_194	[p15l1689t3107r1816b3174],
6	variability	NN	O	variability	nsubj	13	SENT_194	[p15l1860t3108r2035b3174, p15l10t3213r257b3298],
7	in	IN	O	in	_	0	SENT_194	[p15l293t3215r358b3280],
8	platelet	NN	O	platelet	nn	9	SENT_194	[p15l401t3213r708b3298],
9	response	NN	O	response	prep_in	6	SENT_194	[p15l749t3232r1086b3298],
10	to	TO	O	to	_	0	SENT_194	[p15l1124t3220r1201b3281],
11	clopidogrel	NN	O	clopidogrel	prep_to	9	SENT_194	[p15l1238t3213r1674b3298],
12	is	VBZ	O	be	cop	13	SENT_194	[p15l1712t3215r1767b3281],
13	multifactorial	JJ	O	multifactorial	ccomp	3	SENT_194	[p15l1807t3213r2035b3281, p15l9t3320r341b3387],
14	and	CC	O	and	_	0	SENT_194	[p15l401t3320r536b3387],
15	not	RB	O	not	conj_and	3	SENT_194	[p15l601t3326r724b3387],
16	caused	VBN	O	cause	dep	3	SENT_194	[p15l783t3320r1046b3387],
17	only	RB	O	only	advmod	16	SENT_194	[p15l1108t3320r1270b3405],
18	by	IN	O	by	_	0	SENT_194	[p15l1330t3320r1417b3405],
19	a	DT	O	a	det	22	SENT_194	[p15l1474t3338r1515b3387],
20	single	JJ	O	single	amod	22	SENT_194	[p15l1574t3320r1796b3405],
21	gene	NN	O	gene	nn	22	SENT_194	[p15l1855t3337r2040b3405],
22	polymorphism	NN	O	polymorphism	prep_by	16	SENT_194	[p15l12t3428r582b3512],
23	.	.	O	.	_	0	SENT_194	[p15l12t3428r582b3512],

1	Conclusion	NN	O	conclusion	_	0	SENT_195	[p15l10t3663r536b3745],

1	Variability	NN	O	variability	nsubjpass	14	SENT_196	[p16l7t123r409b208],
2	in	IN	O	in	_	0	SENT_196	[p16l432t125r496b190],
3	platelet	NN	O	platelet	nn	4	SENT_196	[p16l526t123r834b208],
4	response	NN	O	response	prep_in	1	SENT_196	[p16l861t141r1199b208],
5	to	TO	O	to	_	0	SENT_196	[p16l1224t129r1301b190],
6	clopidogrel	NN	O	clopidogrel	prep_to	4	SENT_196	[p16l1325t123r1761b208],
7	and	CC	O	and	_	0	SENT_196	[p16l1786t123r1922b190],
8	its	PRP$	O	its	poss	10	SENT_196	[p16l1950t125r2040b190],
9	clinical	JJ	O	clinical	amod	10	SENT_196	[p16l9t231r288b298],
10	relevance	NN	O	relevance	prep_to	4	SENT_196	[p16l346t231r724b298],
11	have	VBP	O	have	aux	14	SENT_196	[p16l781t231r960b298],
12	been	VBN	O	be	auxpass	14	SENT_196	[p16l1016t231r1199b298],
13	well	RB	O	well	advmod	14	SENT_196	[p16l1254t231r1416b298],
14	described	VBN	O	describe	_	0	SENT_196	[p16l1470t231r1872b298],
15	.	.	O	.	_	0	SENT_196	[p16l1470t231r1872b298],

1	Although	IN	O	although	mark	6	SENT_197	[p16l1931t231r2035b298, p16l10t337r274b422],
2	the	DT	O	the	det	4	SENT_197	[p16l311t337r437b405],
3	underlying	JJ	O	underlying	amod	4	SENT_197	[p16l474t337r883b422],
4	mechanisms	NNS	O	mechanism	nsubj	6	SENT_197	[p16l920t337r1390b405],
5	remain	VBP	O	remain	cop	6	SENT_197	[p16l1427t339r1692b405],
6	unclear	JJ	O	unclear	advcl	13	SENT_197	[p16l1731t337r2032b419],
7	,	,	O	,	_	0	SENT_197	[p16l1731t337r2032b419],
8	genetic	JJ	O	genetic	amod	9	SENT_197	[p16l10t446r298b529],
9	polymorphisms	NNS	O	polymorphism	nsubj	13	SENT_197	[p16l347t444r928b529],
10	may	MD	O	may	aux	13	SENT_197	[p16l976t462r1133b529],
11	be	VB	O	be	cop	13	SENT_197	[p16l1180t444r1270b511],
12	partially	RB	O	partially	advmod	13	SENT_197	[p16l1318t444r1645b529],
13	responsible	JJ	O	responsible	_	0	SENT_197	[p16l1692t446r2035b529, p16l12t552r153b619],
14	.	.	O	.	_	0	SENT_197	[p16l1692t446r2035b529, p16l12t552r153b619],

1	However	RB	O	however	advmod	9	SENT_198	[p16l227t554r580b634],
2	,	,	O	,	_	0	SENT_198	[p16l227t554r580b634],
3	the	DT	O	the	det	4	SENT_198	[p16l651t552r778b619],
4	literature	NN	O	literature	nsubj	9	SENT_198	[p16l844t552r1220b619],
5	to	TO	O	to	_	0	SENT_198	[p16l1283t558r1362b619],
6	date	NN	O	date	prep_to	4	SENT_198	[p16l1424t552r1598b619],
7	has	VBZ	O	have	aux	9	SENT_198	[p16l1664t552r1788b619],
8	been	VBN	O	be	cop	9	SENT_198	[p16l1852t552r2036b619],
9	heterogeneous	JJ	O	heterogeneous	_	0	SENT_198	[p16l12t658r587b743],
10	and	CC	O	and	_	0	SENT_198	[p16l628t658r763b725],
11	based	VBN	O	base	conj_and	9	SENT_198	[p16l810t658r1027b725],
12	on	IN	O	on	_	0	SENT_198	[p16l1071t676r1159b725],
13	relatively	RB	O	relatively	advmod	14	SENT_198	[p16l1205t658r1576b743],
14	small	JJ	O	small	amod	15	SENT_198	[p16l1614t658r1816b725],
15	samples	NNS	O	sample	prep_on	11	SENT_198	[p16l1857t676r2035b725, p16l12t766r188b850],
16	.	.	O	.	_	0	SENT_198	[p16l1857t676r2035b725, p16l12t766r188b850],

1	Our	PRP$	O	we	poss	3	SENT_199	[p16l227t767r366b833],
2	present	JJ	DATE	present	amod	3	SENT_199	[p16l397t772r689b850],
3	study	NN	O	study	nsubj	6	SENT_199	[p16l720t766r928b850],
4	did	VBD	O	do	aux	6	SENT_199	[p16l957t766r1073b833],
5	not	RB	O	not	neg	6	SENT_199	[p16l1109t772r1232b833],
6	find	VB	O	find	_	0	SENT_199	[p16l1263t766r1410b833],
7	any	DT	O	any	det	8	SENT_199	[p16l1444t784r1579b850],
8	correlation	NN	O	correlation	dobj	6	SENT_199	[p16l1608t766r2036b833],
9	between	IN	O	between	_	0	SENT_199	[p16l12t872r345b940],
10	T744C	NN	O	t744c	nn	11	SENT_199	[p16l398t873r638b940],
11	polymorphism	NN	O	polymorphism	prep_between	8	SENT_199	[p16l694t872r1236b957],
12	of	IN	O	of	_	0	SENT_199	[p16l1291t872r1369b940],
13	P2Y12	NN	O	p2y12	nn	15	SENT_199	[p16l1422t873r1650b939],
14	receptor	NN	O	receptor	nn	15	SENT_199	[p16l1707t879r2042b957],
15	gene	NN	O	gene	prep_of	11	SENT_199	[p16l10t996r194b1064],
16	and	CC	O	and	_	0	SENT_199	[p16l238t979r374b1046],
17	clopidogrel	NN	O	clopidogrel	nn	18	SENT_199	[p16l420t979r855b1064],
18	responsiveness	NN	O	responsiveness	prep_of	11	SENT_199	[p16l903t980r1478b1064],
19	evaluated	VBN	O	evaluate	partmod	15	SENT_199	[p16l1521t979r1905b1046],
20	by	IN	O	by	_	0	SENT_199	[p16l1954t979r2041b1064],
21	ADP-Ag	NN	O	adp-ag	agent	19	SENT_199	[p16l7t1088r314b1171],
22	,	,	O	,	_	0	SENT_199	[p16l7t1088r314b1171],
23	PRI	NNP	ORGANIZATION	PRI	nn	24	SENT_199	[p16l378t1088r489b1153],
24	VASP	NN	ORGANIZATION	vasp	appos	21	SENT_199	[p16l545t1088r730b1154],
25	and	CC	O	and	_	0	SENT_199	[p16l780t1087r916b1154],
26	P-selectin	NN	O	p-selectin	nn	27	SENT_199	[p16l976t1087r1356b1154],
27	expression	NN	O	expression	appos	21	SENT_199	[p16l1412t1088r1821b1171],
28	in	IN	O	in	_	0	SENT_199	[p16l1877t1088r1942b1153],
29	a	DT	O	a	det	31	SENT_199	[p16l1998t1105r2039b1154],
30	broad	JJ	O	broad	amod	31	SENT_199	[p16l12t1193r228b1261],
31	population	NN	O	population	prep_in	24	SENT_199	[p16l266t1193r678b1278],
32	of	IN	O	of	_	0	SENT_199	[p16l713t1193r791b1261],
33	597	CD	NUMBER	597	num	36	SENT_199	[p16l823t1194r955b1261],
34	NSTE	NNP	O	NSTE	nn	36	SENT_199	[p16l990t1194r1179b1261],
35	ACS	NN	O	ac	nn	36	SENT_199	[p16l1208t1194r1352b1261],
36	patients	NNS	O	patient	prep_of	31	SENT_199	[p16l1388t1195r1728b1278],
37	.	.	O	.	_	0	SENT_199	[p16l1388t1195r1728b1278],

1	Acknowledgment	NN	O	acknowledgment	_	0	SENT_200	[p16l7t1418r784b1512],

1	This	DT	O	this	det	2	SENT_201	[p16l16t1648r174b1715],
2	work	NN	O	work	nsubjpass	4	SENT_201	[p16l198t1648r390b1715],
3	was	VBD	O	be	auxpass	4	SENT_201	[p16l413t1666r559b1715],
4	supported	VBN	O	support	_	0	SENT_201	[p16l585t1648r974b1732],
5	by	IN	O	by	_	0	SENT_201	[p16l1007t1648r1094b1732],
6	the	DT	O	the	det	11	SENT_201	[p16l1120t1648r1246b1715],
7	Assistance	NNP	O	Assistance	nn	11	SENT_201	[p16l1270t1649r1673b1715],
8	Publique	NNP	O	Publique	nn	11	SENT_201	[p16l1704t1648r2039b1732],
9	Hopitaux	NNP	O	Hopitaux	nn	11	SENT_201	[p16l13t1749r360b1838],
10	de	IN	O	de	amod	11	SENT_201	[p16l391t1753r483b1821],
11	Marseille	NNP	ORGANIZATION	Marseille	agent	4	SENT_201	[p16l513t1753r887b1821],
12	.	.	O	.	_	0	SENT_201	[p16l513t1753r887b1821],

1	References	NNS	O	reference	_	0	SENT_202	[p16l13t1999r515b2072],

1	[	NN	O	[	_	0	SENT_203	[p16l51t2223r127b2291],
2	1	CD	NUMBER	1	num	1	SENT_203	[p16l51t2223r127b2291],
3	]	CD	NUMBER	]	num	5	SENT_203	[p16l51t2223r127b2291],
4	Yusuf	NNP	PERSON	Yusuf	nn	5	SENT_203	[p16l170t2223r336b2277],
5	S	NN	PERSON	s	dep	1	SENT_203	[p16l354t2224r404b2289],
6	,	,	O	,	_	0	SENT_203	[p16l354t2224r404b2289],
7	Zhao	NNP	PERSON	Zhao	nn	8	SENT_203	[p16l430t2223r578b2277],
8	F	NN	PERSON	f	appos	5	SENT_203	[p16l600t2224r638b2289],
9	,	,	O	,	_	0	SENT_203	[p16l600t2224r638b2289],
10	Mehta	NNP	ORGANIZATION	Mehta	nn	11	SENT_203	[p16l662t2223r853b2277],
11	SR	NN	ORGANIZATION	sr	appos	5	SENT_203	[p16l873t2224r964b2289],
12	,	,	O	,	_	0	SENT_203	[p16l873t2224r964b2289],
13	Chrolavicius	NNP	O	Chrolavicius	nn	14	SENT_203	[p16l990t2223r1367b2277],
14	S	NNP	O	S	appos	5	SENT_203	[p16l1387t2224r1437b2289],
15	,	,	O	,	_	0	SENT_203	[p16l1387t2224r1437b2289],
16	Tognoni	NNP	PERSON	Tognoni	nn	17	SENT_203	[p16l1461t2224r1698b2291],
17	G	NNP	O	G	appos	5	SENT_203	[p16l1721t2224r1784b2289],
18	,	,	O	,	_	0	SENT_203	[p16l1721t2224r1784b2289],
19	Fox	NNP	ORGANIZATION	Fox	nn	20	SENT_203	[p16l1812t2224r1918b2277],
20	KK	NNP	ORGANIZATION	KK	appos	5	SENT_203	[p16l1939t2224r2034b2277],
21	.	.	O	.	_	0	SENT_203	[p16l1939t2224r2034b2277],

1	Effects	NNS	O	effect	_	0	SENT_204	[p16l174t2311r388b2365],
2	of	IN	O	of	_	0	SENT_204	[p16l411t2311r474b2365],
3	clopidogrel	NN	O	clopidogrel	prep_of	1	SENT_204	[p16l495t2311r844b2379],
4	in	IN	O	in	_	0	SENT_204	[p16l869t2312r921b2365],
5	addition	NN	O	addition	_	0	SENT_204	[p16l948t2311r1203b2365],
6	to	TO	O	to	_	0	SENT_204	[p16l1229t2316r1291b2365],
7	aspirin	NN	O	aspirin	prep_in_addition_to	1	SENT_204	[p16l1315t2312r1520b2379],
8	in	IN	O	in	_	0	SENT_204	[p16l1546t2312r1599b2365],
9	patients	NNS	O	patient	prep_in	1	SENT_204	[p16l1627t2312r1880b2379],
10	with	IN	O	with	_	0	SENT_204	[p16l1903t2311r2038b2365],
11	acute	JJ	O	acute	amod	13	SENT_204	[p16l172t2406r345b2454],
12	coronary	JJ	O	coronary	amod	13	SENT_204	[p16l380t2415r655b2468],
13	syndromes	NNS	O	syndrome	prep_with	9	SENT_204	[p16l689t2400r1018b2468],
14	without	IN	O	without	_	0	SENT_204	[p16l1051t2400r1294b2454],
15	ST-segment	NN	O	st-segment	nn	16	SENT_204	[p16l1330t2401r1687b2468],
16	elevation	NN	O	elevation	prep_without	13	SENT_204	[p16l1722t2400r2033b2454],
17	.	.	O	.	_	0	SENT_204	[p16l1722t2400r2033b2454],

1	N	NN	O	n	nn	3	SENT_205	[p16l171t2491r216b2543],
2	Engl	NNP	O	Engl	nn	3	SENT_205	[p16l237t2489r369b2557],
3	J	NNP	O	J	nsubj	4	SENT_205	[p16l391t2491r426b2543],
4	Med	VBD	O	med	_	0	SENT_205	[p16l447t2489r580b2543],
5	2001	CD	DATE	2001	dobj	4	SENT_205	[p16l602t2490r1209b2555],
6	;	:	O	;	_	0	SENT_205	[p16l602t2490r1209b2555],
7	345:494	CD	NUMBER	345:494	num	8	SENT_205	[p16l602t2490r1209b2555],
8	—	NN	O	—	dep	5	SENT_205	[p16l602t2490r1209b2555],
9	502	CD	NUMBER	502	dep	8	SENT_205	[p16l602t2490r1209b2555],
10	.	.	O	.	_	0	SENT_205	[p16l602t2490r1209b2555],

1	[	NN	O	[	_	0	SENT_206	[p16l51t2578r127b2646],
2	2	CD	NUMBER	2	num	1	SENT_206	[p16l51t2578r127b2646],
3	]	CD	NUMBER	]	num	5	SENT_206	[p16l51t2578r127b2646],
4	Mehta	NNP	ORGANIZATION	Mehta	nn	5	SENT_206	[p16l169t2578r360b2632],
5	SR	NN	ORGANIZATION	sr	dep	1	SENT_206	[p16l408t2579r499b2644],
6	,	,	O	,	_	0	SENT_206	[p16l408t2579r499b2644],
7	Yusuf	NNP	PERSON	Yusuf	nn	8	SENT_206	[p16l550t2578r717b2632],
8	S	NNP	PERSON	S	appos	5	SENT_206	[p16l761t2579r811b2644],
9	,	,	O	,	_	0	SENT_206	[p16l761t2579r811b2644],
10	Peters	NNP	PERSON	Peters	nn	11	SENT_206	[p16l866t2579r1058b2632],
11	RJ	NN	PERSON	rj	appos	5	SENT_206	[p16l1108t2579r1195b2644],
12	,	,	O	,	_	0	SENT_206	[p16l1108t2579r1195b2644],
13	Bertrand	NNP	PERSON	Bertrand	nn	14	SENT_206	[p16l1251t2578r1519b2632],
14	ME	NNP	PERSON	ME	appos	5	SENT_206	[p16l1567t2580r1673b2644],
15	,	,	O	,	_	0	SENT_206	[p16l1567t2580r1673b2644],
16	Lewis	NNP	PERSON	Lewis	nn	17	SENT_206	[p16l1728t2579r1897b2632],
17	BS	NNP	O	BS	appos	5	SENT_206	[p16l1946t2579r2034b2644],
18	,	,	O	,	_	0	SENT_206	[p16l1946t2579r2034b2644],
19	Natarajan	NNP	PERSON	Natarajan	nn	20	SENT_206	[p16l174t2669r479b2735],
20	MK	NNP	PERSON	MK	appos	5	SENT_206	[p16l507t2669r616b2733],
21	,	,	O	,	_	0	SENT_206	[p16l507t2669r616b2733],
22	et	FW	O	et	nn	23	SENT_206	[p16l648t2673r711b2721],
23	al.	FW	O	al.	appos	5	SENT_206	[p16l738t2667r811b2721],
24	.	.	O	.	_	0	SENT_206	[p16l738t2667r811b2721],

1	Effects	NNS	O	effect	nsubj	8	SENT_207	[p16l847t2667r1060b2721],
2	of	IN	O	of	_	0	SENT_207	[p16l1086t2667r1149b2721],
3	pretreatment	NN	O	pretreatment	prep_of	1	SENT_207	[p16l1175t2673r1599b2735],
4	with	IN	O	with	_	0	SENT_207	[p16l1623t2667r1758b2721],
5	clopidogrel	NN	O	clopidogrel	prep_with	3	SENT_207	[p16l1787t2667r2037b2735, p16l172t2756r290b2824],
6	and	CC	O	and	_	0	SENT_207	[p16l320t2756r428b2810],
7	aspirin	NN	O	aspirin	conj_and	5	SENT_207	[p16l460t2758r664b2824],
8	followed	VBN	O	follow	_	0	SENT_207	[p16l695t2756r964b2810],
9	by	IN	O	by	_	0	SENT_207	[p16l997t2756r1067b2824],
10	long-term	JJ	O	long-term	amod	11	SENT_207	[p16l1097t2756r1400b2824],
11	therapy	NN	O	therapy	prep_by	8	SENT_207	[p16l1432t2756r1674b2824],
12	in	IN	O	in	_	0	SENT_207	[p16l1701t2758r1753b2810],
13	patients	NNS	O	patient	prep_in	8	SENT_207	[p16l1787t2758r2040b2824],
14	undergoing	VBG	O	undergo	partmod	13	SENT_207	[p16l173t2845r518b2913],
15	percutaneous	JJ	O	percutaneous	amod	17	SENT_207	[p16l558t2850r979b2913],
16	coronary	JJ	O	coronary	amod	17	SENT_207	[p16l1016t2860r1291b2913],
17	intervention	NN	O	intervention	dobj	14	SENT_207	[p16l1327t2846r1733b2899],
18	:	:	O	:	_	0	SENT_207	[p16l1327t2846r1733b2899],
19	the	DT	O	the	det	21	SENT_207	[p16l1778t2845r1879b2899],
20	PCICURE	NN	O	pcicure	nn	21	SENT_207	[p16l1920t2846r2037b2899, p16l172t2935r334b2988],
21	study	NN	O	study	dep	17	SENT_207	[p16l360t2934r537b3002],
22	.	.	O	.	_	0	SENT_207	[p16l360t2934r537b3002],

1	Lancet	NNP	O	Lancet	_	0	SENT_208	[p16l570t2936r778b2988],
2	2001	CD	DATE	2001	num	1	SENT_208	[p16l802t2935r1373b3000],
3	;	:	O	;	_	0	SENT_208	[p16l802t2935r1373b3000],
4	358:527	CD	NUMBER	358:527	number	5	SENT_208	[p16l802t2935r1373b3000],
5	—	CD	NUMBER	—	dep	1	SENT_208	[p16l802t2935r1373b3000],
6	33	CD	NUMBER	33	dep	5	SENT_208	[p16l802t2935r1373b3000],
7	.	.	O	.	_	0	SENT_208	[p16l802t2935r1373b3000],

1	[	NN	O	[	nn	3	SENT_209	[p16l51t3023r127b3091],
2	3	CD	NUMBER	3	num	3	SENT_209	[p16l51t3023r127b3091],
3	]	NN	O	]	_	0	SENT_209	[p16l51t3023r127b3091],
4	Gurbel	NNP	ORGANIZATION	Gurbel	nn	5	SENT_209	[p16l172t3023r379b3078],
5	PA	NN	ORGANIZATION	pa	dep	3	SENT_209	[p16l404t3024r491b3089],
6	,	,	O	,	_	0	SENT_209	[p16l404t3024r491b3089],
7	Bliden	NNP	PERSON	Bliden	nn	8	SENT_209	[p16l521t3023r709b3077],
8	KP	NNP	O	KP	appos	5	SENT_209	[p16l736t3025r816b3089],
9	,	,	O	,	_	0	SENT_209	[p16l736t3025r816b3089],
10	Hiatt	NNP	PERSON	Hiatt	nn	11	SENT_209	[p16l846t3025r1000b3077],
11	BL	NN	O	bl	appos	5	SENT_209	[p16l1023t3025r1112b3089],
12	,	,	O	,	_	0	SENT_209	[p16l1023t3025r1112b3089],
13	O'Connor	NNP	PERSON	O'Connor	nn	14	SENT_209	[p16l1140t3024r1419b3078],
14	CM	NN	O	cm	appos	5	SENT_209	[p16l1439t3024r1547b3078],
15	.	.	O	.	_	0	SENT_209	[p16l1439t3024r1547b3078],

1	Clopidogrel	NNP	O	Clopidogrel	_	0	SENT_210	[p16l1575t3023r1931b3091],
2	for	IN	O	for	_	0	SENT_210	[p16l1952t3023r2042b3077],
3	coronary	JJ	O	coronary	amod	4	SENT_210	[p16l171t3127r446b3181],
4	stenting	NN	O	stenting	prep_for	1	SENT_210	[p16l463t3114r735b3181],
5	:	:	O	:	_	0	SENT_210	[p16l463t3114r735b3181],
6	response	NN	O	response	nn	7	SENT_210	[p16l765t3127r1035b3181],
7	variability	NN	O	variability	conj_and	1	SENT_210	[p16l1053t3113r1383b3181],
8	,	,	O	,	_	0	SENT_210	[p16l1053t3113r1383b3181],
9	drug	NN	O	drug	nn	10	SENT_210	[p16l1409t3113r1547b3181],
10	resistance	NN	O	resistance	appos	7	SENT_210	[p16l1569t3114r1903b3178],
11	,	,	O	,	_	0	SENT_210	[p16l1569t3114r1903b3178],
12	and	CC	O	and	_	0	SENT_210	[p16l1929t3113r2038b3167],
13	the	DT	O	the	det	14	SENT_210	[p16l171t3201r273b3255],
14	effect	NN	O	effect	conj_and	1	SENT_210	[p16l302t3201r491b3255],
15	of	IN	O	of	_	0	SENT_210	[p16l520t3201r583b3255],
16	pretreatment	NN	O	pretreatment	nn	18	SENT_210	[p16l612t3206r1036b3269],
17	platelet	NN	O	platelet	nn	18	SENT_210	[p16l1067t3201r1313b3269],
18	reactivity	NN	O	reactivity	prep_of	14	SENT_210	[p16l1346t3202r1655b3269],
19	.	.	O	.	_	0	SENT_210	[p16l1346t3202r1655b3269],

1	Circulation	NN	O	circulation	_	0	SENT_211	[p16l1694t3201r2040b3255],
2	2003	CD	DATE	2003	num	1	SENT_211	[p16l171t3291r314b3344],
3	;	:	O	;	_	0	SENT_211	[p16l324t3305r336b3356],
4	1	CD	NUMBER	1	number	5	SENT_211	[p16l353t3292r373b3344],
5	07:2908	CD	NUMBER	07:2908	num	6	SENT_211	[p16l388t3291r711b3345],
6	—	NN	O	—	dep	1	SENT_211	[p16l388t3291r711b3345],
7	1	CD	NUMBER	1	number	8	SENT_211	[p16l388t3291r711b3345],
8	3	CD	NUMBER	3	num	6	SENT_211	[p16l728t3291r779b3344],
9	.	.	O	.	_	0	SENT_211	[p16l728t3291r779b3344],

1	[	NN	O	[	nn	5	SENT_212	[p16l51t3380r127b3448],
2	4	CD	NUMBER	4	num	5	SENT_212	[p16l51t3380r127b3448],
3	]	CD	NUMBER	]	num	5	SENT_212	[p16l51t3380r127b3448],
4	Angiolillo	NNP	O	Angiolillo	nn	5	SENT_212	[p16l169t3380r468b3448],
5	DJ	NNP	O	DJ	_	0	SENT_212	[p16l502t3381r594b3445],
6	,	,	O	,	_	0	SENT_212	[p16l502t3381r594b3445],
7	Fernandez-Ortiz	NNP	O	Fernandez-Ortiz	nn	8	SENT_212	[p16l633t3380r1151b3434],
8	A	NNP	O	A	appos	5	SENT_212	[p16l1179t3380r1239b3445],
9	,	,	O	,	_	0	SENT_212	[p16l1179t3380r1239b3445],
10	Bernardo	NNP	PERSON	Bernardo	nn	11	SENT_212	[p16l1279t3380r1565b3434],
11	E	NNP	PERSON	E	appos	8	SENT_212	[p16l1598t3381r1650b3445],
12	,	,	O	,	_	0	SENT_212	[p16l1598t3381r1650b3445],
13	Ramirez	NNP	PERSON	Ramirez	nn	14	SENT_212	[p16l1690t3381r1945b3434],
14	C	NNP	O	C	appos	8	SENT_212	[p16l1975t3380r2034b3445],
15	,	,	O	,	_	0	SENT_212	[p16l1975t3380r2034b3445],
16	Barrera-Ramirez	NNP	O	Barrera-Ramirez	nn	17	SENT_212	[p16l174t3470r698b3523],
17	C	NNP	O	C	appos	8	SENT_212	[p16l727t3470r786b3535],
18	,	,	O	,	_	0	SENT_212	[p16l727t3470r786b3535],
19	Sabate	NNP	O	Sabate	nn	20	SENT_212	[p16l822t3469r1037b3523],
20	M	NNP	O	M	appos	8	SENT_212	[p16l1065t3470r1134b3535],
21	,	,	O	,	_	0	SENT_212	[p16l1065t3470r1134b3535],
22	et	FW	O	et	nn	23	SENT_212	[p16l1170t3474r1234b3523],
23	al.	FW	O	al.	appos	8	SENT_212	[p16l1265t3469r1338b3523],
24	.	.	O	.	_	0	SENT_212	[p16l1265t3469r1338b3523],

1	Identification	NN	O	identification	_	0	SENT_213	[p16l1380t3469r1808b3523],
2	of	IN	O	of	_	0	SENT_213	[p16l1839t3469r1904b3523],
3	low	JJ	O	low	amod	4	SENT_213	[p16l1933t3469r2042b3523],
4	responders	NNS	O	responder	prep_of	1	SENT_213	[p16l174t3557r519b3625],
5	to	TO	O	to	dep	1	SENT_213	[p16l537t3563r601b3611],
6	a	DT	O	a	det	8	SENT_213	[p16l619t3572r651b3611],
7	300-mg	JJ	O	300-mg	amod	8	SENT_213	[p16l671t3558r902b3625],
8	clopidogrel	NN	O	clopidogrel	pobj	5	SENT_213	[p16l920t3557r1277b3625],
9	loading	VBG	O	load	partmod	8	SENT_213	[p16l1299t3557r1527b3625],
10	dose	NN	O	dose	dobj	9	SENT_213	[p16l1545t3557r1688b3611],
11	in	IN	O	in	_	0	SENT_213	[p16l1707t3559r1760b3611],
12	patients	NNS	O	patient	prep_in	10	SENT_213	[p16l1782t3559r2041b3625],

1	T.	NNP	O	T.	nn	2	SENT_214	[p17l1505t92r1566b159],
2	Cuisset	NNP	O	Cuisset	_	0	SENT_214	[p17l1610t91r1894b160],
3	et	FW	O	et	nn	4	SENT_214	[p17l1930t97r2011b159],
4	al.	FW	O	al.	dep	2	SENT_214	[p17l2047t90r2141b159],
5	.	.	O	.	_	0	SENT_214	[p17l2047t90r2141b159],

1	undergoing	VBG	O	undergo	_	0	SENT_215	[p17l228t342r597b412],
2	coronary	JJ	O	coronary	amod	3	SENT_215	[p17l648t357r940b412],
3	stenting	NN	O	stenting	dobj	1	SENT_215	[p17l989t343r1281b412],
4	.	.	O	.	_	0	SENT_215	[p17l989t343r1281b412],

1	Thromb	NNP	O	Thromb	nn	2	SENT_216	[p17l1343t342r1597b398],
2	Res	NNP	O	Res	_	0	SENT_216	[p17l1647t343r1759b398],
3	2005	CD	DATE	2005	num	2	SENT_216	[p17l1806t343r2145b410],
4	;	:	O	;	_	0	SENT_216	[p17l1806t343r2145b410],
5	115	CD	NUMBER	115	num	7	SENT_216	[p17l1806t343r2145b410],
6	:	:	O	:	_	0	SENT_216	[p17l1806t343r2145b410],
7	101-8	CD	NUMBER	101-8	dep	2	SENT_216	[p17l231t433r443b487],
8	.	.	O	.	_	0	SENT_216	[p17l231t433r443b487],

1	[	NN	O	[	nn	4	SENT_217	[p17l102t522r181b592],
2	5	CD	NUMBER	5	num	4	SENT_217	[p17l102t522r181b592],
3	]	NN	O	]	nn	4	SENT_217	[p17l102t522r181b592],
4	Jaremo	NN	O	jaremo	_	0	SENT_217	[p17l226t524r462b578],
5	P	NN	O	p	dep	4	SENT_217	[p17l504t523r544b590],
6	,	,	O	,	_	0	SENT_217	[p17l504t523r544b590],
7	Lindahl	NNP	PERSON	Lindahl	nn	8	SENT_217	[p17l591t522r821b578],
8	TL	NNP	O	TL	appos	4	SENT_217	[p17l859t524r956b590],
9	,	,	O	,	_	0	SENT_217	[p17l859t524r956b590],
10	Fransson	NNP	PERSON	Fransson	nn	11	SENT_217	[p17l1003t524r1276b578],
11	SG	NNP	O	SG	appos	8	SENT_217	[p17l1317t523r1417b590],
12	,	,	O	,	_	0	SENT_217	[p17l1317t523r1417b590],
13	Richter	NNP	PERSON	Richter	nn	16	SENT_217	[p17l1466t522r1696b578],
14	A.	NNP	O	A.	nn	16	SENT_217	[p17l1730t523r1791b578],
15	Individual	NNP	O	Individual	nn	16	SENT_217	[p17l1840t522r2149b578],
16	variations	NNS	O	variation	appos	8	SENT_217	[p17l225t615r543b670],
17	of	IN	O	of	_	0	SENT_217	[p17l593t614r657b670],
18	platelet	NN	O	platelet	nn	19	SENT_217	[p17l707t614r962b684],
19	inhibition	NN	O	inhibition	prep_of	16	SENT_217	[p17l1013t614r1317b670],
20	after	IN	O	after	_	0	SENT_217	[p17l1371t614r1530b670],
21	loading	VBG	O	load	prepc_after	19	SENT_217	[p17l1582t614r1812b684],
22	doses	NNS	O	dose	dobj	21	SENT_217	[p17l1864t614r2037b670],
23	of	IN	O	of	_	0	SENT_217	[p17l2088t614r2153b670],
24	clopidogrel	NN	O	clopidogrel	prep_of	22	SENT_217	[p17l226t704r606b774],
25	.	.	O	.	_	0	SENT_217	[p17l226t704r606b774],

1	J	NNP	O	J	nn	3	SENT_218	[p17l636t706r672b760],
2	Intern	NNP	O	Intern	nn	3	SENT_218	[p17l696t706r890b760],
3	Med	NNP	O	Med	_	0	SENT_218	[p17l914t704r1052b760],
4	2002	CD	DATE	2002	num	3	SENT_218	[p17l1074t705r1623b772],
5	;	:	O	;	_	0	SENT_218	[p17l1074t705r1623b772],
6	252:233	CD	NUMBER	252:233	number	7	SENT_218	[p17l1074t705r1623b772],
7	—	CD	NUMBER	—	dep	3	SENT_218	[p17l1074t705r1623b772],
8	8	CD	NUMBER	8	dep	7	SENT_218	[p17l1074t705r1623b772],
9	.	.	O	.	_	0	SENT_218	[p17l1074t705r1623b772],

1	[	NN	O	[	dep	5	SENT_219	[p17l102t795r181b865],
2	6	CD	NUMBER	6	num	3	SENT_219	[p17l102t795r181b865],
3	]	CD	NUMBER	]	dep	1	SENT_219	[p17l102t795r181b865],
4	Muller	NNP	O	Muller	dep	5	SENT_219	[p17l225t795r427b851],
5	I	PRP	O	I	dep	21	SENT_219	[p17l452t797r484b863],
6	,	,	O	,	_	0	SENT_219	[p17l452t797r484b863],
7	Besta	NNP	O	Besta	nn	8	SENT_219	[p17l516t796r686b851],
8	F	NN	O	f	appos	5	SENT_219	[p17l712t797r751b863],
9	,	,	O	,	_	0	SENT_219	[p17l712t797r751b863],
10	Schulz	NNP	PERSON	Schulz	nn	11	SENT_219	[p17l780t795r984b851],
11	C	NNP	O	C	appos	5	SENT_219	[p17l1006t796r1065b863],
12	,	,	O	,	_	0	SENT_219	[p17l1006t796r1065b863],
13	Massberg	NNP	LOCATION	Massberg	nn	14	SENT_219	[p17l1093t795r1384b865],
14	S	NNP	LOCATION	S	appos	5	SENT_219	[p17l1408t796r1459b863],
15	,	,	O	,	_	0	SENT_219	[p17l1408t796r1459b863],
16	Schonig	NNP	O	Schonig	nn	17	SENT_219	[p17l1489t795r1731b865],
17	A	NNP	O	A	appos	5	SENT_219	[p17l1752t796r1813b863],
18	,	,	O	,	_	0	SENT_219	[p17l1752t796r1813b863],
19	Gawaz	NNP	PERSON	Gawaz	nn	20	SENT_219	[p17l1842t796r2054b851],
20	M.	NNP	PERSON	M.	appos	5	SENT_219	[p17l2073t797r2143b851],
21	Prevalence	NN	PERSON	prevalence	dep	25	SENT_219	[p17l229t886r578b942],
22	of	IN	O	of	_	0	SENT_219	[p17l615t886r680b942],
23	clopidogrel	NN	O	clopidogrel	nn	24	SENT_219	[p17l713t886r1072b956],
24	non-responders	NNS	O	non-responder	prep_of	21	SENT_219	[p17l1111t886r1605b956],
25	among	IN	O	among	_	0	SENT_219	[p17l1642t900r1851b956],
26	patients	NNS	O	patient	pobj	25	SENT_219	[p17l1889t888r2150b956],
27	with	IN	O	with	_	0	SENT_219	[p17l225t978r364b1034],
28	stable	JJ	O	stable	amod	30	SENT_219	[p17l390t978r584b1034],
29	angina	NN	O	angina	nn	30	SENT_219	[p17l609t979r817b1048],
30	pectoris	NN	O	pectoris	prep_with	26	SENT_219	[p17l845t979r1101b1048],
31	scheduled	VBN	O	schedule	partmod	30	SENT_219	[p17l1125t978r1446b1034],
32	for	IN	O	for	_	0	SENT_219	[p17l1472t978r1564b1034],
33	elective	JJ	O	elective	amod	36	SENT_219	[p17l1586t978r1844b1034],
34	coronary	JJ	O	coronary	amod	36	SENT_219	[p17l1869t993r2151b1048],
35	stent	NN	O	stent	nn	36	SENT_219	[p17l226t1073r389b1124],
36	placement	NN	O	placement	prep_for	31	SENT_219	[p17l417t1068r776b1138],
37	.	.	O	.	_	0	SENT_219	[p17l417t1068r776b1138],

1	Thromb	NNP	O	Thromb	nn	2	SENT_220	[p17l813t1068r1058b1124],
2	Haemost	NNP	O	Haemost	_	0	SENT_220	[p17l1084t1070r1365b1124],
3	2003	CD	DATE	2003	num	2	SENT_220	[p17l1390t1069r1896b1136],
4	;	:	O	;	_	0	SENT_220	[p17l1390t1069r1896b1136],
5	89:783	CD	NUMBER	89:783	num	6	SENT_220	[p17l1390t1069r1896b1136],
6	—	NN	O	—	dep	2	SENT_220	[p17l1390t1069r1896b1136],
7	7	CD	NUMBER	7	dep	6	SENT_220	[p17l1390t1069r1896b1136],
8	.	.	O	.	_	0	SENT_220	[p17l1390t1069r1896b1136],

1	[	NN	O	[	nn	5	SENT_221	[p17l102t1159r181b1229],
2	7	CD	NUMBER	7	num	5	SENT_221	[p17l102t1159r181b1229],
3	]	CD	NUMBER	]	num	5	SENT_221	[p17l102t1159r181b1229],
4	Serebruany	NNP	O	Serebruany	nn	5	SENT_221	[p17l227t1159r589b1229],
5	VL	NNP	O	VL	_	0	SENT_221	[p17l603t1161r701b1227],
6	,	,	O	,	_	0	SENT_221	[p17l603t1161r701b1227],
7	Steinhubl	NNP	O	Steinhubl	nn	8	SENT_221	[p17l724t1159r1025b1215],
8	SR	NN	O	sr	appos	5	SENT_221	[p17l1043t1160r1137b1227],
9	,	,	O	,	_	0	SENT_221	[p17l1043t1160r1137b1227],
10	Berger	NNP	PERSON	Berger	nn	11	SENT_221	[p17l1162t1161r1372b1229],
11	PB	NN	O	pb	appos	8	SENT_221	[p17l1389t1161r1485b1227],
12	,	,	O	,	_	0	SENT_221	[p17l1389t1161r1485b1227],
13	Malinin	NNP	PERSON	Malinin	nn	14	SENT_221	[p17l1507t1159r1735b1215],
14	AI	NNP	O	AI	appos	8	SENT_221	[p17l1751t1160r1833b1227],
15	,	,	O	,	_	0	SENT_221	[p17l1751t1160r1833b1227],
16	Bhatt	NNP	PERSON	Bhatt	nn	17	SENT_221	[p17l1859t1159r2030b1215],
17	DL	NNP	O	DL	appos	8	SENT_221	[p17l2049t1161r2144b1227],
18	,	,	O	,	_	0	SENT_221	[p17l2049t1161r2144b1227],
19	Topol	NNP	PERSON	Topol	nn	20	SENT_221	[p17l225t1251r395b1321],
20	EJ	NNP	O	EJ	appos	8	SENT_221	[p17l416t1253r503b1307],
21	.	.	O	.	_	0	SENT_221	[p17l416t1253r503b1307],

1	Variability	NN	O	variability	_	0	SENT_222	[p17l524t1251r855b1321],
2	in	IN	O	in	_	0	SENT_222	[p17l871t1252r925b1306],
3	platelet	NN	O	platelet	nn	4	SENT_222	[p17l946t1251r1199b1321],
4	responsiveness	NN	O	responsiveness	prep_in	1	SENT_222	[p17l1220t1252r1693b1321],
5	to	TO	O	to	_	0	SENT_222	[p17l1709t1256r1773b1307],
6	clopidogrel	NN	O	clopidogrel	prep_to	1	SENT_222	[p17l1790t1251r2149b1321],
7	among	IN	O	among	_	0	SENT_222	[p17l227t1355r437b1411],
8	544	CD	NUMBER	544	num	9	SENT_222	[p17l463t1342r572b1397],
9	individuals	NNS	O	individual	prep_among	1	SENT_222	[p17l595t1341r958b1397],
10	.	.	O	.	_	0	SENT_222	[p17l595t1341r958b1397],

1	J	NNP	O	J	nn	4	SENT_223	[p17l986t1343r1022b1397],
2	Am	NNP	O	Am	nn	4	SENT_223	[p17l1041t1342r1145b1396],
3	Coll	NNP	O	Coll	nn	4	SENT_223	[p17l1171t1341r1293b1397],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_223	[p17l1319t1341r1550b1397],
5	2005	CD	DATE	2005	num	4	SENT_223	[p17l1573t1342r2118b1409],
6	;	:	O	;	_	0	SENT_223	[p17l1573t1342r2118b1409],
7	45:246	CD	NUMBER	45:246	number	8	SENT_223	[p17l1573t1342r2118b1409],
8	—	CD	NUMBER	—	dep	4	SENT_223	[p17l1573t1342r2118b1409],
9	51	CD	NUMBER	51	dep	8	SENT_223	[p17l1573t1342r2118b1409],
10	.	.	O	.	_	0	SENT_223	[p17l1573t1342r2118b1409],

1	[	NN	O	[	_	0	SENT_224	[p17l102t1432r184b1502],
2	8	CD	NUMBER	8	num	1	SENT_224	[p17l102t1432r184b1502],
3	]	CD	NUMBER	]	num	5	SENT_224	[p17l102t1432r184b1502],
4	Barragan	NNP	PERSON	Barragan	nn	5	SENT_224	[p17l235t1434r527b1502],
5	P	NN	PERSON	p	dep	1	SENT_224	[p17l587t1434r629b1500],
6	,	,	O	,	_	0	SENT_224	[p17l587t1434r629b1500],
7	Bouvier	JJ	PERSON	bouvier	amod	8	SENT_224	[p17l693t1434r944b1488],
8	JL	NN	O	jl	appos	5	SENT_224	[p17l995t1434r1087b1500],
9	,	,	O	,	_	0	SENT_224	[p17l995t1434r1087b1500],
10	Roquebert	NNP	O	Roquebert	nn	11	SENT_224	[p17l1151t1432r1496b1502],
11	PO	NNP	O	PO	appos	5	SENT_224	[p17l1552t1433r1659b1500],
12	,	,	O	,	_	0	SENT_224	[p17l1552t1433r1659b1500],
13	Macaluso	NNP	PERSON	Macaluso	nn	14	SENT_224	[p17l1718t1432r2022b1488],
14	G	NNP	PERSON	G	appos	5	SENT_224	[p17l2076t1433r2144b1500],
15	,	,	O	,	_	0	SENT_224	[p17l2076t1433r2144b1500],
16	Commeau	NNP	O	Commeau	nn	17	SENT_224	[p17l232t1524r547b1580],
17	P	NN	O	p	appos	5	SENT_224	[p17l577t1525r618b1591],
18	,	,	O	,	_	0	SENT_224	[p17l577t1525r618b1591],
19	Comet	NN	O	comet	nn	20	SENT_224	[p17l650t1524r858b1580],
20	B	NN	O	b	appos	5	SENT_224	[p17l886t1525r941b1591],
21	,	,	O	,	_	0	SENT_224	[p17l886t1525r941b1591],
22	et	FW	O	et	nn	23	SENT_224	[p17l973t1529r1038b1579],
23	al.	FW	O	al.	appos	5	SENT_224	[p17l1063t1524r1139b1579],
24	.	.	O	.	_	0	SENT_224	[p17l1063t1524r1139b1579],

1	Resistance	NN	O	resistance	_	0	SENT_225	[p17l1174t1525r1508b1579],
2	to	TO	O	to	_	0	SENT_225	[p17l1534t1529r1598b1579],
3	thienopyridines	NNS	O	thienopyridine	prep_to	1	SENT_225	[p17l1624t1524r2143b1594],
4	:	:	O	:	_	0	SENT_225	[p17l1624t1524r2143b1594],
5	clinical	JJ	O	clinical	amod	6	SENT_225	[p17l231t1615r461b1671],
6	detection	NN	O	detection	dep	1	SENT_225	[p17l486t1615r793b1671],
7	of	IN	O	of	_	0	SENT_225	[p17l820t1615r885b1671],
8	coronary	JJ	O	coronary	amod	10	SENT_225	[p17l907t1630r1189b1685],
9	stent	NN	O	stent	nn	10	SENT_225	[p17l1211t1620r1374b1671],
10	thrombosis	NN	O	thrombosis	prep_of	6	SENT_225	[p17l1399t1615r1750b1671],
11	by	IN	O	by	_	0	SENT_225	[p17l1776t1615r1848b1685],
12	monitoring	NN	O	monitoring	prep_by	10	SENT_225	[p17l1873t1616r2146b1671, p17l232t1707r325b1775],
13	of	IN	O	of	_	0	SENT_225	[p17l353t1705r418b1761],
14	vasodilator-stimulated	JJ	O	vasodilator-stimulated	amod	16	SENT_225	[p17l443t1705r1173b1761],
15	phosphoprotein	NN	O	phosphoprotein	nn	16	SENT_225	[p17l1207t1705r1704b1775],
16	phosphorylation	NN	O	phosphorylation	prep_of	12	SENT_225	[p17l1738t1705r2146b1775, p17l232t1798r376b1852],
17	.	.	O	.	_	0	SENT_225	[p17l1738t1705r2146b1775, p17l232t1798r376b1852],

1	Catheter	NN	MISC	catheter	nn	2	SENT_226	[p17l412t1796r701b1853],
2	Cardiovasc	NN	MISC	cardiovasc	_	0	SENT_226	[p17l725t1796r1071b1853],
3	Interv	NNP	MISC	Interv	dep	2	SENT_226	[p17l1096t1798r1292b1852],
4	2003	CD	DATE	2003	num	3	SENT_226	[p17l1313t1797r1895b1864],
5	;	:	O	;	_	0	SENT_226	[p17l1313t1797r1895b1864],
6	59:295	CD	NUMBER	59:295	num	7	SENT_226	[p17l1313t1797r1895b1864],
7	-302	CD	NUMBER	-302	dep	2	SENT_226	[p17l1313t1797r1895b1864],
8	.	.	O	.	_	0	SENT_226	[p17l1313t1797r1895b1864],

1	[	NN	O	[	dep	5	SENT_227	[p17l102t1889r181b1959],
2	9	CD	NUMBER	9	num	3	SENT_227	[p17l102t1889r181b1959],
3	]	NN	O	]	dep	1	SENT_227	[p17l102t1889r181b1959],
4	Gurbel	NNP	ORGANIZATION	Gurbel	nn	5	SENT_227	[p17l227t1889r440b1945],
5	PA	NN	ORGANIZATION	pa	_	0	SENT_227	[p17l475t1889r565b1956],
6	,	,	O	,	_	0	SENT_227	[p17l475t1889r565b1956],
7	Bliden	NNP	PERSON	Bliden	nn	8	SENT_227	[p17l606t1889r800b1944],
8	KP	NNP	O	KP	appos	5	SENT_227	[p17l837t1890r919b1956],
9	,	,	O	,	_	0	SENT_227	[p17l837t1890r919b1956],
10	Samara	NNP	LOCATION	Samara	nn	11	SENT_227	[p17l958t1889r1191b1945],
11	W	NNP	O	W	appos	5	SENT_227	[p17l1222t1890r1297b1956],
12	,	,	O	,	_	0	SENT_227	[p17l1222t1890r1297b1956],
13	Yoho	NNP	LOCATION	Yoho	nn	14	SENT_227	[p17l1333t1889r1481b1944],
14	JA	NNP	O	JA	appos	5	SENT_227	[p17l1512t1889r1606b1956],
15	,	,	O	,	_	0	SENT_227	[p17l1512t1889r1606b1956],
16	Hayes	NNP	PERSON	Hayes	nn	17	SENT_227	[p17l1647t1890r1831b1959],
17	K	NNP	PERSON	K	appos	5	SENT_227	[p17l1865t1890r1921b1956],
18	,	,	O	,	_	0	SENT_227	[p17l1865t1890r1921b1956],
19	Fissha	NNP	O	Fissha	appos	5	SENT_227	[p17l1962t1889r2150b1944],
20	MZ	JJ	O	mz	dep	19	SENT_227	[p17l225t1981r335b2047],
21	,	,	O	,	_	0	SENT_227	[p17l225t1981r335b2047],
22	et	FW	O	et	nn	23	SENT_227	[p17l391t1985r456b2035],
23	al.	FW	O	al.	appos	5	SENT_227	[p17l507t1979r582b2035],
24	.	.	O	.	_	0	SENT_227	[p17l507t1979r582b2035],

1	Clopidogrel	NNP	O	Clopidogrel	nn	2	SENT_228	[p17l640t1979r1006b2049],
2	effect	NN	O	effect	_	0	SENT_228	[p17l1057t1979r1251b2035],
3	on	IN	O	on	_	0	SENT_228	[p17l1302t1994r1374b2035],
4	platelet	NN	O	platelet	nn	5	SENT_228	[p17l1429t1979r1683b2049],
5	reactivity	NN	O	reactivity	prep_on	2	SENT_228	[p17l1736t1981r2044b2049],
6	in	IN	O	in	_	0	SENT_228	[p17l2094t1981r2148b2035],
7	patients	NNS	O	patient	prep_in	5	SENT_228	[p17l228t2072r489b2140],
8	with	IN	O	with	_	0	SENT_228	[p17l513t2070r652b2126],
9	stent	JJ	O	stent	amod	10	SENT_228	[p17l681t2076r844b2126],
10	thrombosis	NN	O	thrombosis	prep_with	7	SENT_228	[p17l870t2070r1241b2126],
11	:	:	O	:	_	0	SENT_228	[p17l870t2070r1241b2126],
12	results	NNS	O	result	dep	2	SENT_228	[p17l1276t2070r1486b2126],
13	of	IN	O	of	_	0	SENT_228	[p17l1512t2070r1576b2126],
14	the	DT	O	the	det	16	SENT_228	[p17l1600t2070r1705b2126],
15	CREST	NNP	O	CREST	nn	16	SENT_228	[p17l1731t2071r1931b2126],
16	Study	NNP	O	Study	prep_of	12	SENT_228	[p17l1955t2070r2143b2140],
17	.	.	O	.	_	0	SENT_228	[p17l1955t2070r2143b2140],

1	J	NNP	O	J	nn	4	SENT_229	[p17l223t2162r259b2216],
2	Am	NNP	O	Am	nn	4	SENT_229	[p17l279t2161r384b2215],
3	Coll	NNP	O	Coll	nn	4	SENT_229	[p17l412t2161r534b2216],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_229	[p17l563t2161r793b2216],
5	2005	CD	DATE	2005	num	4	SENT_229	[p17l818t2161r1402b2227],
6	;	:	O	;	_	0	SENT_229	[p17l818t2161r1402b2227],
7	46:1827	CD	NUMBER	46:1827	number	8	SENT_229	[p17l818t2161r1402b2227],
8	—	CD	NUMBER	—	dep	4	SENT_229	[p17l818t2161r1402b2227],
9	32	CD	NUMBER	32	dep	8	SENT_229	[p17l818t2161r1402b2227],
10	.	.	O	.	_	0	SENT_229	[p17l818t2161r1402b2227],

1	[	NN	O	[	nn	4	SENT_230	[p17l63t2252r180b2322],
2	10	CD	NUMBER	10	num	4	SENT_230	[p17l63t2252r180b2322],
3	]	NN	O	]	nn	4	SENT_230	[p17l63t2252r180b2322],
4	Wenaweser	NN	O	wenaweser	tmod	12	SENT_230	[p17l225t2253r592b2308],
5	P	NN	O	p	dep	4	SENT_230	[p17l613t2253r654b2320],
6	,	,	O	,	_	0	SENT_230	[p17l613t2253r654b2320],
7	Hess	NNP	PERSON	Hess	nn	10	SENT_230	[p17l683t2253r822b2308],
8	O.	NNP	O	O.	nn	10	SENT_230	[p17l842t2252r907b2308],
9	Stent	NNP	O	Stent	nn	10	SENT_230	[p17l934t2253r1103b2308],
10	thrombosis	NN	O	thrombosis	nsubjpass	12	SENT_230	[p17l1123t2252r1474b2308],
11	is	VBZ	O	be	auxpass	12	SENT_230	[p17l1494t2253r1540b2308],
12	associated	VBN	O	associate	_	0	SENT_230	[p17l1561t2252r1893b2308],
13	with	IN	O	with	_	0	SENT_230	[p17l1915t2252r2054b2308],
14	an	DT	O	a	det	16	SENT_230	[p17l2076t2267r2148b2308],
15	impaired	JJ	O	impaired	amod	16	SENT_230	[p17l227t2342r509b2412],
16	response	NN	O	response	prep_with	12	SENT_230	[p17l534t2357r812b2412],
17	to	TO	O	to	_	0	SENT_230	[p17l832t2348r896b2398],
18	antiplatelet	JJ	O	antiplatelet	amod	19	SENT_230	[p17l916t2342r1299b2412],
19	therapy	NN	O	therapy	prep_to	12	SENT_230	[p17l1318t2342r1578b2412],
20	.	.	O	.	_	0	SENT_230	[p17l1318t2342r1578b2412],

1	J	NNP	O	J	nn	4	SENT_231	[p17l1601t2344r1636b2398],
2	Am	NNP	O	Am	nn	4	SENT_231	[p17l1650t2343r1754b2398],
3	Coll	NNP	O	Coll	nn	4	SENT_231	[p17l1776t2342r1898b2398],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_231	[p17l1920t2342r2150b2398],
5	2005	CD	DATE	2005	num	4	SENT_231	[p17l226t2434r734b2501],
6	;	:	O	;	_	0	SENT_231	[p17l226t2434r734b2501],
7	46	CD	NUMBER	46	num	9	SENT_231	[p17l226t2434r734b2501],
8	:	:	O	:	_	0	SENT_231	[p17l226t2434r734b2501],
9	CS5	CD	NUMBER	cs5	dep	4	SENT_231	[p17l226t2434r734b2501],
10	—	CD	NUMBER	—	number	11	SENT_231	[p17l226t2434r734b2501],
11	6	CD	NUMBER	6	dep	9	SENT_231	[p17l226t2434r734b2501],
12	.	.	O	.	_	0	SENT_231	[p17l226t2434r734b2501],

1	[	RB	O	[	advmod	2	SENT_232	[p17l63t2526r180b2596],
2	11	CD	NUMBER	11	_	0	SENT_232	[p17l63t2526r180b2596],
3	]	CD	NUMBER	]	num	5	SENT_232	[p17l63t2526r180b2596],
4	Matetzky	NNP	O	Matetzky	nn	5	SENT_232	[p17l225t2526r519b2596],
5	S	NN	O	s	dep	2	SENT_232	[p17l545t2527r596b2594],
6	,	,	O	,	_	0	SENT_232	[p17l545t2527r596b2594],
7	Shenkman	NN	PERSON	shenkman	nn	8	SENT_232	[p17l629t2526r952b2582],
8	B	NN	O	b	appos	5	SENT_232	[p17l984t2527r1039b2593],
9	,	,	O	,	_	0	SENT_232	[p17l984t2527r1039b2593],
10	Guetta	NNP	PERSON	Guetta	nn	11	SENT_232	[p17l1073t2527r1293b2582],
11	V	NNP	O	V	appos	5	SENT_232	[p17l1318t2527r1368b2594],
12	,	,	O	,	_	0	SENT_232	[p17l1318t2527r1368b2594],
13	Shechter	NNP	PERSON	Shechter	nn	14	SENT_232	[p17l1402t2526r1687b2582],
14	M	NNP	O	M	appos	5	SENT_232	[p17l1710t2527r1781b2594],
15	,	,	O	,	_	0	SENT_232	[p17l1710t2527r1781b2594],
16	Bienard	NNP	PERSON	Bienard	nn	17	SENT_232	[p17l1816t2526r2056b2582],
17	R	NNP	PERSON	R	appos	5	SENT_232	[p17l2088t2527r2143b2594],
18	,	,	O	,	_	0	SENT_232	[p17l2088t2527r2143b2594],
19	Goldenberg	NNP	PERSON	Goldenberg	appos	5	SENT_232	[p17l227t2616r597b2686],
20	I	PRP	O	I	dep	19	SENT_232	[p17l642t2618r675b2684],
21	,	,	O	,	_	0	SENT_232	[p17l642t2618r675b2684],
22	et	FW	O	et	nn	23	SENT_232	[p17l722t2622r787b2672],
23	al.	FW	O	al.	appos	5	SENT_232	[p17l829t2616r904b2672],
24	.	.	O	.	_	0	SENT_232	[p17l829t2616r904b2672],

1	Clopidogrel	NNP	O	Clopidogrel	nn	2	SENT_233	[p17l952t2616r1318b2686],
2	resistance	NN	O	resistance	nsubjpass	4	SENT_233	[p17l1363t2618r1686b2672],
3	is	VBZ	O	be	auxpass	4	SENT_233	[p17l1728t2618r1774b2672],
4	associated	VBN	O	associate	_	0	SENT_233	[p17l1815t2616r2147b2672],
5	with	IN	O	with	_	0	SENT_233	[p17l225t2707r364b2762],
6	increased	VBN	O	increase	amod	7	SENT_233	[p17l389t2707r695b2762],
7	risk	NN	O	risk	prep_with	4	SENT_233	[p17l723t2707r833b2762],
8	of	IN	O	of	_	0	SENT_233	[p17l853t2707r918b2762],
9	recurrent	JJ	O	recurrent	amod	11	SENT_233	[p17l941t2712r1243b2762],
10	atherothrombotic	JJ	O	atherothrombotic	amod	11	SENT_233	[p17l1266t2707r1838b2762],
11	events	NNS	O	event	prep_of	7	SENT_233	[p17l1861t2712r2071b2762],
12	in	IN	O	in	_	0	SENT_233	[p17l2094t2708r2148b2761],
13	patients	NNS	O	patient	prep_in	11	SENT_233	[p17l228t2799r493b2868],
14	with	IN	O	with	_	0	SENT_233	[p17l543t2798r684b2854],
15	acute	JJ	O	acute	amod	17	SENT_233	[p17l739t2803r919b2854],
16	myocardial	JJ	O	myocardial	amod	17	SENT_233	[p17l974t2798r1332b2868],
17	infarction	NN	O	infarction	prep_with	13	SENT_233	[p17l1385t2798r1726b2854],
18	.	.	O	.	_	0	SENT_233	[p17l1385t2798r1726b2854],

1	Circulation	NN	O	circulation	_	0	SENT_234	[p17l1788t2798r2151b2854],
2	2004	CD	DATE	2004	num	1	SENT_234	[p17l226t2889r814b2957],
3	;	:	O	;	_	0	SENT_234	[p17l226t2889r814b2957],
4	109:3171	CD	NUMBER	109:3171	number	5	SENT_234	[p17l226t2889r814b2957],
5	—	CD	NUMBER	—	dep	1	SENT_234	[p17l226t2889r814b2957],
6	5	CD	NUMBER	5	dep	5	SENT_234	[p17l226t2889r814b2957],
7	.	.	O	.	_	0	SENT_234	[p17l226t2889r814b2957],

1	[	NN	O	[	_	0	SENT_235	[p17l63t2981r180b3051],
2	12	CD	NUMBER	12	num	1	SENT_235	[p17l63t2981r180b3051],
3	]	CD	NUMBER	]	num	5	SENT_235	[p17l63t2981r180b3051],
4	Cuisset	NN	O	cuisset	nn	5	SENT_235	[p17l227t2981r453b3037],
5	T	NN	O	t	dep	1	SENT_235	[p17l469t2982r518b3048],
6	,	,	O	,	_	0	SENT_235	[p17l469t2982r518b3048],
7	Frere	NNP	ORGANIZATION	Frere	nn	8	SENT_235	[p17l545t2982r712b3036],
8	C	NNP	ORGANIZATION	C	appos	5	SENT_235	[p17l730t2981r790b3048],
9	,	,	O	,	_	0	SENT_235	[p17l730t2981r790b3048],
10	Quilici	NNP	PERSON	Quilici	nn	11	SENT_235	[p17l815t2981r1015b3047],
11	J	NNP	PERSON	J	appos	5	SENT_235	[p17l1035t2982r1087b3048],
12	,	,	O	,	_	0	SENT_235	[p17l1035t2982r1087b3048],
13	Barbou	NNP	O	Barbou	nn	14	SENT_235	[p17l1113t2981r1332b3036],
14	F	NN	O	f	appos	5	SENT_235	[p17l1354t2982r1393b3048],
15	,	,	O	,	_	0	SENT_235	[p17l1354t2982r1393b3048],
16	Morange	NNP	ORGANIZATION	Morange	nn	17	SENT_235	[p17l1415t2982r1687b3051],
17	PE	NNP	ORGANIZATION	PE	appos	5	SENT_235	[p17l1707t2982r1800b3048],
18	,	,	O	,	_	0	SENT_235	[p17l1707t2982r1800b3048],
19	Hovasse	NNP	ORGANIZATION	Hovasse	nn	20	SENT_235	[p17l1827t2982r2079b3036],
20	T	NN	ORGANIZATION	t	appos	5	SENT_235	[p17l2094t2982r2144b3048],
21	,	,	O	,	_	0	SENT_235	[p17l2094t2982r2144b3048],
22	et	FW	O	et	nn	23	SENT_235	[p17l226t3077r291b3127],
23	al.	FW	O	al.	appos	5	SENT_235	[p17l309t3072r385b3127],
24	.	.	O	.	_	0	SENT_235	[p17l309t3072r385b3127],

1	High	JJ	O	high	amod	3	SENT_236	[p17l412t3072r547b3142],
2	post	NN	O	post	nn	3	SENT_236	[p17l569t3077r1061b3142],
3	—	NN	O	—	nsubj	7	SENT_236	[p17l569t3077r1061b3142],
4	treatment	NN	O	treatment	nn	6	SENT_236	[p17l569t3077r1061b3142],
5	platelet	NN	O	platelet	nn	6	SENT_236	[p17l1082t3072r1335b3142],
6	reactivity	NN	O	reactivity	dep	3	SENT_236	[p17l1355t3073r1664b3142],
7	identified	VBD	O	identify	_	0	SENT_236	[p17l1681t3072r1992b3127],
8	lowresponders	NNS	O	lowresponder	dobj	7	SENT_236	[p17l2015t3072r2146b3127, p17l229t3163r577b3233],
9	to	TO	O	to	_	0	SENT_236	[p17l601t3168r666b3219],
10	dual	JJ	O	dual	amod	12	SENT_236	[p17l690t3163r825b3219],
11	antiplatelet	JJ	O	antiplatelet	amod	12	SENT_236	[p17l851t3163r1234b3233],
12	therapy	NN	O	therapy	prep_to	7	SENT_236	[p17l1259t3163r1508b3233],
13	at	IN	O	at	_	0	SENT_236	[p17l1532t3168r1595b3219],
14	increased	VBN	O	increase	amod	15	SENT_236	[p17l1620t3163r1925b3219],
15	risk	NN	O	risk	prep_at	7	SENT_236	[p17l1956t3163r2066b3219],
16	of	IN	O	of	_	0	SENT_236	[p17l2088t3163r2153b3219],
17	recurrent	JJ	O	recurrent	amod	19	SENT_236	[p17l229t3259r532b3310],
18	cardiovascular	JJ	O	cardiovascular	amod	19	SENT_236	[p17l574t3254r1042b3310],
19	events	NNS	O	event	prep_of	15	SENT_236	[p17l1083t3259r1293b3310],
20	after	IN	O	after	_	0	SENT_236	[p17l1335t3254r1495b3310],
21	stenting	VBG	O	stent	prepc_after	19	SENT_236	[p17l1535t3255r1796b3324],
22	for	IN	O	for	_	0	SENT_236	[p17l1838t3254r1931b3310],
23	acute	JJ	O	acute	amod	25	SENT_236	[p17l1971t3259r2150b3310],
24	coronary	JJ	O	coronary	amod	25	SENT_236	[p17l226t3360r509b3415],
25	syndrome	NN	O	syndrome	prep_for	21	SENT_236	[p17l530t3345r859b3415],
26	.	.	O	.	_	0	SENT_236	[p17l530t3345r859b3415],

1	J	NNP	O	J	nn	3	SENT_237	[p17l888t3346r923b3401],
2	Thromb	NNP	O	Thromb	nn	3	SENT_237	[p17l948t3345r1194b3401],
3	Haemost	NNP	O	Haemost	_	0	SENT_237	[p17l1218t3346r1499b3401],
4	2006	CD	DATE	2006	num	3	SENT_237	[p17l1521t3345r1985b3412],
5	;	:	O	;	_	0	SENT_237	[p17l1521t3345r1985b3412],
6	4:542	CD	NUMBER	4:542	number	7	SENT_237	[p17l1521t3345r1985b3412],
7	—	CD	NUMBER	—	dep	3	SENT_237	[p17l1521t3345r1985b3412],
8	9	CD	NUMBER	9	dep	7	SENT_237	[p17l1521t3345r1985b3412],
9	.	.	O	.	_	0	SENT_237	[p17l1521t3345r1985b3412],

1	[	RB	O	[	advmod	2	SENT_238	[p17l63t3436r180b3506],
2	13	CD	NUMBER	13	_	0	SENT_238	[p17l63t3436r180b3506],
3	]	CD	NUMBER	]	num	5	SENT_238	[p17l63t3436r180b3506],
4	Fontana	NNP	ORGANIZATION	Fontana	nn	5	SENT_238	[p17l229t3437r484b3492],
5	P	NN	ORGANIZATION	p	dep	2	SENT_238	[p17l510t3437r550b3504],
6	,	,	O	,	_	0	SENT_238	[p17l510t3437r550b3504],
7	Dupont	NNP	ORGANIZATION	Dupont	nn	8	SENT_238	[p17l581t3437r808b3506],
8	A	NNP	O	A	appos	5	SENT_238	[p17l828t3437r889b3504],
9	,	,	O	,	_	0	SENT_238	[p17l828t3437r889b3504],
10	Gandrille	NNP	O	Gandrille	nn	11	SENT_238	[p17l918t3436r1212b3492],
11	S	NNP	O	S	appos	5	SENT_238	[p17l1236t3437r1287b3503],
12	,	,	O	,	_	0	SENT_238	[p17l1236t3437r1287b3503],
13	Bachelot-Loza	NNP	O	Bachelot-Loza	nn	14	SENT_238	[p17l1318t3436r1771b3492],
14	C	NNP	O	C	appos	5	SENT_238	[p17l1794t3437r1854b3504],
15	,	,	O	,	_	0	SENT_238	[p17l1794t3437r1854b3504],
16	Reny	NNP	PERSON	Reny	nn	17	SENT_238	[p17l1885t3437r2036b3506],
17	JL	NNP	PERSON	JL	appos	5	SENT_238	[p17l2056t3437r2144b3504],
18	,	,	O	,	_	0	SENT_238	[p17l2056t3437r2144b3504],
19	Aiach	NNP	O	Aiach	nn	20	SENT_238	[p17l224t3527r398b3583],
20	M	NNP	O	M	appos	5	SENT_238	[p17l442t3529r513b3595],
21	,	,	O	,	_	0	SENT_238	[p17l442t3529r513b3595],
22	et	FW	O	et	nn	23	SENT_238	[p17l562t3532r628b3583],
23	al.	FW	O	al.	appos	5	SENT_238	[p17l672t3527r748b3583],
24	.	.	O	.	_	0	SENT_238	[p17l672t3527r748b3583],

1	Adenosine	NN	LOCATION	adenosine	nsubjpass	6	SENT_239	[p17l796t3527r1126b3583],
2	Diphosphate-Induced	JJ	O	diphosphate-induced	amod	4	SENT_239	[p17l1173t3527r1848b3597],
3	platelet	NN	O	platelet	nn	4	SENT_239	[p17l1897t3527r2150b3597],
4	aggregation	NN	O	aggregation	dep	1	SENT_239	[p17l227t3619r603b3688],
5	is	VBZ	O	be	auxpass	6	SENT_239	[p17l633t3619r679b3673],
6	associated	VBN	O	associate	_	0	SENT_239	[p17l706t3618r1040b3673],
7	with	IN	O	with	_	0	SENT_239	[p17l1068t3618r1208b3673],
8	P2Y12	NN	O	p2y12	nn	11	SENT_239	[p17l1240t3618r1429b3673],
9	gene	NN	O	gene	nn	11	SENT_239	[p17l1458t3631r1610b3688],
10	sequence	NN	O	sequence	nn	11	SENT_239	[p17l1637t3632r1938b3688],
11	variations	NNS	O	variation	prep_with	6	SENT_239	[p17l1964t3619r2147b3673, p17l226t3710r380b3765],
12	in	IN	O	in	_	0	SENT_239	[p17l404t3710r458b3764],
13	healthy	JJ	O	healthy	amod	14	SENT_239	[p17l486t3709r726b3779],
14	subjects	NNS	O	subject	prep_in	6	SENT_239	[p17l748t3709r1034b3779],
15	.	.	O	.	_	0	SENT_239	[p17l748t3709r1034b3779],

1	Circulation	NN	O	circulation	_	0	SENT_240	[p17l1067t3709r1424b3765],
2	2003	CD	DATE	2003	num	1	SENT_240	[p17l1448t3709r2035b3777],
3	;	:	O	;	_	0	SENT_240	[p17l1448t3709r2035b3777],
4	108:989	CD	NUMBER	108:989	number	5	SENT_240	[p17l1448t3709r2035b3777],
5	—	CD	NUMBER	—	dep	1	SENT_240	[p17l1448t3709r2035b3777],
6	95	CD	NUMBER	95	dep	5	SENT_240	[p17l1448t3709r2035b3777],
7	.	.	O	.	_	0	SENT_240	[p17l1448t3709r2035b3777],

1	[	RB	O	[	dep	5	SENT_241	[p18l63t17r180b87],
2	14	CD	NUMBER	14	num	5	SENT_241	[p18l63t17r180b87],
3	]	CD	NUMBER	]	num	5	SENT_241	[p18l63t17r180b87],
4	Angiolillo	NNP	O	Angiolillo	nn	5	SENT_241	[p18l224t17r525b87],
5	DJ	NNP	O	DJ	_	0	SENT_241	[p18l564t18r657b85],
6	,	,	O	,	_	0	SENT_241	[p18l564t18r657b85],
7	Fernandez-Ortiz	NNP	O	Fernandez-Ortiz	nn	8	SENT_241	[p18l702t17r1224b73],
8	A	NNP	O	A	appos	5	SENT_241	[p18l1257t18r1319b85],
9	,	,	O	,	_	0	SENT_241	[p18l1257t18r1319b85],
10	Bernardo	NNP	PERSON	Bernardo	nn	11	SENT_241	[p18l1364t17r1653b73],
11	E	NNP	PERSON	E	appos	5	SENT_241	[p18l1692t18r1745b85],
12	,	,	O	,	_	0	SENT_241	[p18l1692t18r1745b85],
13	Ramirez	NNP	PERSON	Ramirez	nn	14	SENT_241	[p18l1790t18r2048b73],
14	C	NNP	O	C	appos	11	SENT_241	[p18l2084t18r2143b85],
15	,	,	O	,	_	0	SENT_241	[p18l2084t18r2143b85],
16	Cavallari	NNP	PERSON	Cavallari	nn	17	SENT_241	[p18l227t107r506b163],
17	U	NNP	O	U	appos	11	SENT_241	[p18l541t109r602b175],
18	,	,	O	,	_	0	SENT_241	[p18l541t109r602b175],
19	Trabetti	NNP	O	Trabetti	nn	20	SENT_241	[p18l636t107r891b163],
20	E	NNP	O	E	appos	11	SENT_241	[p18l927t109r979b175],
21	,	,	O	,	_	0	SENT_241	[p18l927t109r979b175],
22	et	FW	O	et	nn	23	SENT_241	[p18l1015t112r1080b163],
23	al.	FW	O	al.	appos	11	SENT_241	[p18l1110t107r1185b163],
24	.	.	O	.	_	0	SENT_241	[p18l1110t107r1185b163],

1	Lack	NN	O	lack	_	0	SENT_242	[p18l1224t107r1367b163],
2	of	IN	O	of	_	0	SENT_242	[p18l1395t107r1459b163],
3	association	NN	O	association	prep_of	1	SENT_242	[p18l1486t108r1838b163],
4	between	IN	O	between	_	0	SENT_242	[p18l1873t107r2148b163],
5	the	DT	O	the	det	9	SENT_242	[p18l226t200r334b256],
6	P2Y12	NN	O	p2y12	nn	9	SENT_242	[p18l391t200r585b255],
7	receptor	NN	O	receptor	nn	9	SENT_242	[p18l643t205r929b270],
8	gene	NN	O	gene	nn	9	SENT_242	[p18l982t213r1137b270],
9	polymorphism	NN	O	polymorphism	prep_between	1	SENT_242	[p18l1193t200r1657b270],
10	and	CC	O	and	_	0	SENT_242	[p18l1713t200r1828b256],
11	platelet	NN	O	platelet	nn	12	SENT_242	[p18l1886t200r2151b270],
12	response	NN	O	response	conj_and	9	SENT_242	[p18l229t306r507b361],
13	to	TO	O	to	_	0	SENT_242	[p18l548t296r612b347],
14	clopidogrel	NN	O	clopidogrel	prep_to	9	SENT_242	[p18l652t291r1011b361],
15	in	IN	O	in	_	0	SENT_242	[p18l1054t292r1107b346],
16	patients	NNS	O	patient	prep_in	1	SENT_242	[p18l1152t292r1413b361],
17	with	IN	O	with	_	0	SENT_242	[p18l1451t291r1590b347],
18	coronary	JJ	O	coronary	amod	20	SENT_242	[p18l1633t306r1915b361],
19	artery	NN	O	artery	nn	20	SENT_242	[p18l1955t296r2152b361],
20	disease	NN	O	disease	prep_with	16	SENT_242	[p18l226t381r480b437],
21	.	.	O	.	_	0	SENT_242	[p18l226t381r480b437],

1	Thromb	NNP	O	Thromb	nn	2	SENT_243	[p18l516t381r762b437],
2	Res	NNP	O	Res	_	0	SENT_243	[p18l787t382r896b437],
3	2005	CD	DATE	2005	num	2	SENT_243	[p18l919t382r1469b449],
4	;	:	O	;	_	0	SENT_243	[p18l919t382r1469b449],
5	116:491	CD	NUMBER	116:491	number	6	SENT_243	[p18l919t382r1469b449],
6	-7	CD	NUMBER	-7	dep	2	SENT_243	[p18l919t382r1469b449],
7	.	.	O	.	_	0	SENT_243	[p18l919t382r1469b449],

1	[	RB	O	[	advmod	30	SENT_244	[p18l63t473r180b543],
2	15	CD	NUMBER	15	num	6	SENT_244	[p18l63t473r180b543],
3	]	CD	NUMBER	]	num	6	SENT_244	[p18l63t473r180b543],
4	von	NNP	PERSON	von	nn	6	SENT_244	[p18l225t488r335b529],
5	Beckerath	NNP	PERSON	Beckerath	nn	6	SENT_244	[p18l374t473r693b529],
6	N	NNP	PERSON	N	nsubjpass	30	SENT_244	[p18l734t475r794b541],
7	,	,	O	,	_	0	SENT_244	[p18l734t475r794b541],
8	von	NNP	PERSON	von	nn	10	SENT_244	[p18l833t488r943b529],
9	Beckerath	NNP	PERSON	Beckerath	nn	10	SENT_244	[p18l983t473r1303b529],
10	O	NNP	PERSON	O	appos	6	SENT_244	[p18l1340t474r1405b541],
11	,	,	O	,	_	0	SENT_244	[p18l1340t474r1405b541],
12	Koch	NNP	PERSON	Koch	nn	13	SENT_244	[p18l1448t473r1594b529],
13	W	NNP	O	W	appos	6	SENT_244	[p18l1629t475r1703b541],
14	,	,	O	,	_	0	SENT_244	[p18l1629t475r1703b541],
15	Eichinger	NNP	PERSON	Eichinger	nn	16	SENT_244	[p18l1747t473r2043b543],
16	M	NNP	O	M	appos	6	SENT_244	[p18l2073t475r2144b541],
17	,	,	O	,	_	0	SENT_244	[p18l2073t475r2144b541],
18	Schomig	NNP	O	Schomig	nn	19	SENT_244	[p18l227t565r490b635],
19	A	NNP	O	A	appos	6	SENT_244	[p18l522t566r584b633],
20	,	,	O	,	_	0	SENT_244	[p18l522t566r584b633],
21	Kastrati	NNP	PERSON	Kastrati	nn	27	SENT_244	[p18l627t566r872b621],
22	A.	NNP	O	A.	nn	27	SENT_244	[p18l907t566r968b621],
23	A	NNP	O	A	nn	27	SENT_244	[p18l1007t566r1050b620],
24	P2Y12	NN	O	p2y12	nn	27	SENT_244	[p18l1085t566r1273b620],
25	gene	NN	O	gene	nn	27	SENT_244	[p18l1309t578r1461b635],
26	H2	NN	O	h2	nn	27	SENT_244	[p18l1498t566r1576b620],
27	haplotype	NN	O	haplotype	appos	6	SENT_244	[p18l1614t565r1932b635],
28	is	VBZ	O	be	auxpass	30	SENT_244	[p18l1967t566r2013b621],
29	not	RB	O	not	neg	30	SENT_244	[p18l2048t570r2150b621],
30	associated	VBN	O	associate	_	0	SENT_244	[p18l227t656r559b712],
31	with	IN	O	with	_	0	SENT_244	[p18l596t656r734b712],
32	increased	VBN	O	increase	amod	33	SENT_244	[p18l772t656r1077b712],
33	adenosine	NN	O	adenosine	prep_with	30	SENT_244	[p18l1115t656r1437b712],
34	diphosphate-induced	JJ	O	diphosphate-induced	amod	36	SENT_244	[p18l1473t656r2147b726],
35	platelet	NN	O	platelet	nn	36	SENT_244	[p18l228t746r482b816],
36	aggregation	NN	O	aggregation	npadvmod	33	SENT_244	[p18l510t747r887b816],
37	after	IN	O	after	_	0	SENT_244	[p18l917t746r1077b802],
38	initiation	NN	O	initiation	prep_after	33	SENT_244	[p18l1104t747r1394b802],
39	of	IN	O	of	_	0	SENT_244	[p18l1425t746r1489b802],
40	clopidogrel	NN	O	clopidogrel	nn	41	SENT_244	[p18l1514t746r1873b816],
41	therapy	NN	O	therapy	prep_of	38	SENT_244	[p18l1903t746r2151b816],
42	with	IN	O	with	_	0	SENT_244	[p18l225t838r364b894],
43	a	DT	O	a	det	46	SENT_244	[p18l387t853r420b894],
44	high	JJ	O	high	amod	46	SENT_244	[p18l443t838r572b908],
45	loading	NN	O	loading	nn	46	SENT_244	[p18l597t838r826b908],
46	dose	NN	O	dose	prep_with	33	SENT_244	[p18l847t838r1011b894],
47	.	.	O	.	_	0	SENT_244	[p18l847t838r1011b894],

1	Blood	NNP	O	Blood	nn	3	SENT_245	[p18l1038t838r1221b894],
2	Coagul	NNP	O	Coagul	nn	3	SENT_245	[p18l1240t838r1454b908],
3	Fibrinolysis	NNP	O	Fibrinolysis	_	0	SENT_245	[p18l1474t838r1844b908],
4	2005	CD	DATE	2005	num	3	SENT_245	[p18l1862t839r2031b906],
5	;	:	O	;	_	0	SENT_245	[p18l1862t839r2031b906],
6	16	CD	NUMBER	16	num	8	SENT_245	[p18l2049t839r2145b895],
7	:	:	O	:	_	0	SENT_245	[p18l2049t839r2145b895],
8	199-204	CD	NUMBER	199-204	dep	3	SENT_245	[p18l231t929r516b983],
9	.	.	O	.	_	0	SENT_245	[p18l231t929r516b983],

1	[	RB	O	[	advmod	2	SENT_246	[p18l63t1018r180b1088],
2	16	CD	NUMBER	16	_	0	SENT_246	[p18l63t1018r180b1088],
3	]	CD	NUMBER	]	num	5	SENT_246	[p18l63t1018r180b1088],
4	Lev	NN	O	lev	nn	5	SENT_246	[p18l229t1020r336b1074],
5	E	NN	O	e	dep	2	SENT_246	[p18l358t1020r410b1086],
6	,	,	O	,	_	0	SENT_246	[p18l358t1020r410b1086],
7	Patel	NNP	ORGANIZATION	Patel	nn	8	SENT_246	[p18l440t1018r599b1074],
8	RT	NN	ORGANIZATION	rt	appos	5	SENT_246	[p18l623t1019r707b1086],
9	,	,	O	,	_	0	SENT_246	[p18l623t1019r707b1086],
10	Guthikonda	NNP	PERSON	Guthikonda	nn	11	SENT_246	[p18l734t1018r1102b1074],
11	S	NNP	O	S	appos	5	SENT_246	[p18l1124t1019r1176b1086],
12	,	,	O	,	_	0	SENT_246	[p18l1124t1019r1176b1086],
13	Lopez	NNP	PERSON	Lopez	nn	14	SENT_246	[p18l1205t1020r1390b1088],
14	D	NNP	PERSON	D	appos	5	SENT_246	[p18l1412t1019r1470b1086],
15	,	,	O	,	_	0	SENT_246	[p18l1412t1019r1470b1086],
16	Bray	NNP	LOCATION	Bray	nn	17	SENT_246	[p18l1500t1019r1638b1088],
17	PF	NNP	LOCATION	PF	appos	5	SENT_246	[p18l1660t1019r1739b1086],
18	,	,	O	,	_	0	SENT_246	[p18l1660t1019r1739b1086],
19	Kleiman	NNP	PERSON	Kleiman	nn	20	SENT_246	[p18l1769t1018r2022b1074],
20	NS	NNP	O	NS	appos	5	SENT_246	[p18l2048t1019r2143b1074],
21	.	.	O	.	_	0	SENT_246	[p18l2048t1019r2143b1074],

1	Genetic	JJ	O	genetic	amod	2	SENT_247	[p18l227t1110r476b1165],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_247	[p18l519t1109r998b1179],
3	of	IN	O	of	_	0	SENT_247	[p18l1039t1109r1103b1165],
4	the	DT	O	the	det	7	SENT_247	[p18l1141t1109r1246b1165],
5	platelet	NN	O	platelet	nn	7	SENT_247	[p18l1289t1109r1543b1179],
6	receptors	NNS	O	receptor	nn	7	SENT_247	[p18l1586t1114r1890b1179],
7	P2Y12	NN	O	p2y12	prep_of	2	SENT_247	[p18l1933t1110r2143b1177],
8	,	,	O	,	_	0	SENT_247	[p18l1933t1110r2143b1177],
9	PZY1	NN	O	pzy1	nn	12	SENT_247	[p18l229t1202r370b1256],
10	and	CC	O	and	_	0	SENT_247	[p18l414t1201r526b1257],
11	GP	NN	O	gp	nn	12	SENT_247	[p18l562t1202r647b1257],
12	Illa	NN	PERSON	illum	prep_of	2	SENT_247	[p18l685t1202r774b1257],
13	and	CC	O	and	_	0	SENT_247	[p18l809t1201r920b1257],
14	response	NN	O	response	conj_and	7	SENT_247	[p18l959t1216r1238b1271],
15	to	TO	O	to	_	0	SENT_247	[p18l1271t1206r1335b1257],
16	aspirin	NN	O	aspirin	prep_to	2	SENT_247	[p18l1369t1202r1580b1271],
17	and	CC	O	and	_	0	SENT_247	[p18l1616t1201r1728b1257],
18	clopidogrel	NN	O	clopidogrel	conj_and	16	SENT_247	[p18l1763t1201r2143b1271],
19	.	.	O	.	_	0	SENT_247	[p18l1763t1201r2143b1271],

1	Thromb	NNP	O	Thromb	nn	2	SENT_248	[p18l229t1291r475b1347],
2	Res	NNP	O	Res	_	0	SENT_248	[p18l501t1292r609b1347],
3	2007	CD	DATE	2007	num	2	SENT_248	[p18l633t1292r841b1359],
4	;	:	O	;	_	0	SENT_248	[p18l633t1292r841b1359],
5	1	CD	NUMBER	1	number	6	SENT_248	[p18l633t1292r841b1359],
6	19:355	CD	NUMBER	19:355	dep	2	SENT_248	[p18l863t1292r1220b1348],
7	—	NN	O	—	dep	6	SENT_248	[p18l863t1292r1220b1348],
8	60	CD	NUMBER	60	num	7	SENT_248	[p18l863t1292r1220b1348],
9	.	.	O	.	_	0	SENT_248	[p18l863t1292r1220b1348],

1	[	NN	O	[	nn	5	SENT_249	[p18l63t1383r180b1453],
2	17	CD	NUMBER	17	num	5	SENT_249	[p18l63t1383r180b1453],
3	]	CD	NUMBER	]	num	5	SENT_249	[p18l63t1383r180b1453],
4	Kastrati	NNP	PERSON	Kastrati	nn	5	SENT_249	[p18l229t1385r481b1439],
5	A	NNP	O	A	_	0	SENT_249	[p18l515t1384r576b1451],
6	,	,	O	,	_	0	SENT_249	[p18l515t1384r576b1451],
7	von	NNP	PERSON	von	nn	9	SENT_249	[p18l616t1398r728b1439],
8	Beckerath	NNP	PERSON	Beckerath	nn	9	SENT_249	[p18l767t1383r1094b1439],
9	N	NNP	PERSON	N	appos	5	SENT_249	[p18l1133t1385r1194b1451],
10	,	,	O	,	_	0	SENT_249	[p18l1133t1385r1194b1451],
11	Joost	NNP	PERSON	Joost	nn	12	SENT_249	[p18l1234t1385r1405b1439],
12	A	NNP	O	A	appos	5	SENT_249	[p18l1436t1384r1499b1451],
13	,	,	O	,	_	0	SENT_249	[p18l1436t1384r1499b1451],
14	Pogatsa-Murray	NNP	O	Pogatsa-Murray	nn	15	SENT_249	[p18l1542t1385r2045b1453],
15	G	NNP	O	G	appos	5	SENT_249	[p18l2078t1384r2144b1451],
16	,	,	O	,	_	0	SENT_249	[p18l2078t1384r2144b1451],
17	Gorchakova	NNP	PERSON	Gorchakova	nn	18	SENT_249	[p18l227t1474r609b1530],
18	O	NNP	PERSON	O	appos	5	SENT_249	[p18l631t1475r697b1542],
19	,	,	O	,	_	0	SENT_249	[p18l631t1475r697b1542],
20	Schomig	NNP	O	Schomig	nn	22	SENT_249	[p18l723t1474r992b1544],
21	A.	NNP	O	A.	nn	22	SENT_249	[p18l1011t1475r1072b1530],
22	Loading	NNP	O	Loading	appos	5	SENT_249	[p18l1102t1474r1352b1544],
23	with	IN	O	with	_	0	SENT_249	[p18l1371t1474r1512b1530],
24	600	CD	NUMBER	600	num	26	SENT_249	[p18l1535t1475r1648b1530],
25	mg	NN	O	mg	nn	26	SENT_249	[p18l1670t1488r1762b1544],
26	clopidogrel	NN	O	clopidogrel	prep_with	22	SENT_249	[p18l1782t1474r2150b1544],
27	in	IN	O	in	_	0	SENT_249	[p18l227t1566r281b1620],
28	patients	NNS	O	patient	prep_in	26	SENT_249	[p18l313t1566r579b1635],
29	with	IN	O	with	_	0	SENT_249	[p18l605t1565r746b1621],
30	coronary	JJ	O	coronary	amod	32	SENT_249	[p18l776t1580r1064b1635],
31	artery	NN	O	artery	nn	32	SENT_249	[p18l1091t1570r1292b1635],
32	disease	NN	O	disease	conj_and	32	SENT_249	[p18l1318t1565r1556b1621],
33	with	IN	O	with	_	0	SENT_249	[p18l1582t1565r1724b1621],
34	and	CC	O	and	_	0	SENT_249	[p18l1754t1565r1867b1621],
35	without	IN	O	without	_	0	SENT_249	[p18l1896t1565r2150b1621],
36	chronic	JJ	O	chronic	amod	38	SENT_249	[p18l226t1656r484b1712],
37	clopidogrel	NN	O	clopidogrel	nn	38	SENT_249	[p18l538t1656r934b1726],
38	therapy	NN	O	therapy	prep_without	32	SENT_249	[p18l990t1656r1275b1726],
39	.	.	O	.	_	0	SENT_249	[p18l990t1656r1275b1726],

1	Circulation	NN	O	circulation	_	0	SENT_250	[p18l1342t1656r1735b1712],
2	2004	CD	DATE	2004	num	1	SENT_250	[p18l1790t1657r2145b1724],
3	;	:	O	;	_	0	SENT_250	[p18l1790t1657r2145b1724],
4	110	CD	NUMBER	110	num	6	SENT_250	[p18l1790t1657r2145b1724],
5	:	:	O	:	_	0	SENT_250	[p18l1790t1657r2145b1724],
6	1916-9	CD	NUMBER	1916-9	dep	1	SENT_250	[p18l231t1748r483b1803],
7	.	.	O	.	_	0	SENT_250	[p18l231t1748r483b1803],

1	[	NN	O	[	_	0	SENT_251	[p18l63t1838r180b1908],
2	18	CD	NUMBER	18	num	1	SENT_251	[p18l63t1838r180b1908],
3	]	CD	NUMBER	]	num	5	SENT_251	[p18l63t1838r180b1908],
4	Gurbel	NNP	ORGANIZATION	Gurbel	nn	5	SENT_251	[p18l227t1838r441b1894],
5	PA	NN	ORGANIZATION	pa	dep	1	SENT_251	[p18l466t1838r555b1905],
6	,	,	O	,	_	0	SENT_251	[p18l466t1838r555b1905],
7	Bliden	NNP	PERSON	Bliden	nn	8	SENT_251	[p18l586t1838r781b1893],
8	KP	NNP	O	KP	appos	5	SENT_251	[p18l808t1839r890b1905],
9	,	,	O	,	_	0	SENT_251	[p18l808t1839r890b1905],
10	Hayes	NNP	ORGANIZATION	Hayes	nn	11	SENT_251	[p18l921t1839r1105b1908],
11	KM	NNP	ORGANIZATION	KM	appos	5	SENT_251	[p18l1130t1839r1238b1905],
12	,	,	O	,	_	0	SENT_251	[p18l1130t1839r1238b1905],
13	Yoho	NNP	LOCATION	Yoho	nn	14	SENT_251	[p18l1264t1838r1413b1893],
14	JA	NNP	LOCATION	JA	appos	5	SENT_251	[p18l1434t1838r1529b1905],
15	,	,	O	,	_	0	SENT_251	[p18l1434t1838r1529b1905],
16	Herzog	NNP	PERSON	Herzog	nn	17	SENT_251	[p18l1559t1839r1778b1908],
17	WR	NNP	O	WR	appos	5	SENT_251	[p18l1798t1839r1921b1905],
18	,	,	O	,	_	0	SENT_251	[p18l1798t1839r1921b1905],
19	Tantry	NNP	LOCATION	Tantry	nn	20	SENT_251	[p18l1947t1839r2152b1908],
20	US	NNP	LOCATION	US	appos	5	SENT_251	[p18l229t1929r325b1984],
21	.	.	O	.	_	0	SENT_251	[p18l229t1929r325b1984],

1	The	DT	O	the	det	2	SENT_252	[p18l351t1928r471b1984],
2	relation	NN	O	relation	_	0	SENT_252	[p18l495t1928r742b1984],
3	of	IN	O	of	_	0	SENT_252	[p18l765t1928r830b1984],
4	dosing	NN	O	dosing	prep_of	2	SENT_252	[p18l849t1928r1051b1998],
5	to	TO	O	to	_	0	SENT_252	[p18l1072t1933r1136b1984],
6	clopidogrel	NN	O	clopidogrel	nn	7	SENT_252	[p18l1157t1928r1516b1998],
7	responsiveness	NN	O	responsiveness	prep_to	4	SENT_252	[p18l1541t1929r2014b1998],
8	and	CC	O	and	_	0	SENT_252	[p18l2036t1928r2148b1984],
9	the	DT	O	the	det	10	SENT_252	[p18l227t2019r331b2075],
10	incidence	NN	O	incidence	conj_and	4	SENT_252	[p18l362t2019r671b2075],
11	of	IN	O	of	_	0	SENT_252	[p18l701t2019r766b2075],
12	high	JJ	O	high	amod	15	SENT_252	[p18l797t2019r926b2089],
13	post-treatment	JJ	O	post-treatment	amod	15	SENT_252	[p18l961t2025r1453b2089],
14	platelet	NN	O	platelet	nn	15	SENT_252	[p18l1486t2019r1739b2089],
15	aggregation	NN	O	aggregation	prep_of	10	SENT_252	[p18l1771t2021r2147b2089],
16	in	IN	O	in	_	0	SENT_252	[p18l227t2112r280b2166],
17	patients	NNS	O	patient	prep_in	15	SENT_252	[p18l308t2112r569b2181],
18	undergoing	VBG	O	undergo	partmod	2	SENT_252	[p18l595t2111r950b2181],
19	coronary	JJ	O	coronary	amod	20	SENT_252	[p18l974t2125r1256b2181],
20	stenting	NN	O	stenting	dobj	18	SENT_252	[p18l1279t2112r1559b2181],
21	.	.	O	.	_	0	SENT_252	[p18l1279t2112r1559b2181],

1	J	NNP	O	J	nn	4	SENT_253	[p18l1587t2112r1623b2166],
2	Am	NNP	O	Am	nn	4	SENT_253	[p18l1641t2111r1745b2166],
3	Coll	NNP	O	Coll	nn	4	SENT_253	[p18l1771t2111r1893b2167],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_253	[p18l1920t2111r2150b2167],
5	2005	CD	DATE	2005	num	4	SENT_253	[p18l226t2201r771b2267],
6	;	:	O	;	_	0	SENT_253	[p18l226t2201r771b2267],
7	45:1392	CD	NUMBER	45:1392	number	8	SENT_253	[p18l226t2201r771b2267],
8	—	CD	NUMBER	—	dep	4	SENT_253	[p18l226t2201r771b2267],
9	6	CD	NUMBER	6	dep	8	SENT_253	[p18l226t2201r771b2267],
10	.	.	O	.	_	0	SENT_253	[p18l226t2201r771b2267],

1	[	NN	O	[	nn	5	SENT_254	[p18l63t2291r180b2361],
2	19	CD	NUMBER	19	num	5	SENT_254	[p18l63t2291r180b2361],
3	]	CD	NUMBER	]	num	5	SENT_254	[p18l63t2291r180b2361],
4	Angiolillo	NNP	O	Angiolillo	nn	5	SENT_254	[p18l224t2291r519b2361],
5	DJ	NNP	O	DJ	_	0	SENT_254	[p18l566t2293r658b2359],
6	,	,	O	,	_	0	SENT_254	[p18l566t2293r658b2359],
7	Fernandez-Ortiz	NNP	O	Fernandez-Ortiz	nn	8	SENT_254	[p18l712t2291r1222b2347],
8	A	NNP	O	A	appos	5	SENT_254	[p18l1265t2292r1326b2359],
9	,	,	O	,	_	0	SENT_254	[p18l1265t2292r1326b2359],
10	Bernardo	NNP	PERSON	Bernardo	nn	11	SENT_254	[p18l1381t2291r1664b2347],
11	E	NNP	PERSON	E	appos	8	SENT_254	[p18l1712t2293r1765b2359],
12	,	,	O	,	_	0	SENT_254	[p18l1712t2293r1765b2359],
13	Costa	NNP	O	Costa	nn	14	SENT_254	[p18l1817t2292r1987b2347],
14	MA	NNP	O	MA	appos	8	SENT_254	[p18l2032t2292r2144b2359],
15	,	,	O	,	_	0	SENT_254	[p18l2032t2292r2144b2359],
16	Sabate	NNP	O	Sabate	nn	17	SENT_254	[p18l227t2383r440b2439],
17	M	NNP	O	M	appos	8	SENT_254	[p18l458t2384r528b2450],
18	,	,	O	,	_	0	SENT_254	[p18l458t2384r528b2450],
19	Jimenez	NNP	PERSON	Jimenez	appos	8	SENT_254	[p18l553t2383r1119b2449],
20	.	.	O	.	_	0	SENT_254	[p18l553t2383r1119b2449],

1	—	NN	O	—	_	0	SENT_255	[p18l553t2383r1119b2449],
2	.	.	O	.	_	0	SENT_255	[p18l553t2383r1119b2449],

1	Quevedo	NNP	PERSON	Quevedo	nn	2	SENT_256	[p18l553t2383r1119b2449],
2	P	NN	O	p	_	0	SENT_256	[p18l1141t2384r1181b2450],
3	,	,	O	,	_	0	SENT_256	[p18l1141t2384r1181b2450],
4	et	FW	O	et	nn	5	SENT_256	[p18l1207t2388r1272b2438],
5	al.	FW	O	al.	appos	2	SENT_256	[p18l1292t2383r1366b2438],
6	.	.	O	.	_	0	SENT_256	[p18l1292t2383r1366b2438],

1	High	JJ	O	high	amod	2	SENT_257	[p18l1395t2383r1528b2453],
2	clopidogrel	NN	O	clopidogrel	_	0	SENT_257	[p18l1551t2383r1902b2453],
3	loading	VBG	O	load	partmod	2	SENT_257	[p18l1925t2383r2151b2453],
4	dose	NN	O	dose	dobj	3	SENT_257	[p18l226t2474r369b2530],
5	during	IN	O	during	_	0	SENT_257	[p18l394t2474r592b2544],
6	coronary	JJ	O	coronary	amod	7	SENT_257	[p18l618t2489r895b2544],
7	stenting	NN	O	stenting	prep_during	3	SENT_257	[p18l919t2475r1193b2544],
8	:	:	O	:	_	0	SENT_257	[p18l919t2475r1193b2544],
9	effects	NNS	O	effect	dep	2	SENT_257	[p18l1225t2474r1445b2530],
10	on	IN	O	on	_	0	SENT_257	[p18l1470t2489r1543b2530],
11	drug	NN	O	drug	nn	12	SENT_257	[p18l1570t2474r1709b2544],
12	response	NN	O	response	prep_on	9	SENT_257	[p18l1738t2489r2011b2544],
13	and	CC	O	and	_	0	SENT_257	[p18l2038t2474r2148b2530],
14	interindividual	JJ	O	interindividual	amod	15	SENT_257	[p18l227t2564r686b2620],
15	variability	NN	O	variability	conj_and	12	SENT_257	[p18l708t2564r1038b2634],
16	.	.	O	.	_	0	SENT_257	[p18l708t2564r1038b2634],

1	Eur	NNP	O	Eur	nn	3	SENT_258	[p18l1066t2566r1175b2620],
2	Heart	NNP	O	Heart	nn	3	SENT_258	[p18l1194t2566r1374b2620],
3	J	NNP	O	J	_	0	SENT_258	[p18l1392t2566r1428b2620],
4	2004	CD	DATE	2004	num	3	SENT_258	[p18l1449t2565r2020b2632],
5	;	:	O	;	_	0	SENT_258	[p18l1449t2565r2020b2632],
6	25:1903	CD	DATE	25:1903	number	7	SENT_258	[p18l1449t2565r2020b2632],
7	-10	CD	DATE	-10	dep	3	SENT_258	[p18l1449t2565r2020b2632],
8	.	.	O	.	_	0	SENT_258	[p18l1449t2565r2020b2632],

1	Role	NN	O	role	_	0	SENT_259	[p18l98t2709r173b2741],
2	of	IN	O	of	_	0	SENT_259	[p18l189t2709r225b2741],
3	the	DT	O	the	det	5	SENT_259	[p18l240t2709r299b2741],
4	T744C	NN	O	t744c	nn	5	SENT_259	[p18l314t2709r426b2741],
5	polymorphism	NN	O	polymorphism	prep_of	1	SENT_259	[p18l444t2709r696b2749],
6	of	IN	O	of	_	0	SENT_259	[p18l713t2709r750b2741],
7	the	DT	O	the	det	9	SENT_259	[p18l765t2709r824b2741],
8	P2Y12	NN	O	p2y12	nn	9	SENT_259	[p18l841t2709r948b2740],
9	gene	NN	O	gene	prep_of	5	SENT_259	[p18l965t2717r1051b2749],
10	on	IN	O	on	_	0	SENT_259	[p18l1067t2717r1108b2741],
11	a	DT	O	a	det	13	SENT_259	[p18l1126t2718r1145b2741],
12	600-mg	JJ	O	600-mg	amod	13	SENT_259	[p18l1161t2709r1293b2749],
13	dose	NN	O	dose	prep_on	9	SENT_259	[p18l1310t2709r1391b2741],
14	of	IN	O	of	_	0	SENT_259	[p18l1407t2709r1444b2741],
15	clopidogrel	NN	O	clopidogrel	prep_of	13	SENT_259	[p18l1458t2709r1661b2749],
16	in	IN	O	in	_	0	SENT_259	[p18l1678t2710r1708b2740],
17	597	CD	NUMBER	597	num	18	SENT_259	[p18l1727t2709r1789b2741],
18	patients	NNS	O	patient	prep_in	15	SENT_259	[p18l1805t2710r1953b2749],
19	899	CD	NUMBER	899	dep	1	SENT_259	[p18l1999t2709r2061b2741],

1	[	RB	O	[	advmod	2	SENT_260	[p18l13t2907r126b2975],
2	20	CD	NUMBER	20	_	0	SENT_260	[p18l13t2907r126b2975],
3	]	CD	NUMBER	]	num	5	SENT_260	[p18l13t2907r126b2975],
4	Gurbel	NNP	ORGANIZATION	Gurbel	nn	5	SENT_260	[p18l171t2907r378b2961],
5	PA	NN	ORGANIZATION	pa	dep	2	SENT_260	[p18l406t2908r493b2973],
6	,	,	O	,	_	0	SENT_260	[p18l406t2908r493b2973],
7	Bliden	NNP	PERSON	Bliden	nn	8	SENT_260	[p18l526t2907r715b2961],
8	KP	NNP	O	KP	appos	5	SENT_260	[p18l743t2908r824b2973],
9	,	,	O	,	_	0	SENT_260	[p18l743t2908r824b2973],
10	Zaman	NNP	PERSON	Zaman	nn	11	SENT_260	[p18l855t2908r1058b2961],
11	KA	NN	O	ka	appos	5	SENT_260	[p18l1087t2908r1183b2973],
12	,	,	O	,	_	0	SENT_260	[p18l1087t2908r1183b2973],
13	Yoho	NNP	LOCATION	Yoho	nn	14	SENT_260	[p18l1212t2907r1356b2961],
14	JA	NNP	LOCATION	JA	appos	5	SENT_260	[p18l1379t2908r1471b2973],
15	,	,	O	,	_	0	SENT_260	[p18l1379t2908r1471b2973],
16	Hayes	NNP	PERSON	Hayes	nn	17	SENT_260	[p18l1504t2908r1683b2975],
17	KM	NNP	O	KM	appos	5	SENT_260	[p18l1709t2908r1814b2973],
18	,	,	O	,	_	0	SENT_260	[p18l1709t2908r1814b2973],
19	Tantry	NNP	LOCATION	Tantry	nn	20	SENT_260	[p18l1842t2908r2041b2975],
20	US	NNP	LOCATION	US	appos	5	SENT_260	[p18l173t2996r266b3049],
21	.	.	O	.	_	0	SENT_260	[p18l173t2996r266b3049],

1	Clopidogrel	NNP	O	Clopidogrel	nsubj	25	SENT_261	[p18l320t2995r676b3063],
2	loading	VBG	O	load	partmod	1	SENT_261	[p18l726t2995r949b3063],
3	with	IN	O	with	_	0	SENT_261	[p18l995t2995r1130b3049],
4	eptifibatide	NN	O	eptifibatide	prep_with	2	SENT_261	[p18l1180t2995r1551b3063],
5	to	TO	O	to	aux	6	SENT_261	[p18l1598t3000r1661b3049],
6	arrest	VB	O	arrest	xcomp	2	SENT_261	[p18l1708t3000r1891b3049],
7	the	DT	O	the	det	8	SENT_261	[p18l1938t2995r2039b3049],
8	reactivity	NN	O	reactivity	dobj	6	SENT_261	[p18l173t3086r473b3152],
9	of	IN	O	of	_	0	SENT_261	[p18l506t3084r568b3138],
10	platelets	NNS	O	platelet	prep_of	8	SENT_261	[p18l602t3084r896b3152],
11	:	:	O	:	_	0	SENT_261	[p18l602t3084r896b3152],
12	results	NNS	O	result	dep	8	SENT_261	[p18l940t3084r1144b3138],
13	of	IN	O	of	_	0	SENT_261	[p18l1178t3084r1240b3138],
14	the	DT	O	the	det	15	SENT_261	[p18l1272t3084r1373b3138],
15	Clopidogrel	NNP	O	Clopidogrel	prep_of	12	SENT_261	[p18l1408t3084r1764b3152],
16	Loading	VBG	O	load	xcomp	6	SENT_261	[p18l1801t3084r2040b3152],
17	With	IN	O	with	_	0	SENT_261	[p18l169t3174r312b3228],
18	Eptifibatide	NN	O	eptifibatide	prep_with	16	SENT_261	[p18l366t3174r736b3242],
19	to	TO	O	to	_	0	SENT_261	[p18l786t3179r848b3228],
20	Arrest	NN	O	arrest	prep_to	18	SENT_261	[p18l896t3175r1088b3228],
21	the	DT	O	the	det	22	SENT_261	[p18l1137t3174r1239b3228],
22	Reactivity	NN	O	reactivity	dobj	16	SENT_261	[p18l1292t3175r1604b3242],
23	of	IN	O	of	_	0	SENT_261	[p18l1651t3174r1714b3228],
24	Platelets	NNS	O	platelet	prep_of	22	SENT_261	[p18l1764t3174r2040b3228],
25	(	VBP	O	(	_	0	SENT_261	[p18l175t3263r393b3330],
26	CLEAR	JJ	O	clear	amod	27	SENT_261	[p18l175t3263r393b3330],
27	PLATELETS	NNS	O	platelet	nsubj	28	SENT_261	[p18l420t3263r774b3330],
28	)	VBP	O	)	ccomp	25	SENT_261	[p18l420t3263r774b3330],
29	study	NN	O	study	dobj	28	SENT_261	[p18l802t3262r979b3330],
30	.	.	O	.	_	0	SENT_261	[p18l802t3262r979b3330],

1	Circulation	NN	O	circulation	_	0	SENT_262	[p18l1013t3262r1359b3316],
2	2005	CD	DATE	2005	num	1	SENT_262	[p18l1384t3263r1955b3328],
3	;	:	O	;	_	0	SENT_262	[p18l1384t3263r1955b3328],
4	111:1153	CD	NUMBER	111:1153	number	5	SENT_262	[p18l1384t3263r1955b3328],
5	-9	CD	NUMBER	-9	dep	1	SENT_262	[p18l1384t3263r1955b3328],
6	.	.	O	.	_	0	SENT_262	[p18l1384t3263r1955b3328],

1	[	NN	O	[	_	0	SENT_263	[p18l13t3351r126b3419],
2	21	CD	NUMBER	21	num	6	SENT_263	[p18l13t3351r126b3419],
3	]	CD	NUMBER	]	num	6	SENT_263	[p18l13t3351r126b3419],
4	von	NNP	PERSON	von	nn	6	SENT_263	[p18l169t3366r276b3405],
5	Beckerath	NNP	PERSON	Beckerath	nn	6	SENT_263	[p18l307t3351r618b3405],
6	N	NNP	PERSON	N	nn	28	SENT_263	[p18l649t3353r708b3417],
7	,	,	O	,	_	0	SENT_263	[p18l649t3353r708b3417],
8	Taubert	NNP	PERSON	Taubert	nn	9	SENT_263	[p18l738t3351r978b3405],
9	D	NNP	O	D	appos	6	SENT_263	[p18l1007t3352r1064b3417],
10	,	,	O	,	_	0	SENT_263	[p18l1007t3352r1064b3417],
11	Pogatsa-Murray	NNP	O	Pogatsa-Murray	nn	12	SENT_263	[p18l1099t3352r1576b3419],
12	G	NNP	O	G	appos	6	SENT_263	[p18l1601t3352r1665b3417],
13	,	,	O	,	_	0	SENT_263	[p18l1601t3352r1665b3417],
14	Schomig	NNP	O	Schomig	nn	15	SENT_263	[p18l1698t3351r1953b3419],
15	E	NNP	O	E	appos	6	SENT_263	[p18l1982t3353r2034b3417],
16	,	,	O	,	_	0	SENT_263	[p18l1982t3353r2034b3417],
17	Kastrati	NNP	PERSON	Kastrati	nn	18	SENT_263	[p18l173t3442r411b3494],
18	A	NNP	O	A	appos	6	SENT_263	[p18l457t3441r517b3506],
19	,	,	O	,	_	0	SENT_263	[p18l457t3441r517b3506],
20	Schomig	NNP	O	Schomig	nn	22	SENT_263	[p18l569t3440r824b3508],
21	A.	NNP	O	A.	nn	22	SENT_263	[p18l867t3441r927b3494],
22	Absorption	NNP	O	Absorption	appos	6	SENT_263	[p18l976t3440r1333b3508],
23	,	,	O	,	_	0	SENT_263	[p18l976t3440r1333b3508],
24	metabolization	NN	O	metabolization	appos	6	SENT_263	[p18l1386t3440r1877b3506],
25	,	,	O	,	_	0	SENT_263	[p18l1386t3440r1877b3506],
26	and	CC	O	and	_	0	SENT_263	[p18l1929t3440r2037b3494],
27	antiplatelet	JJ	O	antiplatelet	nn	28	SENT_263	[p18l171t3529r543b3597],
28	effects	NNS	O	effect	nsubj	54	SENT_263	[p18l564t3529r781b3583],
29	of	IN	O	of	_	0	SENT_263	[p18l801t3529r864b3583],
30	300	CD	NUMBER	300	prep_of	28	SENT_263	[p18l884t3530r1036b3595],
31	-	:	O	-	_	0	SENT_263	[p18l884t3530r1036b3595],
32	,	,	O	,	_	0	SENT_263	[p18l884t3530r1036b3595],
33	600	CD	NUMBER	600	appos	28	SENT_263	[p18l1064t3530r1216b3595],
34	-	:	O	-	_	0	SENT_263	[p18l1064t3530r1216b3595],
35	,	,	O	,	_	0	SENT_263	[p18l1064t3530r1216b3595],
36	and	CC	O	and	_	0	SENT_263	[p18l1243t3529r1352b3583],
37	900-mg	JJ	O	900-mg	amod	39	SENT_263	[p18l1375t3530r1603b3597],
38	loading	NN	O	loading	nn	39	SENT_263	[p18l1627t3529r1850b3597],
39	doses	NNS	O	dose	nsubj	54	SENT_263	[p18l1871t3529r2040b3583],
40	of	IN	O	of	_	0	SENT_263	[p18l170t3618r233b3672],
41	clopidogrel	NN	O	clopidogrel	prep_of	39	SENT_263	[p18l267t3618r636b3686],
42	:	:	O	:	_	0	SENT_263	[p18l267t3618r636b3686],
43	results	NNS	O	result	dep	39	SENT_263	[p18l682t3618r887b3672],
44	of	IN	O	of	_	0	SENT_263	[p18l923t3618r986b3672],
45	the	DT	O	the	det	49	SENT_263	[p18l1021t3618r1122b3672],
46	ISAR-CHOICE	NN	O	isar-choice	nn	49	SENT_263	[p18l1163t3619r1552b3672],
47	(	NN	O	(	nn	49	SENT_263	[p18l1594t3620r2040b3686],
48	lntracoronary	JJ	O	lntracoronary	amod	49	SENT_263	[p18l1594t3620r2040b3686],
49	Stenting	NN	O	stenting	prep_of	43	SENT_263	[p18l171t3708r429b3775],
50	and	CC	O	and	_	0	SENT_263	[p18l464t3707r573b3761],
51	Antithrombotic	JJ	O	antithrombotic	amod	52	SENT_263	[p18l607t3707r1085b3761],
52	Regimen	NN	O	regimen	prep_of	43	SENT_263	[p18l1123t3708r1405b3775],
53	:	:	O	:	_	0	SENT_263	[p18l1123t3708r1405b3775],
54	Choose	VB	O	choose	rcmod	1	SENT_263	[p18l1446t3707r1666b3762],
55	Between	IN	O	between	_	0	SENT_263	[p18l1702t3709r1969b3761],
56	3	CD	NUMBER	3	prep_between	54	SENT_263	[p18l2008t3708r2037b3761],

1	High	JJ	O	high	amod	3	SENT_264	[p19l173t18r305b86],
2	Oral	JJ	O	oral	amod	3	SENT_264	[p19l347t18r475b72],
3	Doses	NNS	O	dose	nsubj	7	SENT_264	[p19l518t19r688b72],
4	for	IN	O	for	_	0	SENT_264	[p19l727t18r817b72],
5	Immediate	NNP	O	Immediate	nn	6	SENT_264	[p19l858t18r1189b72],
6	Clopidogrel	NNP	O	Clopidogrel	prep_for	3	SENT_264	[p19l1229t18r1584b86],
7	Effect	NN	O	effect	_	0	SENT_264	[p19l1628t18r1837b86],
8	)	CD	NUMBER	)	num	9	SENT_264	[p19l1628t18r1837b86],
9	Trial	NN	O	trial	dobj	7	SENT_264	[p19l1877t18r2033b72],
10	.	.	O	.	_	0	SENT_264	[p19l1877t18r2033b72],

1	Circulation	NN	O	circulation	_	0	SENT_265	[p19l173t106r519b160],
2	2005	CD	DATE	2005	num	1	SENT_265	[p19l542t107r744b172],
3	;	:	O	;	_	0	SENT_265	[p19l542t107r744b172],
4	1	CD	NUMBER	1	number	5	SENT_265	[p19l542t107r744b172],
5	12:2946	CD	NUMBER	12:2946	dep	1	SENT_265	[p19l766t107r1150b161],
6	—	NN	O	—	dep	5	SENT_265	[p19l766t107r1150b161],
7	50	CD	NUMBER	50	num	6	SENT_265	[p19l766t107r1150b161],
8	.	.	O	.	_	0	SENT_265	[p19l766t107r1150b161],

1	[	NN	O	[	nn	5	SENT_266	[p19l13t195r126b263],
2	22	CD	NUMBER	22	num	5	SENT_266	[p19l13t195r126b263],
3	]	CD	NUMBER	]	num	5	SENT_266	[p19l13t195r126b263],
4	Patti	NNP	PERSON	Patti	nn	5	SENT_266	[p19l173t197r314b249],
5	G	NNP	PERSON	G	_	0	SENT_266	[p19l356t196r419b261],
6	,	,	O	,	_	0	SENT_266	[p19l356t196r419b261],
7	Colonna	NNP	PERSON	Colonna	nn	8	SENT_266	[p19l464t195r712b250],
8	G	NNP	PERSON	G	appos	5	SENT_266	[p19l751t196r815b261],
9	,	,	O	,	_	0	SENT_266	[p19l751t196r815b261],
10	Pasceri	NNP	O	Pasceri	nn	11	SENT_266	[p19l862t197r1076b249],
11	V	NNP	O	V	appos	5	SENT_266	[p19l1114t197r1164b261],
12	,	,	O	,	_	0	SENT_266	[p19l1114t197r1164b261],
13	Pepe	NNP	PERSON	Pepe	nn	14	SENT_266	[p19l1211t197r1357b263],
14	LL	NNP	PERSON	LL	appos	5	SENT_266	[p19l1398t197r1483b261],
15	,	,	O	,	_	0	SENT_266	[p19l1398t197r1483b261],
16	Montinaro	NNP	O	Montinaro	nn	17	SENT_266	[p19l1525t197r1840b249],
17	A	NNP	O	A	appos	5	SENT_266	[p19l1876t196r1936b261],
18	,	,	O	,	_	0	SENT_266	[p19l1876t196r1936b261],
19	Di	NNP	PERSON	Di	nn	23	SENT_266	[p19l1983t197r2037b249],
20	Sciascio	NNP	PERSON	Sciascio	nn	23	SENT_266	[p19l171t285r415b339],
21	G.	NNP	O	G.	nn	23	SENT_266	[p19l465t285r528b339],
22	Randomized	NNP	O	Randomized	nn	23	SENT_266	[p19l586t285r962b339],
23	Trial	NNP	O	Trial	appos	5	SENT_266	[p19l1012t285r1149b339],
24	of	IN	O	of	_	0	SENT_266	[p19l1199t285r1262b339],
25	High	NNP	O	High	nn	27	SENT_266	[p19l1311t285r1443b353],
26	Loading	NNP	O	Loading	nn	27	SENT_266	[p19l1498t285r1736b353],
27	Dose	NN	O	dose	prep_of	23	SENT_266	[p19l1788t286r1930b339],
28	of	IN	O	of	_	0	SENT_266	[p19l1979t285r2042b339],
29	Clopidogrel	NNP	O	Clopidogrel	prep_of	5	SENT_266	[p19l171t373r529b441],
30	for	IN	O	for	_	0	SENT_266	[p19l579t373r668b427],
31	Reduction	NNP	O	Reduction	prep_for	29	SENT_266	[p19l719t373r1027b427],
32	of	IN	O	of	_	0	SENT_266	[p19l1079t373r1141b427],
33	Periprocedural	NNP	O	Periprocedural	nn	35	SENT_266	[p19l1191t373r1651b441],
34	Myocardial	JJ	O	myocardial	amod	35	SENT_266	[p19l1700t373r2039b441],
35	Infarction	NN	O	infarction	prep_of	31	SENT_266	[p19l175t462r473b516],
36	in	IN	O	in	_	0	SENT_266	[p19l518t464r570b516],
37	Patients	NNS	O	patient	prep_in	35	SENT_266	[p19l617t464r866b516],
38	Undergoing	VBG	O	undergo	partmod	5	SENT_266	[p19l911t462r1263b530],
39	Coronary	JJ	O	coronary	amod	40	SENT_266	[p19l1306t463r1587b530],
40	Intervention	NN	O	intervention	dobj	38	SENT_266	[p19l1631t464r2033b516],
41	.	.	O	.	_	0	SENT_266	[p19l1631t464r2033b516],

1	Results	NNS	O	result	_	0	SENT_267	[p19l174t552r394b606],
2	From	IN	O	from	_	0	SENT_267	[p19l448t553r603b606],
3	the	DT	O	the	det	5	SENT_267	[p19l656t552r760b606],
4	ARMYDA	NNP	O	ARMYDA	nn	5	SENT_267	[p19l809t552r1134b606],
5	—	NN	O	—	prep_from	1	SENT_267	[p19l809t552r1134b606],
6	2	CD	NUMBER	2	number	7	SENT_267	[p19l809t552r1134b606],
7	(	CD	NUMBER	(	num	9	SENT_267	[p19l1191t552r1601b620],
8	Antiplatelet	JJ	O	antiplatelet	amod	9	SENT_267	[p19l1191t552r1601b620],
9	therapy	NN	O	therapy	dep	1	SENT_267	[p19l1652t552r1900b620],
10	for	IN	O	for	_	0	SENT_267	[p19l1949t552r2041b606],
11	Reduction	NN	O	reduction	prep_for	9	SENT_267	[p19l174t641r495b695],
12	of	IN	O	of	_	0	SENT_267	[p19l550t641r615b695],
13	MYocardial	JJ	O	myocardial	amod	14	SENT_267	[p19l663t641r1015b695],
14	Damage	NN	O	damage	prep_of	11	SENT_267	[p19l1070t642r1324b709],
15	during	IN	O	during	_	0	SENT_267	[p19l1377t641r1581b709],
16	Angioplasty	NNP	O	Angioplasty	prep_during	14	SENT_267	[p19l1632t641r2037b709],
17	)	CD	NUMBER	)	num	16	SENT_267	[p19l1632t641r2037b709],
18	Study	NNP	O	Study	dep	9	SENT_267	[p19l171t728r354b796],
19	.	.	O	.	_	0	SENT_267	[p19l171t728r354b796],

1	Circulation	NN	O	circulation	_	0	SENT_268	[p19l388t728r734b783],
2	2005	CD	DATE	2005	num	1	SENT_268	[p19l759t729r962b794],
3	;	:	O	;	_	0	SENT_268	[p19l759t729r962b794],
4	1	CD	NUMBER	1	number	5	SENT_268	[p19l759t729r962b794],
5	1	CD	NUMBER	1	dep	1	SENT_268	[p19l983t730r1003b782],
6	1	CD	NUMBER	1	num	7	SENT_268	[p19l1025t730r1045b782],
7	(	NN	O	(	dep	5	SENT_268	[p19l1063t729r1539b797],
8	16	CD	NUMBER	16	number	9	SENT_268	[p19l1063t729r1539b797],
9	)	CD	NUMBER	)	dep	5	SENT_268	[p19l1063t729r1539b797],
10	:2099	CD	NUMBER	:2099	num	11	SENT_268	[p19l1063t729r1539b797],
11	-106	CD	NUMBER	-106	dep	9	SENT_268	[p19l1063t729r1539b797],
12	.	.	O	.	_	0	SENT_268	[p19l1063t729r1539b797],

1	[	NN	O	[	_	0	SENT_269	[p19l13t817r126b885],
2	23	CD	NUMBER	23	num	1	SENT_269	[p19l13t817r126b885],
3	]	CD	NUMBER	]	num	4	SENT_269	[p19l13t817r126b885],
4	CuissetT	NN	O	cuissett	dep	1	SENT_269	[p19l171t818r448b883],
5	,	,	O	,	_	0	SENT_269	[p19l171t818r448b883],
6	Frere	NNP	PERSON	Frere	nn	7	SENT_269	[p19l473t819r634b871],
7	C	NNP	O	C	appos	4	SENT_269	[p19l650t818r708b883],
8	,	,	O	,	_	0	SENT_269	[p19l650t818r708b883],
9	Quilici	NNP	PERSON	Quilici	nn	10	SENT_269	[p19l730t817r921b881],
10	J	NNP	PERSON	J	appos	4	SENT_269	[p19l939t819r989b883],
11	,	,	O	,	_	0	SENT_269	[p19l939t819r989b883],
12	Morange	NNP	ORGANIZATION	Morange	nn	13	SENT_269	[p19l1009t819r1269b885],
13	PE	NNP	ORGANIZATION	PE	appos	4	SENT_269	[p19l1287t819r1377b883],
14	,	,	O	,	_	0	SENT_269	[p19l1287t819r1377b883],
15	Nait-Saidi	NNP	PERSON	Nait-Saidi	nn	16	SENT_269	[p19l1402t817r1693b872],
16	L	NNP	PERSON	L	appos	4	SENT_269	[p19l1715t819r1763b883],
17	,	,	O	,	_	0	SENT_269	[p19l1715t819r1763b883],
18	Carvajal	NNP	PERSON	Carvajal	nn	19	SENT_269	[p19l1786t817r2039b885],
19	J	NNP	PERSON	J	appos	4	SENT_269	[p19l170t908r220b972],
20	,	,	O	,	_	0	SENT_269	[p19l170t908r220b972],
21	et	FW	O	et	nn	22	SENT_269	[p19l253t912r316b961],
22	al.	FW	O	al.	appos	4	SENT_269	[p19l343t907r415b961],
23	.	.	O	.	_	0	SENT_269	[p19l343t907r415b961],

1	Benefit	NNP	O	Benefit	_	0	SENT_270	[p19l452t907r672b961],
2	of	IN	O	of	_	0	SENT_270	[p19l698t907r761b961],
3	a	DT	O	a	det	7	SENT_270	[p19l786t921r819b961],
4	600	CD	NUMBER	600	num	7	SENT_270	[p19l847t907r953b961],
5	mg	NN	O	mg	nn	7	SENT_270	[p19l982t920r1070b975],
6	loading	NN	O	loading	nn	7	SENT_270	[p19l1100t907r1319b975],
7	dose	NN	O	dose	prep_of	1	SENT_270	[p19l1346t907r1485b961],
8	of	IN	O	of	_	0	SENT_270	[p19l1512t907r1575b961],
9	clopidogrel	NN	O	clopidogrel	prep_of	1	SENT_270	[p19l1599t907r1939b975],
10	on	IN	O	on	_	0	SENT_270	[p19l1967t921r2038b961],
11	platelet	NN	O	platelet	nn	12	SENT_270	[p19l227t1291r476b1361],
12	reactivity	NN	O	reactivity	prep_on	9	SENT_270	[p19l496t1292r798b1361],
13	and	CC	O	and	_	0	SENT_270	[p19l814t1291r925b1347],
14	clinical	JJ	O	clinical	amod	15	SENT_270	[p19l945t1291r1170b1347],
15	outcomes	NNS	O	outcome	conj_and	9	SENT_270	[p19l1187t1296r1491b1347],
16	in	IN	O	in	_	0	SENT_270	[p19l1509t1292r1562b1346],
17	patients	NNS	O	patient	prep_in	15	SENT_270	[p19l1584t1292r1839b1361],
18	with	IN	O	with	_	0	SENT_270	[p19l1855t1291r1993b1347],
19	nonST	JJ	O	nonst	amod	20	SENT_270	[p19l2014t1306r2148b1347, p19l225t1382r300b1437],
20	elevation	NN	O	elevation	prep_with	17	SENT_270	[p19l317t1381r609b1437],
21	Acute	JJ	O	acute	amod	23	SENT_270	[p19l638t1382r821b1437],
22	Coronary	JJ	O	coronary	amod	23	SENT_270	[p19l848t1382r1133b1451],
23	Syndrome	NN	O	syndrome	dep	15	SENT_270	[p19l1160t1381r1469b1451],
24	undergoing	VBG	O	undergo	partmod	1	SENT_270	[p19l1500t1381r1848b1451],
25	coronary	JJ	O	coronary	amod	26	SENT_270	[p19l1876t1396r2154b1451],
26	stenting	NN	O	stenting	dobj	24	SENT_270	[p19l225t1474r500b1542],
27	.	.	O	.	_	0	SENT_270	[p19l225t1474r500b1542],

1	J	NNP	O	J	nn	4	SENT_271	[p19l525t1474r561b1528],
2	Am	NNP	O	Am	nn	4	SENT_271	[p19l578t1473r682b1528],
3	Coll	NNP	O	Coll	nn	4	SENT_271	[p19l707t1472r827b1528],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_271	[p19l853t1472r1079b1528],
5	2006	CD	DATE	2006	num	4	SENT_271	[p19l1101t1473r1673b1540],
6	;	:	O	;	_	0	SENT_271	[p19l1101t1473r1673b1540],
7	48:1339	CD	NUMBER	48:1339	number	8	SENT_271	[p19l1101t1473r1673b1540],
8	-45	CD	NUMBER	-45	dep	4	SENT_271	[p19l1101t1473r1673b1540],
9	.	.	O	.	_	0	SENT_271	[p19l1101t1473r1673b1540],

1	[	NN	O	[	nn	5	SENT_272	[p19l62t1564r179b1634],
2	24	CD	NUMBER	24	num	5	SENT_272	[p19l62t1564r179b1634],
3	]	CD	NUMBER	]	num	5	SENT_272	[p19l62t1564r179b1634],
4	Kastrati	NNP	PERSON	Kastrati	nn	5	SENT_272	[p19l228t1565r468b1620],
5	A	NNP	O	A	_	0	SENT_272	[p19l509t1565r570b1632],
6	,	,	O	,	_	0	SENT_272	[p19l509t1565r570b1632],
7	Mehilli	NNP	PERSON	Mehilli	nn	8	SENT_272	[p19l614t1564r821b1620],
8	J	NNP	PERSON	J	appos	5	SENT_272	[p19l863t1565r915b1632],
9	,	,	O	,	_	0	SENT_272	[p19l863t1565r915b1632],
10	Neumann	NNP	PERSON	Neumann	nn	11	SENT_272	[p19l963t1565r1254b1620],
11	FJ	NNP	O	FJ	appos	8	SENT_272	[p19l1300t1565r1385b1632],
12	,	,	O	,	_	0	SENT_272	[p19l1300t1565r1385b1632],
13	Dotzer	NNP	O	Dotzer	nn	14	SENT_272	[p19l1434t1565r1641b1620],
14	F	NN	O	f	appos	8	SENT_272	[p19l1682t1566r1720b1632],
15	,	,	O	,	_	0	SENT_272	[p19l1682t1566r1720b1632],
16	Ten	CD	PERSON	ten	num	18	SENT_272	[p19l1765t1566r1872b1620],
17	Berg	NN	PERSON	berg	nn	18	SENT_272	[p19l1918t1565r2055b1634],
18	J	NN	O	j	appos	8	SENT_272	[p19l2095t1566r2146b1632],
19	,	,	O	,	_	0	SENT_272	[p19l2095t1566r2146b1632],
20	Bollwein	NN	O	bollwein	nn	21	SENT_272	[p19l228t1654r491b1710],
21	H	NN	O	h	appos	8	SENT_272	[p19l520t1656r581b1722],
22	,	,	O	,	_	0	SENT_272	[p19l520t1656r581b1722],
23	et	FW	O	et	nn	24	SENT_272	[p19l611t1659r676b1710],
24	al.	FW	O	al.	appos	8	SENT_272	[p19l699t1654r773b1710],
25	.	.	O	.	_	0	SENT_272	[p19l699t1654r773b1710],

1	Abciximab	NNP	O	Abciximab	_	0	SENT_273	[p19l802t1654r1131b1710],
2	in	IN	O	in	_	0	SENT_273	[p19l1154t1655r1209b1709],
3	patients	NNS	O	patient	prep_in	1	SENT_273	[p19l1236t1655r1492b1724],
4	with	IN	O	with	_	0	SENT_273	[p19l1513t1654r1651b1710],
5	acute	JJ	O	acute	amod	7	SENT_273	[p19l1677t1660r1853b1710],
6	coronary	JJ	O	coronary	amod	7	SENT_273	[p19l1876t1669r2154b1724],
7	syndromes	NNS	O	syndrome	prep_with	3	SENT_273	[p19l225t1746r558b1816],
8	undergoing	VBG	O	undergo	partmod	7	SENT_273	[p19l597t1746r946b1816],
9	percutaneous	JJ	O	percutaneous	amod	11	SENT_273	[p19l986t1752r1412b1816],
10	coronary	JJ	O	coronary	amod	11	SENT_273	[p19l1448t1761r1725b1816],
11	intervention	NN	O	intervention	dobj	8	SENT_273	[p19l1763t1747r2150b1802],
12	after	IN	O	after	_	0	SENT_273	[p19l225t1836r382b1892],
13	clopidogrel	NN	O	clopidogrel	nn	14	SENT_273	[p19l413t1836r764b1906],
14	pretreatment	NN	O	pretreatment	prep_after	8	SENT_273	[p19l799t1842r1248b1906],
15	:	:	O	:	_	0	SENT_273	[p19l799t1842r1248b1906],
16	the	DT	O	the	det	17	SENT_273	[p19l1286t1836r1389b1892],
17	ISAR-REACT	NN	O	isar-react	dep	1	SENT_273	[p19l1426t1837r1789b1892],
18	2	CD	NUMBER	2	dep	17	SENT_273	[p19l1820t1837r1854b1892],
19	randomized	VBN	O	randomize	partmod	1	SENT_273	[p19l1890t1836r2149b1892, p19l225t1927r352b1983],
20	trial	NN	O	trial	dobj	19	SENT_273	[p19l377t1927r528b1983],
21	.	.	O	.	_	0	SENT_273	[p19l377t1927r528b1983],

1	JAMA	NNP	O	JAMA	_	0	SENT_274	[p19l553t1928r729b1983],
2	2006	CD	DATE	2006	num	1	SENT_274	[p19l752t1928r1329b1995],
3	;	:	O	;	_	0	SENT_274	[p19l752t1928r1329b1995],
4	295:1531	CD	NUMBER	295:1531	number	5	SENT_274	[p19l752t1928r1329b1995],
5	-8	CD	NUMBER	-8	dep	1	SENT_274	[p19l752t1928r1329b1995],
6	.	.	O	.	_	0	SENT_274	[p19l752t1928r1329b1995],

1	[	NN	O	[	_	0	SENT_275	[p19l62t2019r179b2089],
2	25	CD	NUMBER	25	num	1	SENT_275	[p19l62t2019r179b2089],
3	]	CD	NUMBER	]	num	5	SENT_275	[p19l62t2019r179b2089],
4	Jernberg	NN	O	jernberg	nn	5	SENT_275	[p19l224t2019r509b2089],
5	T	NN	O	t	dep	1	SENT_275	[p19l542t2021r591b2087],
6	,	,	O	,	_	0	SENT_275	[p19l542t2021r591b2087],
7	Payne	NNP	PERSON	Payne	nn	8	SENT_275	[p19l635t2020r820b2089],
8	CD	NNP	O	CD	appos	5	SENT_275	[p19l855t2020r959b2087],
9	,	,	O	,	_	0	SENT_275	[p19l855t2020r959b2087],
10	Winters	NNP	ORGANIZATION	Winters	nn	11	SENT_275	[p19l998t2020r1244b2075],
11	KJ	NNP	ORGANIZATION	KJ	appos	5	SENT_275	[p19l1282t2021r1373b2087],
12	,	,	O	,	_	0	SENT_275	[p19l1282t2021r1373b2087],
13	Darstein	NN	PERSON	darstein	nn	14	SENT_275	[p19l1416t2020r1677b2075],
14	C	NN	PERSON	c	appos	5	SENT_275	[p19l1714t2020r1774b2087],
15	,	,	O	,	_	0	SENT_275	[p19l1714t2020r1774b2087],
16	Brandt	NNP	PERSON	Brandt	nn	17	SENT_275	[p19l1818t2019r2029b2075],
17	JT	NNP	O	JT	appos	5	SENT_275	[p19l2063t2021r2145b2087],
18	,	,	O	,	_	0	SENT_275	[p19l2063t2021r2145b2087],
19	Jakubowski	NNP	PERSON	Jakubowski	nn	20	SENT_275	[p19l224t2110r588b2166],
20	A	NNP	O	A	appos	5	SENT_275	[p19l610t2111r672b2178],
21	,	,	O	,	_	0	SENT_275	[p19l610t2111r672b2178],
22	et	FW	O	et	nn	23	SENT_275	[p19l699t2116r764b2166],
23	al.	FW	O	al.	appos	5	SENT_275	[p19l786t2110r862b2166],
24	.	.	O	.	_	0	SENT_275	[p19l786t2110r862b2166],

1	Prasugrel	NNP	O	Prasugrel	nsubj	2	SENT_276	[p19l892t2110r1184b2180],
2	achieves	VBZ	O	achieve	_	0	SENT_276	[p19l1206t2110r1482b2166],
3	greater	JJR	O	greater	amod	4	SENT_276	[p19l1504t2116r1742b2180],
4	inhibition	NN	O	inhibition	dobj	2	SENT_276	[p19l1761t2110r2066b2166],
5	of	IN	O	of	_	0	SENT_276	[p19l2090t2110r2154b2166],
6	platelet	NN	O	platelet	nn	7	SENT_276	[p19l227t2202r481b2272],
7	aggregation	NN	O	aggregation	prep_of	4	SENT_276	[p19l520t2203r897b2272],
8	and	CC	O	and	_	0	SENT_276	[p19l939t2202r1051b2258],
9	a	DT	O	a	det	11	SENT_276	[p19l1093t2217r1126b2258],
10	lower	JJR	O	lower	amod	11	SENT_276	[p19l1169t2202r1347b2258],
11	rate	NN	O	rate	conj_and	4	SENT_276	[p19l1386t2207r1515b2258],
12	of	IN	O	of	_	0	SENT_276	[p19l1554t2202r1619b2258],
13	non-responders	NNS	O	non-responder	prep_of	11	SENT_276	[p19l1657t2202r2151b2272],
14	compared	VBN	O	compare	_	0	SENT_276	[p19l224t2292r549b2362],
15	with	IN	O	with	prepc_compared_with	2	SENT_276	[p19l602t2292r744b2348],
16	clopidogrel	NN	O	clopidogrel	pobj	2	SENT_276	[p19l798t2292r1168b2362],
17	in	IN	O	in	_	0	SENT_276	[p19l1221t2293r1276b2347],
18	aspirin-treated	JJ	O	aspirin-treated	amod	19	SENT_276	[p19l1331t2292r1827b2362],
19	patients	NNS	O	patient	prep_in	16	SENT_276	[p19l1884t2293r2152b2362],
20	with	IN	O	with	_	0	SENT_276	[p19l223t2383r362b2439],
21	stable	JJ	O	stable	amod	24	SENT_276	[p19l396t2383r590b2439],
22	coronary	JJ	O	coronary	amod	24	SENT_276	[p19l622t2398r904b2453],
23	artery	NN	O	artery	nn	24	SENT_276	[p19l934t2389r1131b2453],
24	disease	NN	O	disease	prep_with	19	SENT_276	[p19l1161t2383r1415b2439],
25	.	.	O	.	_	0	SENT_276	[p19l1161t2383r1415b2439],

1	Eur	NNP	O	Eur	nn	3	SENT_277	[p19l1451t2385r1562b2439],
2	Heart	NNP	O	Heart	nn	3	SENT_277	[p19l1589t2385r1772b2439],
3	J	NNP	O	J	_	0	SENT_277	[p19l1798t2385r1834b2439],
4	2006	CD	DATE	2006	num	3	SENT_277	[p19l1862t2384r2146b2451],
5	;	:	O	;	_	0	SENT_277	[p19l1862t2384r2146b2451],
6	27	CD	NUMBER	27	num	8	SENT_277	[p19l1862t2384r2146b2451],
7	:	:	O	:	_	0	SENT_277	[p19l1862t2384r2146b2451],
8	1166-73	CD	NUMBER	1166-73	dep	3	SENT_277	[p19l230t2474r515b2529],
9	.	.	O	.	_	0	SENT_277	[p19l230t2474r515b2529],

1	[	NN	O	[	nn	5	SENT_278	[p19l62t2564r179b2634],
2	26	CD	NUMBER	26	num	5	SENT_278	[p19l62t2564r179b2634],
3	]	CD	NUMBER	]	num	5	SENT_278	[p19l62t2564r179b2634],
4	Hollopeter	NNP	PERSON	Hollopeter	nn	5	SENT_278	[p19l228t2564r569b2634],
5	G	NNP	PERSON	G	_	0	SENT_278	[p19l611t2565r676b2632],
6	,	,	O	,	_	0	SENT_278	[p19l611t2565r676b2632],
7	Jantzen	NNP	ORGANIZATION	Jantzen	nn	8	SENT_278	[p19l725t2566r975b2620],
8	HM	NNS	ORGANIZATION	hm	appos	5	SENT_278	[p19l1024t2566r1138b2632],
9	,	,	O	,	_	0	SENT_278	[p19l1024t2566r1138b2632],
10	Vincent	NNP	PERSON	Vincent	nn	11	SENT_278	[p19l1185t2565r1430b2620],
11	D	NNP	PERSON	D	appos	8	SENT_278	[p19l1477t2565r1535b2632],
12	,	,	O	,	_	0	SENT_278	[p19l1477t2565r1535b2632],
13	Li	NNP	PERSON	Li	nn	14	SENT_278	[p19l1587t2565r1636b2619],
14	G	NNP	PERSON	G	appos	8	SENT_278	[p19l1682t2565r1747b2632],
15	,	,	O	,	_	0	SENT_278	[p19l1682t2565r1747b2632],
16	England	NNP	LOCATION	England	nn	17	SENT_278	[p19l1799t2564r2046b2634],
17	L	NNP	O	L	appos	8	SENT_278	[p19l2095t2566r2145b2632],
18	,	,	O	,	_	0	SENT_278	[p19l2095t2566r2145b2632],
19	Ramakrishnan	NNP	PERSON	Ramakrishnan	nn	20	SENT_278	[p19l228t2655r670b2711],
20	V	NNP	O	V	appos	8	SENT_278	[p19l708t2657r759b2723],
21	,	,	O	,	_	0	SENT_278	[p19l708t2657r759b2723],
22	et	FW	O	et	nn	23	SENT_278	[p19l801t2661r866b2711],
23	al.	FW	O	al.	appos	8	SENT_278	[p19l903t2655r979b2711],
24	.	.	O	.	_	0	SENT_278	[p19l903t2655r979b2711],

1	Identification	NN	O	identification	nsubj	7	SENT_279	[p19l1026t2655r1456b2711],
2	of	IN	O	of	_	0	SENT_279	[p19l1495t2655r1560b2711],
3	the	DT	O	the	det	6	SENT_279	[p19l1594t2655r1699b2711],
4	platelet	NN	O	platelet	nn	6	SENT_279	[p19l1738t2655r1991b2725],
5	ADP	NN	O	adp	nn	6	SENT_279	[p19l2025t2656r2151b2711],
6	receptor	NN	O	receptor	prep_of	1	SENT_279	[p19l228t2752r524b2817],
7	targeted	VBN	O	target	_	0	SENT_279	[p19l579t2747r874b2817],
8	by	IN	O	by	_	0	SENT_279	[p19l935t2747r1010b2817],
9	antithrombotic	JJ	O	antithrombotic	amod	10	SENT_279	[p19l1064t2747r1589b2802],
10	drugs	NNS	O	drug	prep_by	7	SENT_279	[p19l1645t2747r1851b2817],
11	.	.	O	.	_	0	SENT_279	[p19l1645t2747r1851b2817],

1	Nature	NNP	O	Nature	_	0	SENT_280	[p19l1916t2748r2153b2802],
2	2001	CD	DATE	2001	num	1	SENT_280	[p19l224t2838r363b2894],
3	;	:	O	;	_	0	SENT_280	[p19l382t2838r774b2905],
4	409:202	CD	NUMBER	409:202	num	5	SENT_280	[p19l382t2838r774b2905],
5	—	NN	O	—	dep	1	SENT_280	[p19l382t2838r774b2905],
6	7	CD	NUMBER	7	dep	5	SENT_280	[p19l382t2838r774b2905],
7	.	.	O	.	_	0	SENT_280	[p19l382t2838r774b2905],

1	[	NN	O	[	nn	5	SENT_281	[p19l62t2929r179b2999],
2	27	CD	NUMBER	27	num	5	SENT_281	[p19l62t2929r179b2999],
3	]	CD	NUMBER	]	num	5	SENT_281	[p19l62t2929r179b2999],
4	Samara	NNP	ORGANIZATION	Samara	nn	5	SENT_281	[p19l225t2930r459b2985],
5	WM	NNP	ORGANIZATION	WM	_	0	SENT_281	[p19l479t2931r611b2997],
6	,	,	O	,	_	0	SENT_281	[p19l479t2931r611b2997],
7	Bliden	NNP	PERSON	Bliden	nn	8	SENT_281	[p19l642t2929r836b2985],
8	KP	NNP	O	KP	appos	5	SENT_281	[p19l863t2931r946b2997],
9	,	,	O	,	_	0	SENT_281	[p19l863t2931r946b2997],
10	Tantry	NNP	LOCATION	Tantry	nn	11	SENT_281	[p19l971t2931r1176b2999],
11	US	NNP	LOCATION	US	appos	5	SENT_281	[p19l1198t2930r1294b2997],
12	,	,	O	,	_	0	SENT_281	[p19l1198t2930r1294b2997],
13	Gurbel	NNP	LOCATION	Gurbel	nn	14	SENT_281	[p19l1322t2929r1536b2985],
14	PA.	NNP	LOCATION	PA.	appos	5	SENT_281	[p19l1561t2930r1650b2985],
15	.	.	O	.	_	0	SENT_281	[p19l1561t2930r1650b2985],

1	The	DT	O	the	det	2	SENT_282	[p19l1676t2929r1796b2985],
2	difference	NN	O	difference	_	0	SENT_282	[p19l1817t2929r2151b2985],
3	between	IN	O	between	_	0	SENT_282	[p19l227t3020r502b3076],
4	clopidogrel	NN	O	clopidogrel	nn	5	SENT_282	[p19l554t3020r914b3090],
5	responsiveness	NN	O	responsiveness	prep_between	2	SENT_282	[p19l968t3022r1441b3090],
6	and	CC	O	and	_	0	SENT_282	[p19l1492t3020r1603b3076],
7	post-treatment	JJ	O	post-treatment	amod	9	SENT_282	[p19l1658t3026r2151b3090],
8	platelet	NN	O	platelet	nn	9	SENT_282	[p19l227t3112r481b3182],
9	reactivity	NN	O	reactivity	prep_between	2	SENT_282	[p19l510t3113r829b3182],
10	.	.	O	.	_	0	SENT_282	[p19l510t3113r829b3182],

1	Thromb	NNP	O	Thromb	nn	2	SENT_283	[p19l865t3112r1111b3167],
2	Res	NNP	O	Res	_	0	SENT_283	[p19l1137t3113r1245b3167],
3	2005	CD	DATE	2005	num	2	SENT_283	[p19l1269t3112r1819b3179],
4	;	:	O	;	_	0	SENT_283	[p19l1269t3112r1819b3179],
5	115:89	CD	NUMBER	115:89	number	6	SENT_283	[p19l1269t3112r1819b3179],
6	-94	CD	NUMBER	-94	dep	2	SENT_283	[p19l1269t3112r1819b3179],
7	.	.	O	.	_	0	SENT_283	[p19l1269t3112r1819b3179],

